Sentence,class,file
"I am also thankful to Mr. Justin MakiiBadrul Hasan and Josef D. Ja ¨rhult 2 (page number not for citation purpose)Citation: Infection Ecology and Epidemiology 2015, 5: 29761 - http://dx.doi.org/10.3402/iee.v5.29761",Non-OADS,/arxiv_data1/oa_pdf/84/49/IEE-5-29761.PMC4683987.pdf
"Clin Microbiol Infect 2015; 21:1000.e1 /C14.Epidemiology of VRE carriage in crows, Bangladesh Citation: Infection Ecology and Epidemiology 2015, 5: 29761 - http://dx.doi.org/10.3402/iee.v5.29761 3 (page number not for citation purpose)",Non-OADS,/arxiv_data1/oa_pdf/84/49/IEE-5-29761.PMC4683987.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/), permitting all non-commer cial use, distribution, and reproduction in any medium, provided the original work is properly cited.1 Citation: Microbial Ecology in Health & Disease 2015, 26: 28853 - http://dx.doi.org/10.3402/mehd.v26.28853 (page number not for citation purpose)",Non-OADS,/arxiv_data1/oa_pdf/a9/c0/MEHD-26-28853.PMC4683989.pdf
"2 (page number not for citation purpose)Citation: Microbial Ecology in Health & Disease 2015, 26: 28853 - http://dx.doi.org/10.3402/mehd.v26.28853",Non-OADS,/arxiv_data1/oa_pdf/a9/c0/MEHD-26-28853.PMC4683989.pdf
"pilosicoli -induced avian intestinal spirochaetosis Citation: Microbial Ecology in Health & Disease 2015, 26: 28853 - http://dx.doi.org/10.3402/mehd.v26.28853 3 (page number not for citation purpose)",Non-OADS,/arxiv_data1/oa_pdf/a9/c0/MEHD-26-28853.PMC4683989.pdf
"4 (page number not for citation purpose)Citation: Microbial Ecology in Health & Disease 2015, 26: 28853 - http://dx.doi.org/10.3402/mehd.v26.28853",Non-OADS,/arxiv_data1/oa_pdf/a9/c0/MEHD-26-28853.PMC4683989.pdf
"pilosicoli -induced avian intestinal spirochaetosis Citation: Microbial Ecology in Health & Disease 2015, 26: 28853 - http://dx.doi.org/10.3402/mehd.v26.28853 5 (page number not for citation purpose)",Non-OADS,/arxiv_data1/oa_pdf/a9/c0/MEHD-26-28853.PMC4683989.pdf
"6 (page number not for citation purpose)Citation: Microbial Ecology in Health & Disease 2015, 26: 28853 - http://dx.doi.org/10.3402/mehd.v26.28853",Non-OADS,/arxiv_data1/oa_pdf/a9/c0/MEHD-26-28853.PMC4683989.pdf
"Glob Supply Chain Stand Poor Global Supply Chains, Standards and the Poor, 8 gr.Available from: http://www.ers.usda.gov/data-products/food-price-outlook.aspx [cited 19 February 2015].",Non-OADS,/arxiv_data1/oa_pdf/a9/c0/MEHD-26-28853.PMC4683989.pdf
"pilosicoli -induced avian intestinal spirochaetosis Citation: Microbial Ecology in Health & Disease 2015, 26: 28853 - http://dx.doi.org/10.3402/mehd.v26.28853 7 (page number not for citation purpose)",Non-OADS,/arxiv_data1/oa_pdf/a9/c0/MEHD-26-28853.PMC4683989.pdf
"8 (page number not for citation purpose)Citation: Microbial Ecology in Health & Disease 2015, 26: 28853 - http://dx.doi.org/10.3402/mehd.v26.28853",Non-OADS,/arxiv_data1/oa_pdf/a9/c0/MEHD-26-28853.PMC4683989.pdf
Available from: http://www.ema.,Non-OADS,/arxiv_data1/oa_pdf/a9/c0/MEHD-26-28853.PMC4683989.pdf
"pilosicoli -induced avian intestinal spirochaetosis Citation: Microbial Ecology in Health & Disease 2015, 26: 28853 - http://dx.doi.org/10.3402/mehd.v26.28853 9 (page number not for citation purpose)",Non-OADS,/arxiv_data1/oa_pdf/a9/c0/MEHD-26-28853.PMC4683989.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/), permitting all non-commercial use , distribution, and reproduction in any medium, provided the original work is properly cited.1 Citation: Microbial Ecology in Health & Disease 2015, 26: 29719 - http://dx.doi.org/10.3402/mehd.v26.29719 (page number not for citation purpose)",Non-OADS,/arxiv_data1/oa_pdf/20/44/MEHD-26-29719.PMC4683992.pdf
"2 (page number not for citation purpose)Citation: Microbial Ecology in Health & Disease 2015, 26: 29719 - http://dx.doi.org/10.3402/mehd.v26.29719",Non-OADS,/arxiv_data1/oa_pdf/20/44/MEHD-26-29719.PMC4683992.pdf
"BDNF , brain-derived neurotrophic factor; GAPDH, glyceraldehyde three-phosphate dehydrogenase.Gut microbiota and social behaviour in mice Citation: Microbial Ecology in Health & Disease 2015, 26: 29719 - http://dx.doi.org/10.3402/mehd.v26.29719 3 (page number not for citation purpose)",Non-OADS,/arxiv_data1/oa_pdf/20/44/MEHD-26-29719.PMC4683992.pdf
"4 (page number not for citation purpose)Citation: Microbial Ecology in Health & Disease 2015, 26: 29719 - http://dx.doi.org/10.3402/mehd.v26.29719",Non-OADS,/arxiv_data1/oa_pdf/20/44/MEHD-26-29719.PMC4683992.pdf
"* pB0.05, ** pB0.01 compared with SPF mice.Gut microbiota and social behaviour in mice Citation: Microbial Ecology in Health & Disease 2015, 26: 29719 - http://dx.doi.org/10.3402/mehd.v26.29719 5 (page number not for citation purpose)",Non-OADS,/arxiv_data1/oa_pdf/20/44/MEHD-26-29719.PMC4683992.pdf
"6 (page number not for citation purpose)Citation: Microbial Ecology in Health & Disease 2015, 26: 29719 - http://dx.doi.org/10.3402/mehd.v26.29719",Non-OADS,/arxiv_data1/oa_pdf/20/44/MEHD-26-29719.PMC4683992.pdf
"Consumption of fermented milk product with probioticGut microbiota and social behaviour in mice Citation: Microbial Ecology in Health & Disease 2015, 26: 29719 - http://dx.doi.org/10.3402/mehd.v26.29719 7 (page number not for citation purpose)",Non-OADS,/arxiv_data1/oa_pdf/20/44/MEHD-26-29719.PMC4683992.pdf
"Microb Ecol Health Dis 2015; 26:28177, doi: http://dx.doi.org/10.3402/mehd.v26.28177 39.",Non-OADS,/arxiv_data1/oa_pdf/20/44/MEHD-26-29719.PMC4683992.pdf
"8 (page number not for citation purpose)Citation: Microbial Ecology in Health & Disease 2015, 26: 29719 - http://dx.doi.org/10.3402/mehd.v26.29719",Non-OADS,/arxiv_data1/oa_pdf/20/44/MEHD-26-29719.PMC4683992.pdf
Statistical analysis was performed using Image J ( http://imagej.nih.gov/ij ) and SigmaPlot  (Systat Software).,OADS,/arxiv_data1/oa_pdf/a4/61/emss-66379.PMC4684100.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/d9/03/mdv482.PMC4684151.pdf
ClinicalTrials.gov: NCT01594749 ( https://clinicaltrials.gov/ct2/show/NCT01594749 ).,Non-OADS,/arxiv_data1/oa_pdf/d9/03/mdv482.PMC4684151.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/d4/13/mdv487.PMC4684153.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/8b/70/mdv488.PMC4684154.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/07/a7/mdv501.PMC4684157.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/09/27/mdv504.PMC4684158.pdf
"EAU guidelines on renal cell carcinoma, 2013. http://uroweb.org/wp-content/uploads/08-Renal-Cell-Carcinoma_LR.pdf (August 2015, date last accessed).",Non-OADS,/arxiv_data1/oa_pdf/09/27/mdv504.PMC4684158.pdf
"2014. http://www.england.nhs.uk/ ourwork/pe/cdf/ (August 2015, date last accessed).",Non-OADS,/arxiv_data1/oa_pdf/09/27/mdv504.PMC4684158.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/59/42/jev123.PMC4684160.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/b3/12/jev203.PMC4684161.pdf
"7,12,13 Arterioscler Thromb Vasc Biol is available at http://atvb.ahajournals.org DOI: 10.1161/ATVBAHA.115.305990Objective—The V1 (VHS107.1.42) immunoglobulin heavy chain gene is thought to be critical in producing IgM natural  antibodies of the T15-idiotype that protect against both atherosclerosis and infection from Streptococcus pneumoniae.",Non-OADS,/arxiv_data1/oa_pdf/ec/f2/atv-36-25.PMC4684249.pdf
"The online-only Data Supplement is available with this article at http://atvb.ahajournals.org/lookup/suppl/doi:10.1161/ATVBAHA.115.305990/-/DC1.Correspondence to Stephen Malin, Department of Medicine, Karolinska Institutet, Center for Molecular Medicine, L8:03, Karolinska University  Hospital, S-171 76 Stockholm, Sweden.",Non-OADS,/arxiv_data1/oa_pdf/ec/f2/atv-36-25.PMC4684249.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/), permitting all non-commercial use , distribution, and reproduction in any medium, provided the original work is properly cited.1 Citation: Journal of Oral Microbiology 2015, 7: 29800 - http://dx.doi.org/10.3402/jom.v7.29800 (page number not for citation purpose)",Non-OADS,/arxiv_data1/oa_pdf/aa/7d/JOM-7-29800.PMC4684579.pdf
"2 (page number not for citation purpose)Citation: Journal of Oral Microbiology 2015, 7: 29800 - http://dx.doi.org/10.3402/jom.v7.29800",Non-OADS,/arxiv_data1/oa_pdf/aa/7d/JOM-7-29800.PMC4684579.pdf
"The SidD protein isIron and gene expression in A. oris Citation: Journal of Oral Microbiology 2015, 7: 29800 - http://dx.doi.org/10.3402/jom.v7.29800 3 (page number not for citation purpose)",Non-OADS,/arxiv_data1/oa_pdf/aa/7d/JOM-7-29800.PMC4684579.pdf
"4 (page number not for citation purpose)Citation: Journal of Oral Microbiology 2015, 7: 29800 - http://dx.doi.org/10.3402/jom.v7.29800",Non-OADS,/arxiv_data1/oa_pdf/aa/7d/JOM-7-29800.PMC4684579.pdf
"‘****’ indicates signiﬁcant difference ( pB0.02) in gene expression.Iron and gene expression in A. oris Citation: Journal of Oral Microbiology 2015, 7: 29800 - http://dx.doi.org/10.3402/jom.v7.29800 5 (page number not for citation purpose)",Non-OADS,/arxiv_data1/oa_pdf/aa/7d/JOM-7-29800.PMC4684579.pdf
"6 (page number not for citation purpose)Citation: Journal of Oral Microbiology 2015, 7: 29800 - http://dx.doi.org/10.3402/jom.v7.29800",Non-OADS,/arxiv_data1/oa_pdf/aa/7d/JOM-7-29800.PMC4684579.pdf
"‘*’ indicates identical amino acids; ‘.’ and ‘:’ indicate conservative substitution.Iron and gene expression in A. oris Citation: Journal of Oral Microbiology 2015, 7: 29800 - http://dx.doi.org/10.3402/jom.v7.29800 7 (page number not for citation purpose)",Non-OADS,/arxiv_data1/oa_pdf/aa/7d/JOM-7-29800.PMC4684579.pdf
doi: http://dx.doi.org/10.1099/ mic.0.027706-0 9.,Non-OADS,/arxiv_data1/oa_pdf/aa/7d/JOM-7-29800.PMC4684579.pdf
doi: http://dx.doi.org/10.1007/s10096-014- 2160-5 12.,Non-OADS,/arxiv_data1/oa_pdf/aa/7d/JOM-7-29800.PMC4684579.pdf
"8 (page number not for citation purpose)Citation: Journal of Oral Microbiology 2015, 7: 29800 - http://dx.doi.org/10.3402/jom.v7.29800",Non-OADS,/arxiv_data1/oa_pdf/aa/7d/JOM-7-29800.PMC4684579.pdf
doi: http://dx.doi.org/10.1128/ JB.01648-12 22.,OADS,/arxiv_data1/oa_pdf/aa/7d/JOM-7-29800.PMC4684579.pdf
doi: http://dx.doi.org/10.1093/molbev/mss278 25.,Non-OADS,/arxiv_data1/oa_pdf/aa/7d/JOM-7-29800.PMC4684579.pdf
Mol Syst Biol 2011; 7: 539. doi: http://dx.doi.org/10.1038/msb.2011.7526.,OADS,/arxiv_data1/oa_pdf/aa/7d/JOM-7-29800.PMC4684579.pdf
doi: http://dx.doi.org/10.1371/journal.ppat.1000949 29.,Non-OADS,/arxiv_data1/oa_pdf/aa/7d/JOM-7-29800.PMC4684579.pdf
"PLoS One 2012; 7: e37919.Iron and gene expression in A. oris Citation: Journal of Oral Microbiology 2015, 7: 29800 - http://dx.doi.org/10.3402/jom.v7.29800 9 (page number not for citation purpose)",Non-OADS,/arxiv_data1/oa_pdf/aa/7d/JOM-7-29800.PMC4684579.pdf
"Open Access This article is distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 InternationalLicense (http://creativecommons.org/licenses/by-nc/4.0/), which per- mits any noncommercial use, distribution, and reproduction in any medium, provided you give appropriate credit to the originalauthor(s) and the source, provide a link to the Creative Commonslicense, and indicate if changes were made.",Non-OADS,/arxiv_data1/oa_pdf/e2/15/40259_2015_Article_149.PMC4684580.pdf
Available at: http://www.ema.europa.eu/docs/en_ GB/document_library/Medicine_QA/2009/12/WC500020062.,Non-OADS,/arxiv_data1/oa_pdf/e2/15/40259_2015_Article_149.PMC4684580.pdf
Available at: http://ec.europa.eu/health/ﬁles/eudralex/ vol-1/dir_2001_83_cons/dir2001_83_cons_20081230_en.pdf .,Non-OADS,/arxiv_data1/oa_pdf/e2/15/40259_2015_Article_149.PMC4684580.pdf
Available at: http://www.europabio.,Non-OADS,/arxiv_data1/oa_pdf/e2/15/40259_2015_Article_149.PMC4684580.pdf
Available at: http://www.ema.europa.eu/docs/en_GB/document_ library/Scientiﬁc_guideline/2009/09/WC500002805.pdf .,Non-OADS,/arxiv_data1/oa_pdf/e2/15/40259_2015_Article_149.PMC4684580.pdf
2011.Available at: http://www.ema.europa.eu/docs/en_GB/document_ library/Scientiﬁc_guideline/2011/06/WC500107636.pdf .,Non-OADS,/arxiv_data1/oa_pdf/e2/15/40259_2015_Article_149.PMC4684580.pdf
Available at: http://ec.europa.eu/health/ﬁles/ eudralex/vol-1/dir_2010_84/dir_2010_84_en.pdf .,Non-OADS,/arxiv_data1/oa_pdf/e2/15/40259_2015_Article_149.PMC4684580.pdf
Available at: http://www.ema.europa.eu/docs/en_ GB/document_library/Scientiﬁc_guideline/2009/09/WC500002802.pdf .,Non-OADS,/arxiv_data1/oa_pdf/e2/15/40259_2015_Article_149.PMC4684580.pdf
Available at: http://www.aemps.gob.es/cima/ﬁchasTecnicas.,Non-OADS,/arxiv_data1/oa_pdf/e2/15/40259_2015_Article_149.PMC4684580.pdf
Available at: http://goo.gl/BZBKa3 .,Non-OADS,/arxiv_data1/oa_pdf/e2/15/40259_2015_Article_149.PMC4684580.pdf
Available at: http://www.bcﬁ.be .,Non-OADS,/arxiv_data1/oa_pdf/e2/15/40259_2015_Article_149.PMC4684580.pdf
Available at: https://www.lakemedelsverket.se/LMF/ .,Non-OADS,/arxiv_data1/oa_pdf/e2/15/40259_2015_Article_149.PMC4684580.pdf
"Funding This work was funded by Amgen Inc. Open Access This article is distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 InternationalLicense (http://creativecommons.org/licenses/by-nc/4.0/), which per- mits any noncommercial use, distribution, and reproduction in any medium, provided you give appropriate credit to the originalauthor(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made.",Non-OADS,/arxiv_data1/oa_pdf/1c/55/40259_2015_Article_147.PMC4684584.pdf
2013. http://www.ema.europa.eu/ docs/en_GB/document_library/EPAR_-_Public_assessment_ report/human/002576/WC500151486.pdf .,Non-OADS,/arxiv_data1/oa_pdf/1c/55/40259_2015_Article_147.PMC4684584.pdf
2013. http://www.ema.eur opa.eu/docs/en_GB/document_library/EPAR_-_Public_assessment_report/human/ 002608/WC500152908.pdf .,Non-OADS,/arxiv_data1/oa_pdf/1c/55/40259_2015_Article_147.PMC4684584.pdf
2014. http://www.ema.europa.eu/ docs/en_GB/document_library/EPAR_-_Public_assessment_re port/human/002615/WC500166820.pdf .,Non-OADS,/arxiv_data1/oa_pdf/1c/55/40259_2015_Article_147.PMC4684584.pdf
"US Food and Drug Administration, 2014. http://www.accessdata.fda.gov/ scripts/cder/ob/docs/queryai.cfm .",OADS,/arxiv_data1/oa_pdf/1c/55/40259_2015_Article_147.PMC4684584.pdf
http://www.fda.gov/downloads/Drugs/GuidanceCompliance RegulatoryInformation/UCM216146.pdf .,Non-OADS,/arxiv_data1/oa_pdf/1c/55/40259_2015_Article_147.PMC4684584.pdf
http://www.biosimilarsforum.org/news/biosimilars-forum- statement-regarding-need-appropriate-coding-biosimilars .,Non-OADS,/arxiv_data1/oa_pdf/1c/55/40259_2015_Article_147.PMC4684584.pdf
"Funding This study was funded by Samsung Bioepis Co., Ltd. Open Access This article is distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/), which per-mits any noncommercial use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, andindicate if changes were made.",Non-OADS,/arxiv_data1/oa_pdf/17/18/40259_2015_Article_150.PMC4684585.pdf
2014. http://www.ema.europa.eu/docs/en_GB/document_ library/EPAR_-_Product_Information/human/000240/ WC500050888.pdf .,Non-OADS,/arxiv_data1/oa_pdf/17/18/40259_2015_Article_150.PMC4684585.pdf
2015. http://www.ema.europa.eu/docs/en_GB/document_ library/EPAR_-_Product_Information/human/002576/WC500150 871.pdf .,Non-OADS,/arxiv_data1/oa_pdf/17/18/40259_2015_Article_150.PMC4684585.pdf
2012. http://www.fda.gov/downloads/drugs/ guidancecomplianceregulatoryinformation/guidances/ ucm291128.pdf .,Non-OADS,/arxiv_data1/oa_pdf/17/18/40259_2015_Article_150.PMC4684585.pdf
"This Open Access article is distributed under the terms of the Creative Commons Attribution Noncommercial License (http://creativecommons.org/licenses/by-nc/4.0/) which permits noncommercial use, dis-tribution, and reproduction in any medium, provided the original author(s) and the source are credited.AIDS PATIENT CARE and STDs Volume 29, Number 12, 2015DOI: 10.1089/apc.2015.0089 651",Non-OADS,/arxiv_data1/oa_pdf/04/e2/apc.2015.0089.PMC4684655.pdf
Available from: http://dhsprogram.com/publications/publication-fr264-dhs- ﬁnal-reports.cfm 2.,Non-OADS,/arxiv_data1/oa_pdf/04/e2/apc.2015.0089.PMC4684655.pdf
"Kampala, Uganda; Available from: http://dhsprogram.com/publications/publication-fr264-dhs- ﬁnal-reports.cfm (Last accessed November 5, 2015).",Non-OADS,/arxiv_data1/oa_pdf/04/e2/apc.2015.0089.PMC4684655.pdf
"This Open Access article is distributed under the terms of the Creative Commons Attribution Noncommercial License (http://creativecommons.org/licenses/by-nc/4.0/) which permits any noncommercial use,distribution, and reproduction in any medium, provided the original author(s) and the source are credited.THYROID Volume 25, Number 12, 2015DOI: 10.1089/thy.2015.0309 1379",Non-OADS,/arxiv_data1/oa_pdf/df/11/thy.2015.0309.PMC4684666.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/6d/23/jis14-0139.PMC4684676.pdf
2009. http://faostat.fao.org/site/567/DesktopDefault.aspx?PageID ¼ 567#ancor (accessed 12 October 2012).,Non-OADS,/arxiv_data1/oa_pdf/b5/81/ieu121.PMC4684677.pdf
http://pubs.cas.psu.edu/freepubs/ pdfs/agrs114.pdf (accessed 3 February 2013).,Non-OADS,/arxiv_data1/oa_pdf/b5/81/ieu121.PMC4684677.pdf
http://www.freshfromﬂorida.,Non-OADS,/arxiv_data1/oa_pdf/b5/81/ieu121.PMC4684677.pdf
http://usda01.li brary.cornell.edu/usda/nass/NoncFruiNu//2010s/2012/NoncFruiNu-07-06- 2012.pdf (accessed 12 June 2013).,Non-OADS,/arxiv_data1/oa_pdf/b5/81/ieu121.PMC4684677.pdf
http://www.kimvdlinde.com/professional/Zaprionus%20distribution%20US.,Non-OADS,/arxiv_data1/oa_pdf/b5/81/ieu121.PMC4684677.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/a7/49/jis14-0183.PMC4684678.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/27/86/ieu096.PMC4684679.pdf
"The `se de Doctorat, Universite ´ de Lie `ge (http://hdl.handle.net/2268/ 84257).",Non-OADS,/arxiv_data1/oa_pdf/27/86/ieu096.PMC4684679.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/a6/6e/jis14-0177.PMC4684680.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/37/f4/ieu141.PMC4684681.pdf
(http://neoquimica.provisorio.ws/arquivos/bulas/ todas/1046503480014.pdf).,Non-OADS,/arxiv_data1/oa_pdf/37/f4/ieu141.PMC4684681.pdf
(http://oatd.org/ oatd/record?record ¼oai%5C:unicamp.br%5C:vtls000436821) (accessed 2 January 2014).,OADS,/arxiv_data1/oa_pdf/37/f4/ieu141.PMC4684681.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/e8/7d/jis14-0148.PMC4684683.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/0c/37/ieu138.PMC4684684.pdf
(http://www.napant.sk/fauna/chr_chro baky/chrobaky.pdf) (accessed 5 May 2012) (in Czech).,Non-OADS,/arxiv_data1/oa_pdf/0c/37/ieu138.PMC4684684.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/94/d2/jis14-0169.PMC4684685.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/bb/22/ieu101.PMC4684686.pdf
(http://meteobelgique.be).,Non-OADS,/arxiv_data1/oa_pdf/bb/22/ieu101.PMC4684686.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/ae/0b/ieu063.PMC4684687.pdf
(http://botany.si.edu/onagraceae/index.cfm) (accessed April2012).,Non-OADS,/arxiv_data1/oa_pdf/ae/0b/ieu063.PMC4684687.pdf
Two trials are currently on- going to address the role of carbohydrates in diarrhea and clinical recovery in severe malnutrition (NCT02246296 [https://clinicaltrials.gov/ct2/show/ NCT02246296] and ISRCTN13916953 [http://www.,Non-OADS,/arxiv_data1/oa_pdf/29/c3/nuv058.PMC4684688.pdf
http://www.who.int/nutrition/publica-tions/en/manage_severe_malnutrition_eng.pdf.,Non-OADS,/arxiv_data1/oa_pdf/29/c3/nuv058.PMC4684688.pdf
http://www.who.int/nutrition/publica-tions/severemalnutrition/9789241598163_eng.pdf.,Non-OADS,/arxiv_data1/oa_pdf/29/c3/nuv058.PMC4684688.pdf
http://www.who.int/child_adolescent_health/documents/fnb_v27n3_suppl/en/.,Non-OADS,/arxiv_data1/oa_pdf/29/c3/nuv058.PMC4684688.pdf
http://www.who.int/nutrition/topics/Statement_ community_based_man_sev_acute_mal_eng.pdf.,Non-OADS,/arxiv_data1/oa_pdf/29/c3/nuv058.PMC4684688.pdf
http://www.who.int/nutrition/publications/guidelines/updates_management_SAM_infantandchildren/en/index.html.,Non-OADS,/arxiv_data1/oa_pdf/29/c3/nuv058.PMC4684688.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License ( http://creativecommons.org/licenses/by-nc/4.0/ ), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/44/6c/evv183.PMC4684695.pdf
Supplementary Material Supplementary ﬁgures S1–S3 andtables S1–S15 are available atGenome Biology and Evolution online ( http://www.gbe.,Non-OADS,/arxiv_data1/oa_pdf/44/6c/evv183.PMC4684695.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License ( http://creativecommons.org/licenses/by-nc/4.0/ ), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/6e/1d/evv188.PMC4684696.pdf
"2013 ) (supplementary table S2 ,Supplementary Material online) using ssu-aligner v0.1 (Available from: http://selab.janelia.",OADS,/arxiv_data1/oa_pdf/6e/1d/evv188.PMC4684696.pdf
"Visual display of the summarytree was done using FigTree v1.4.2 ( http://tree.bio.ed.ac.uk/ software/ﬁgtree/ , last accessed January 13, 2015) and edited in Inkscape v0.91 ( http://www.inkscape.org/en/ , last accessed January 13, 2015).",OADS,/arxiv_data1/oa_pdf/6e/1d/evv188.PMC4684696.pdf
Available from: http://www.bioinfo.de/isb/gcb99/talks/chevreux/ .,Non-OADS,/arxiv_data1/oa_pdf/6e/1d/evv188.PMC4684696.pdf
"Availablefrom: http://dx.doi.org/10.1017/CBO9780511610493.007 .Liu L, et al.",OADS,/arxiv_data1/oa_pdf/6e/1d/evv188.PMC4684696.pdf
Available from: http://www.r-project.org/ .,Non-OADS,/arxiv_data1/oa_pdf/6e/1d/evv188.PMC4684696.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License ( http://creativecommons.org/licenses/by-nc/4.0/ ), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/ce/fc/evv185.PMC4684699.pdf
"(2010) provided a sex-averaged linkage map for a two- generation outbred pedigree based on SNPs for P. taeda (accession number: TG091, http://dendrome.ucdavis.edu/ cmap/ , last accessed May 21, 2015).",Non-OADS,/arxiv_data1/oa_pdf/ce/fc/evv185.PMC4684699.pdf
Supplementary Material Supplementary ﬁgures S1–S5 andtables S1–S3 are available atGenome Biology and Evolution online ( http://www.gbe.,Non-OADS,/arxiv_data1/oa_pdf/ce/fc/evv185.PMC4684699.pdf
Vienna (Austria): R Foundation for Statistical Computing.Available from: http://www.R-project.org/ .,Non-OADS,/arxiv_data1/oa_pdf/ce/fc/evv185.PMC4684699.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License ( http://creativecommons.org/licenses/by-nc/4.0/ ), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/35/e7/evv193.PMC4684700.pdf
Supplementary Material Supplementary ﬁgures S1–S6 andtables S1–S6 are available atGenome Biology and Evolution online ( http://www.gbe.,OADS,/arxiv_data1/oa_pdf/35/e7/evv193.PMC4684700.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License ( http://creativecommons.org/licenses/by-nc/4.0/ ), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/c9/19/evv182.PMC4684701.pdf
"(2012) and which are avail- able at http://pseudobase.biology.duke.edu (last accessed October 1, 2015) and GenBank (accession numbers: AFC12SRX091462, Flagstaff14 SRX091308, Flagstaff16SRX091303, Flagstaff18 SRX091310, Mather32 SRX091461,MatherTL SRX091324, MSH9 SRX091465, MSH24SRX091463, PP1134 SRX091323, PP1137 SRX091311).Additionally, we used 11 whole-genome sequences of D. mir- anda (Lines: MA28, MAO101.4, MAO3.3, MAO3.4, MAO3.5, MAO3.6, ML14, ML16, ML6f, SP138, and SP235), previouslysequenced and provided by Doris Bachtrog’s lab (GenBankaccession number PRJNA277849).",OADS,/arxiv_data1/oa_pdf/c9/19/evv182.PMC4684701.pdf
Supplementary Material Supplementary ﬁgures S1–S13 andtables S1–S4 are available atGenome Biology and Evolution online ( http://www.gbe.,OADS,/arxiv_data1/oa_pdf/c9/19/evv182.PMC4684701.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License ( http://creativecommons.org/licenses/by-nc/4.0/ ), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/d5/6c/evv184.PMC4684702.pdf
"For identiﬁcationand classiﬁcation of predict ed holins, homology searches were conducted against the Transporter Classiﬁcation (TC) database ( http://www.tcdb.org ).",OADS,/arxiv_data1/oa_pdf/d5/6c/evv184.PMC4684702.pdf
"Protein domains were local- ized using SMART ( http://smart.embl-heidelberg.de/ )a n d InterPro ( https://www.ebi.ac.uk/interpro )a n a l y s e s .Genome Sequencing and Nucleotide Accession Numbers GenBank accession numbers of the nucleotide sequences of the R tailocin clusters from P. putida strain BW11M1, RW10S1 and RW10S2 are KP698091, KP698092 and KP698093, respectively.",OADS,/arxiv_data1/oa_pdf/d5/6c/evv184.PMC4684702.pdf
"fluorescens Tailocins The BW11M1 and RW10S2 PtbB proteins, together with the large majority of the pseudomonad tailocin holins, belong tothe same TC family ( http://www.tcdb.org )(Saier and Reddy 2015 )a st h e P. aeruginosa pyocin R holins (TC /C01.E.20) and are not related to the P2 type (TC /C01.E.3) or /C8CTX type (TC/C01.E.56).",Non-OADS,/arxiv_data1/oa_pdf/d5/6c/evv184.PMC4684702.pdf
"Belonging to the glycoside hydrolase family 19 (Pfam PF00182; CAZY-GH19; http://www.cazy.org ), these enzymes are different from the lysozyme deployed by P2 (glycoside hydrolase family 24; PF00959) and the peptidogly- can-binding endolysin of /C8CTX (carrying domains PF01471 and PF11860).",Non-OADS,/arxiv_data1/oa_pdf/d5/6c/evv184.PMC4684702.pdf
"VP882and /C8HAP-1 are temperate phages with a linear plasmid- like genome, belonging to the Hapunalikevirus genus within theMyoviridae (http://viralzone.expasy.org/ ).",Non-OADS,/arxiv_data1/oa_pdf/d5/6c/evv184.PMC4684702.pdf
Supplementary Material Supplementary ﬁles S1–S3 andtables S1–S3 are available at Genome Biology and Evolution online ( http://www.gbe.,Non-OADS,/arxiv_data1/oa_pdf/d5/6c/evv184.PMC4684702.pdf
"Washington (DC): National Academies  Press (US); 2011. http://www.ncbi.nlm.nih.gov/books/NBK62461/  [accessed July 27, 2015] 6.",Non-OADS,/arxiv_data1/oa_pdf/7d/51/nihms740710.PMC4684734.pdf
"Vienna, Austria: R  Foundation for Statistical Computing; 2014. http://www.R-project.org/ 28.",Non-OADS,/arxiv_data1/oa_pdf/7d/51/nihms740710.PMC4684734.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/e5/9b/nihms736095.PMC4684758.pdf
"Microarray and Quantitative Real Time Reverse Transcriptase Polymerase Chain Reaction (qRT- PCR) Microarray data from canine HSA cell lines is deposited in the Gene Expression Omnibus (http://www.ncbi.nlm.nih.gov/geo; accession number GSE22129).2qRT-PCR was performed as described.2Brieﬂy, total RNA was prepared with the Ambion RNA Mini Kit,band cDNA was prepared using the Superscript cDNA Synthesis Kit.bqRT-PCR was done using the SYBRgreen method.bGene expression for S1P 1and sphingosine kinase 1 (SK1) was determined as a ratio of GAPDH expression using the2 /C0DDCTmethod.10The primer sequences are listed in Supplemen- tary Table 1.",OADS,/arxiv_data1/oa_pdf/ba/13/JVIM-29-1088.PMC4684944.pdf
"Here,  a  sense  mutation  at  exon 14  of  the  JAK2  gene  (g.1849  G>T)5,6results  in  the  substitu- tion of  a  valine  for  a  phenylalanine  at  position  617  located http://dx.doi.org/10.1016/j.bjhh.2014.10.001 1516-8484/©  2015  Associac ¸ã o  Brasileira  de  Hematologia,  Hemoterapia  e  Terapia  Celular.",Non-OADS,/arxiv_data1/oa_pdf/5b/a1/main.PMC4685044.pdf
http://dx.doi.org/10.1016/j.bjhh.2015.05.007 Available  online  2  July  2015,OADS,/arxiv_data1/oa_pdf/9f/ea/main.PMC4685045.pdf
"http://dx.doi.org/10.1016/j.bjhh.2015.05.005 1516-8484/©  2015  Associac ¸ã o  Brasileira  de  Hematologia,  Hemoterapia  e  Terapia  Celular.",Non-OADS,/arxiv_data1/oa_pdf/61/e1/main.PMC4685046.pdf
"http://dx.doi.org/10.1016/j.bjhh.2015.05.006 1516-8484/©  2015  Associac ¸ã o  Brasileira  de  Hematologia,  Hemoterapia  e  Terapia  Celular.",Non-OADS,/arxiv_data1/oa_pdf/5a/de/main.PMC4685047.pdf
"2  0  1  5;3  7(5) :290–291 www.rbhh.orgRevista  Brasileira  de  Hematologia  e  Hemoterapia Brazilian Journal of  Hematology  and  Hemotherapy Scientiﬁc  Comment Impact  on  patient  of  the  detection  of  weakly expressed  RhD  antigens  in  blood  donors/H22845 Helio Moraes-Souzaa,b,∗,  Vitor  Mendonc ¸a  Alvesa aUniversidade Federal  do  Triângulo  Mineiro  (UFTM),  Uberaba,  MG,  Brazil bHemocentro  Regional  de  Uberaba/Fundac ¸ão  Hemominas,  Uberaba,  MG,  Brazil a r  t  i  c  l  e  i  n  f  o Article  history: Received  14  July  2015 Accepted 28 July 2015 Available  online  5  August  2015 Due to  blood  transfusions,  pregnancy,  and  organ/tissue transplants  or  grafts,1red  blood  cell  alloimmunization  may lead  to  serious  complications,  such  as  hemolytic  transfusion reactions,2–4which  have  been  regarded  as  one  of  the  most frequent  causes  of  transfusion-related  deaths  in  recent  years according to  reports  from  the  Food  and  Drug  Administration (FDA).5 Rh, the  most  complex  blood  group  system,  has  the  highest clinical importance after  the  ABO  group.6,7The  D  antigen, found in  Rh-positive  individuals,  is  the  most  important  in  the system  as  it  is  the  most  immunogenic.7,8Therefore,  given  the risk of  alloimmunization,  RhD-positive  red  blood  cells  must not  be  transfused  to  RhD-negative  patients  except  in  emer- gencies involving  massive  hemorrhage  when  RhD-negative units  are  not  available.7 The RhD protein has  417  amino  acids  divided  into  seven intracellular  segments,  twelve  transmembrane  segments  and six  extracellular  segments.9Amino  acid  substitution  in  the intracellular or  transmembrane  segment  of  the  RhD  protein leads  to  weakening  of  the  D  antigen  expression  in  the  mem- brane of  red  blood  cells  resulting  in  a  weak  D  phenotype.6–13 Hence, weak  D  testing  must  always  be  performed  in  blood DOI  of  original  article:  http://dx.doi.org/10.1016/j.bjhh.2015.06.001 .",Non-OADS,/arxiv_data1/oa_pdf/9f/4c/main.PMC4685078.pdf
"A study  by  Schmidt  et  al.14showed  positive  results  for  the RhD antigen  in  5.9%  of  152  blood  donors  –  who  had  been http://dx.doi.org/10.1016/j.bjhh.2015.07.007 1516-8484/©  2015  Associac ¸ã o  Brasileira  de  Hematologia,  Hemoterapia  e  Terapia  Celular.",Non-OADS,/arxiv_data1/oa_pdf/9f/4c/main.PMC4685078.pdf
Available from:  http://www.fda.gov/BiologicsBloodVaccines/ SafetyAvailability/ReportaProblem/TransfusionDonationFatalities/ucm391574.htm [accessed 08.04.15].,Non-OADS,/arxiv_data1/oa_pdf/9f/4c/main.PMC4685078.pdf
"A recent  systematic  review  reported  frequencies  of  MBL ranging  from  <1%  to  18.2%.5This  wide  variation  reﬂects  dif- ferent study  populations  (general  population,  blood  donor population,  outpatients  from  clinics  and  relatives  of  CLL patients  –  familial  cases  or  sporadic  cases)  and  the  sensitivity of the  multiparameter  ﬂow  cytometry  employed  (two  or  three DOI of  original  article:  http://dx.doi.org/10.1016/j.bjhh.2015.05.006 .",OADS,/arxiv_data1/oa_pdf/62/d4/main.PMC4685083.pdf
"The  risk  of  progression  to  CLL  is around  1%  per  year.10In  contrast,  in  low-count  MBL  almost 95% of  the  cases  have  less  than  1.0  ×  109/L  clonal  B  cells  and have  a  low  risk  of  progression  to  CLL.11Of  note,  this  condition http://dx.doi.org/10.1016/j.bjhh.2015.06.003 1516-8484/©  2015  Associac ¸ã o  Brasileira  de  Hematologia,  Hemoterapia  e  Terapia  Celular.",Non-OADS,/arxiv_data1/oa_pdf/62/d4/main.PMC4685083.pdf
"http://dx.doi.org/10.1016/j.bjhh.2015.07.003 1516-8484/©  2015  Associac ¸ã o  Brasileira  de  Hematologia,  Hemoterapia  e  Terapia  Celular.",Non-OADS,/arxiv_data1/oa_pdf/95/5d/main.PMC4685084.pdf
"http://dx.doi.org/10.1016/j.bjhh.2015.07.004 1516-8484/©  2015  Associac ¸ã o  Brasileira  de  Hematologia,  Hemoterapia  e  Terapia  Celular.",Non-OADS,/arxiv_data1/oa_pdf/8b/5c/main.PMC4685086.pdf
"http://dx.doi.org/10.1016/j.bjhh.2015.07.002 1516-8484/©  2015  Associac ¸ã o  Brasileira  de  Hematologia,  Hemoterapia  e  Terapia  Celular.",Non-OADS,/arxiv_data1/oa_pdf/96/35/main.PMC4685090.pdf
"da  Silva  Malta).transfusion reactions  and  hemolytic  diseases  of  the  fetus  and newborns.1Despite  methodological  advances,  discrepancies in Rh  typing  are  still  a  problem  during  routine  immunohema- tology service  tests.2–4 http://dx.doi.org/10.1016/j.bjhh.2015.06.001 1516-8484/©  2015  Associac ¸ã o  Brasileira  de  Hematologia,  Hemoterapia  e  Terapia  Celular.",Non-OADS,/arxiv_data1/oa_pdf/2a/97/main.PMC4685092.pdf
"Borelli).and  several  studies  have  been  undertaken  to  identify  infection sources.3–5 Epidemiological studies  have  evidenced  the  prevalence  of TTV  in  other  pathological  conditions,  such  as  in  autoimmune diseases,4respiratory  conditions6and  cancer.7However,  infor- mation is still  lacking  on  TTV  infection  and  the  development  of pathologies,  as  well  as  the  change  in  the  course  of  a  particular disease.3,5 http://dx.doi.org/10.1016/j.bjhh.2015.07.005 1516-8484/©  2015  Associac ¸ã o  Brasileira  de  Hematologia,  Hemoterapia  e  Terapia  Celular.",Non-OADS,/arxiv_data1/oa_pdf/c3/7b/main.PMC4685100.pdf
"http://dx.doi.org/10.1016/j.bjhh.2015.05.008 1516-8484/©  2015  Associac ¸ã o  Brasileira  de  Hematologia,  Hemoterapia  e  Terapia  Celular.",Non-OADS,/arxiv_data1/oa_pdf/e0/9c/main.PMC4685101.pdf
"On  the  other  hand,  in  automated  HPLC,  the  mea- surement  of  Hb  A2is  inaccurate  when  Hb  S  is  present.2,3,10 As  the  amount  of  Hb  S  is  related  to  the  degree  of  inaccuracy, levels are  higher  in  patients  with  sickle  cell  anemia  (SCA)  or Hb S//H9252-thalassemia (S-/H9252Thal)  than  in  sickle  cell  trait.2Thus, the  amount  of  Hb  A2does  not  indicate  BTT  when  Hb  A  and beta gene  variants  are  found  together.11Furthermore,  when beta  gene  variants  are  present  without  Hb  A,  the  diagnosis  of concomitant  BTT  is  not  necessarily  associated  to  the  elevation of Hb  A2and  so  further  investigations  using  family  studies  or DNA  analysis  are  necessary.10 As mentioned  above,  /H9251-Thal  is  capable  of  interfering  in  the determination of  Hb  A2.4Individuals  with  the  /H92510-thalassemia trait  or  homozygous  for  /H9251+-thalassemia  have  lower  levels  of Hb A2,  but  the  inﬂuence  of  the  coinheritance  of  /H9251-Thal  and BTT on  Hb  A2levels  is  uncertain.6 In Brazil, the  incidence  of  /H9251-Thal  varies  from  0.11  to  0.22% depending  on  the  geographical  region  studied.12–15It  is  well known  that  the  association  of  /H9251-Thal  and  SCA  is  common  in http://dx.doi.org/10.1016/j.bjhh.2015.06.002 1516-8484/©  2015  Associac ¸ã o  Brasileira  de  Hematologia,  Hemoterapia  e  Terapia  Celular.",Non-OADS,/arxiv_data1/oa_pdf/0a/61/main.PMC4685102.pdf
"Figueiredo).in the  general  population  is  2–8%  and  the  estimated  number of affected individuals  is  about  7.2  million.1Sickle  hemoglobin (Hb  S)  is  caused  by  a  mutation  of  a  single  nucleotide  (HBB glu(E)6Val(A); GAG>GTG;  rs334;  HBB:c.20A>T;  MIM:  #603903)2 in  the  beta  globin  gene,  which  results  in  glutamic  acid  being http://dx.doi.org/10.1016/j.bjhh.2015.07.006 1516-8484/©  2015  Associac ¸ã o  Brasileira  de  Hematologia,  Hemoterapia  e  Terapia  Celular.",Non-OADS,/arxiv_data1/oa_pdf/a5/09/main.PMC4685105.pdf
Available  from:  http://omim.org/entry/603903  [cited 02.06.15].,Non-OADS,/arxiv_data1/oa_pdf/a5/09/main.PMC4685105.pdf
Available from:  http://omim.org/entry/147620  [cited 02.06.15].,OADS,/arxiv_data1/oa_pdf/a5/09/main.PMC4685105.pdf
"http://dx.doi.org/10.1016/j.bjhh.2015.07.001 1516-8484/©  2015  Associac ¸ã o  Brasileira  de  Hematologia,  Hemoterapia  e  Terapia  Celular.",Non-OADS,/arxiv_data1/oa_pdf/3a/56/main.PMC4685106.pdf
"This isan Open Access article distributed under the terms of theCreative Commons Attribution-NonCommercial-NoDerivs licence (http://creativecommons.org/licenses/by-nc-nd/4.0/), which permits non-commercial reproduction and distribution ofthework, in any medium, provided the original work is not alteredor transformed in any way, and that the work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/75/bd/ofv177.PMC4685150.pdf
Available at: http://www.theguardian.,Non-OADS,/arxiv_data1/oa_pdf/75/bd/ofv177.PMC4685150.pdf
"This isan Open Access article distributed under the terms of theCreative Commons Attribution-NonCommercial-NoDerivs licence (http://creativecommons.org/licenses/by-nc-nd/4.0/), which permits non-commercial reproduction and distribution ofthework, in any medium, provided the original work is not alteredor transformed in any way, and that the work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/9e/2d/ofv179.PMC4685151.pdf
Avail- able at: http://oig.hhs.gov/oei/reports/oei-03- 13-00650.pdf .,Non-OADS,/arxiv_data1/oa_pdf/9e/2d/ofv179.PMC4685151.pdf
Available at:http://oig.hhs.gov/oas/reports/region6/ 60700042.pdf .,Non-OADS,/arxiv_data1/oa_pdf/9e/2d/ofv179.PMC4685151.pdf
Available at: http://www.fda.gov/AboutFDA/ CentersOf ﬁces/Of ﬁceofMedicalProductsand Tobacco/CDER/ucm129385.htm .,Non-OADS,/arxiv_data1/oa_pdf/9e/2d/ofv179.PMC4685151.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/ licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/40/07/rjv157.PMC4685160.pdf
Urease wasContents lists available at ScienceDirect journal homepage: www.elsevier.com/locate/mmcrMedical Mycology Case Reports http://dx.doi.org/10.1016/j.mmcr.2015.11.001 2211-7539/ &2015 Published by Elsevier B.V. on behalf of International Society for Human and Animal Mycology nCorresponding author.,OADS,/arxiv_data1/oa_pdf/3e/d4/main.PMC4685175.pdf
Supplementary Information Supplementary data associated with this article can be found in the online version at: http://dx.doi.org/10.1016/j.mmcr.2015.11.001 .,OADS,/arxiv_data1/oa_pdf/3e/d4/main.PMC4685175.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/e4/02/ehv290.PMC4685177.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/a6/38/ehv489.PMC4685179.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/14/da/main.PMC4685192.pdf
This is an open access article under the CC BY- NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/14/da/main.PMC4685192.pdf
URL: www.ksu.edu.sahttp://dx.doi.org/10.1016/j.jsha.2015.06.004 Production and hosting by Elsevier,Non-OADS,/arxiv_data1/oa_pdf/14/da/main.PMC4685192.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/ad/9a/main.PMC4685199.pdf
This is an open access article under the CC BY-NC- ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/ad/9a/main.PMC4685199.pdf
URL: www.ksu.edu.sahttp://dx.doi.org/10.1016/j.jsha.2015.05.005 Production and hosting by Elsevier,Non-OADS,/arxiv_data1/oa_pdf/ad/9a/main.PMC4685199.pdf
2015 [accessed 2015March 1] Available from: < http://www.who.int/mediacentre/ factsheets/fs317/en/ >.,Non-OADS,/arxiv_data1/oa_pdf/ad/9a/main.PMC4685199.pdf
2010 [accessed 2014 January 20] Available from: <http://www.emcreg.org/publications/monographs/acep/ 2009/ACEP2009_dbd.pdf >.,Non-OADS,/arxiv_data1/oa_pdf/ad/9a/main.PMC4685199.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/8c/65/main.PMC4685201.pdf
Contents lists available at ScienceDirect Annals of Medicine and Surgery journal homepage: www.annalsjournal.com http://dx.doi.org/10.1016/j.amsu.2015.10.007 2049-0801/ ©2015 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/8c/65/main.PMC4685201.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/55/a5/main.PMC4685202.pdf
This is an open access article under the CC BY- NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/55/a5/main.PMC4685202.pdf
URL: www.ksu.edu.sahttp://dx.doi.org/10.1016/j.jsha.2015.06.001Production and hosting by Elsevier,OADS,/arxiv_data1/oa_pdf/55/a5/main.PMC4685202.pdf
Contents lists available at ScienceDirect Prostate International journal homepage: http://p-international.org.,Non-OADS,/arxiv_data1/oa_pdf/a9/4d/main.PMC4685203.pdf
"http://dx.doi.org/10.1016/j.prnil.2015.09.002 p2287-8882 e2287-903X/Copyright ©2015 Asian Paci ﬁc Prostate Society, Published by Elsevier.",Non-OADS,/arxiv_data1/oa_pdf/a9/4d/main.PMC4685203.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/dc/8f/main.PMC4685204.pdf
Contents lists available at ScienceDirect Annals of Medicine and Surgery journal homepage: www.annalsjournal.com http://dx.doi.org/10.1016/j.amsu.2015.10.019 2049-0801/ ©2015 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/dc/8f/main.PMC4685204.pdf
Contents lists available at ScienceDirect Prostate International journal homepage: http://p-international.org.,Non-OADS,/arxiv_data1/oa_pdf/67/7c/main.PMC4685206.pdf
"http://dx.doi.org/10.1016/j.prnil.2015.09.001 p2287-8882 e2287-903X/Copyright ©2015 Asian Paci ﬁc Prostate Society, Published by Elsevier.",Non-OADS,/arxiv_data1/oa_pdf/67/7c/main.PMC4685206.pdf
2015. http://dx.doi.org/10.1016/j.clgc.2015.05.010.,OADS,/arxiv_data1/oa_pdf/67/7c/main.PMC4685206.pdf
Available from: http://globocan.iarc.fr .,Non-OADS,/arxiv_data1/oa_pdf/67/7c/main.PMC4685206.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/7d/1d/main.PMC4685207.pdf
This is an open access article under the CC BY- NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/7d/1d/main.PMC4685207.pdf
URL: www.ksu.edu.sahttp://dx.doi.org/10.1016/j.jsha.2015.06.006 Production and hosting by Elsevier,Non-OADS,/arxiv_data1/oa_pdf/7d/1d/main.PMC4685207.pdf
Contents lists available at ScienceDirect Prostate International journal homepage: http://p-international.org.,Non-OADS,/arxiv_data1/oa_pdf/82/dc/main.PMC4685208.pdf
"http://dx.doi.org/10.1016/j.prnil.2015.10.015 p2287-8882 e2287-903X/Copyright ©2015 Asian Paci ﬁc Prostate Society, Published by Elsevier.",Non-OADS,/arxiv_data1/oa_pdf/82/dc/main.PMC4685208.pdf
This is an open access article under the CC BY- NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/31/d6/main.PMC4685209.pdf
URL: www.ksu.edu.sahttp://dx.doi.org/10.1016/j.jsha.2015.05.003Production and hosting by Elsevier,OADS,/arxiv_data1/oa_pdf/31/d6/main.PMC4685209.pdf
Available online:<http://www.ema.europa.eu/docs/en_GB/document_ library/Press_release/2011/11/WC500117818.pdf >; 2011 [accessed 20.03.15].,Non-OADS,/arxiv_data1/oa_pdf/31/d6/main.PMC4685209.pdf
Available at: < http://www.ema.europa.eu/docs/ en_GB/document_library/EPA R_-_Product_Information/ human/000829/WC500041059.pdf >; 2013 [accessed 02.10.14].,Non-OADS,/arxiv_data1/oa_pdf/31/d6/main.PMC4685209.pdf
Summary of product characteristics; 2013 Available at:<http://ec.europa.eu/health/d ocuments/community-register/ 2013/20131115127024/anx_127024_en.pdf >.,Non-OADS,/arxiv_data1/oa_pdf/31/d6/main.PMC4685209.pdf
Available at: <http://www.accessdata.fda.go v/drugsatfda_docs/label/ 2012/202155s000lbl.pdf >; 2012 [accessed 17.05.13].,Non-OADS,/arxiv_data1/oa_pdf/31/d6/main.PMC4685209.pdf
Contents lists available at ScienceDirect Prostate International journal homepage: http://p-international.org.,Non-OADS,/arxiv_data1/oa_pdf/51/cc/main.PMC4685210.pdf
"http://dx.doi.org/10.1016/j.prnil.2015.09.007 p2287-8882 e2287-903X/Copyright ©2015 Asian Paci ﬁc Prostate Society, Published by Elsevier.",Non-OADS,/arxiv_data1/oa_pdf/51/cc/main.PMC4685210.pdf
Available from: http://www.cdc.gov/cancer/prostate/index.htm .,Non-OADS,/arxiv_data1/oa_pdf/51/cc/main.PMC4685210.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/3e/f0/main.PMC4685211.pdf
Contents lists available at ScienceDirect Annals of Medicine and Surgery journal homepage: www.annalsjournal.com http://dx.doi.org/10.1016/j.amsu.2015.10.017 2049-0801/ ©2015 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/3e/f0/main.PMC4685211.pdf
"45(2010) e9 ee14, http://dx.doi.org/10.1016/j.jpedsurg.2009.12.009 .",OADS,/arxiv_data1/oa_pdf/3e/f0/main.PMC4685211.pdf
"38 (2008) 230e232, http://dx.doi.org/10.1007/s00247-007-0648-1 .",Non-OADS,/arxiv_data1/oa_pdf/3e/f0/main.PMC4685211.pdf
"26 (2010) 753 e757, http://dx.doi.org/10.1007/s00383-009-2468-x .",Non-OADS,/arxiv_data1/oa_pdf/3e/f0/main.PMC4685211.pdf
"Case Rep. 7 (2013) 223, http://dx.doi.org/10.1186/1752-1947-7-223 .",Non-OADS,/arxiv_data1/oa_pdf/3e/f0/main.PMC4685211.pdf
"26 (2003) 243 e248, http://dx.doi.org/10.1016/S1386- 6346(03)00089-5 .",Non-OADS,/arxiv_data1/oa_pdf/3e/f0/main.PMC4685211.pdf
"Imaging 96(2015) 301 e303, http://dx.doi.org/10.1016/j.diii.2013.07.001 .",OADS,/arxiv_data1/oa_pdf/3e/f0/main.PMC4685211.pdf
"449 (2006) 730 e733, http://dx.doi.org/ 10.1007/s00428-006-0320-4 .",Non-OADS,/arxiv_data1/oa_pdf/3e/f0/main.PMC4685211.pdf
"8 (2004) 342 e346, http://dx.doi.org/10.1053/j.anndiagpath.2004.08.004 .",Non-OADS,/arxiv_data1/oa_pdf/3e/f0/main.PMC4685211.pdf
"10 (2014)151e153, http://dx.doi.org/10.4103/0972-9941.134879 .",Non-OADS,/arxiv_data1/oa_pdf/3e/f0/main.PMC4685211.pdf
"24 (2014) 43 e50, http://dx.doi.org/10.1016/j.ijid.2014.01.012 .",OADS,/arxiv_data1/oa_pdf/3e/f0/main.PMC4685211.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/57/a9/main.PMC4685212.pdf
evaluated the use of the melt granulation (MG) process to enhance the tableting properties of poorly compactableContents lists available at ScienceDirect journal homepage: www.elsevier.com/locate/rinphsResults in Pharma Sciences http://dx.doi.org/10.1016/j.rinphs.2015.09.001 2211-2863/ &2015 The Authors.,OADS,/arxiv_data1/oa_pdf/57/a9/main.PMC4685212.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/57/a9/main.PMC4685212.pdf
"The 129 genome: highly  reprogrammable by nuclear transfer The uniqueness of the 129 strain was  further recognized in somatic cell nuclear Received: July 13, 2015 Accepted: August 25, 2015Published online in J-STAGE: September 20, 2015 ©2015 by the Society for Reproduction and Development Correspondence: A Ogura (e-mail: ogura@rtc.riken.go.jp) This is an open-access article distributed under the terms of the Creative Commons Attribution Non- Commercial No Derivatives (by-nc-nd) License <http://creativecommons.org/licenses/by-nc-nd/3.0/>.Journal of Reproduction and Development, Vol.",Non-OADS,/arxiv_data1/oa_pdf/43/99/jrd-61-489.PMC4685213.pdf
"Bovine oocytes injected with MKP1 mRNA, which encodes  a dual-specificity MAPK phosphatase, resumed and progressed  Received: May 28, 2015 Accepted: June 30, 2015 ©2015 by the Society for Reproduction and Development Correspondence: R. Prochazka (e-mail: prochazka@iapg.cas.cz) This is an open-access article distributed under the terms of the Creative  Commons Attribution Non-Commercial No Derivatives (by-nc-nd) License <http://creativecommons.org/licenses/by-nc-nd/3.0/>.Journal of Reproduction and Development, Vol.",Non-OADS,/arxiv_data1/oa_pdf/c5/c1/jrd-61-495.PMC4685214.pdf
"All animal  experiments were approved and performed under the guidelines of  the Animal Research Committee, Kyoto University.Received: March 24, 2015 Accepted: July 1, 2015Published online in J-STAGE: July 27, 2015 ©2015 by the Society for Reproduction and Development Correspondence: M Yamada (e-mail: masayasu@kais.kyoto-u.ac.jp) This is an open-access article distributed under the terms of the Creative  Commons Attribution Non-Commercial No Derivatives (by-nc-nd) License <http://creativecommons.org/licenses/by-nc-nd/3.0/>.Journal of Reproduction and Development, Vol.",Non-OADS,/arxiv_data1/oa_pdf/02/b8/jrd-61-503.PMC4685215.pdf
"Wakayama and Yanagimachi [15] demonstrated that live offspring  Received: February 19, 2015 Accepted: July 2, 2015Published online in J-STAGE: August 3, 2015 ©2015 by the Society for Reproduction and Development Correspondence: H Watanabe (e-mail: h-wata@asahikawa-med.ac.jp) This is an open-access article distributed under the terms of the Creative  Commons Attribution Non-Commercial No Derivatives (by-nc-nd) License <http://creativecommons.org/licenses/by-nc-nd/3.0/>.Journal of Reproduction and Development, Vol.",Non-OADS,/arxiv_data1/oa_pdf/ce/d9/jrd-61-511.PMC4685216.pdf
"This	is	an	open-access	article	distributed	under	the	terms	of	the	Creative 	 Commons	 Attribution	Non-Commercial	No	Derivatives	(by-nc-nd)	License 	 <http://creativecommons.org/licenses/by-nc-nd/3.0/>.Journal of Reproduction and Development, Vol.",Non-OADS,/arxiv_data1/oa_pdf/03/97/jrd-61-519.PMC4685217.pdf
"However, there are very few studies that have directly  compared the cryosurvival of embryos vitrified using these systems.Received: May 18, 2015 Accepted: July 11, 2015Published online in J-STAGE: July 23, 2015 ©2015 by the Society for Reproduction and Development Correspondence: LK Bartolac (e-mail: louise.bartolac@sydney.edu.au) This is an open-access article distributed under the terms of the Creative  Commons Attribution Non-Commercial No Derivatives (by-nc-nd) License <http://creativecommons.org/licenses/by-nc-nd/3.0/>.Journal of Reproduction and Development, Vol.",Non-OADS,/arxiv_data1/oa_pdf/58/5f/jrd-61-525.PMC4685218.pdf
"Contrary to OCT4, ncRNAs in XIC, have been known  to have low sequence homology caused by rapid evolution [18],  Received: February 20, 2015 Accepted: July 13, 2015Published online in J-STAGE: August 10, 2015 ©2015 by the Society for Reproduction and Development Correspondence: C-K Lee (e-mail: leeck@snu.ac.kr) This is an open-access article distributed under the terms of the Creative  Commons Attribution Non-Commercial No Derivatives (by-nc-nd) License <http://creativecommons.org/licenses/by-nc-nd/3.0/>.Journal of Reproduction and Development, Vol.",Non-OADS,/arxiv_data1/oa_pdf/76/c2/jrd-61-533.PMC4685219.pdf
"This is an open-access article distributed under the terms of the Creative  Commons Attribution Non-Commercial No Derivatives (by-nc-nd) License <http://creativecommons.org/licenses/by-nc-nd/3.0/>.Journal of Reproduction and Development, Vol.",Non-OADS,/arxiv_data1/oa_pdf/cb/04/jrd-61-541.PMC4685220.pdf
"Received: May 7, 2015 Accepted: August 6, 2015Published online in J-STAGE: September 12, 2015 ©2015 by the Society for Reproduction and Development Correspondence: HG Kim (e-mail: hg-kim@korea.ac.kr) and SH Hyun (e-mail: shhyun@cbu.ac.kr) This is an open-access article distributed under the terms of the Creative  Commons Attribution Non-Commercial No Derivatives (by-nc-nd) License <http://creativecommons.org/licenses/by-nc-nd/3.0/>.Journal of Reproduction and Development, Vol.",Non-OADS,/arxiv_data1/oa_pdf/11/c5/jrd-61-549.PMC4685221.pdf
"They were provided with water and mouse chow ad libitum and maintained on a 14/10 h light/dark cycle in the Laboratory Animal Facility of the College of Animal Received: April 20, 2015 Accepted: August 7, 2015Published online in J-STAGE: September 28, 2015 ©2015 by the Society for Reproduction and Development Correspondence: W Zhang (e-mail: zwcfz1221@126.com) This is an open-access article distributed under the terms of the Creative  Commons Attribution Non-Commercial No Derivatives (by-nc-nd) License <http://creativecommons.org/licenses/by-nc-nd/3.0/>.Journal of Reproduction and Development, Vol.",Non-OADS,/arxiv_data1/oa_pdf/aa/41/jrd-61-559.PMC4685222.pdf
"Materials and Methods Cows The study was carried out at the Clinic for Cattle of the University  of Veterinary Medicine, Hannover, Germany, between September Received: February 15, 2015 Accepted: August 18, 2015Published online in J-STAGE: September 18, 2015 ©2015 by the Society for Reproduction and Development Correspondence: M Heppelmann (e-mail: Maike.Heppelmann@tiho-hannover.de) This is an open-access article distributed under the terms of the Creative  Commons Attribution Non-Commercial No Derivatives (by-nc-nd) License <http://creativecommons.org/licenses/by-nc-nd/3.0/>.Journal of Reproduction and Development, Vol.",Non-OADS,/arxiv_data1/oa_pdf/45/30/jrd-61-565.PMC4685223.pdf
"To our knowledge, the distinctive features of CPA treatment regimens applied by different reports using different vitrification methods have  not been compared for the vitrification of porcine oocytes using a  Received: July 1, 2015 Accepted: August 25, 2015Published online in J-STAGE: September 27, 2015 ©2015 by the Society for Reproduction and Development Correspondence: T Somfai (e-mail: somfai@affrc.go.jp) This is an open-access article distributed under the terms of the Creative  Commons Attribution Non-Commercial No Derivatives (by-nc-nd) License <http://creativecommons.org/licenses/by-nc-nd/3.0/>.Journal of Reproduction and Development, Vol.",Non-OADS,/arxiv_data1/oa_pdf/8f/34/jrd-61-571.PMC4685224.pdf
"Thus, the duration of  Received: July 8, 2015 Accepted: August 31, 2015Published online in J-STAGE: September 27, 2015 ©2015 by the Society for Reproduction and Development Correspondence: T Tharasanit (e-mail: theerawat.t@chula.ac.th) This is an open-access article distributed under the terms of the Creative  Commons Attribution Non-Commercial No Derivatives (by-nc-nd) License <http://creativecommons.org/licenses/by-nc-nd/3.0/>.Journal of Reproduction and Development, Vol.",Non-OADS,/arxiv_data1/oa_pdf/aa/08/jrd-61-581.PMC4685225.pdf
"In	addition,	the	high	 affinity	of	the	present	ZF-binding	 module	pair	was	compared	 with	 that	of	a	previously	 reported	ZF-binding	 module	pair	having	a	high	 affinity	score	by	a	single-strand	 annealing	 (SSA)	assay	using	partial	 eGFP-coding	 plasmid	DNA	in	order	to	clarify	the	“context-dependent 	 effect”	of	the	DNA	sequence.Received:	June	29,	2015 Accepted:	 August	31,	2015 Published	online	in	J-STAGE:	October	9,	2015 ©2015	by	the	Society	for	Reproduction	and	Development Correspondence:	W	Fujii	(e-mail:	awtrfj@mail.ecc.u-tokyo.ac.jp)	and 	  K	Naito	(e-mail:	aknaito@mail.ecc.u-tokyo.ac.jp) This	is	an	open-access	article	distributed	under	the	terms	of	the	Creative 	 Commons	 Attribution	Non-Commercial	No	Derivatives	(by-nc-nd)	License 	 <http://creativecommons.org/licenses/by-nc-nd/3.0/>.Journal of Reproduction and Development, Vol.",Non-OADS,/arxiv_data1/oa_pdf/f2/b6/jrd-61-589.PMC4685226.pdf
"In the present study, we analyzed the clinical data for human  embryos manipulated with ART, which reportedly contained a  Received: April 22, 2015 Accepted: June 30, 2015Published online in J-STAGE: September 4, 2015 ©2015 by the Society for Reproduction and Development Correspondence: N Yamauchi (e-mail: ny0531@agr.kyushu-u.ac.jp) This is an open-access article distributed under the terms of the Creative  Commons Attribution Non-Commercial No Derivatives (by-nc-nd) License <http://creativecommons.org/licenses/by-nc-nd/3.0/>.Journal of Reproduction and Development, Vol.",Non-OADS,/arxiv_data1/oa_pdf/fc/bb/jrd-61-595.PMC4685227.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/84/6c/main.PMC4685230.pdf
Contents lists available at ScienceDirect Annals of Medicine and Surgery journal homepage: www.annalsjournal.com http://dx.doi.org/10.1016/j.amsu.2015.11.001 2049-0801/ ©2015 The Author.,Non-OADS,/arxiv_data1/oa_pdf/84/6c/main.PMC4685230.pdf
"2015 (2015), http://dx.doi.org/10.1155/2015/194541 .",Non-OADS,/arxiv_data1/oa_pdf/84/6c/main.PMC4685230.pdf
"10 (2009) 104, http://dx.doi.org/10.1186/1471-2350-10- 104.",Non-OADS,/arxiv_data1/oa_pdf/84/6c/main.PMC4685230.pdf
Available from: http://www.ncbi.nlm.,Non-OADS,/arxiv_data1/oa_pdf/84/6c/main.PMC4685230.pdf
Contents lists available at ScienceDirect Prostate International journal homepage: http://p-international.org.,Non-OADS,/arxiv_data1/oa_pdf/98/84/main.PMC4685231.pdf
"http://dx.doi.org/10.1016/j.prnil.2015.09.006 p2287-8882 e2287-903X/Copyright ©2015 Asian Paci ﬁc Prostate Society, Published by Elsevier.",Non-OADS,/arxiv_data1/oa_pdf/98/84/main.PMC4685231.pdf
Available from: https://www.prias-project.org/ .,Non-OADS,/arxiv_data1/oa_pdf/98/84/main.PMC4685231.pdf
Avail- able from: http://dx.doi.org/10.1111/bju.12892 .,Non-OADS,/arxiv_data1/oa_pdf/98/84/main.PMC4685231.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/f9/76/main.PMC4685232.pdf
This is an open access article under the CC BY-NC- ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/f9/76/main.PMC4685232.pdf
URL: www.ksu.edu.sahttp://dx.doi.org/10.1016/j.jsha.2015.05.002 Production and hosting by Elsevier,Non-OADS,/arxiv_data1/oa_pdf/f9/76/main.PMC4685232.pdf
Contents lists available at ScienceDirect Prostate International journal homepage: http://p-international.org.,Non-OADS,/arxiv_data1/oa_pdf/f1/c8/main.PMC4685234.pdf
"http://dx.doi.org/10.1016/j.prnil.2015.09.005 p2287-8882 e2287-903X/Copyright ©2015 Asian Paci ﬁc Prostate Society, Published by Elsevier.",Non-OADS,/arxiv_data1/oa_pdf/f1/c8/main.PMC4685234.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/de/10/main.PMC4685236.pdf
Contents lists available at ScienceDirect Annals of Medicine and Surgery journal homepage: www.annalsjournal.com http://dx.doi.org/10.1016/j.amsu.2015.10.020 2049-0801/ ©2015 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/de/10/main.PMC4685236.pdf
"Guarantor Francesco Selvaggi, MD, EBSQ Colo. Unit of General Surgery, Second University of Naples Piazza Miraglia, 2 e80138 Naples, Italy Tel/fax: þ39 818902291 Email: fselvaggi@hotmail.com References [1] G. Latella, G. Rogler, G. Bamias, et al., Results of the 4th scienti ﬁc workshop of the ECCO (I): pathophysiology of intestinal ﬁbrosis in IBD, J. Crohns Colitis 8 (2014) 1147 e1165, http://dx.doi.org/10.1016/j.crohns.2014.03.008 .",Non-OADS,/arxiv_data1/oa_pdf/de/10/main.PMC4685236.pdf
"2014 (2014) 340341, http://dx.doi.org/10.1155/ 2014/340341 .",Non-OADS,/arxiv_data1/oa_pdf/de/10/main.PMC4685236.pdf
"2) (2013) S9, http://dx.doi.org/10.1186/1471-2482-13- S2-S9 .",Non-OADS,/arxiv_data1/oa_pdf/de/10/main.PMC4685236.pdf
"[14] S. Canonico, R. Benevento, G. Perna, R. Guerniero, G. Sciaudone, G. Pellino, A. Santoriello, F. Selvaggi, Sutureless ﬁxation with ﬁbrin glue of lightweight mesh in open inguinal hernia repair: effect on postoperative pain: a double- blind, randomized trial versus standard heavyweight mesh, Surgery 153(2013) 126 e130, http://dx.doi.org/10.1016/j.surg.2012.06.024 .",Non-OADS,/arxiv_data1/oa_pdf/de/10/main.PMC4685236.pdf
"2) (2013) S57, http://dx.doi.org/10.1186/1471-2482-13-S2- S57.",Non-OADS,/arxiv_data1/oa_pdf/de/10/main.PMC4685236.pdf
"18 (2014) 847 e850, http://dx.doi.org/10.1007/s10151-014-1180-6 .",Non-OADS,/arxiv_data1/oa_pdf/de/10/main.PMC4685236.pdf
"29 (2014) 1401 e1410, http://dx.doi.org/ 10.1007/s00384-014-1999-3 .",Non-OADS,/arxiv_data1/oa_pdf/de/10/main.PMC4685236.pdf
"17 (2011) E28 eE30, http://dx.doi.org/10.1002/ ibd.21642 .",Non-OADS,/arxiv_data1/oa_pdf/de/10/main.PMC4685236.pdf
"46 (2011) 163 e168, http://dx.doi.org/ 10.1159/000324398 .",Non-OADS,/arxiv_data1/oa_pdf/de/10/main.PMC4685236.pdf
"1) (2012) S31, http://dx.doi.org/10.1186/1471-2482-12- S1-S31 .",Non-OADS,/arxiv_data1/oa_pdf/de/10/main.PMC4685236.pdf
"1)(2014) S156 eS158, http://dx.doi.org/10.1016/j.ijsu.2014.05.022 .",Non-OADS,/arxiv_data1/oa_pdf/de/10/main.PMC4685236.pdf
"[45] L. Egan, R. D'Inca, T. Jess, et al., Non-colorectal intestinal tract carcinomas in inﬂammatory bowel disease: results of the 3rd ECCO Pathogenesis Scienti ﬁc Workshop (II), J. Crohns Colitis 8 (2014) 19 e30,http://dx.doi.org/10.1016/ j.crohns.2013.04.009 .",Non-OADS,/arxiv_data1/oa_pdf/de/10/main.PMC4685236.pdf
http://dx.doi.org/10.1093/ecco-jcc/jjv141 .,Non-OADS,/arxiv_data1/oa_pdf/de/10/main.PMC4685236.pdf
"Gee, E. Nicolai, et al., Evaluation of quantitative PET/MR enterography biomarkers for discrimination of in ﬂammatory strictures from ﬁbrotic strictures in Crohn disease, Radiology (2015 Oct 5) 150566 [Epub ahead of print], http://dx.doi.org/10.1148/radiol.2015150566 .",Non-OADS,/arxiv_data1/oa_pdf/de/10/main.PMC4685236.pdf
"2014 (2014) 146281, http://dx.doi.org/10.1155/2014/146281 .",Non-OADS,/arxiv_data1/oa_pdf/de/10/main.PMC4685236.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/7c/68/main.PMC4685237.pdf
This is an open access article under the CC BY- NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/7c/68/main.PMC4685237.pdf
URL: www.ksu.edu.sahttp://dx.doi.org/10.1016/j.jsha.2015.06.003Production and hosting by Elsevier,OADS,/arxiv_data1/oa_pdf/7c/68/main.PMC4685237.pdf
Contents lists available at ScienceDirect Prostate International journal homepage: http://p-international.org.,Non-OADS,/arxiv_data1/oa_pdf/d0/95/main.PMC4685238.pdf
"http://dx.doi.org/10.1016/j.prnil.2015.09.003 p2287-8882 e2287-903X/Copyright ©2015 Asian Paci ﬁc Prostate Society, Published by Elsevier.",Non-OADS,/arxiv_data1/oa_pdf/d0/95/main.PMC4685238.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/34/05/main.PMC4685239.pdf
Contents lists available at ScienceDirect Annals of Medicine and Surgery journal homepage: www.annalsjournal.com http://dx.doi.org/10.1016/j.amsu.2015.10.018 2049-0801/ ©2015 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/34/05/main.PMC4685239.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/6b/ca/main.PMC4685240.pdf
This is an open access article under the CC BY- NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/6b/ca/main.PMC4685240.pdf
URL: www.ksu.edu.sahttp://dx.doi.org/10.1016/j.jsha.2015.09.001 Production and hosting by Elsevier,Non-OADS,/arxiv_data1/oa_pdf/6b/ca/main.PMC4685240.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org /licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/f8/59/main.PMC4685242.pdf
This is an open access article under the CC BY- NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/f8/59/main.PMC4685242.pdf
URL: www.ksu.edu.sahttp://dx.doi.org/10.1016/j.jsha.2015.04.001 Production and hosting by Elsevier,Non-OADS,/arxiv_data1/oa_pdf/f8/59/main.PMC4685242.pdf
"In NSCs derived from human embryonic  stem cells (hESCs), VEGF-C/VEGFR3 mediates intracellular activation of AKT and ERK  This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/3.0/ ).",Non-OADS,/arxiv_data1/oa_pdf/ea/96/nihms743270.PMC4685253.pdf
"SUPPLEMENTAL INFORMATION Supplemental Information includes Supplemental Experimental Procedures, six figures, and two tables and can be found with this  article online at http://dx.doi.org/10.1016/j.celrep.2015.01.049 .",OADS,/arxiv_data1/oa_pdf/ea/96/nihms743270.PMC4685253.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/), permitting all non-commercial use , distribution, and reproduction in any medium, provided the original work is properly cited.1 Citation: Journal of Extracellular Vesicles 2015, 4: 29338 - http://dx.doi.org/10.3402/jev.v4.29338 (page number not for citation purpose)",Non-OADS,/arxiv_data1/oa_pdf/1e/04/JEV-4-29338.PMC4685295.pdf
"2 (page number not for citation purpose)Citation: Journal of Extracellular Vesicles 2015, 4: 29338 - http://dx.doi.org/10.3402/jev.v4.29338",OADS,/arxiv_data1/oa_pdf/1e/04/JEV-4-29338.PMC4685295.pdf
"Table I. Trauma patients characteristics (n /C30169) Median (IQR) N (%) Age (years) 34 (23, 51) Male 122 (72) ISS 29 (19, 36)Penetrating 47 (28)Platelet count, 10 9/L 231 (185, 276) INR 1.3 (1.1, 1.5)24 h transfused, total blood products, U11 (4, 21) 169 (100) 24 h RBC, U 5 (2, 10) 169 (100) 24 h FFP , U 6 (3, 11) 154 (91) 24 h platelets, U 12 (6, 18) 46 (27)24 h mortality 22 (13) ISS, Injury Severity Score; INR, International Normalized Ratio.Relationship between microvesicles and outcomes following trauma Citation: Journal of Extracellular Vesicles 2015, 4: 29338 - http://dx.doi.org/10.3402/jev.v4.29338 3 (page number not for citation purpose)",Non-OADS,/arxiv_data1/oa_pdf/1e/04/JEV-4-29338.PMC4685295.pdf
"4 (page number not for citation purpose)Citation: Journal of Extracellular Vesicles 2015, 4: 29338 - http://dx.doi.org/10.3402/jev.v4.29338",OADS,/arxiv_data1/oa_pdf/1e/04/JEV-4-29338.PMC4685295.pdf
"*Denotes p B0.005 compared to alive.Relationship between microvesicles and outcomes following trauma Citation: Journal of Extracellular Vesicles 2015, 4: 29338 - http://dx.doi.org/10.3402/jev.v4.29338 5 (page number not for citation purpose)",OADS,/arxiv_data1/oa_pdf/1e/04/JEV-4-29338.PMC4685295.pdf
"6 (page number not for citation purpose)Citation: Journal of Extracellular Vesicles 2015, 4: 29338 - http://dx.doi.org/10.3402/jev.v4.29338",OADS,/arxiv_data1/oa_pdf/1e/04/JEV-4-29338.PMC4685295.pdf
"Finally, the transfusion requirements results could potentially be affected by thenumber of patients who died soon after hospital admissionRelationship between microvesicles and outcomes following trauma Citation: Journal of Extracellular Vesicles 2015, 4: 29338 - http://dx.doi.org/10.3402/jev.v4.29338 7 (page number not for citation purpose)",Non-OADS,/arxiv_data1/oa_pdf/1e/04/JEV-4-29338.PMC4685295.pdf
"2015;4:27066, doi: http://dx.doi.org/10.3402/jev.v4.27066 3.",Non-OADS,/arxiv_data1/oa_pdf/1e/04/JEV-4-29338.PMC4685295.pdf
Available from: http://webappa.cbc.gov/cgi-bin/broker.exe 11.,OADS,/arxiv_data1/oa_pdf/1e/04/JEV-4-29338.PMC4685295.pdf
"2014;3:25625, doi: http://dx.doi.org/10.3402/jev.v3.25625 16.",Non-OADS,/arxiv_data1/oa_pdf/1e/04/JEV-4-29338.PMC4685295.pdf
"8 (page number not for citation purpose)Citation: Journal of Extracellular Vesicles 2015, 4: 29338 - http://dx.doi.org/10.3402/jev.v4.29338",OADS,/arxiv_data1/oa_pdf/1e/04/JEV-4-29338.PMC4685295.pdf
"2014;3: 20795, doi: http://dx.doi.org/10.3402/jev.v3.20795 29.",Non-OADS,/arxiv_data1/oa_pdf/1e/04/JEV-4-29338.PMC4685295.pdf
"2015;46:775 /C180.Relationship between microvesicles and outcomes following trauma Citation: Journal of Extracellular Vesicles 2015, 4: 29338 - http://dx.doi.org/10.3402/jev.v4.29338 9 (page number not for citation purpose)",OADS,/arxiv_data1/oa_pdf/1e/04/JEV-4-29338.PMC4685295.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/), permitting all non-commercial use , distribution, and reproduction in any medium, provided the original work is properly cited.1 Citation: Infection Ecology and Epidemiology 2015, 5: 30264 - http://dx.doi.org/10.3402/iee.v5.30264 (page number not for citation purpose)",Non-OADS,/arxiv_data1/oa_pdf/e5/83/IEE-5-30264.PMC4685299.pdf
"2 (page number not for citation purpose)Citation: Infection Ecology and Epidemiology 2015, 5: 30264 - http://dx.doi.org/10.3402/iee.v5.30264",Non-OADS,/arxiv_data1/oa_pdf/e5/83/IEE-5-30264.PMC4685299.pdf
"The MPH at Virginia Tech has been so well- received locally, nationally, and globally that the faculty are currently working on developing an undergraduatedegree in public health with both a core One Health course and a One Health concentration.One Health meets Education Citation: Infection Ecology and Epidemiology 2015, 5: 30264 - http://dx.doi.org/10.3402/iee.v5.30264 3 (page number not for citation purpose)",Non-OADS,/arxiv_data1/oa_pdf/e5/83/IEE-5-30264.PMC4685299.pdf
"SUPPLEMENTARY MATERIAL  is linked to the online version of the paper at  http://www.nature.com/ajg       Am J Gastroenterol   2015; 110:1640–1646; doi: 10.1038/ajg.2015.206; published online 14 July 2015     1   Department of Community Health Sciences, University of Manitoba ,  Winnipeg ,  Manitoba ,  Canada   ;     2   Screening Programs, CancerCare Manitoba ,  Winnipeg ,   Manitoba ,  Canada   ;     3   Epidemiology and Cancer Registry, CancerCare Manitoba ,  Winnipeg ,  Manitoba ,  Canada   ;     4   Department of Internal Medicine, University of  Manitoba ,  Winnipeg ,  Manitoba ,  Canada   ;     5   Medical Oncology and Haematology, CancerCare Manitoba ,  Winnipeg ,  Manitoba ,  Canada   .",Non-OADS,/arxiv_data1/oa_pdf/fc/85/ajg2015206a.PMC4685313.pdf
Available from     http://nccrt.org/tools/80-percent-by-2018/   16.,OADS,/arxiv_data1/oa_pdf/fc/85/ajg2015206a.PMC4685313.pdf
"To view a copy of this license, visit  http://creativecommons.org/licenses/by-nc-sa/4.0/",Non-OADS,/arxiv_data1/oa_pdf/fc/85/ajg2015206a.PMC4685313.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by- nc-sa/4.0/Hyaluronan –immune system –tumor angiogenesis FM Spinelli and G Demarchi 9 Clinical & Translational Immunology",Non-OADS,/arxiv_data1/oa_pdf/18/19/cti201535a.PMC4685440.pdf
"This Open Access article is distributed under the terms of the Creative Commons Attribution Noncommercial License (http://creativecommons.org/licenses/by-nc/4.0/) which permits any non- commercial use, distribution, and reproduction in any medium, provided the original author(s) and the source are credited.HIGH ALTITUDE MEDICINE & BIOLOGY Volume 16, Number 4, 2015DOI: 10.1089/ham.2015.0055 352",Non-OADS,/arxiv_data1/oa_pdf/f2/de/ham.2015.0055.PMC4685480.pdf
"This Open Access article is distributed under the terms of the Creative Commons Attribution Noncommercial License (http://creativecommons.org/licenses/by-nc/4.0/) which permits any noncommercial use,distribution, and reproduction in any medium, provided the original author(s) and the source are credited.JOURNAL OF AEROSOL MEDICINE AND PULMONARY DRUG DELIVERY Volume 28, Number 6, 2015Mary Ann Liebert, Inc.Pp.",Non-OADS,/arxiv_data1/oa_pdf/27/bc/jamp.2015.1224.PMC4685483.pdf
Available at http://www.wma .net/en/30publications/10policies/b3/17c.pdf.,Non-OADS,/arxiv_data1/oa_pdf/27/bc/jamp.2015.1224.PMC4685483.pdf
Available at http://www.goldcopd.org/Guidelines/ guidelines-global-strategy-for-diagnosis-management-2007-3 .html.,Non-OADS,/arxiv_data1/oa_pdf/27/bc/jamp.2015.1224.PMC4685483.pdf
Available at http://www.goldcopd.org/guidelines-global-strategy-for-diagnosis-management.html.,Non-OADS,/arxiv_data1/oa_pdf/27/bc/jamp.2015.1224.PMC4685483.pdf
"Open AccessB G Challis, N J W Albrechtsen and othersPhenotypic heterogeneity of glucagonomasID: 15-0105; December 2015 DOI: 10.1530/EDM-15-0105 This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivs 3.0Unported License .q2015 The authors http://www.edmcasereports.com Published by Bioscientiﬁca Ltd.",Non-OADS,/arxiv_data1/oa_pdf/f0/be/edmcr-2015-150105.PMC4685488.pdf
"B G Challis, N J W Albrechtsen and othersPhenotypic heterogeneity of glucagonomasID: 15-0105; December 2015 DOI: 10.1530/EDM-15-0105 http://www.edmcasereports.com 2",OADS,/arxiv_data1/oa_pdf/f0/be/edmcr-2015-150105.PMC4685488.pdf
"Assayed hormone Case 1 Case 2Reference range Proglucagon (pM) 3504 786 10–40 PYY (pg/ml) 237 – 25–140PP (pM) 542 7085 0–300 Somatostatin (pM) 74 63 0–150 VIP (pM) 14 15 0–30Gastrin (pM) 10 17 0–40 Chromogranin A (pM) 146 1380 0–60 Chromogranin B (pM) 205 425 0–150 B G Challis, N J W Albrechtsen and othersPhenotypic heterogeneity of glucagonomasID: 15-0105; December 2015 DOI: 10.1530/EDM-15-0105 http://www.edmcasereports.com 3",Non-OADS,/arxiv_data1/oa_pdf/f0/be/edmcr-2015-150105.PMC4685488.pdf
"Assayed hormone Case 1 (pM) Case 2 (pM)Reference range (pM) Total glucagon 2112 (1176) 552 (240) 3–20 Intact glucagon 123 (108) 655 (337) 3–20 Intact GLP-1 853 (491) 190 (123) 1–15Total amidated GLP-1426 (174) 282 (138) 5–40 Total glycine extended GLP-1400 (252) 128 (80) 5–20 GLP-2 366 (60) 426 (138) 5–50 Glicentin 1940 (928) 278 (150) 10–50Oxyntomodulin 172 (51) 8 (8) 5–50 B G Challis, N J W Albrechtsen and othersPhenotypic heterogeneity of glucagonomasID: 15-0105; December 2015 DOI: 10.1530/EDM-15-0105 http://www.edmcasereports.com 4",Non-OADS,/arxiv_data1/oa_pdf/f0/be/edmcr-2015-150105.PMC4685488.pdf
"B G Challis, N J W Albrechtsen and othersPhenotypic heterogeneity of glucagonomasID: 15-0105; December 2015 DOI: 10.1530/EDM-15-0105 http://www.edmcasereports.com 5",OADS,/arxiv_data1/oa_pdf/f0/be/edmcr-2015-150105.PMC4685488.pdf
"(doi:10.1172/JCI7456 ) 4 Roberts RE, Zhao M, Whitelaw BC, Ramage J, Diaz-Cano S, Roux CWI, Quaglia A, Huang GC & Aylwin SJB 2012 GLP-1 and glucagon secretionfrom a pancreatic neuroendocrine tumor causing diabetes and B G Challis, N J W Albrechtsen and othersPhenotypic heterogeneity of glucagonomasID: 15-0105; December 2015 DOI: 10.1530/EDM-15-0105 http://www.edmcasereports.com 6",Non-OADS,/arxiv_data1/oa_pdf/f0/be/edmcr-2015-150105.PMC4685488.pdf
"( doi:10.4158/EP.9.1.22 ) Received in ﬁnal form 16 November 2015 Accepted 1 December 2015 B G Challis, N J W Albrechtsen and othersPhenotypic heterogeneity of glucagonomasID: 15-0105; December 2015 DOI: 10.1530/EDM-15-0105 http://www.edmcasereports.com 7",Non-OADS,/arxiv_data1/oa_pdf/f0/be/edmcr-2015-150105.PMC4685488.pdf
"This Open Access article is distributed under the terms of the Creative Commons Attribution Noncommercial License (http://creativecommons.org/licenses/by-nc/4.0/) which permits any noncommercial use,distribution, and reproduction in any medium, provided the original author(s) and the source are credited.JOURNAL OF AEROSOL MEDICINE AND PULMONARY DRUG DELIVERY Volume 28, Number 6, 2015Mary Ann Liebert, Inc.Pp.",Non-OADS,/arxiv_data1/oa_pdf/5e/da/jamp.2015.1225.PMC4685503.pdf
Available at http://www.em a.europa.eu/docs/en_GB/ document_library/EPAR_-_Summary_for_the_public/human/ 002751/WC500168426.pdf.,Non-OADS,/arxiv_data1/oa_pdf/5e/da/jamp.2015.1225.PMC4685503.pdf
Available at http://www.accessdata.fda.gov/drugsatfda_docs/label/2014/ 205625s000lbl.pdf.,Non-OADS,/arxiv_data1/oa_pdf/5e/da/jamp.2015.1225.PMC4685503.pdf
"This Open Access article is distributed under the terms of the Creative Commons Attribution Noncommercial License (http://creativecommons.org/licenses/by-nc/4.0/) which permits any noncommercial use,distribution, and reproduction in any medium, provided the original author(s) and the source are credited.JOURNAL OF AEROSOL MEDICINE AND PULMONARY DRUG DELIVERY Volume 28, Number 6, 2015Mary Ann Liebert, Inc.Pp.",Non-OADS,/arxiv_data1/oa_pdf/c8/54/jamp.2015.1223.PMC4685506.pdf
Available at http://www.ginasthma.com.,Non-OADS,/arxiv_data1/oa_pdf/c8/54/jamp.2015.1223.PMC4685506.pdf
Available at http://www.ema.europa.eu/docs/ en_GB/document_library/EPAR_-_Summary_for_the_ public/human/002809/WC500167432.pdf.,Non-OADS,/arxiv_data1/oa_pdf/c8/54/jamp.2015.1223.PMC4685506.pdf
FDA Medication Guide: ANORO/C210ELLIPTA/C2102013: Available at http://www.fda.gov/downloads/drugs/drugsafety/ ucm380278.pdf.,Non-OADS,/arxiv_data1/oa_pdf/c8/54/jamp.2015.1223.PMC4685506.pdf
Available at http://www.accessdata.fda.gov/drugsatfda_docs/ label/2014/205625s000lbl.pdf.,Non-OADS,/arxiv_data1/oa_pdf/c8/54/jamp.2015.1223.PMC4685506.pdf
Available at http://www.ema.europa.eu/docs/en_GB/ document_library/EPAR_-_Summary_for_the_public/human/ 002673/WC500157636.pdf.,Non-OADS,/arxiv_data1/oa_pdf/c8/54/jamp.2015.1223.PMC4685506.pdf
Avail- able at http://www.fda.gov/downloads/drugs/drugsafety/ ucm352347.pdf.,Non-OADS,/arxiv_data1/oa_pdf/c8/54/jamp.2015.1223.PMC4685506.pdf
Available at http://www.fda.gov/Regulatory Information/Guidances/ucm259748.htm.,Non-OADS,/arxiv_data1/oa_pdf/c8/54/jamp.2015.1223.PMC4685506.pdf
Available at http://www.nhlbi .nih.gov/ﬁles/docs/guidelines/asthgdln.pdf.,Non-OADS,/arxiv_data1/oa_pdf/c8/54/jamp.2015.1223.PMC4685506.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivatives License ( http://creativecommons.org/licenses/by-nc-nd/ 4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited, and is not alter ed, transformed, or built upon in any way.CONTACT Jan Ostermann jano@mailbox.sc.eduAIDS CARE, 2015 VOL.",Non-OADS,/arxiv_data1/oa_pdf/0a/bb/caic-27-059.PMC4685596.pdf
"S1, 59 –64 http://dx.doi.org/10.1080/09540121.2015.1090534",Non-OADS,/arxiv_data1/oa_pdf/0a/bb/caic-27-059.PMC4685596.pdf
"Published by Taylor & Francis This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivativesLicense ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited, and is not altered, transformed, or built upon in any way.Critical Public Health, 2014 Vol.",Non-OADS,/arxiv_data1/oa_pdf/ec/80/ccph-24-196.PMC4685599.pdf
"2, 196 –209, http://dx.doi.org/10.1080/09581596.2013.872771",Non-OADS,/arxiv_data1/oa_pdf/ec/80/ccph-24-196.PMC4685599.pdf
"3, 241–249, http://dx.doi.org/10.1080/10803548.2015.1081764 Exposure to ﬂour dust in the occupational environment Agata Stobnicka∗and Rafał L. Górny Central Institute for Labour Protection – National Research Institute (CIOP-PIB), Poland Exposure to ﬂour dust can be found in the food industry and animal feed production.",Non-OADS,/arxiv_data1/oa_pdf/25/a0/tose-21-241.PMC4685600.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivatives License ( http://creativecommons.org/licenses/ by-nc-nd/4.0/ ), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited, and is not alter ed, transformed, or built upon in any way.",Non-OADS,/arxiv_data1/oa_pdf/25/a0/tose-21-241.PMC4685600.pdf
"Avail-able from: http://www.irsst.qc.ca/en/-irsst-publication- characterization-of-dusts-in-traditional-bakeries-r-760.html [15] Tiikkainen U, Louhelainen K, Nordman H. The Nordic Expert Group for Criteria Documentation of Health Risksfrom Chemicals.",Non-OADS,/arxiv_data1/oa_pdf/25/a0/tose-21-241.PMC4685600.pdf
Available from: http://guidance.echa.europa.eu /docs/guidance_document/information_requirements_r14_en.pdf.,Non-OADS,/arxiv_data1/oa_pdf/25/a0/tose-21-241.PMC4685600.pdf
Available from: http://osha.europa.eu/en/ seminars/occupational-risks-from-biological-agents-facing- up-the-challenges.,Non-OADS,/arxiv_data1/oa_pdf/25/a0/tose-21-241.PMC4685600.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivatives License ( http://creativecommons.org/ licenses/by-nc-nd/4.0/ ), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited, and is not alter ed, transformed, or built upon in any way.AIDS Care , 2015 Vol.",Non-OADS,/arxiv_data1/oa_pdf/98/13/caic-27-028.PMC4685607.pdf
"S1, 28 –35, http://dx.doi.org/10.1080/09540121.2015.1034648",Non-OADS,/arxiv_data1/oa_pdf/98/13/caic-27-028.PMC4685607.pdf
"Retrieved Septem- ber 20, 2014, from http://www.unc.edu/preacher/sobel/ sobel.htm Qiao, S., Li, X., & Stanton, B.",Non-OADS,/arxiv_data1/oa_pdf/98/13/caic-27-028.PMC4685607.pdf
"Published by Taylor & Francis This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivatives License ( http://creativecommons.org/licenses/by-nc-nd/ 4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited, and is not altered, transformed, or built upon in any way.CONTACT Dennis Norris dennis.norris@mrc-cbu.cam.ac.ukLANGUAGE, COGNITION AND NEUROSCIENCE, 2016 VOL.",Non-OADS,/arxiv_data1/oa_pdf/06/12/plcp-31-004.PMC4685608.pdf
"1, 4 –18 http://dx.doi.org/10.1080/23273798.2015.1081703",Non-OADS,/arxiv_data1/oa_pdf/06/12/plcp-31-004.PMC4685608.pdf
"3, 318–329, http://dx.doi.org/10.1080/10803548.2015.1081771 Corrosion of connectors used in equipment protecting against falls from a height Marcin Jachowicz∗ Central Institute for Labour Protection – National Research Institute (CIOP-PIB), Poland Connectors are commonly found in personal equipment protecting against falls from a height.",Non-OADS,/arxiv_data1/oa_pdf/47/da/tose-21-318.PMC4685609.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivatives License ( http://creativecommons.org/licenses/ by-nc-nd/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited, and is not alter ed, transformed, or built upon in any way.",Non-OADS,/arxiv_data1/oa_pdf/47/da/tose-21-318.PMC4685609.pdf
"S1, 83 –89, http://dx.doi.org/10.1080/09540121.2015.1071772",Non-OADS,/arxiv_data1/oa_pdf/7a/2e/caic-27-083.PMC4685610.pdf
"Retrieved from http://virtualmentor.ama-assn.org/ 2012/04/msoc1-1204.html Nie, J.",OADS,/arxiv_data1/oa_pdf/7a/2e/caic-27-083.PMC4685610.pdf
"Retrieved 21 November 2014, from http://www.gov.cn/ ﬂfg/2006-02/12/content_186324.htm .",Non-OADS,/arxiv_data1/oa_pdf/7a/2e/caic-27-083.PMC4685610.pdf
"An unof ﬁcial and very inaccurate English translation is available from International Labour Organization(ILO) at http://www.ilo.org/wcmsp5/groups/public/ — ed_protect/ —protrav/ —ilo_aids/documents/ legaldocument/wcms_113144.pdf Svensson, M. (2002).",Non-OADS,/arxiv_data1/oa_pdf/7a/2e/caic-27-083.PMC4685610.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivatives License ( http://creativecommons.org/ Licenses/by-nc-nd/4.0/ ), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited, and is not alter ed, transformed, or built upon in any way.",Non-OADS,/arxiv_data1/oa_pdf/0b/73/caic-27-006.PMC4685612.pdf
"S1, 6 –17, http://dx.doi.org/10.1080/09540121.2015.1026307",Non-OADS,/arxiv_data1/oa_pdf/0b/73/caic-27-006.PMC4685612.pdf
"1, 137 –146 http://dx.doi.org/10.1080/19440049.2015.1110623 © 2015 Federal Food Safety and Veterinary Office FSVO.",Non-OADS,/arxiv_data1/oa_pdf/16/03/tfac-33-137.PMC4685613.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivatives License ( http://creativecommons.org/licenses/by-nc- nd/4.0/ ), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited, and is not altered, transformed, or built upon in any way.",Non-OADS,/arxiv_data1/oa_pdf/16/03/tfac-33-137.PMC4685613.pdf
ORCID Otmar Zoller http://orcid.org/0000-0003-0956-7604144 O. ZOLLER ET AL.,Non-OADS,/arxiv_data1/oa_pdf/16/03/tfac-33-137.PMC4685613.pdf
"Available from: http://www.cvuas.de/pub/beitrag.asp?subid=1&Thema_ID= 3&ID=2138&lang=EN&Pdf=No De Kruif CA, Marsman JW, Venekamp JC, Falke HE, Noordhoek J, Blaauboer BJ, Wortelboer HM.",Non-OADS,/arxiv_data1/oa_pdf/16/03/tfac-33-137.PMC4685613.pdf
"http://www2.epa.gov /sites/production/files/2014-05/docu ments/bpa_final.pdf Yi-Ming L, Zhuo-Lun Z, Yong-Fu H. 1993 .",OADS,/arxiv_data1/oa_pdf/16/03/tfac-33-137.PMC4685613.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivatives License ( http://creativecommons.org/ licenses/by-nc-nd/4.0/ ), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited, and is not alter ed, transformed, or built upon in any way.",Non-OADS,/arxiv_data1/oa_pdf/6d/d6/caic-27-036.PMC4685614.pdf
"S1, 36 –46, http://dx.doi.org/10.1080/09540121.2015.1051501",Non-OADS,/arxiv_data1/oa_pdf/6d/d6/caic-27-036.PMC4685614.pdf
"Retrieved from http://www.unaids.org/en/dataanalysis/knowyourre sponse/countryprogressreports/2014countries/KEN_narra tive_report_2014.pdf Nöstlinger, C., Bartoli, G., Gordillo, V., Roberfroid, D., & Colebunders, R. (2006).",OADS,/arxiv_data1/oa_pdf/6d/d6/caic-27-036.PMC4685614.pdf
"Retrieved from http://www.unaids.org/en/media/unaids/ contentassets/documents/epidemiology/2013/gr2013/UNA IDS_Global_Report_2013_en.pdf Vreeman, R. C., Nyandiko, W. M., Ayaya, S. O., Walumbe, E. G., Marrero, D. G., & Inui, T. S. (2010).",Non-OADS,/arxiv_data1/oa_pdf/6d/d6/caic-27-036.PMC4685614.pdf
"3, 365–372, http://dx.doi.org/10.1080/10803548.2015.1081775 Application of the MERIT survey in the multi-criteria quality assessment of occupational health and safety management Zygmunt Korban∗ Silesian University of Technology, Poland Occupational health and safety management systems apply audit examinations as an integral element of these systems.",Non-OADS,/arxiv_data1/oa_pdf/b5/b6/tose-21-365.PMC4685617.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivatives License ( http://creativecommons.org/licenses/ by-nc-nd/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited, and is not alter ed, transformed, or built upon in any way.",Non-OADS,/arxiv_data1/oa_pdf/b5/b6/tose-21-365.PMC4685617.pdf
"3, 373–381, http://dx.doi.org/10.1080/10803548.2015.1081776 Quality assessment of occupational health and safety management at the level of business units making up the organizational structure of a coal mine: a case study Zygmunt Korban∗ Silesian University of Technology, Poland The audit of the health and safety management system is understood as a form and tool of controlling.",Non-OADS,/arxiv_data1/oa_pdf/41/82/tose-21-373.PMC4685619.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivatives License ( http://creativecommons.org/licenses/ by-nc-nd/4.0/ ), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited, and is not alter ed, transformed, or built upon in any way.",Non-OADS,/arxiv_data1/oa_pdf/41/82/tose-21-373.PMC4685619.pdf
"S1, 90 –98, http://dx.doi.org/10.1080/09540121.2015.1062077",Non-OADS,/arxiv_data1/oa_pdf/b6/c3/caic-27-090.PMC4685622.pdf
"ORCID Dean A. Murphy http://orcid.org/0000-0003-2752-7091 John B.F. de Wit http://orcid.org/0000-0002-5895-7935 References Berger, B. E., Estwing Ferrans, C., & Lashley, F. R. (2001).",Non-OADS,/arxiv_data1/oa_pdf/b6/c3/caic-27-090.PMC4685622.pdf
"To view a copy of this license, visit http://creativecommons.org/ licenses/by-nc-nd/4.0/",Non-OADS,/arxiv_data1/oa_pdf/59/e6/mtm201534.PMC4685663.pdf
"Perinatal infection is the predominant mode of transmission in areas of high prevalence, horizontal transmission, particularly inearly childhood, accounts for most cases of chronic HBV infec-tion in areas of intermediate prevalence, while unprotected sexual© G Mena, AL García-Basteiro, and JM Bayas *Correspondence to: AL García-Basteiro; Email: alberto.garcia-basteiro@ isglobal.org Submitted: 02/10/2015; Revised: 05/11/2015; Accepted: 05/21/2015http://dx.doi.org/10.1080/21645515.2015.1055424 This is an Open Access article distributed under the terms of the Creative Commons Attribution-Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/), which permits unrestricted non-commercial use,distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/0d/7c/khvi-11-11-1055424.PMC4685678.pdf
Atlanta: CDC; 2014 [updated July 2014]; Available at: http://www.cdc.gov/Fea tures/WorldHepatitisDay/ 3.,Non-OADS,/arxiv_data1/oa_pdf/0d/7c/khvi-11-11-1055424.PMC4685678.pdf
Geneva: WHO; 2008 [updated June 2014]; Available at: http://www.who.int/mediacentre/factsheets/fs328/en/ 5.,Non-OADS,/arxiv_data1/oa_pdf/0d/7c/khvi-11-11-1055424.PMC4685678.pdf
Available at: http://www.euro.who.int/__data/assets/ pdf_ﬁle/0011/152012/e95792.pdf 12.,OADS,/arxiv_data1/oa_pdf/0d/7c/khvi-11-11-1055424.PMC4685678.pdf
Available at: http://www.fda.gov/BiologicsBloodVaccines/Vac cines/default.htm 31.,Non-OADS,/arxiv_data1/oa_pdf/0d/7c/khvi-11-11-1055424.PMC4685678.pdf
Available at: http://www.ema.europa.eu/ema/ 32.,Non-OADS,/arxiv_data1/oa_pdf/0d/7c/khvi-11-11-1055424.PMC4685678.pdf
"Public Health England, Lon- don, March 2013 [updated December 2013] [accessedSeptember 2014]; Available at: https://www.gov.uk/ government/publications/hepatitis-b-the-green-book- chapter-18 130.",Non-OADS,/arxiv_data1/oa_pdf/0d/7c/khvi-11-11-1055424.PMC4685678.pdf
"*Correspondence to: Martha Sedegah; Email: martha.sedegah.civ@mail.mil; Michael R Hollingdale; Email: michael.r.hollingdale.ctr@mail.milSubmitted: 11/24/2014; Revised: 01/27/2015; Accepted: 02/07/2015 http://dx.doi.org/10.1080/21645515.2015.1019186 This is an Open Access article distributed under the terms of the Creative Commons Attribution-Non-Commercial License (http://creativecommons.o rg/licenses/ by-nc/3.0/), which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/eb/50/khvi-11-11-1019186.PMC4685686.pdf
"Website https://cdmrp.org; MilitaryInfectious Research Program “Phase 1/2a clinical trials assessingthe safety, tolerability, immunogenicity and protective efﬁcacy ofAd5-CA, a 2-antigen, adenovirus-vectored Plasmodium falcipa- rum malaria vaccine, in healthy, malaria-naive adults work unit number 62787A 870 F 1432.",Non-OADS,/arxiv_data1/oa_pdf/eb/50/khvi-11-11-1019186.PMC4685686.pdf
PLoS One 2013; 8:1371; PMID:23457473; http://dx.doi.org/10.1371/journal.,OADS,/arxiv_data1/oa_pdf/eb/50/khvi-11-11-1019186.PMC4685686.pdf
Hum Vaccin Immunother 2013; 9:2165-2177; PMID:23899517; http://dx.doi.org/10.4161/hv.24941 3.,Non-OADS,/arxiv_data1/oa_pdf/eb/50/khvi-11-11-1019186.PMC4685686.pdf
PLoS One 2014; 9:e106241; PMID:25211344; http://dx.doi.org/10.1371/journal.,Non-OADS,/arxiv_data1/oa_pdf/eb/50/khvi-11-11-1019186.PMC4685686.pdf
J Immunol 2013; 190:5128- 5141; PMID:23589611; http://dx.doi.org/10.4049/jimmunol.1203396 5.,Non-OADS,/arxiv_data1/oa_pdf/eb/50/khvi-11-11-1019186.PMC4685686.pdf
PLoS One 2012; 7:e36508; PMID:22563506; http://dx.doi.org/10.1371/journal.,Non-OADS,/arxiv_data1/oa_pdf/eb/50/khvi-11-11-1019186.PMC4685686.pdf
Science 2011; 334:475- 480; PMID:21903775; http://dx.doi.org/10.1126/ science.1211548 7.,Non-OADS,/arxiv_data1/oa_pdf/eb/50/khvi-11-11-1019186.PMC4685686.pdf
PLoS One 2011; 6:e24586; PMID:22003383; http://dx.doi.org/ 10.1371/journal.pone.0024586 8.,Non-OADS,/arxiv_data1/oa_pdf/eb/50/khvi-11-11-1019186.PMC4685686.pdf
PLoS One 2011; 6:e25868; PMID:22003411; http://dx.doi.org/10.1371/journal.,Non-OADS,/arxiv_data1/oa_pdf/eb/50/khvi-11-11-1019186.PMC4685686.pdf
Hum Vaccin Immunother 2013; 9:2165-2177; PMID:23899517; http://dx.doi.org/10.4161/hv.24941 10.,Non-OADS,/arxiv_data1/oa_pdf/eb/50/khvi-11-11-1019186.PMC4685686.pdf
PLoS Pathog 2011; 7:e1002389;PMID:22144890; http://dx.doi.org/10.1371/journal.,Non-OADS,/arxiv_data1/oa_pdf/eb/50/khvi-11-11-1019186.PMC4685686.pdf
Vaccine 2010; 28:4644-4652; PMID:20451637; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/eb/50/khvi-11-11-1019186.PMC4685686.pdf
PLoS One 2014; 9:e107903; PMID:25254500; http://dx.doi.org/ 10.1371/journal.pone.0107903 14.,Non-OADS,/arxiv_data1/oa_pdf/eb/50/khvi-11-11-1019186.PMC4685686.pdf
J Infect Dis 1998; 177:1664-1673; PMID:9607847; http://dx.doi.org/10.1086/515331 15.,Non-OADS,/arxiv_data1/oa_pdf/eb/50/khvi-11-11-1019186.PMC4685686.pdf
Malar J 2011; 10:29; PMID:21303498; http://dx.doi.org/10.1186/ 1475-2875-10-29 16.,Non-OADS,/arxiv_data1/oa_pdf/eb/50/khvi-11-11-1019186.PMC4685686.pdf
Eur J Immunol 2012; 43:693-704; PMID:23229763; http://dx.doi.org/ 10.1002/eji.201142262 17.,Non-OADS,/arxiv_data1/oa_pdf/eb/50/khvi-11-11-1019186.PMC4685686.pdf
Science 2013; 341:1359-1365; PMID:23929949; http://dx.doi.org/10.1126/science.1241800 19.,Non-OADS,/arxiv_data1/oa_pdf/eb/50/khvi-11-11-1019186.PMC4685686.pdf
PLoS One 2014; 9(9):e106241; PMID:25211344; http://dx.doi.org/10.1371/journal.pone.0106241 20.,Non-OADS,/arxiv_data1/oa_pdf/eb/50/khvi-11-11-1019186.PMC4685686.pdf
Mem InstOswaldo Cruz 2011; 106(Suppl 1):172-178; PMID:21881772; http://dx.doi.org/10.1590/S0074-02762011000900022 22.,OADS,/arxiv_data1/oa_pdf/eb/50/khvi-11-11-1019186.PMC4685686.pdf
Genes Immun 2013; 14 (5):302-9; PMID:23594961; http://dx.doi.org/ 10.1038/gene.2013.20 23.,Non-OADS,/arxiv_data1/oa_pdf/eb/50/khvi-11-11-1019186.PMC4685686.pdf
Proc Natl Acad Sci U S A 2014; 111:1479- 1484; PMID:24474774; http://dx.doi.org/10.1073/ pnas.1323318111 24.,OADS,/arxiv_data1/oa_pdf/eb/50/khvi-11-11-1019186.PMC4685686.pdf
J Immunol 2012; 188:5054-5062; PMID:22504653; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/eb/50/khvi-11-11-1019186.PMC4685686.pdf
J Immunol 2013; 190:2720-2735;PMID:23390298; http://dx.doi.org/10.4049/ jimmunol.1202861 27.,Non-OADS,/arxiv_data1/oa_pdf/eb/50/khvi-11-11-1019186.PMC4685686.pdf
Gene Ther 2006; 13:1110- 1117; PMID:16525482; http://dx.doi.org/10.1038/sj.gt.3302751 28.,OADS,/arxiv_data1/oa_pdf/eb/50/khvi-11-11-1019186.PMC4685686.pdf
J Virol 2003; 77:4911-4927; PMID:12663797; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/eb/50/khvi-11-11-1019186.PMC4685686.pdf
PLoS Pathog 2012; 8:e1002504; PMID:22319445; http://dx.doi.org/10.1371/journal.,Non-OADS,/arxiv_data1/oa_pdf/eb/50/khvi-11-11-1019186.PMC4685686.pdf
Nat Immunol 2007; 8:239-245; PMID:17304234; http://dx.doi.org/ 10.1038/ni1443 32.,Non-OADS,/arxiv_data1/oa_pdf/eb/50/khvi-11-11-1019186.PMC4685686.pdf
Front Microbiol 2014; 5:249; PMID:24904561; http://dx.doi.org/10.3389/fmicb.2014.00249 2714 Volume 11 Issue 11 Human Vaccines & Immunotherapeutics,Non-OADS,/arxiv_data1/oa_pdf/eb/50/khvi-11-11-1019186.PMC4685686.pdf
J Immunol 2013; 190:1038-1047; PMID:23264654; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/eb/50/khvi-11-11-1019186.PMC4685686.pdf
N Engl J Med 2011; 365:1004-1013;PMID:21916638; http://dx.doi.org/10.1056/ NEJMoa1008115 35.,Non-OADS,/arxiv_data1/oa_pdf/eb/50/khvi-11-11-1019186.PMC4685686.pdf
J Exp Med 1997; 186:1407- 1418; PMID:9348298; http://dx.doi.org/10.1084/ jem.186.9.1407 37.,Non-OADS,/arxiv_data1/oa_pdf/eb/50/khvi-11-11-1019186.PMC4685686.pdf
PLoS One 2011; 6:e25868; PMID:22003411; http://dx.doi.org/10.1371/journal.,Non-OADS,/arxiv_data1/oa_pdf/eb/50/khvi-11-11-1019186.PMC4685686.pdf
"2The many determinants of this increased risk of acquiring infectious diseasesin prisons (with a corresponding impact on the community)© Víctor-Guillermo Sequera, Salom /C19e Valencia, Alberto L García-Basteiro, Andr /C19es Marco, and Jos /C19e M Bayas *Correspondence to: Alberto L García-Basteiro; Email: alberto.garcia- basteiro@isglobal.org Submitted: 03/03/2015; Revised: 04/27/2015; Accepted: 05/10/2015http://dx.doi.org/10.1080/21645515.2015.1051269 This is an Open Access article distributed under the terms of the Creative Commons Attribution-Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/), which permits unrestricted non-commercial use,distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/46/53/khvi-11-11-1051269.PMC4685700.pdf
Clin Infect Dis 2007;45(8):1047-55; PMID:17879924; http://dx.doi.org/10.1086/521910 3.,Non-OADS,/arxiv_data1/oa_pdf/46/53/khvi-11-11-1051269.PMC4685700.pdf
Expert Rev Vaccines 2013; 12(5):469-71; PMID:23659294; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/46/53/khvi-11-11-1051269.PMC4685700.pdf
Rev Esp Sanid Penit 2012; (14):99-105; PMID:23165633; http://dx.doi.org/ 10.4321/S1575-06202012000300005 6.,Non-OADS,/arxiv_data1/oa_pdf/46/53/khvi-11-11-1051269.PMC4685700.pdf
Women Health 2006; 44 (1):119-36; PMID:17182530; http://dx.doi.org/10.1300/J013v44n01_07 8.,Non-OADS,/arxiv_data1/oa_pdf/46/53/khvi-11-11-1051269.PMC4685700.pdf
Psychiatr Serv 2003; 54(2):201-7; PMID:12556601; http://dx.doi.org/10.1176/appi.,Non-OADS,/arxiv_data1/oa_pdf/46/53/khvi-11-11-1051269.PMC4685700.pdf
Am J Public Heal 1991; 81(10):1318-20; PMID:1928533; http://dx.doi.org/10.2105/ AJPH.81.10.1318 12.,Non-OADS,/arxiv_data1/oa_pdf/46/53/khvi-11-11-1051269.PMC4685700.pdf
J Am Geriatr Soc2012; 60(6):1150-6; PMID:22642489; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/46/53/khvi-11-11-1051269.PMC4685700.pdf
J Gen Intern Med 2010; 25(10):1038-44;PMID:20532651; http://dx.doi.org/10.1007/s11606- 010-1416-8 15.,Non-OADS,/arxiv_data1/oa_pdf/46/53/khvi-11-11-1051269.PMC4685700.pdf
Prev Med 2004; 38 (5):607-12; PMID:15066363; http://dx.doi.org/ 10.1016/j.ypmed.2003.11.020 16.,OADS,/arxiv_data1/oa_pdf/46/53/khvi-11-11-1051269.PMC4685700.pdf
Luxembourg: Publication Ofﬁce of the European Union; 2012. http://www.emcdda.europa.eu/publications/selected-issues/prison.,Non-OADS,/arxiv_data1/oa_pdf/46/53/khvi-11-11-1051269.PMC4685700.pdf
J Public Health Policy 2011; 32(1):32-45; PMID:21160535; http://dx.doi.org/10.1057/ jphp.2010.47 18.,Non-OADS,/arxiv_data1/oa_pdf/46/53/khvi-11-11-1051269.PMC4685700.pdf
J Epidemiol Community Health 2009 Nov; 63(11):912-9; PMID:19648129; http://dx.doi.org/10.1136/jech.2009.090662 20.,Non-OADS,/arxiv_data1/oa_pdf/46/53/khvi-11-11-1051269.PMC4685700.pdf
Lancet 2011; 377(9769):956-65; PMID:21093904; http://dx.doi.org/10.1016/S0140-6736(10)61053-7 21.,Non-OADS,/arxiv_data1/oa_pdf/46/53/khvi-11-11-1051269.PMC4685700.pdf
Cancer 2005; 104(10):2197-204; PMID:16206295; http://dx.doi.org/ 10.1002/cncr.21468 23.,Non-OADS,/arxiv_data1/oa_pdf/46/53/khvi-11-11-1051269.PMC4685700.pdf
PLoS Med 2010; 7(12): e1000381; PMID:21203587; http://dx.doi.org/ 10.1371/journal.pmed.1000381 25.,Non-OADS,/arxiv_data1/oa_pdf/46/53/khvi-11-11-1051269.PMC4685700.pdf
Global Tuberculosis Report 2013. http://apps.who.int/iris/bitstream/ 10665/91355/1/9789241564656_eng.pdf.,Non-OADS,/arxiv_data1/oa_pdf/46/53/khvi-11-11-1051269.PMC4685700.pdf
Am J Public Health 2002; 92(11):1789-94; PMID:12406810; http://dx.doi.org/10.2105/ AJPH.92.11.1789 27.,Non-OADS,/arxiv_data1/oa_pdf/46/53/khvi-11-11-1051269.PMC4685700.pdf
J Public Health 2011; 33(2):197-204; PMID:21345883; http://dx.doi.org/10.1093/pubmed/fdr011 29.,Non-OADS,/arxiv_data1/oa_pdf/46/53/khvi-11-11-1051269.PMC4685700.pdf
J Med Microbiol 2007;56(Pt 3):391-7; PMID:17314372; http://dx.doi.org/ 10.1099/jmm.0.46859-0 30.,Non-OADS,/arxiv_data1/oa_pdf/46/53/khvi-11-11-1051269.PMC4685700.pdf
J Infect Pub- lic Health 2013; 6(3):186-95; PMID:23668463;http://dx.doi.org/10.1016/j.jiph.2012.12.003 31.,Non-OADS,/arxiv_data1/oa_pdf/46/53/khvi-11-11-1051269.PMC4685700.pdf
Eur J Clin Microbiol Infect Dis 2011; 30 (7):857-62; PMID:21274586; http://dx.doi.org/ 10.1007/s10096-011-1166-5 32.,Non-OADS,/arxiv_data1/oa_pdf/46/53/khvi-11-11-1051269.PMC4685700.pdf
BMC Public Health 2010; 10:777;PMID:21176146; http://dx.doi.org/10.1186/1471- 2458-10-777 www.tandfonline.com 2623 Human Vaccines & Immunotherapeutics,Non-OADS,/arxiv_data1/oa_pdf/46/53/khvi-11-11-1051269.PMC4685700.pdf
Int J Infect Dis 2010; 14(Suppl 3):e60-6;PMID:20189863; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/46/53/khvi-11-11-1051269.PMC4685700.pdf
AIDS Care 2014; 26(9):1122-6; PMID:24499303; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/46/53/khvi-11-11-1051269.PMC4685700.pdf
Med J Aust 2013; 198(7):376-9;PMID:23581958; http://dx.doi.org/10.5694/ mja12.11110 38.,Non-OADS,/arxiv_data1/oa_pdf/46/53/khvi-11-11-1051269.PMC4685700.pdf
BMJ 2000; 321(7253):78-82; PMID:10884256; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/46/53/khvi-11-11-1051269.PMC4685700.pdf
Rev Soc Bras Med Trop 2010; 43(5):512-5; PMID:21085860; http://dx.doi.org/10.1590/ S0037-86822010000500008 41.,Non-OADS,/arxiv_data1/oa_pdf/46/53/khvi-11-11-1051269.PMC4685700.pdf
J Urban Health 2012; 89(1):108-16; PMID:22143408; http://dx.doi.org/10.1007/s11524-011-9626-x 42.,Non-OADS,/arxiv_data1/oa_pdf/46/53/khvi-11-11-1051269.PMC4685700.pdf
Ann Epidemiol 2009; 19(9):647-50;PMID:19596205; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/46/53/khvi-11-11-1051269.PMC4685700.pdf
Prison J 1995; 75(4):413-30; http://dx.doi.org/10.1177/ 0032855595075004002 44.,Non-OADS,/arxiv_data1/oa_pdf/46/53/khvi-11-11-1051269.PMC4685700.pdf
Am JGastroenterol 2009; 104(4):1024-31; PMID: 19240708; http://dx.doi.org/10.1038/ajg.2008.143 45.,Non-OADS,/arxiv_data1/oa_pdf/46/53/khvi-11-11-1051269.PMC4685700.pdf
J Health Care Poor Underserved 2010; 21(3): 1071-87; PMID:20693745; http://dx.doi.org/10.1353/hpu.0.034946.,Non-OADS,/arxiv_data1/oa_pdf/46/53/khvi-11-11-1051269.PMC4685700.pdf
J Correct Heal Care 2009; 15(1):58-82; PMID:19477812; http://dx.doi.org/10.1177/1078345808326622 47.,Non-OADS,/arxiv_data1/oa_pdf/46/53/khvi-11-11-1051269.PMC4685700.pdf
J Sex Res 2002; 39(3):217-27; PMID:12476269; http://dx.doi.org/10.1080/00224490209552144 48.,Non-OADS,/arxiv_data1/oa_pdf/46/53/khvi-11-11-1051269.PMC4685700.pdf
Am J Infect Control 2007; 35(7):477-80; PMID:17765561; http://dx.doi.org/10.1016/j.ajic.2006.08.002 50.,Non-OADS,/arxiv_data1/oa_pdf/46/53/khvi-11-11-1051269.PMC4685700.pdf
Epidemiol Infect 2004; 132(3):409-15; PMID:15188710; http://dx.doi.org/10.1017/S0950268803001882 51.,Non-OADS,/arxiv_data1/oa_pdf/46/53/khvi-11-11-1051269.PMC4685700.pdf
Vaccine 2005; 23(8):1021-8; PMID:15620475; http://dx.doi.org/ 10.1016/j.vaccine.2004.07.038 53.,Non-OADS,/arxiv_data1/oa_pdf/46/53/khvi-11-11-1051269.PMC4685700.pdf
J Urban Health 2010; 87(4):603-16; PMID:20390391; http://dx.doi.org/10.1007/s11524-010-9450-8 54.,Non-OADS,/arxiv_data1/oa_pdf/46/53/khvi-11-11-1051269.PMC4685700.pdf
Sex Transm Dis 2009; 36(2 Suppl): S3-4; PMID:19131905; http://dx.doi.org/10.1097/OLQ.0b013e318195ad6c 57.,Non-OADS,/arxiv_data1/oa_pdf/46/53/khvi-11-11-1051269.PMC4685700.pdf
PLoS One 2009; 4(11): e7558; PMID:19907649; http://dx.doi.org/10.1371/ journal.pone.0007558 58.,Non-OADS,/arxiv_data1/oa_pdf/46/53/khvi-11-11-1051269.PMC4685700.pdf
Addiction 2008; 103(2):251-5; PMID:18199304; http://dx.doi.org/10.1111/j.1360- 0443.2007.02081.x 59.,Non-OADS,/arxiv_data1/oa_pdf/46/53/khvi-11-11-1051269.PMC4685700.pdf
Vaccine 1993; 11(14):1441-4;PMID:8310764; http://dx.doi.org/10.1016/0264- 410X(93)90174-V 60.,Non-OADS,/arxiv_data1/oa_pdf/46/53/khvi-11-11-1051269.PMC4685700.pdf
Rev Soc Bras Med Trop 2000; 33(1):27-30; PMID:10881115; http://dx.doi.org/10.1590/S0037-86822000000100004 61.,Non-OADS,/arxiv_data1/oa_pdf/46/53/khvi-11-11-1051269.PMC4685700.pdf
PLoS One 2014; 9(6):e99559; PMID:24926687; http://dx.doi.org/10.1371/journal.pone.0099559 62.,Non-OADS,/arxiv_data1/oa_pdf/46/53/khvi-11-11-1051269.PMC4685700.pdf
"Fact Sheet N /C14204, 2014. http://www.who.int/mediacentre/fact sheets/fs204/en/.",Non-OADS,/arxiv_data1/oa_pdf/46/53/khvi-11-11-1051269.PMC4685700.pdf
Global Community Hepa- titis Policy Report 2014. http://www.worldhepatitisal liance.org/en/civil-society-report-2014.html.,Non-OADS,/arxiv_data1/oa_pdf/46/53/khvi-11-11-1051269.PMC4685700.pdf
Epidemiol Infect 2010; 138(11):1610-20; PMID:20202285; http://dx.doi.org/10.1017/ S0950268810000476 66.,Non-OADS,/arxiv_data1/oa_pdf/46/53/khvi-11-11-1051269.PMC4685700.pdf
Drug Alco-hol Depend 2012; 123(1–3):269-72; PMID:22138538; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/46/53/khvi-11-11-1051269.PMC4685700.pdf
Rev Bras Epidemiol 2009; 12(2):124-31; http://dx.doi.org/10.1590/S1415-790X2009000200003 70.,Non-OADS,/arxiv_data1/oa_pdf/46/53/khvi-11-11-1051269.PMC4685700.pdf
BMC Infect Dis 2008; 8:33; PMID:18328097; http://dx.doi.org/10.1186/ 1471-2334-8-33 71.,Non-OADS,/arxiv_data1/oa_pdf/46/53/khvi-11-11-1051269.PMC4685700.pdf
Addiction 2010; 105(7): 1311-2; PMID:20642514; http://dx.doi.org/10.1111/j.1360- 0443.2010.02968.x 73.,Non-OADS,/arxiv_data1/oa_pdf/46/53/khvi-11-11-1051269.PMC4685700.pdf
Public Health Rep 2001; 116(3):203-9;PMID:12034909; http://dx.doi.org/10.1093/phr/ 116.3.203 74.,Non-OADS,/arxiv_data1/oa_pdf/46/53/khvi-11-11-1051269.PMC4685700.pdf
Health Protection Agency and Department of Health 2013. https://www.gov.uk/government/publi cations/infection-control- in-prisons-and-places-of- detention.,Non-OADS,/arxiv_data1/oa_pdf/46/53/khvi-11-11-1051269.PMC4685700.pdf
Health Policy 2011; 100 (2–3):297-304; PMID:21269722; http://dx.doi.org/ 10.1016/j.healthpol.2010.12.007 77.,Non-OADS,/arxiv_data1/oa_pdf/46/53/khvi-11-11-1051269.PMC4685700.pdf
Rev Soc Bras Med Trop 2011; 44(5):652-3; PMID:22031090; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/46/53/khvi-11-11-1051269.PMC4685700.pdf
Vaccine 2010 Sep 24;28(41):6653-7; PMID: 20723630; http://dx.doi.org/10.1016/j.vaccine.2010.08.037 80.,Non-OADS,/arxiv_data1/oa_pdf/46/53/khvi-11-11-1051269.PMC4685700.pdf
J Med Virol 2008; 80(7):1181-8; PMID:18461630; http://dx.doi.org/10.1002/jmv.21207 81.,Non-OADS,/arxiv_data1/oa_pdf/46/53/khvi-11-11-1051269.PMC4685700.pdf
Infection 2013; 41(1):69-76;PMID:23264095; http://dx.doi.org/10.1007/s15010- 012-0385-8 82.,Non-OADS,/arxiv_data1/oa_pdf/46/53/khvi-11-11-1051269.PMC4685700.pdf
Vac- cine 2003; 21(19–20):2224-33; PMID:12744847; http://dx.doi.org/10.1016/S0264-410X(03)00137-3 84.,Non-OADS,/arxiv_data1/oa_pdf/46/53/khvi-11-11-1051269.PMC4685700.pdf
Vaccine 2007; 25(41):7125-31; PMID:17766016; http://dx.doi.org/10.1016/j.,Non-OADS,/arxiv_data1/oa_pdf/46/53/khvi-11-11-1051269.PMC4685700.pdf
BMC Public Health 2011; 11:351; PMID:21595969; http://dx.doi.org/10.1186/1471-2458-11-351 86.,Non-OADS,/arxiv_data1/oa_pdf/46/53/khvi-11-11-1051269.PMC4685700.pdf
Royal College of General Practitioners 2005; p 1-6. http://www.smmgp.org.uk/download/guidance/guidance014.pdf.,Non-OADS,/arxiv_data1/oa_pdf/46/53/khvi-11-11-1051269.PMC4685700.pdf
Vaccine 2012; 30(48):6878- 82; PMID:22989688; http://dx.doi.org/10.1016/j.,Non-OADS,/arxiv_data1/oa_pdf/46/53/khvi-11-11-1051269.PMC4685700.pdf
Int J Infect Dis 2008;12(1):3- 11; PMID:17643334; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/46/53/khvi-11-11-1051269.PMC4685700.pdf
Vaccine 2004; 22(9–10):1241-8; PMID:15003653; http://dx.doi.org/10.1016/j.,Non-OADS,/arxiv_data1/oa_pdf/46/53/khvi-11-11-1051269.PMC4685700.pdf
Fact Sheets 2012. http://www.wpro.who.int/mediacentre/fact sheets/fs_20120307_tetanus/en/.,Non-OADS,/arxiv_data1/oa_pdf/46/53/khvi-11-11-1051269.PMC4685700.pdf
"Immuniza- tion, surveillance, assessment and monitoring 2012.http://www.who.int/immunization/monitoring_sur veillance/burden/diphtheria/en/.",OADS,/arxiv_data1/oa_pdf/46/53/khvi-11-11-1051269.PMC4685700.pdf
http://www.who.int/immunization/diseases/pertussis/en/.,Non-OADS,/arxiv_data1/oa_pdf/46/53/khvi-11-11-1051269.PMC4685700.pdf
J Adolesc Health 2008; 43(6):609-11; PMID:19027650; http://dx.doi.org/10.1016/j.,Non-OADS,/arxiv_data1/oa_pdf/46/53/khvi-11-11-1051269.PMC4685700.pdf
Diagn Microbiol Infect Dis 2010; 66(2):225-7; PMID:19800751; http://dx.doi.org/10.1016/j.diagmicrobio.2009.05.008 99.,OADS,/arxiv_data1/oa_pdf/46/53/khvi-11-11-1051269.PMC4685700.pdf
N Engl J Med 1994; 331(10):643-8; PMID:8052273; http://dx.doi.org/10.1056/ NEJM199409083311004 100.,OADS,/arxiv_data1/oa_pdf/46/53/khvi-11-11-1051269.PMC4685700.pdf
Operational guidance 2014. https://www.gov.uk/government/ uploads/system/uploads/attachment_data/ﬁle/371897/Guidance_on_seasonal_ﬂu_2014_to_15_in_prisons.,Non-OADS,/arxiv_data1/oa_pdf/46/53/khvi-11-11-1051269.PMC4685700.pdf
Public Health 2010; 124(2):119-21; PMID:20149400; http://dx.doi.org/10.1016/j.puhe.2009.12.005 107.,Non-OADS,/arxiv_data1/oa_pdf/46/53/khvi-11-11-1051269.PMC4685700.pdf
2):S339-44; PMID:19797746; http://dx.doi.org/10.2105/AJPH.2009.175174 108.,Non-OADS,/arxiv_data1/oa_pdf/46/53/khvi-11-11-1051269.PMC4685700.pdf
Epidemiol Infect 2005; 133(1):107-12; PMID:15724717; http://dx.doi.org/10.1017/S0950268804003243 109.,Non-OADS,/arxiv_data1/oa_pdf/46/53/khvi-11-11-1051269.PMC4685700.pdf
"Accessed January 8, 2015; http://dx.doi.org/10.2307/ 4575142 110.",Non-OADS,/arxiv_data1/oa_pdf/46/53/khvi-11-11-1051269.PMC4685700.pdf
J R Soc Med 2012; 105(2):66-73; PMID:22357982; http://dx.doi.org/10.1258/jrsm.2012.110249 111.,Non-OADS,/arxiv_data1/oa_pdf/46/53/khvi-11-11-1051269.PMC4685700.pdf
Aust N Z J Public Health 2001; 25(5):443-6;PMID:11688625; http://dx.doi.org/10.1111/j.1467- 842X.2001.tb00290.x 112.,Non-OADS,/arxiv_data1/oa_pdf/46/53/khvi-11-11-1051269.PMC4685700.pdf
http://www.basl.org.uk/uploaded_ﬁles/ infection%20inside.pdf.,Non-OADS,/arxiv_data1/oa_pdf/46/53/khvi-11-11-1051269.PMC4685700.pdf
Geneva 2012. http://www.who.int/immunization/newsroom/Mea sles_Rubella_StrategicPlan_2012_2020.pdf?ua D1.,Non-OADS,/arxiv_data1/oa_pdf/46/53/khvi-11-11-1051269.PMC4685700.pdf
J R Soc Interface 2010; 7(52):1537-44; PMID:20392713; http://dx.doi.org/ 10.1098/rsif.2010.0086 119.,OADS,/arxiv_data1/oa_pdf/46/53/khvi-11-11-1051269.PMC4685700.pdf
Sex Transm Infect 2014; 90(6):455-62; PMID:24812407; http://dx.doi.org/10.1136/ sextrans-2013-051456 121.,Non-OADS,/arxiv_data1/oa_pdf/46/53/khvi-11-11-1051269.PMC4685700.pdf
J Adolesc Health2011; 48(6):540-52; PMID:21575812; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/46/53/khvi-11-11-1051269.PMC4685700.pdf
J Med Virol 2014; 86 (9):1528-33; PMID:24838771; http://dx.doi.org/ 10.1002/jmv.23972 124.,Non-OADS,/arxiv_data1/oa_pdf/46/53/khvi-11-11-1051269.PMC4685700.pdf
J Microbiol Immunol Infect 2013; 46(4):282-7; PMID:22841621; http://dx.doi.org/10.1016/j.,Non-OADS,/arxiv_data1/oa_pdf/46/53/khvi-11-11-1051269.PMC4685700.pdf
"Rev Esp Sanid Penit 2011; 13:84-90; PMID:22071487; http://dx.doi.org/ 10.4321/S1575-06202011000300003 126. de Sanjos /C19e S, Valls I, Paz Ca ~nadas M, Lloveras B, Quintana MJ, Shah KV, Bosch FX.",Non-OADS,/arxiv_data1/oa_pdf/46/53/khvi-11-11-1051269.PMC4685700.pdf
Med Clin 2000; 115(3):81-4; PMID:10965480; http://dx.doi.org/ 10.1016/S0025-7753(00)71472-2 127.,OADS,/arxiv_data1/oa_pdf/46/53/khvi-11-11-1051269.PMC4685700.pdf
London (UK) 2013. https://www.gov.,Non-OADS,/arxiv_data1/oa_pdf/46/53/khvi-11-11-1051269.PMC4685700.pdf
J Adolesc Health 2010; 46(5):495-8; PMID:20413087; http://dx.doi.org/10.1016/j.jadohealth.2009.10.007 130.,Non-OADS,/arxiv_data1/oa_pdf/46/53/khvi-11-11-1051269.PMC4685700.pdf
J Womens Health (Larchmt) 2011; 20 (12):1839-45; PMID:22004180; http://dx.doi.org/ 10.1089/jwh.2011.2864 131.,Non-OADS,/arxiv_data1/oa_pdf/46/53/khvi-11-11-1051269.PMC4685700.pdf
"Tappero JW, Reporter R, Wenger JD, Ward BA, Reeves MW, Missbach TS, Plikaytis BD, Mascola L, Schuchat A. Meningoc occal disease in Los Angeles County, California, and among men in t h ec o u n t yj a i l s .NE n g lJM e d1 9 9 6 ;3 3 5 : 8 3 3 - 4 0 ;PMID:8778600; http://dx.doi.org/10.1056/ NEJM199609193351201 135.",Non-OADS,/arxiv_data1/oa_pdf/46/53/khvi-11-11-1051269.PMC4685700.pdf
"World Health Organization, Varicella and Herpes Zoster Vaccination Position Paper – June 2014.http://www.who.int/immunization/position_papers/ WHO_pp_varicella_herpes_zoster_june2014_sum m a r y .",Non-OADS,/arxiv_data1/oa_pdf/46/53/khvi-11-11-1051269.PMC4685700.pdf
J Correct Health Care 2014; 20(4):292-301; PMID:25201912; http://dx.doi.org/ 10.1177/1078345814541535 138.,Non-OADS,/arxiv_data1/oa_pdf/46/53/khvi-11-11-1051269.PMC4685700.pdf
Scand J Infect Dis 2008; 40 (11–12):943-5; PMID:18720259; http://dx.doi.org/ 10.1080/00365540802308449 140.,OADS,/arxiv_data1/oa_pdf/46/53/khvi-11-11-1051269.PMC4685700.pdf
Public Health 2003; 117(6):446-51; PMID:14522161; http://dx.doi.org/ 10.1016/S0033-3506(03)00138-0 141.,Non-OADS,/arxiv_data1/oa_pdf/46/53/khvi-11-11-1051269.PMC4685700.pdf
Int Health 2014; 6(3):203-7; PMID:24682723; http://dx.doi.org/10.1093/ inthealth/ihu017 142.,Non-OADS,/arxiv_data1/oa_pdf/46/53/khvi-11-11-1051269.PMC4685700.pdf
"Global Tuberculosis Report, 2014. http://www.who.int/tb/publications/ global_report/es/ Accessed January 05, 2015 143.",Non-OADS,/arxiv_data1/oa_pdf/46/53/khvi-11-11-1051269.PMC4685700.pdf
http://www.who.int/tb/challenges/prisons/en/.,Non-OADS,/arxiv_data1/oa_pdf/46/53/khvi-11-11-1051269.PMC4685700.pdf
"Literature Review on Tuberculosis in Prisons, 2008. http://www.who.int/tb/challenges/prisons/tb_in_prisons_lit_review_10feb 08.pdf?.",Non-OADS,/arxiv_data1/oa_pdf/46/53/khvi-11-11-1051269.PMC4685700.pdf
Denmark 2013. http://www.euro.,Non-OADS,/arxiv_data1/oa_pdf/46/53/khvi-11-11-1051269.PMC4685700.pdf
https://www.gov.uk/government/publications/prison- health-performance-and-quality-indicator-report-and-guidance.,Non-OADS,/arxiv_data1/oa_pdf/46/53/khvi-11-11-1051269.PMC4685700.pdf
Vaccine 2004; 22(29–30):3897-901; PMID:15364437; http://dx.doi.org/10.1016/j.,Non-OADS,/arxiv_data1/oa_pdf/46/53/khvi-11-11-1051269.PMC4685700.pdf
J Urban Health 2001;78(2):214-35; PMID:11419576; http://dx.doi.org/ 10.1093/jurban/78.2.214 153.,Non-OADS,/arxiv_data1/oa_pdf/46/53/khvi-11-11-1051269.PMC4685700.pdf
This  is  an  open  access  article  under  the  CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/16/1b/main.PMC4685718.pdf
http://dx.doi.org/10.1016/j.toxrep.2015.09.010 2214-7500/© 2015  The  Authors.,Non-OADS,/arxiv_data1/oa_pdf/16/1b/main.PMC4685718.pdf
This  is  an  open  access  article  under  the  CC  BY-NC-ND  license  (http://creativecommons.org/licenses/ by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/16/1b/main.PMC4685718.pdf
"Supplementary  data Supplementary  data  associated  with  this  article  can  be  found, in  the  online  version,  at  http://dx.doi.org/10.1016/j.toxrep.2015.09.",OADS,/arxiv_data1/oa_pdf/16/1b/main.PMC4685718.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/cd/de/main.PMC4685735.pdf
http://dx.doi.org/10.1016/j.scog.2015.10.006 2215-0013/Published by Elsevier Inc.,Non-OADS,/arxiv_data1/oa_pdf/cd/de/main.PMC4685735.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/cd/de/main.PMC4685735.pdf
Contents lists available at ScienceDirect Schizophrenia Research: Cognition journal homepage: http://www.schizrescognition.com/,Non-OADS,/arxiv_data1/oa_pdf/cd/de/main.PMC4685735.pdf
"At the time this study was initiated, the MCCB battery was not yet available but the list of recommended measures for the MCCB Beta Version were available on the MATRICS website ( http://www.matrics.",Non-OADS,/arxiv_data1/oa_pdf/cd/de/main.PMC4685735.pdf
"We demonstrated that MEG functions by inhibiting TRPM6/ TRPM7 magnesium channel activity, as MEG reduced intracellular magnesium level, while TRPM6/TRPM7 channel modulation and magnesium-withdrawalReceived: 11 August 2015 Revised: 4 November 2015 Accepted: 5 November 2015 Heliyon (2015) e00046 http://dx.doi.org/10.1016/j.heliyon.2015.e00046 2405-8440/© 2015 The Authors.",Non-OADS,/arxiv_data1/oa_pdf/3b/fb/main.PMC4685751.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/3b/fb/main.PMC4685751.pdf
"In this study, through a small scale chemical screen, we discovered a novel small molecule Mesendogen (MEG for short) that robustly enhanced the growth Article No~e00046 2 http://dx.doi.org/10.1016/j.heliyon.2015.e00046 2405-8440/© 2015 The Authors.",Non-OADS,/arxiv_data1/oa_pdf/3b/fb/main.PMC4685751.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/3b/fb/main.PMC4685751.pdf
"To prove the existence of such a population, one must demonstrate Article No~e00046 3 http://dx.doi.org/10.1016/j.heliyon.2015.e00046 2405-8440/© 2015 The Authors.",Non-OADS,/arxiv_data1/oa_pdf/3b/fb/main.PMC4685751.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/3b/fb/main.PMC4685751.pdf
Article No~e00046 4 http://dx.doi.org/10.1016/j.heliyon.2015.e00046 2405-8440/© 2015 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/3b/fb/main.PMC4685751.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/3b/fb/main.PMC4685751.pdf
Article No~e00046 5 http://dx.doi.org/10.1016/j.heliyon.2015.e00046 2405-8440/© 2015 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/3b/fb/main.PMC4685751.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/3b/fb/main.PMC4685751.pdf
4 A and Article No~e00046 6 http://dx.doi.org/10.1016/j.heliyon.2015.e00046 2405-8440/© 2015 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/3b/fb/main.PMC4685751.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/3b/fb/main.PMC4685751.pdf
Article No~e00046 7 http://dx.doi.org/10.1016/j.heliyon.2015.e00046 2405-8440/© 2015 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/3b/fb/main.PMC4685751.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/3b/fb/main.PMC4685751.pdf
Article No~e00046 8 http://dx.doi.org/10.1016/j.heliyon.2015.e00046 2405-8440/© 2015 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/3b/fb/main.PMC4685751.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/3b/fb/main.PMC4685751.pdf
Article No~e00046 9 http://dx.doi.org/10.1016/j.heliyon.2015.e00046 2405-8440/© 2015 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/3b/fb/main.PMC4685751.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/3b/fb/main.PMC4685751.pdf
Article No~e00046 10 http://dx.doi.org/10.1016/j.heliyon.2015.e00046 2405-8440/© 2015 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/3b/fb/main.PMC4685751.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/3b/fb/main.PMC4685751.pdf
"In brief, a number of structurally similar compoundswith the same basic chemical backbone but modified by different side groups at Article No~e00046 11 http://dx.doi.org/10.1016/j.heliyon.2015.e00046 2405-8440/© 2015 The Authors.",Non-OADS,/arxiv_data1/oa_pdf/3b/fb/main.PMC4685751.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/3b/fb/main.PMC4685751.pdf
Article No~e00046 12 http://dx.doi.org/10.1016/j.heliyon.2015.e00046 2405-8440/© 2015 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/3b/fb/main.PMC4685751.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/3b/fb/main.PMC4685751.pdf
Article No~e00046 13 http://dx.doi.org/10.1016/j.heliyon.2015.e00046 2405-8440/© 2015 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/3b/fb/main.PMC4685751.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/3b/fb/main.PMC4685751.pdf
Article No~e00046 14 http://dx.doi.org/10.1016/j.heliyon.2015.e00046 2405-8440/© 2015 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/3b/fb/main.PMC4685751.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/3b/fb/main.PMC4685751.pdf
As prolonged depletion of cellular Mg 2+ Article No~e00046 15 http://dx.doi.org/10.1016/j.heliyon.2015.e00046 2405-8440/© 2015 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/3b/fb/main.PMC4685751.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/3b/fb/main.PMC4685751.pdf
Article No~e00046 16 http://dx.doi.org/10.1016/j.heliyon.2015.e00046 2405-8440/© 2015 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/3b/fb/main.PMC4685751.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/3b/fb/main.PMC4685751.pdf
Article No~e00046 17 http://dx.doi.org/10.1016/j.heliyon.2015.e00046 2405-8440/© 2015 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/3b/fb/main.PMC4685751.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/3b/fb/main.PMC4685751.pdf
"Notably, both channel modulators and MEG significantly inhibited neural differentiation activity induced by Dorsomorphin, a dual inhibitor of Nodal and Article No~e00046 18 http://dx.doi.org/10.1016/j.heliyon.2015.e00046 2405-8440/© 2015 The Authors.",Non-OADS,/arxiv_data1/oa_pdf/3b/fb/main.PMC4685751.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/3b/fb/main.PMC4685751.pdf
Article No~e00046 19 http://dx.doi.org/10.1016/j.heliyon.2015.e00046 2405-8440/© 2015 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/3b/fb/main.PMC4685751.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/3b/fb/main.PMC4685751.pdf
Article No~e00046 20 http://dx.doi.org/10.1016/j.heliyon.2015.e00046 2405-8440/© 2015 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/3b/fb/main.PMC4685751.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/3b/fb/main.PMC4685751.pdf
"By studying the molecular mechanism underlying the function of MEG, we have demonstrated a regulatory role of intracellular Mg 2+homeostasis during Article No~e00046 21 http://dx.doi.org/10.1016/j.heliyon.2015.e00046 2405-8440/© 2015 The Authors.",Non-OADS,/arxiv_data1/oa_pdf/3b/fb/main.PMC4685751.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/3b/fb/main.PMC4685751.pdf
"For the feeder-independent condition, hESCs and hiPSCs were cultured on Matrigel(BD Biosciences)-coated plates in mTeSR1 medium (StemCell Technologies) as Article No~e00046 22 http://dx.doi.org/10.1016/j.heliyon.2015.e00046 2405-8440/© 2015 The Authors.",Non-OADS,/arxiv_data1/oa_pdf/3b/fb/main.PMC4685751.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/3b/fb/main.PMC4685751.pdf
Small scale screening of mesoderm and DE inducers Previously a high-throughput chemical screening was conducted at theHigh-Throughput Screening Facility (HTSF) at the University of Illinois at Urbana −Champaign ( http://www.scs.illinois.edu/htsf/index.html ).,Non-OADS,/arxiv_data1/oa_pdf/3b/fb/main.PMC4685751.pdf
"For MEG induction, MEG was either added to the mTeSR1 medium on day “-1”as the “MEG->A-BVF ”or“pre-treatment ”condition (10 μM), or added to the mesoderm induction medium as the “MEG+A-BVF ”or“combination ” Article No~e00046 23 http://dx.doi.org/10.1016/j.heliyon.2015.e00046 2405-8440/© 2015 The Authors.",Non-OADS,/arxiv_data1/oa_pdf/3b/fb/main.PMC4685751.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/3b/fb/main.PMC4685751.pdf
Article No~e00046 24 http://dx.doi.org/10.1016/j.heliyon.2015.e00046 2405-8440/© 2015 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/3b/fb/main.PMC4685751.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/3b/fb/main.PMC4685751.pdf
"Antibody Source Catalog Number Dilution OCT4 Santa Cruz sc-9081 1:1,000 (WB) SOX2 Millipore AB5603 1:500 (WB) α-TUBULIN Abcam ab11304 1:10,000 (WB) GAPDH GeneScript A00192 1:10,000 (WB) T R&D systems AF2085 1:500 (WB/IF) EOMES Abcam ab23345 1:500 (WB/IF) SOX17 R&D systems AF1924 1:500 (WB/IF) FOXA2 Millipore 07-633 1:500 (WB/IF)CER1 Thermo-Pierce MA5-15554 1:500 (WB) AFP DAKO A0008 1:500 (WB) SOX1 R&D systems AF3369 1:500 (WB) PAX6 Covance PRB-278P 1:500 (WB) T-PE R&D Systems IC2085P 1:20 (FACS)EOMES-APC R&D Systems IC6166A 1:20 (FACS) FOXA2-Alexa488 R&D Systems IC2400G 1:40 (FACS) SOX17-APC R&D Systems IC1924A 1:20 (FACS) Goat IgG-PE isotype control R&D Systems IC108P 1:20 (FACS) Goat IgG-APC isotype control R&D Systems IC108A 1:20 (FACS)Mouse IgG 2B-APC isotype control BioLegend 400319 1:20 (FACS) Goat IgG-Alexa488 isotype control R&D Systems IC108G 1:40 (FACS) Article No~e00046 25 http://dx.doi.org/10.1016/j.heliyon.2015.e00046 2405-8440/© 2015 The Authors.",Non-OADS,/arxiv_data1/oa_pdf/3b/fb/main.PMC4685751.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/3b/fb/main.PMC4685751.pdf
Article No~e00046 26 http://dx.doi.org/10.1016/j.heliyon.2015.e00046 2405-8440/© 2015 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/3b/fb/main.PMC4685751.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/3b/fb/main.PMC4685751.pdf
Primer Name Forward Primer (5 ′–3′) Reverse Primer (5 ′–3′) ACTB agagctacgagctgcctgac cgtggatgccacaggact T (Brachyury) gctgtgacaggtacccaacc catgcaggtgagttgtcagaa EOMES gtggggaggtcgaggttc tgttctggaggtccatggtagMIXL1 ggcgtcagagtgggaaatcc gcagttcacatctacctcaagag EVX1 ttcacccgagagcagattg ccggttctggaaccacac TBX6 gaacggcagaaactgtaagagg gtgtgtctccgctcccatag HAND1 aaaggccctacttccagagc tgcgctgttaatgctctcag MEOX1 aaagtgtcccctgcattctg cactccagggttccacatctMESP1 ctgttggagacctggatgc cgtcagttgtcccttgtcac SOX17 acgccgagttgagcaaga tctgcctcctccacgaag FOXA2 tgggagcggtgaagatggaagggcac tcatgccagcgcccacgtacgacgac CER1 acagtgcccttcagccagact acaactactttttcacagccttcgt GSC gaggagaaagtggaggtctggtt ctctgatgaggaccgcttctgGATA4 ggaagcccaagaacctgaat gttgctggagttgctggaa GATA6 aatacttcccccacaacacaa ctctcccgcaccagtcat AFP agcttggtggtggatgaaac ccctcttcagcaaagcagac SOX7 ctcagggcagggaggtct gcactcggataaggagagtcc Article No~e00046 27 http://dx.doi.org/10.1016/j.heliyon.2015.e00046 2405-8440/© 2015 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/3b/fb/main.PMC4685751.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/3b/fb/main.PMC4685751.pdf
Target shRNA Sequence (5 ′–3′) TRPM6 TRPM6-1 ccggcctggcataaagaatgtatatctcgagatatacattctttatgccaggttttt TRPM6-2 ccggccctctaatctaaagcgagttctcgagaactcgctttagattagagggttttt TRPM6-3 ccggccaaattctaatggagtgtatctcgagatacactccattagaatttggtttttTRPM6-4 ccgggctccctatctgataactcaactcgagttgagttatcagatagggagcttttt NEK3 NEK3-1 ccgggcagtcccatagaacagaaatctcgagatttctgttctatgggactgcttttt NEK3-2 ccggccttattatgtgcctccagaactcgagttctggaggcacataataaggttttt NEK3-3 ccggcgaagcataacacaccaagaactcgagttcttggtgtgttatgcttcgttttt Article No~e00046 28 http://dx.doi.org/10.1016/j.heliyon.2015.e00046 2405-8440/© 2015 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/3b/fb/main.PMC4685751.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/3b/fb/main.PMC4685751.pdf
A primary requirement for nodal in the formation and Article No~e00046 29 http://dx.doi.org/10.1016/j.heliyon.2015.e00046 2405-8440/© 2015 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/3b/fb/main.PMC4685751.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/3b/fb/main.PMC4685751.pdf
Article No~e00046 30 http://dx.doi.org/10.1016/j.heliyon.2015.e00046 2405-8440/© 2015 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/3b/fb/main.PMC4685751.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/3b/fb/main.PMC4685751.pdf
Article No~e00046 31 http://dx.doi.org/10.1016/j.heliyon.2015.e00046 2405-8440/© 2015 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/3b/fb/main.PMC4685751.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/3b/fb/main.PMC4685751.pdf
Article No~e00046 32 http://dx.doi.org/10.1016/j.heliyon.2015.e00046 2405-8440/© 2015 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/3b/fb/main.PMC4685751.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/3b/fb/main.PMC4685751.pdf
"This article is distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License ( http://creativecommons.org/licenses/ by-nc/4.0/ ), which permits any noncommercial use, distribution, and reproduction in any med- ium, provided you give appropriate credit to the original author(s) and the source, provide a linkto the Creative Commons license, and indicate if changes were made.",Non-OADS,/arxiv_data1/oa_pdf/74/d8/40120_2015_Article_38.PMC4685862.pdf
"This article is distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License ( http://creativecommons.org/licenses/ by-nc/4.0/ ), which permits any noncommercial use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, andindicate if changes were made.",Non-OADS,/arxiv_data1/oa_pdf/df/0f/40120_2015_Article_33.PMC4685863.pdf
"Cambridge: Genzyme Corporation, a Sanoﬁcompany; 2012. http://products.sanoﬁ.us/aubagio/ aubagio.pdf .",Non-OADS,/arxiv_data1/oa_pdf/df/0f/40120_2015_Article_33.PMC4685863.pdf
"This article is distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License ( http://creativecommons.org/licenses/ by-nc/4.0/ ), which permits any noncommercialuse, distribution, and reproduction in any med- ium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate ifchanges were made.",Non-OADS,/arxiv_data1/oa_pdf/f5/36/40120_2015_Article_34.PMC4685864.pdf
Available from: http://www.orpha.net .,Non-OADS,/arxiv_data1/oa_pdf/f5/36/40120_2015_Article_34.PMC4685864.pdf
Available from http://emedicine.medscape.com/ article/1170810-overview .,Non-OADS,/arxiv_data1/oa_pdf/f5/36/40120_2015_Article_34.PMC4685864.pdf
http://www.janssencns.,Non-OADS,/arxiv_data1/oa_pdf/37/d0/40120_2015_Article_30.PMC4685865.pdf
http://www.janssencns.,Non-OADS,/arxiv_data1/oa_pdf/37/d0/40120_2015_Article_30.PMC4685865.pdf
http://pi.lilly.com/us/zyprexa_ relprevv.pdf .,Non-OADS,/arxiv_data1/oa_pdf/37/d0/40120_2015_Article_30.PMC4685865.pdf
http://www.janssencns.com/shared/ product/invegatrinza/prescribing-information.pdf .,Non-OADS,/arxiv_data1/oa_pdf/37/d0/40120_2015_Article_30.PMC4685865.pdf
This article is distributed under the terms of the Creative Commons Attribution- NonCommercial 4.0 International License(http://creativecommons.org/licenses/by-nc/4.,Non-OADS,/arxiv_data1/oa_pdf/71/56/40120_2015_Article_35.PMC4685866.pdf
This article is distributed under the terms of the Creative Commons Attribution- NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.,Non-OADS,/arxiv_data1/oa_pdf/75/3a/40120_2015_Article_36.PMC4685867.pdf
http://www.msif.org .,Non-OADS,/arxiv_data1/oa_pdf/75/3a/40120_2015_Article_36.PMC4685867.pdf
"Two hundred clinicians highly experienced in prescribing DMF for MS in the United States and Canada were invited to complete the ﬁrst questionnaire and provide relevantdemographic information through a Web-based survey tool (Survey Monkey /C210, http://www.surveymonkey.com ).",OADS,/arxiv_data1/oa_pdf/d3/1a/40120_2015_Article_37.PMC4685868.pdf
"This article is distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License ( http://creativecommons.org/licenses/ by-nc/4.0/ ), which permits any non- commercial use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made.",Non-OADS,/arxiv_data1/oa_pdf/d3/1a/40120_2015_Article_37.PMC4685868.pdf
http://www.ema.europa.,Non-OADS,/arxiv_data1/oa_pdf/d3/1a/40120_2015_Article_37.PMC4685868.pdf
http://pareonline.net/ getvn.asp?v=12&n=10 .,OADS,/arxiv_data1/oa_pdf/d3/1a/40120_2015_Article_37.PMC4685868.pdf
"Open Access This article is distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License ( http://creativecommons.org/licenses/ by-nc/4.0/ ), which permits any noncommer- cial use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, andindicate if changes were made.",Non-OADS,/arxiv_data1/oa_pdf/a8/70/40120_2015_Article_31.PMC4685869.pdf
Safety and pharmacokinetic assessment of orally administered tafamidis in healthy volunteers.Available from: https://clinicaltrials.gov/ct2/show/ NCT01994889?term=%22tafamidis%22 ?and?%22 cardiomyopathy%22&rank=1 .,Non-OADS,/arxiv_data1/oa_pdf/a8/70/40120_2015_Article_31.PMC4685869.pdf
"This article is distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License ( http://creativecommons.org/licenses/ by-nc/4.0/ ), which permits any non- commercial use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license,and indicate if changes were made.",Non-OADS,/arxiv_data1/oa_pdf/e9/e2/40120_2015_Article_32.PMC4685870.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/84/c8/ppa-9-1741.PMC4685885.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpPatient Preference and Adherence 2015:9 1741–1750Patient Preference and Adherence Dove press submit your manuscript | www.dovepress.co m Dove press  1741OriginAl reseArchopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/PPA.S9378 3The interactive web-based program Msmonitor  for self-management and multidisciplinary care  in multiple sclerosis: concept, content, and pilot  results Peter Joseph Jongen,1,2 ludovicus  g sinnige,3 Björn M van geel,4  Freek Verheul,5 Wim l Verhagen,6  ruud A van der Kruijk,7 reinoud  haverkamp,8 hans M schrijver,9  J coby Baart,10 leo h Visser,11  edo P Arnoldus,12 h Jacobus  gilhuis,13 Paul Pop,14 Monique  Booy,15 Wim lemmens,16 rogier  Donders,16 Anton Kool,17 esther  van noort17 1Department of community and  Occupational Medicine, University  Medical center groningen, University  groningen, groningen, 2Ms4 research  institute, nijmegen, 3Multiple sclerosis  centre leeuwarden, Medical centre  leeuwarden, leeuwarden, 4Department  of neurology, Medical centre Alkmaar,   Alkmaar, 5Department of n eurology,   groene hart hospital, gouda, 6Department  of neurology, canisius Wilhelmina hospital,   nijmegen, 7Department of n eurology,   slingeland hospital, Doetinchem,   8Department of neurology, Zuwe  hofpoort hospital, Woerden, 9Multiple  sclerosis centre, Westfries gasthuis,   hoorn, 10Department of n eurology,   Ziekenhuisgroep T wente, Almelo-hengelo,   11Multiple sclerosis centre Midden Brabant,   st elisabeth hospital, 12Multiple sclerosis  centre Midden Brabant, T weesteden  hospital, Tilburg, 13Department of  neurology, reinier de graaf gasthuis,   Delft, 14Department of neurology, Viecuri  Medical centre, Venlo-Venray, 15Multiple  sclerosis centre, Amphia hospital, Breda,   16Department for health evidence, radboud  University nijmegen Medical centre,   nijmegen, 17curavista bv, geertruidenberg,   the netherlandsBackground:  There is a growing need to offer persons with multiple sclerosis (PwMS)  possibilities for self-management and to integrate multidisciplinary health data.",Non-OADS,/arxiv_data1/oa_pdf/84/c8/ppa-9-1741.PMC4685885.pdf
"Anti-inflammatory immune-modulating or immune-suppressing  drugs may substantially reduce the frequency and severity of relapses, and thus modify the correspondence: Peter Joseph Jongen Department of community and  Occupational Medicine, University Medical  center groningen, University groningen,  Antonius Deusinglaan 1, 9713 AV groningen,  the netherlands email p.j.h.jongen@rug.n l Journal name: Patient Preference and Adherence Article Designation: Original Research Y ear: 2015 Volume: 9 Running head verso: Jongen et al Running head recto: Web-based self-management and care in multiple sclerosis DOI: http://dx.doi.org/10.2147/PPA.S93783",Non-OADS,/arxiv_data1/oa_pdf/84/c8/ppa-9-1741.PMC4685885.pdf
"The MSmonitor project and the protocol  for analysis of the pilot data were not reviewed by an ethical  committee, as they did not qualify for being tested according  to the Dutch Medical Research Involving Human Subjects  Act of 1999 ( http://wetten.overheid.nl/BWBR000940 8).28 Data analysis To explore the potential value of the MSmonitor program  with respect to the self-management of fatigue, we analyzed  the relationships between the levels of fatigue (MFIS-5) and  HRQoL (LMSQoL) on the one hand, and the usage of the  Activities Diary on the other.",Non-OADS,/arxiv_data1/oa_pdf/84/c8/ppa-9-1741.PMC4685885.pdf
"Patient Preference and Adherence Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/patient-preference-and-adherence-journa lPatient Preference and Adherence is an international, peer-reviewed,  open access journal that focuses on the growing importance of patient   preference  and adherence throughout the therapeutic continuum.",Non-OADS,/arxiv_data1/oa_pdf/84/c8/ppa-9-1741.PMC4685885.pdf
Available from: http://wetten.overheid.nl/ BWBR0009408/geldigheidsdatum_16-10-2015.,Non-OADS,/arxiv_data1/oa_pdf/84/c8/ppa-9-1741.PMC4685885.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/e3/bb/tcrm-11-1829.PMC4685887.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpTherapeutics and Clinical Risk Management 2015:11 1829–1835Therapeutics and Clinical Risk Management Dove press submit your manuscript | www.dovepress.co m Dove press  1829ORiginal ReseaRChopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/TCRM.S9488 9The effect of low-sodium dialysate on ambulatory  blood pressure measurement parameters in  patients undergoing hemodialysis serkan akdag1 aytac akyol1 huseyin altug Cakmak2 aydin Rodi T osu3 Muntecep asker1 Mehmet Yaman4 naci Babat1 Yasemin soyoral5 Muhammed Bilal Cegin6 ali Kemal gur7 hasan ali gumrukcuoglu1 1Department of Cardiology, Yuzuncu  Yil University Medical Faculty,  Van,   2Department of Cardiology, Rize  Kackar government hospital,   Rize, 3Department of Cardiology,   Mehmet akif ersoy Thoracic and  Cardiovascular surgery education  and Training hospital, istanbul,   4Department of Cardiology, samsun  education and Training hospital,   samsun, 5Department of nephrology,   6Department of anesthesiology  and Reanimation, 7Department of  Cardiovascular surgery, Yuzuncu Yil  University Medical Faculty, Van, T urkeyBackground:  End stage renal disease is related to increased cardiovascular mortality and  morbidity.",Non-OADS,/arxiv_data1/oa_pdf/e3/bb/tcrm-11-1829.PMC4685887.pdf
"ABPM has been reported to be a Correspondence: serkan akdag Department of Cardiology, Yuzuncu  Yil University Medical Faculty, Campus  street, Van 65100, Turkey Tel +90 554 698 3126 Fax +90 432 217 1717 email sercardiocon@hotmail.com.t r Journal name: Therapeutics and Clinical Risk Management Article Designation: Original Research Y ear: 2015 Volume: 11 Running head verso: Akdag et al Running head recto: Low-sodium dialysate and ambulatory BP measurement parameters DOI: http://dx.doi.org/10.2147/TCRM.S94889",Non-OADS,/arxiv_data1/oa_pdf/e3/bb/tcrm-11-1829.PMC4685887.pdf
"Therapeutics and Clinical Risk Management Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/therapeutics-and-clinical-risk-management-journa lTherapeutics and Clinical Risk Management is an international, peer- reviewed journal of clinical therapeutics and risk management, focusing  on concise rapid reporting of clinical studies in all therapeutic areas,  outcomes, safety, and programs for the effective, safe, and sustained  use of medicines.",Non-OADS,/arxiv_data1/oa_pdf/e3/bb/tcrm-11-1829.PMC4685887.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/e3/bb/tcrm-11-1829.PMC4685887.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/a6/fc/sccaa-8-163.PMC4685888.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.ph pStem Cells and Cloning: Advances and Applications 2015:8 163–174Stem Cells and Cloning: Advances and Applications Dove press submit your manuscript | www.dovepress.co m Dove press  163Reviewopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/SCCAA.S6083 2Stem cell technology for tendon regeneration:  current status, challenges, and future research  directions Pauline Po Yee Lui Headquarter, Hospital Authority, Hong  Kong SAR, People’s Republic of China Correspondence: Pauline Po Yee Lui   Headquarter, Hospital Authority,   9/F, Rumsey Street Carpark Building,   2 Rumsey Street, Sheung wan, Hong  Kong SAR, People’s Republic of China   Tel +852 9809 4026   email paulinelui00@gmail.co mAbstract:  Tendon injuries are a common cause of physical disability.",Non-OADS,/arxiv_data1/oa_pdf/a6/fc/sccaa-8-163.PMC4685888.pdf
"Stem Cells and Cloning: Advances and Applications Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/stem-cells-and-cloning-advances-and-applications-journa lStem Cells and Cloning: Advances and Applications is an international,  peer-reviewed, open access journal.",Non-OADS,/arxiv_data1/oa_pdf/a6/fc/sccaa-8-163.PMC4685888.pdf
Visit http://www.dovepress.com/ testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/a6/fc/sccaa-8-163.PMC4685888.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/55/3f/tacg-8-283.PMC4685889.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.ph pThe Application of Clinical Genetics 2015:8 283–290The Application of Clinical Genetics Dove press submit your manuscript | www.dovepress.co m Dove press  283Reviewopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/TACG.S5861 2insights into genetic susceptibility in the etiology  of spontaneous preterm birth Sasha e Parets1 Anna K Knight2 Alicia K Smith1,2 1Department of Psychiatry and  Behavioral Sciences, emory University  School of Medicine, Atlanta, GA, USA;   2Genetics and Molecular Biology  Program, emory University, Atlanta,   GA, USA Correspondence: Alicia K Smith   Department of Psychiatry and Behavioral  Sciences, emory University School of  Medicine, 101 woodruff Circle Ne, Suite   4113, Atlanta, GA  30322, USA   Tel +1 404 712 9582  Fax +1 404 727 3233  email alicia.smith@emory.ed uAbstract:  Preterm birth (PTB; ,37 weeks of gestation) is a complex disorder, whose etiology  is influenced by a variety of factors.",Non-OADS,/arxiv_data1/oa_pdf/55/3f/tacg-8-283.PMC4685889.pdf
"The Application of Clinical Genetics Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/the-application-of-clinical-genetics-journa lThe Application of Clinical Genetics is an international, peer-reviewed  open access journal that welcomes laboratory and clinical findings in  the field of human genetics.",Non-OADS,/arxiv_data1/oa_pdf/55/3f/tacg-8-283.PMC4685889.pdf
Visit http://www.dovepress.com/testimonials.ph p to read real quotes  from published authors.,Non-OADS,/arxiv_data1/oa_pdf/55/3f/tacg-8-283.PMC4685889.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/ab/88/ott-8-3715.PMC4685932.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpOncoTargets and Therapy 2015:8 3715–3720OncoTargets and Therapy Dove press submit your manuscript | www.dovepress.co m Dove press  3715Reviewopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/OTT .S8292 7Risks on N-acetyltransferase 2 and bladder  cancer: a meta-analysis Zongheng Zhu1  Jinshan Zhang2  wei Jiang3 Xianjue Zhang4 Y oukong Li4 Xiaoming Xu5 1Department of General Surgery,   Huangshi Love & Health Hospital,   Huangshi, 2Department of Tumor  surgery, Huangshi Central Hospital,   Huangshi, 3Department of Urinary  Surgery, Huangshi No 5 Hospital,   Huangshi, 4Department of Urinary  Surgery Jingzhou Central Hospital,   Jingzhou, 5Department of Bone  Surgery, Jingzhou Central Hospital,   Jingzhou, People’s Republic of ChinaBackground:  It is known that bladder cancer disease is closely related to aromatic amine  compounds, which could cause cancer by regulating of N-acetylation and N-acetyltransferase 1  and 2 (NAT1 and NAT2).",Non-OADS,/arxiv_data1/oa_pdf/ab/88/ott-8-3715.PMC4685932.pdf
"The purpose of this  meta-analysis explores the risk of NAT2 slow acetylation and the bladder cancer.Correspondence: Jinshan Zhang Department of Tumor surgery, Huangshi  Central Hospital, Tianjin Road 141#,  Huangshi 435000, People’s Republic of  China email 1656299889@qq.co m wei Jiang  Department of Urinary Surgery, Huangshi  No 5 Hospital, Xialu Road 98#, Huangshi  435000, People’s Republic of China email 1103606211@qq.co mJournal name: OncoTargets and Therapy Article Designation: Review Y ear: 2015 Volume: 8 Running head verso: Xu et al Running head recto: Risks of NAT2 on bladder cancer DOI: http://dx.doi.org/10.2147/OTT.S82927",Non-OADS,/arxiv_data1/oa_pdf/ab/88/ott-8-3715.PMC4685932.pdf
"OncoTargets and Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/oncotargets-and-therapy-journa lOncoTargets and Therapy is an international, peer-reviewed, open  access journal focusing on the pathological basis of all cancers, potential  targets for therapy and treatment protocols employed to improve the  management of cancer patients.",Non-OADS,/arxiv_data1/oa_pdf/ab/88/ott-8-3715.PMC4685932.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/ab/88/ott-8-3715.PMC4685932.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/75/dc/ott-8-3721.PMC4685933.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpOncoTargets and Therapy 2015:8 3721–3730OncoTargets and Therapy Dove press submit your manuscript | www.dovepress.co m Dove press  3721Original researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/OTT .S8977 9nrBP1 is downregulated in breast cancer and   nrBP1 overexpression inhibits cancer cell   proliferation through Wnt/ β-catenin signaling  pathway hong Wei1 hongbin Wang2 Qiao Ji1 Jiawei sun1 lin Tao1 Xianli Zhou1 1Department of Ultrasonography,   The second affiliated hospital  of harbin Medical University,   2Department of Breast surgery,   harbin Medical University cancer  hospital, harbin, heilongjiang,   People’s republic of chinaAbstract:  Nuclear receptor binding protein 1 (NRBP1) is a highly conserved protein that is  ubiquitously expressed across cell types in humans.",Non-OADS,/arxiv_data1/oa_pdf/75/dc/ott-8-3721.PMC4685933.pdf
"In recent years, landmark discoveries in the field of breast cancer  research and the use of gene expression profiling to identify distinct subtypes of  breast cancer have contributed to the significant improvement in the survival rate  and treatment outcome in breast cancer patients.3–5 Targeting the pathways that pro - mote or sustain the growth and invasion of carcinoma cells is critical to the effective  treatment of breast cancer.correspondence: Xianli Zhou Department of Ultrasonography,  The Second Affiliated Hospital of Harbin  Medical University, 246 Xuefu road,  nangang, harbin, heilongjiang 150086,  People’s republic of china Tel +86 451 8660 5925 Fax +86 451 8660 5085 email xianlizhou2fh@126.co m Journal name: OncoTargets and Therapy Article Designation: Original Research Y ear: 2015 Volume: 8 Running head verso: Wei et al Running head recto: Downregulated NRBP1 in breast cancer inhibits cell proliferation DOI: http://dx.doi.org/10.2147/OTT.S89779",Non-OADS,/arxiv_data1/oa_pdf/75/dc/ott-8-3721.PMC4685933.pdf
"OncoTargets and Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/oncotargets-and-therapy-journa lOncoTargets and Therapy is an international, peer-reviewed, open  access journal focusing on the pathological basis of all cancers, potential  targets for therapy and treatment protocols employed to improve the  management of cancer patients.",Non-OADS,/arxiv_data1/oa_pdf/75/dc/ott-8-3721.PMC4685933.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/75/dc/ott-8-3721.PMC4685933.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/e5/02/main.PMC4685945.pdf
http://dx.doi.org/10.1016/j.pmedr.2015.10.0142211-3355/© 2015 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/e5/02/main.PMC4685945.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/e5/02/main.PMC4685945.pdf
Contents lists available at ScienceDirect Preventive Medicine Reports journal homepage: http://ees.elsevier.com/pmedr,Non-OADS,/arxiv_data1/oa_pdf/e5/02/main.PMC4685945.pdf
This  is  an  open  access  article  under  the  CC BY-NC-ND license  (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/15/18/main.PMC4685965.pdf
http://dx.doi.org/10.1016/j.chiabu.2015.05.021 0145-2134/© 2015  The  Authors.,Non-OADS,/arxiv_data1/oa_pdf/15/18/main.PMC4685965.pdf
This  is  an  open  access  article  under  the  CC  BY-NC-ND  license  (http://creativecommons.org/ licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/15/18/main.PMC4685965.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/), permitting all non-commer cial use, distribution, and reproduction in any medium, provided the original work is properly cited.1 Citation: Infection Ecology and Epidemiology 2015, 5: 29853 - http://dx.doi.org/10.3402/iee.v5.29853 (page number not for citation purpose)",Non-OADS,/arxiv_data1/oa_pdf/a3/4b/IEE-5-29853.PMC4685977.pdf
"2 (page number not for citation purpose)Citation: Infection Ecology and Epidemiology 2015, 5: 29853 - http://dx.doi.org/10.3402/iee.v5.29853",Non-OADS,/arxiv_data1/oa_pdf/a3/4b/IEE-5-29853.PMC4685977.pdf
"Temporal maps for chikungunya virus emergence across the globe.Emergence of Alphaviruses causing arthritis in humans Citation: Infection Ecology and Epidemiology 2015, 5: 29853 - http://dx.doi.org/10.3402/iee.v5.29853 3 (page number not for citation purpose)",Non-OADS,/arxiv_data1/oa_pdf/a3/4b/IEE-5-29853.PMC4685977.pdf
"4 (page number not for citation purpose)Citation: Infection Ecology and Epidemiology 2015, 5: 29853 - http://dx.doi.org/10.3402/iee.v5.29853",Non-OADS,/arxiv_data1/oa_pdf/a3/4b/IEE-5-29853.PMC4685977.pdf
"These strains have been shown to vary according to their level of viru- lence in mice and also in terms of their antigens (111 /C1114).Emergence of Alphaviruses causing arthritis in humans Citation: Infection Ecology and Epidemiology 2015, 5: 29853 - http://dx.doi.org/10.3402/iee.v5.29853 5 (page number not for citation purpose)",Non-OADS,/arxiv_data1/oa_pdf/a3/4b/IEE-5-29853.PMC4685977.pdf
"6 (page number not for citation purpose)Citation: Infection Ecology and Epidemiology 2015, 5: 29853 - http://dx.doi.org/10.3402/iee.v5.29853",Non-OADS,/arxiv_data1/oa_pdf/a3/4b/IEE-5-29853.PMC4685977.pdf
"Ann N Y Acad Sci 2007; 1102: 96 /C1108.Emergence of Alphaviruses causing arthritis in humans Citation: Infection Ecology and Epidemiology 2015, 5: 29853 - http://dx.doi.org/10.3402/iee.v5.29853 7 (page number not for citation purpose)",Non-OADS,/arxiv_data1/oa_pdf/a3/4b/IEE-5-29853.PMC4685977.pdf
"8 (page number not for citation purpose)Citation: Infection Ecology and Epidemiology 2015, 5: 29853 - http://dx.doi.org/10.3402/iee.v5.29853",Non-OADS,/arxiv_data1/oa_pdf/a3/4b/IEE-5-29853.PMC4685977.pdf
doi: http://dx.doi.org/10.1371/journal.pntd.0001786 86.,Non-OADS,/arxiv_data1/oa_pdf/a3/4b/IEE-5-29853.PMC4685977.pdf
"Estimated risk of Chikungunya viremic bloodEmergence of Alphaviruses causing arthritis in humans Citation: Infection Ecology and Epidemiology 2015, 5: 29853 - http://dx.doi.org/10.3402/iee.v5.29853 9 (page number not for citation purpose)",Non-OADS,/arxiv_data1/oa_pdf/a3/4b/IEE-5-29853.PMC4685977.pdf
doi: http://dx.doi.org/10.1371/journal.pntd.0001892 98.,Non-OADS,/arxiv_data1/oa_pdf/a3/4b/IEE-5-29853.PMC4685977.pdf
Emerging Infectious Diseases 2006; 21. doi: http://dx.doi.org/10.3201/ eid2105.141385Olivia Wesula Lwande et al.,Non-OADS,/arxiv_data1/oa_pdf/a3/4b/IEE-5-29853.PMC4685977.pdf
"10 (page number not for citation purpose)Citation: Infection Ecology and Epidemiology 2015, 5: 29853 - http://dx.doi.org/10.3402/iee.v5.29853",Non-OADS,/arxiv_data1/oa_pdf/a3/4b/IEE-5-29853.PMC4685977.pdf
"The high -throughput data was deposited in the Gene  Expression Omnibus (GEO; http://www.ncbi.nlm.nih.gov /geo/),  which is the predominant public repository for microarray  data (21).",OADS,/arxiv_data1/oa_pdf/73/79/mmr-13-01-0107.PMC4686054.pdf
"In addition,  the annotation information of the GeneChip was obtained from  the GPL1216 mi croarray platform ( http://www.ncbi.nlm.nih.",OADS,/arxiv_data1/oa_pdf/73/79/mmr-13-01-0107.PMC4686054.pdf
"The f our microarray datasets, GSE41499, GSE33482,  GSE15372 and GSE28739, were downloaded from the Gene  Expression Omnibus database (GEO; http://www.ncbi.nlm.",OADS,/arxiv_data1/oa_pdf/e2/41/mmr-13-01-0188.PMC4686085.pdf
"A total of 11 miRNAs (miR -130a, miR -214, let -7i,  miR- 125b, miR- 376c, miR- 199a, miR- 93, miR- 141, miR- 130b,  miR-193b* and miR -200c) were investigated in PubMed  (http://www.ncbi.nlm.nih.gov/pubmed/; Table II), which  were those reported to be highly associated with MDR in  EOC (29 -39).",OADS,/arxiv_data1/oa_pdf/e2/41/mmr-13-01-0188.PMC4686085.pdf
The above -mentioned 11 miRNAs were entered  into TargetScan (http://genes.mit.edu/tscan /targetscan2003.,OADS,/arxiv_data1/oa_pdf/e2/41/mmr-13-01-0188.PMC4686085.pdf
"html) and PicTar (http://pictar.mdc -berlin.de/) (40,41),  respectively, to determine the relative miRNA target genes.",OADS,/arxiv_data1/oa_pdf/e2/41/mmr-13-01-0188.PMC4686085.pdf
"The Benjamini- Hochberg  (BH) (42) method was used to analyze gene expression,  which was performed in GEO2R (http://www.ncbi.nlm.nih.",OADS,/arxiv_data1/oa_pdf/e2/41/mmr-13-01-0188.PMC4686085.pdf
"Genetic pathway enrich - ment analysis was performed in the Kyoto Encyclopedia of  Genes and Genomes (KEGG) database using the Database  for Annotation, Visualization and Integrated Discovery  (DAVID) tool (http://david.abcc.ncifcrf.gov/) (45,46).",OADS,/arxiv_data1/oa_pdf/e2/41/mmr-13-01-0188.PMC4686085.pdf
"Another web server, DIANA -miRPath (http://www.microrna.",Non-OADS,/arxiv_data1/oa_pdf/e2/41/mmr-13-01-0188.PMC4686085.pdf
"Text mining methods from the  literature and disease levels were combined to screen for  MDR -associated genes in EOC, which were performed in the  COREMINE (http://www.coremine.com/medical/#search)  and IPAD (http://bioinfo.hsc.unt.edu/ipad/) (48) databases,  respectively.",OADS,/arxiv_data1/oa_pdf/e2/41/mmr-13-01-0188.PMC4686085.pdf
"All experimental protocols were  approved by the Institutional Animal Ethics Committee of  Shriram Institute for Industrial Research (Delhi, India), and  guidelines set by the Committee for the Purpose of Control  and Supervision of Experiments on Animals ( http://icmr.nic.",Non-OADS,/arxiv_data1/oa_pdf/f0/db/mmr-13-01-0592.PMC4686098.pdf
Microarray date were obtained  from the Gene Expression Omnibus (GEO; http://www.ncbi.,OADS,/arxiv_data1/oa_pdf/2c/8f/mmr-13-01-0035.PMC4686114.pdf
The overexpression  vectors containing short hairpin (sh)RNA for SNAIL1 were  designed based on the nucleotide sequence (NM_005985.3)  obtained from the GenBank database ( http://www.ncbi.nlm.,OADS,/arxiv_data1/oa_pdf/8e/8d/mmr-13-01-0778.PMC4686115.pdf
"The content was sourced from RefSeq Build 36.3 (http:// www.ncbi.nlm.nih.gov/refseq/), Ensemble Release  52 (http:// asia.ensembl.org/index.html?redirect=no), Unigene Build  216  (http://www.ncbi.nlm.nih.gov/unigene/) and GenBank (http:// www.ncbi.nlm.nih.gov/genbank).",OADS,/arxiv_data1/oa_pdf/19/c1/mmr-13-01-0641.PMC4686122.pdf
http://dx.doi.org/10.1128/MMBR.00043-12 .,Non-OADS,/arxiv_data1/oa_pdf/c6/af/zjb77.PMC4686200.pdf
http://dx.doi.org/10.1038/nrmicro2109 .,Non-OADS,/arxiv_data1/oa_pdf/c6/af/zjb77.PMC4686200.pdf
Annu Rev Genet 40:385– 407. http://dx.doi.org/10.1146/annurev.genet.40 .110405.090423 .,Non-OADS,/arxiv_data1/oa_pdf/c6/af/zjb77.PMC4686200.pdf
http://dx.doi.org/10.1002/pro.2093 .,Non-OADS,/arxiv_data1/oa_pdf/c6/af/zjb77.PMC4686200.pdf
Second messenger regulation of bioﬁlm formation: breakthroughs in understanding c-di-GMP effector systems.Annu Rev Cell Dev Biol 28:439 – 462. http://dx.doi.org/10.1146/annurev -cellbio-101011-155705 .,Non-OADS,/arxiv_data1/oa_pdf/c6/af/zjb77.PMC4686200.pdf
http://dx.doi.org/10.1101/gad.289504 .,Non-OADS,/arxiv_data1/oa_pdf/c6/af/zjb77.PMC4686200.pdf
http://dx.doi.org/10.1128/JB.187.5.1792-1798.2005 .,Non-OADS,/arxiv_data1/oa_pdf/c6/af/zjb77.PMC4686200.pdf
http://dx.doi.org/10.1074/jbc.M506500200 .,Non-OADS,/arxiv_data1/oa_pdf/c6/af/zjb77.PMC4686200.pdf
http://dx.doi.org/10.1074/jbc.M504429200 .,Non-OADS,/arxiv_data1/oa_pdf/c6/af/zjb77.PMC4686200.pdf
http://dx.doi.org/10.1101/gad.502409 .,Non-OADS,/arxiv_data1/oa_pdf/c6/af/zjb77.PMC4686200.pdf
J Biol Chem 286:2910 – 2917. http://dx.doi.org/10.1074/jbc.M110.196220 .,OADS,/arxiv_data1/oa_pdf/c6/af/zjb77.PMC4686200.pdf
http://dx.doi.org/10.1016/j.str.2009.06.010 .,OADS,/arxiv_data1/oa_pdf/c6/af/zjb77.PMC4686200.pdf
http://dx.doi .org/10.1111/j.1574-6976.2009.00194.x .,Non-OADS,/arxiv_data1/oa_pdf/c6/af/zjb77.PMC4686200.pdf
http://dx.doi.org/10.1371/journal.pgen.1002268 .,Non-OADS,/arxiv_data1/oa_pdf/c6/af/zjb77.PMC4686200.pdf
http://dx.doi.org/10.1111 /j.1365-2958.2010.07184.x .,Non-OADS,/arxiv_data1/oa_pdf/c6/af/zjb77.PMC4686200.pdf
Science 315: 853– 856. http://dx.doi.org/10.1126/science.1137223 .,Non-OADS,/arxiv_data1/oa_pdf/c6/af/zjb77.PMC4686200.pdf
Mol Microbiol 68:827– 837. http://dx.doi.org/10.1111/j.1365-2958.2008.06197.x .,OADS,/arxiv_data1/oa_pdf/c6/af/zjb77.PMC4686200.pdf
http://dx.doi.org /10.1073/pnas.0836639100 .,Non-OADS,/arxiv_data1/oa_pdf/c6/af/zjb77.PMC4686200.pdf
J Bacteriol 185:6083– 6094. http://dx.doi.org/10.1128/JB.185.20 .6083-6094.2003 .,Non-OADS,/arxiv_data1/oa_pdf/c6/af/zjb77.PMC4686200.pdf
http://dx.doi.org/10 .1371/journal.pone.0023920 .Skotnicka et al.,OADS,/arxiv_data1/oa_pdf/c6/af/zjb77.PMC4686200.pdf
http://dx.doi.org/10.1046/j.1365 -2958.2002.03258.x .,Non-OADS,/arxiv_data1/oa_pdf/c6/af/zjb77.PMC4686200.pdf
Microbiology 150:4085– 4093. http://dx.doi.org/10.1099/mic.0 .27381-0 .,Non-OADS,/arxiv_data1/oa_pdf/c6/af/zjb77.PMC4686200.pdf
http://dx.doi.org/10.1099/mic.0.27743-0 .,Non-OADS,/arxiv_data1/oa_pdf/c6/af/zjb77.PMC4686200.pdf
J Bacteriol 190:613– 624. http://dx.doi.org/10.1128/JB.01502-07 .,Non-OADS,/arxiv_data1/oa_pdf/c6/af/zjb77.PMC4686200.pdf
http://dx.doi.org/10.1128/JB.186.4.1001-1008.2004 .,Non-OADS,/arxiv_data1/oa_pdf/c6/af/zjb77.PMC4686200.pdf
http://dx.doi.org/10.1111/j.1365-2958.2009.06891.x .,Non-OADS,/arxiv_data1/oa_pdf/c6/af/zjb77.PMC4686200.pdf
http://dx.doi.org/10.1128 /JB.01793-07 .,Non-OADS,/arxiv_data1/oa_pdf/c6/af/zjb77.PMC4686200.pdf
http://dx.doi.org/10.1016/j.mimet.2010.03.020 .,OADS,/arxiv_data1/oa_pdf/c6/af/zjb77.PMC4686200.pdf
http://dx.doi .org/10.1111/j.1462-2920.2009.02094.x .,Non-OADS,/arxiv_data1/oa_pdf/c6/af/zjb77.PMC4686200.pdf
http://dx.doi.org/10.1128/IAI .05153-11 .,Non-OADS,/arxiv_data1/oa_pdf/c6/af/zjb77.PMC4686200.pdf
Mol Microbiol 93:439 – 452. http://dx.doi.org/10.1111/mmi.12672 .,OADS,/arxiv_data1/oa_pdf/c6/af/zjb77.PMC4686200.pdf
http://dx.doi.org/10.1128/JB.188.7 .2681-2691.2006 .,OADS,/arxiv_data1/oa_pdf/c6/af/zjb77.PMC4686200.pdf
http://dx.doi.org/10.1128/mBio.00316-10 .,Non-OADS,/arxiv_data1/oa_pdf/c6/af/zjb77.PMC4686200.pdf
http://dx.doi.org/10.1074/jbc.M603589200 .,Non-OADS,/arxiv_data1/oa_pdf/c6/af/zjb77.PMC4686200.pdf
Mol Micro- biol61:447– 456. http://dx.doi.org/10.1111/j.1365-2958.2006.05230.x .,OADS,/arxiv_data1/oa_pdf/c6/af/zjb77.PMC4686200.pdf
http://dx.doi.org/10.1046/j.1365-2958.2001.02428.x .,Non-OADS,/arxiv_data1/oa_pdf/c6/af/zjb77.PMC4686200.pdf
http://dx.doi.org/10 .1073/pnas.0406134101 .,Non-OADS,/arxiv_data1/oa_pdf/c6/af/zjb77.PMC4686200.pdf
http://dx.doi.org/10.1074 /jbc.M704702200 .,Non-OADS,/arxiv_data1/oa_pdf/c6/af/zjb77.PMC4686200.pdf
Science 327:866 – 868. http://dx.doi.org/10.1126/science.1181185 .,Non-OADS,/arxiv_data1/oa_pdf/c6/af/zjb77.PMC4686200.pdf
Integration of cyclic di-GMP and quorum sensing in the control of vpsT and aphA inVibrio cholerae .J Bacteriol 193:6331– 6341. http://dx.doi.org/10.1128/JB.05167-11 .,Non-OADS,/arxiv_data1/oa_pdf/c6/af/zjb77.PMC4686200.pdf
http://dx.doi.org/10.1111/j.1365-2958.2008.06281.x .,Non-OADS,/arxiv_data1/oa_pdf/c6/af/zjb77.PMC4686200.pdf
http://dx.doi.org/10.1016/j.molcel.2010.03.001 .,OADS,/arxiv_data1/oa_pdf/c6/af/zjb77.PMC4686200.pdf
http://dx.doi.org/10.1371/journal.ppat.1002493 .,Non-OADS,/arxiv_data1/oa_pdf/c6/af/zjb77.PMC4686200.pdf
http://dx.doi.org/10.1111/j.1365 -2958.2006.05156.x .,Non-OADS,/arxiv_data1/oa_pdf/c6/af/zjb77.PMC4686200.pdf
http://dx.doi .org/10.1016/j.jmb.2013.03.021 .,OADS,/arxiv_data1/oa_pdf/c6/af/zjb77.PMC4686200.pdf
J Mol Biol 393:848 – 866. http://dx.doi.org/10.1016/j.jmb.2009.07.065 .,OADS,/arxiv_data1/oa_pdf/c6/af/zjb77.PMC4686200.pdf
http://dx.doi.org/10.1016/j.str.2007.06.016 .,OADS,/arxiv_data1/oa_pdf/c6/af/zjb77.PMC4686200.pdf
http://dx.doi.org/10.1074/jbc.M808221200 .,Non-OADS,/arxiv_data1/oa_pdf/c6/af/zjb77.PMC4686200.pdf
J Bacteriol 190:3622– 3631. http://dx.doi.org/10.1128/JB.00165-08 .,Non-OADS,/arxiv_data1/oa_pdf/c6/af/zjb77.PMC4686200.pdf
http://dx.doi.org/10.1111/mmi .12447 .,Non-OADS,/arxiv_data1/oa_pdf/c6/af/zjb77.PMC4686200.pdf
http://dx.doi.org/10.1128/mBio.00163-11 .,Non-OADS,/arxiv_data1/oa_pdf/c6/af/zjb77.PMC4686200.pdf
http://dx.doi.org /10.1099/mic.0.053892-0 .,Non-OADS,/arxiv_data1/oa_pdf/c6/af/zjb77.PMC4686200.pdf
http://dx.doi.org/10.1007/BF00270004 .,Non-OADS,/arxiv_data1/oa_pdf/c6/af/zjb77.PMC4686200.pdf
http://dx.doi.org/10.1046/j.1365-2958.1998.01160.x .,Non-OADS,/arxiv_data1/oa_pdf/c6/af/zjb77.PMC4686200.pdf
http://dx.doi.org/10.1016/0378 -1119(86)90117-4 .Skotnicka et al.,OADS,/arxiv_data1/oa_pdf/c6/af/zjb77.PMC4686200.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/80/7f/copd-10-2665.PMC4686222.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpInternational Journal of COPD 2015:10 2665–2674International Journal of COPD Dove press submit your manuscript | www.dovepress.co m Dove press  2665OrIg Inal researChopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/COPD.S9139 2Frequency and risk factors of COPD exacerbations  and hospitalizations: a nationwide study in greece  (greek Obstructive lung Disease epidemiology  and health economics: gOlDen study) evangelos C alexopoulos1 Foteini Malli2 eirini Mitsiki3 eleni g Bania2 Christos Varounis3 Konstantinos I  gourgoulianis1 1school of social sciences, hellenic  Open University, Patras, 2respiratory  Medicine Department, University of  Thessaly Medical school, University  hospital of larissa, larissa, 3Medical  Department, novartis hellas, athens,   greeceBackground:  COPD exacerbations and hospitalizations have been associated with poor  prognosis for the COPD patient.",Non-OADS,/arxiv_data1/oa_pdf/80/7f/copd-10-2665.PMC4686222.pdf
"COPD is estimated to become the fifth- leading cause of years lost through early mortality or handicap (disability-adjusted  life years) by 2020,1 while according to World Health Organization estimates it is  predicted to become the third-leading cause of global mortality by the year 2030.2  Projected increases in the burden of COPD are attributed to a worldwide aging Correspondence: eirini Mitsiki Medical Department, novartis hellas,  12th Km national road no 1, 14451  athens, greece email eirini.mitsiki@novartis.co m Journal name: International Journal of COPD Article Designation: Original Research Y ear: 2015 Volume: 10 Running head verso: Alexopoulos et al Running head recto: COPD exacerbations and hospitalizations in Greece DOI: http://dx.doi.org/10.2147/COPD.S91392",Non-OADS,/arxiv_data1/oa_pdf/80/7f/copd-10-2665.PMC4686222.pdf
"Available from: http://www.goldcopd.org/uploads/users/files/ GOLD_Report_2013_Feb20.pd f. Accessed November 10, 2015.",OADS,/arxiv_data1/oa_pdf/80/7f/copd-10-2665.PMC4686222.pdf
"International Journal of COPD Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/international-journal-of-chronic-obstructive-pulmonary-disease-journa lThe International Journal of COPD is an international, peer-reviewed  journal of therapeutics and pharmacology focusing on concise rapid  reporting of clinical studies and reviews in COPD.",Non-OADS,/arxiv_data1/oa_pdf/80/7f/copd-10-2665.PMC4686222.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/80/7f/copd-10-2665.PMC4686222.pdf
"Available from: http://www.goldcopd.org/uploads/users/files/ GOLDReport_April112011.pd f. Accessed November 10, 2015.",OADS,/arxiv_data1/oa_pdf/80/7f/copd-10-2665.PMC4686222.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/9b/83/clep-7-517.PMC4686223.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.ph pClinical Epidemiology 2015:7 517–527Clinical Epidemiology Dove press submit your manuscript | www.dovepress.co m Dove press  517Original rEsEarChopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/CLEP .S8510 7Validation of second trimester miscarriages and  spontaneous deliveries Kirstine sneider1 Jens langhoff-roos2 iben Blaabjerg sundtoft3 Ole Bjarne Christiansen4,5 1Department of Clinical research,   Vendsyssel hospital, hjørring,   2Department of Obstetrics,   rigshospitalet, University of  Copenhagen, Copenhagen,   3Department of Obstetrics and  gynecology, aarhus University  hospital, aarhus, 4Department of  Obstetrics and gynecology, aalborg  University hospital, aalborg, 5The  Fertility Clinic, University hospital,   Copenhagen, Denmark Correspondence: Kirstine sneider   Department of Clinical research,  Vendsyssel hospital, hjørring, Denmark   Email k.sneider@rn.d kObjective:  To validate the diagnosis of second trimester miscarriages/deliveries (16 +0 weeks  to 27+6 weeks of gestation) recorded as miscarriages in the Danish National Patient Registry  or spontaneous deliveries in the Danish Medical Birth Registry, and asses the validity of risk  factors, pregnancy complications, and cerclage by review of medical records.",Non-OADS,/arxiv_data1/oa_pdf/9b/83/clep-7-517.PMC4686223.pdf
"Clinical Epidemiology Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/clinical-epidemiology-journa lClinical Epidemiology is an international, peer-reviewed, open access,  online journal focusing on disease and drug epidemiology, identifica - tion of risk factors and screening procedures to develop optimal pre - ventative initiatives and programs.",Non-OADS,/arxiv_data1/oa_pdf/9b/83/clep-7-517.PMC4686223.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/a8/f2/copd-10-2657.PMC4686224.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpInternational Journal of COPD 2015:10 2657–2663International Journal of COPD Dove press submit your manuscript | www.dovepress.co m Dove press  2657OrIg Inal researChopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/COPD.S8532 4adherence to gOlD guideline treatment  recommendations among pulmonologists  in T urkey elif sen,1 salih Zeki guclu,2  Isil Kibar,3 Ulku Ocal,4  Veysel Yilmaz,5 Onur Celik,6  Filiz Cimen,7 Fusun T opcu,8  Meltem Orhun,9 hikmet  T ereci,10 aylin Konya,11  Idilhan ar,11 sevgi saryal1 1Department of Pulmonary Diseases,  ankara University school of Medicine,  ankara, 2Pulmonary Diseases  Department, Izmir Dr suat seren  surgery Training and research  hospital, Izmir, 3Pulmonary Diseases  Department, Istanbul hospital, Istanbul,  4Pulmonary Diseases Department,  adana Prof Dr n usret Karasu  Pulmonary Diseases hospital, adana,  5Pulmonary Diseases Department,  Yedikule Pulmonary Diseases and  surgery Training and research  hospital, Istanbul, 6Pulmonary  Diseases Department, Nihat Kitapçı  Pulmonary Diseases and surgery  hospital, erzurum, 7Pulmonary  Diseases Department, atatürk  Pulmonary Diseases and surgery  Training and research hospital,  ankara, 8Department of Pulmonary  Diseases, Dicle University school  of Medicine, Diyarbakir, 9Pulmonary  Diseases Department, Uskudar  state hospital, Istanbul, 10Pulmonary  Diseases Department, samsun  Pulmonary Diseases and Thoracic  surgery hospital, 11Pulmonary Diseases  Department, novartis Pharmaceuticals,  Istanbul, T urkeyBackground:  Low adherence to Global initiative for chronic Obstructive Lung Disease  (GOLD) guideline recommendations has been reported worldwide.",Non-OADS,/arxiv_data1/oa_pdf/a8/f2/copd-10-2657.PMC4686224.pdf
"The low adherence to guideline treatment recommen - dations has been reported in several studies.4–6 Under or overprescription cause the Correspondence: elif sen Department of Pulmonary Diseases,  ankara University school of Medicine,  Mamak Caddesi 12/a, Cebeci, ankara,  06100, Turkey Tel +90 532 452 7660 Fax +90 312 310 6370 email esen@ankara.edu.t r Journal name: International Journal of COPD Article Designation: Original Research Y ear: 2015 Volume: 10 Running head verso: Sen et al Running head recto: COPD treatment and GOLD adherence in Turkey DOI: http://dx.doi.org/10.2147/COPD.S85324",Non-OADS,/arxiv_data1/oa_pdf/a8/f2/copd-10-2657.PMC4686224.pdf
"International Journal of COPD Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/international-journal-of-chronic-obstructive-pulmonary-disease-journa lThe International Journal of COPD is an international, peer-reviewed  journal of therapeutics and pharmacology focusing on concise rapid  reporting of clinical studies and reviews in COPD.",Non-OADS,/arxiv_data1/oa_pdf/a8/f2/copd-10-2657.PMC4686224.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/a8/f2/copd-10-2657.PMC4686224.pdf
"The full terms of this license are available at https://www.dovepress.com/ terms.php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/0c/31/dhps-7-157.PMC4686225.pdf
"For  permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).Drug, Healthcare and Patient Safety 2015:7 157–167Drug, Healthcare and Patient Safety Dove press submit your manuscript | www.dovepress.co m Dove press  157Reviewopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/DHPS.S6964 0Clinical efficacy, safety, and tolerability of  fingolimod for the treatment of relapsing- remitting multiple sclerosis Alberto Gajofatto1,2 Marco T uratti2 Salvatore Monaco1,2 Maria Donata Benedetti2 1Department of Neurological,   Biomedical and Movement Sciences,   University of verona, verona, italy;  2Division of Neurology B, verona  University Hospital , verona, italy Correspondence: Alberto Gajofatto   Department of Neurological, Biomedical  and Movement Sciences, University of  verona, Policlinico Borgo Roma, Piazzale  LA Scuro  10, verona  37134, italy   Tel +39 045 8124 678  Fax +39 045 8027 492  email alberto.gajofatto@univr.i tAbstract:  Fingolimod is a selective immunosuppressive agent approved worldwide for the  treatment of relapsing-remitting multiple sclerosis (MS), a chronic and potentially disabling  neurological condition.",Non-OADS,/arxiv_data1/oa_pdf/0c/31/dhps-7-157.PMC4686225.pdf
Available from: http://www.wsj.com/articles/ SB1000142405274870425630457532071413815924 0.,Non-OADS,/arxiv_data1/oa_pdf/0c/31/dhps-7-157.PMC4686225.pdf
Available from: https://www.novartis.,Non-OADS,/arxiv_data1/oa_pdf/0c/31/dhps-7-157.PMC4686225.pdf
"Available from: http://www.ema.europa.eu/docs/en_GB/ document_library/Press_release/2012/04/WC500125690.pd f. Accessed  November  11, 2015.",Non-OADS,/arxiv_data1/oa_pdf/0c/31/dhps-7-157.PMC4686225.pdf
"Available from: http://www.fda.gov/Drugs/DrugSafety/ ucm456919.ht m. Accessed September  25, 2015.",Non-OADS,/arxiv_data1/oa_pdf/0c/31/dhps-7-157.PMC4686225.pdf
Available from: http://www.ema.,Non-OADS,/arxiv_data1/oa_pdf/0c/31/dhps-7-157.PMC4686225.pdf
"Drug, Healthcare and Patient Safety Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/drug-healthcare-and-patient-safety-journa lDrug, Healthcare and Patient Safety is an international, peer-reviewed  open-access journal exploring patient safety issues in the healthcare  continuum from diagnostic and screening interventions through to treat - ment, drug therapy and surgery.",Non-OADS,/arxiv_data1/oa_pdf/0c/31/dhps-7-157.PMC4686225.pdf
Visit http://www.dovepress.com/   testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/0c/31/dhps-7-157.PMC4686225.pdf
Available from: http://www.ema.,Non-OADS,/arxiv_data1/oa_pdf/0c/31/dhps-7-157.PMC4686225.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/3a/28/dddt-9-6421.PMC4686226.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpDrug Design, Development and Therapy 2015:9 6421–6431Drug Design, Development and Therapy Dove press submit your manuscript | www.dovepress.co m Dove press  6421Original researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/DDDT .S9560 6autophagy facilitates lung adenocarcinoma  resistance to cisplatin treatment by activation of  aMPK/mTOr signaling pathway Tao Wu1 Min-cong Wang1 li Jing1 Zhi-Yan liu2 hui guo1 Ying liu3 Yi-Yang Bai1 Yang-Zi cheng1 Ke-Jun nan1 Xuan liang1 1Department of Medical Oncology,   The First affiliated hospital of Xi’an  Jiaotong University, 2Department of  respiratory Medicine, Xi’an central  hospital, 3Department of Medical  Oncology, shaanxi Provincial People’s  hospital, Xi’an, shaanxi, People’s  republic of chinaAbstract:  Resistance to cisplatin-based therapy is a major challenge in the control of lung  cancer progression.",Non-OADS,/arxiv_data1/oa_pdf/3a/28/dddt-9-6421.PMC4686226.pdf
"Keywords:  autophagy, lung cancer, A549 cells, A549/DDP cells, chemoresistance, AMPK,  chloroquine Introduction Lung cancer is a major health problem with a high incidence and mortality rate  worldwide.1 Surgery remains the cornerstone of therapy in early-stage lung cancer  patients.2 However, the majority of patients have locally advanced or distant meta - static disease at diagnosis and thus do not undergo surgery.3 Thus, for these patients,  platinum-based combination chemotherapy is the mainstay of palliation.4 However,  the clinical outcome is still disappointing and the median survival for these individuals  is only approximately 10 months.5,6 The platinum chemotherapeutic agent, cisplatin, is a major frontline drug to treat  various human malignant tumors, including lung cancer.7,8 Nonetheless, clinical usage  of this drug is limited because of intrinsic and acquired resistance.9 To date, mounting  evidence indicates that cisplatin resistance has a multifactorial nature, and the underlying  mechanisms remain obscure; most often targeting one mechanism of resistance fails to correspondence: Ke-Jun nan; Xuan liang Department of Medical Oncology, The  First Affiliated Hospital of Xi’an Jiaotong  University, 277 Yanta West road, Xi’an,  shaanxi 710061, People’s republic of  china  Tel +86 29 8532 4086 Fax +86 29 8532 4086 email nankj@163.co m;   elva_0209@126.co m Journal name: Drug Design, Development and Therapy Article Designation: Original Research Y ear: 2015 Volume: 9 Running head verso: Wu et al Running head recto: Autophagy facilitates lung adenocarcinoma resistance to cisplatin DOI: http://dx.doi.org/10.2147/DDDT.S95606",Non-OADS,/arxiv_data1/oa_pdf/3a/28/dddt-9-6421.PMC4686226.pdf
"Drug Design, Development and Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/drug-design-development-and-therapy-journa lDrug Design, Development and Therapy is an international, peer- reviewed open-access journal that spans the spectrum of drug design  and development through to clinical applications.",Non-OADS,/arxiv_data1/oa_pdf/3a/28/dddt-9-6421.PMC4686226.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/3a/28/dddt-9-6421.PMC4686226.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/30/41/dddt-9-6407.PMC4686227.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpDrug Design, Development and Therapy 2015:9 6407–6419Drug Design, Development and Therapy Dove press submit your manuscript | www.dovepress.co m Dove press  6407Reviewopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/DDDT .S7664 8Idiopathic pulmonary fibrosis: current treatment  options and critical appraisal of nintedanib Francesco Bonella1 Susanne Stowasser2 Lutz wollin3 1interstitial and Rare Lung Disease  Unit, Ruhrlandklinik, University  Hospital, University of Duisburg- essen, essen, 2Boehringer ingelheim  Pharma GmbH & Co. KG, Ingelheim  am Rhein, 3Boehringer ingelheim  Pharma GmbH & Co. KG, Biberach  an der Riss, GermanyAbstract:  Idiopathic pulmonary fibrosis (IPF) is the most common type of idiopathic intersti - tial pneumonia and is characterized by a poor prognosis, with an estimated 5-year survival of  approximately 20%.",Non-OADS,/arxiv_data1/oa_pdf/30/41/dddt-9-6407.PMC4686227.pdf
"The overall range of incidence of IPF varies from 0.22 to  93.7 per 100,000 per year worldwide, but excluding old studies and different popula - tions (Asia and South America) is likely to be 2.8–9.3 per 100,000 per year in Europe  and North America.2 The prevalence of IPF is estimated to be between 200 and 500  cases per 100,000 people.3,4 The diagnosis of IPF requires the exclusion of known causes of pulmonary  fibrosis and the presence of a typical radiologic and pathologic pattern called usual  interstitial pneumonia (UIP).5 Radiologically, UIP pattern is characterized by Correspondence: Lutz Wollin Boehringer Ingelheim Pharma GmbH &   Co. KG, Birkendorfer Strasse 65,  88397 Biberach an der Riss, Germany Tel +49 7351 54 94993 Fax +49 7351 83 94993 email stefan-lutz.wollin@boehringer- ingelheim.co m Journal name: Drug Design, Development and Therapy Article Designation: Review Y ear: 2015 Volume: 9 Running head verso: Bonella et al Running head recto: Nintedanib in idiopathic pulmonary fibrosis DOI: http://dx.doi.org/10.2147/DDDT.S76648",Non-OADS,/arxiv_data1/oa_pdf/30/41/dddt-9-6407.PMC4686227.pdf
"Drug Design, Development and Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/drug-design-development-and-therapy-journa lDrug Design, Development and Therapy is an international, peer- reviewed open-access journal that spans the spectrum of drug design  and development through to clinical applications.",Non-OADS,/arxiv_data1/oa_pdf/30/41/dddt-9-6407.PMC4686227.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/30/41/dddt-9-6407.PMC4686227.pdf
Available from: http://www.iclaf.com/ conference /index.,Non-OADS,/arxiv_data1/oa_pdf/30/41/dddt-9-6407.PMC4686227.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/2a/2c/dddt-9-6433.PMC4686228.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpDrug Design, Development and Therapy 2015:9 6433–6444Drug Design, Development and Therapy Dove press submit your manuscript | www.dovepress.co m Dove press  6433Original researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/DDDT .S9227 3enhanced antitumoral activity of doxorubicin  against lung cancer cells using biodegradable  poly(butylcyanoacrylate) nanoparticles consolación Melguizo1,2,* laura cabeza1,* Jose Prados1,2 raúl Ortiz1,3 Octavio caba1,3 ana r rama1,3 Ángel V Delgado4 José l arias1,2,5 1institute of Biopathology and  regenerative Medicine (iBiM er),   Biomedical research center,   2Biosanitary institute of granada  (iBs granada), sas Universidad de  granada, granada, 3Department of  health science, University of Jaén,   Jaén, 4Department of applied Physics,   5Department of Pharmacy and  Pharmaceutical T echnology, University  of granada, granada, spain *These authors contributed equally  to this workAbstract:  Doxorubicin (Dox) is widely used for the combined chemotherapy of solid tumors.",Non-OADS,/arxiv_data1/oa_pdf/2a/2c/dddt-9-6433.PMC4686228.pdf
"It is used correspondence: Jose Prados institute of Biopathology and  regenerative Medicine (iBiMer),  Biomedical research center, University  of granada, avenida del conocimiento,  granada 18100, spain Tel +34 958 248 819 Fax +34 958 246 296 email jcprados@ugr.e s Journal name: Drug Design, Development and Therapy Article Designation: Original Research Y ear: 2015 Volume: 9 Running head verso: Melguizo et al Running head recto: Doxorubicin-loaded NPs to improve lung cancer therapy DOI: http://dx.doi.org/10.2147/DDDT.S92273",Non-OADS,/arxiv_data1/oa_pdf/2a/2c/dddt-9-6433.PMC4686228.pdf
Available from: http://www.cancer.,Non-OADS,/arxiv_data1/oa_pdf/2a/2c/dddt-9-6433.PMC4686228.pdf
"Drug Design, Development and Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/drug-design-development-and-therapy-journa lDrug Design, Development and Therapy is an international, peer- reviewed open-access journal that spans the spectrum of drug design  and development through to clinical applications.",Non-OADS,/arxiv_data1/oa_pdf/2a/2c/dddt-9-6433.PMC4686228.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/2a/2c/dddt-9-6433.PMC4686228.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/5d/18/ijwh-7-957.PMC4686315.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpInternational Journal of Women’s Health 2015:7 957–964International Journal of Women’s Health Dove press submit your manuscript | www.dovepress.co m Dove press  957OrIg Inal researcHopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/IJWH.S9074 1contraceptive use in women with hypertension  and diabetes: cross-sectional study in northwest  ethiopia T ensae Tadesse Mekonnen1 solomon Meseret  Woldeyohannes2 T egbar Yigzaw3 1Department of Midwifery, Tseda  Health science college, 2Department  of epidemiology and Biostatistics,   Institute of Public Health, University  of gondar, gondar, 3Jhpiego-ethiopia,   addis ababa, ethiopiaPurpose:  Women with diabetes and hypertension are at increased risk of pregnancy  complications, including those from surgical delivery and their offspring are at risk for con - genital anomalies.",Non-OADS,/arxiv_data1/oa_pdf/5d/18/ijwh-7-957.PMC4686315.pdf
"Women comprise 60% of the world’s poor, and  poverty worsens the chances of survival from chronic disease.4correspondence: T ensae Tadesse  Mekonnen Department of Midwifery, Tseda Health  science college, PO Box 102, gondar,  ethiopia Tel/fax +251 5 8111 6221 email almaztade@gmail.co m Journal name: International Journal of Women’s Health Article Designation: Original Research Y ear: 2015 Volume: 7 Running head verso: Mekonnen et al Running head recto: Contraceptive use in women with hypertension and diabetes DOI: http://dx.doi.org/10.2147/IJWH.S90741",Non-OADS,/arxiv_data1/oa_pdf/5d/18/ijwh-7-957.PMC4686315.pdf
"Available  from: http://www.who.int/nmh/publications/ncd_report_full_en.pd f.  Accessed September 17, 2015.",OADS,/arxiv_data1/oa_pdf/5d/18/ijwh-7-957.PMC4686315.pdf
"Available from: http://www.who.int/ pmnch/topics/maternal/2011_women_ncd_report.pdf.pd f. Accessed  September 17, 2015.",Non-OADS,/arxiv_data1/oa_pdf/5d/18/ijwh-7-957.PMC4686315.pdf
Available from: http://www.cdc.gov/ reproductivehealt h.  9.,Non-OADS,/arxiv_data1/oa_pdf/5d/18/ijwh-7-957.PMC4686315.pdf
"International Journal of Women’s Health Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/international-journal-of-womens-health-journa lThe International Journal of Women’s Health is an international, peer- reviewed open-access journal publishing original research, reports,  editorials, reviews and commentaries on all aspects of women’s  healthcare including gynecology, obstetrics, and breast cancer.",Non-OADS,/arxiv_data1/oa_pdf/5d/18/ijwh-7-957.PMC4686315.pdf
Visit http://www.dovepress.com/testimonials.ph p to read real quotes  from published authors.,Non-OADS,/arxiv_data1/oa_pdf/5d/18/ijwh-7-957.PMC4686315.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/46/b4/imcrj-8-333.PMC4686316.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.ph pInternational Medical Case Reports Journal 2015:8 333–336International Medical Case Reports Journal Dove press submit your manuscript | www.dovepress.co m Dove press  333Case Repo Rtopen access to scientific and medical research open access Full text article http: //dx.doi.org/10.2147/IMCRJ.S8609 8sacrococcygeal teratoma in a female newborn  with clinical features of trisomy 13: a case report  from Central africa toni Kasole Lubala1,2 olivier Mukuku1 Mick pongombo shongo1,2 augustin Mulangu  Mutombo1 Nina Lubala1 oscar Numbi Luboya1 prosper Lukusa-tshilobo3 1Department of paediatrics, Faculty  of Medicine, 2Center for Human  Genetics, Faculty of Medicine,   University of Lubumbashi, Lubumbashi,   3Department of paediatrics and  Centre for Human Genetics,   University Hospital, University of  Kinshasa, Kinshasa, Democratic  Republic of Congo Correspondence: olivier Mukuku   Department of paediatrics, Faculty of  Medicine, University of Lubumbashi,  po Box 1825, Lubumbashi, province of  Katanga, Democratic Republic of Congo   tel +243 9 9792 5649   email oliviermukuku@yahoo.f rIntroduction:  The objective of this report is to describe the first patient presenting clinical  features of trisomy 13 in association with a sacrococcygeal teratoma.",Non-OADS,/arxiv_data1/oa_pdf/46/b4/imcrj-8-333.PMC4686316.pdf
"International Medical Case Reports Journal Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/international-medical-case-reports-journal-journa lThe International Medical Case Reports Journal is an international,  peer-reviewed open-access journal publishing original case reports  from all medical specialties.",Non-OADS,/arxiv_data1/oa_pdf/46/b4/imcrj-8-333.PMC4686316.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/46/b4/imcrj-8-333.PMC4686316.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/c1/8f/imcrj-8-337.PMC4686317.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.ph pInternational Medical Case Reports Journal 2015:8 337–344International Medical Case Reports Journal Dove press submit your manuscript | www.dovepress.co m Dove press  337Case Repo Rtopen access to scientific and medical research open access Full text article http: //dx.doi.org/10.2147/IMCRJ.S9315 9Consecutive successful pregnancies subsequent   to intravenous immunoglobulin therapy in a  patient with recurrent spontaneous miscarriage Michael F Diejomaoh1,2 Zainab Bello2 Waleed al Jassar1,2 Jiri Jirous2 Kavitha Karunakaran2 asiya t Mohammed1 1Department of obstetrics and  Gynaecology, Faculty of Medicine,   Kuwait University, safat, 2Maternity  Hospital, shuwaikh, Kuwait Correspondence: Michael F Diejomaoh   Department of obstetrics and  Gynaecology, Faculty of Medicine, Kuwait  University, po Box 24923,   safat 13110, Kuwait   tel +965 2531 9601/ +965 6674 1876   Fax +965 2533 8906   email michaeldiejo@hotmail.co mBackground:  Recurrent spontaneous miscarriage (RSM) has a multifactorial etiology, mainly  due to karyotype abnormalities including balanced translocation, anatomical uterine disorders,  and immunological factors, although in 50%–60% the etiology is unexplained.",Non-OADS,/arxiv_data1/oa_pdf/c1/8f/imcrj-8-337.PMC4686317.pdf
"International Medical Case Reports Journal Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/international-medical-case-reports-journal-journa lThe International Medical Case Reports Journal is an international,  peer-reviewed open-access journal publishing original case reports  from all medical specialties.",Non-OADS,/arxiv_data1/oa_pdf/c1/8f/imcrj-8-337.PMC4686317.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/c1/8f/imcrj-8-337.PMC4686317.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/53/b9/jpr-8-871.PMC4686318.pdf
"Information on how to request permission may be found at: http://www.dovepress.com/permissions.ph pJournal of Pain Research 2015:8 871–877Journal of Pain Research Dove press submit your manuscript | www.dovepress.co m Dove press  871Reviewopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/JPR.S5311 3T erminology, criteria, and definitions in complex  regional pain syndrome: challenges and solutions Katherine Dutton1 Geoffrey Littlejohn2 1Department of Rheumatology,   T ownsville Hospital, Douglas, QLD,   Australia; 2Department of Medicine,   Monash University, Melbourne, viC,   Australia Correspondence: Geoffrey Littlejohn  Suite H, Monash Medical Centre,   246 Clayton Road, Clayton, Melbourne,   viC, Australia   email geoff.littlejohn@monash.ed uAbstract:  Complex regional pain syndrome has long been recognized as a severe and high  impact chronic pain disorder.",Non-OADS,/arxiv_data1/oa_pdf/53/b9/jpr-8-871.PMC4686318.pdf
"Journal of Pain Research Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/journal-of-pain-research-journa lThe Journal of Pain Research is an international, peer-reviewed, open  access, online journal that welcomes laboratory and clinical findings  in the fields of pain research and the prevention and management  of pain.",Non-OADS,/arxiv_data1/oa_pdf/53/b9/jpr-8-871.PMC4686318.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/53/b9/jpr-8-871.PMC4686318.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/b2/af/ndt-11-3065.PMC4686319.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpNeuropsychiatric Disease and Treatment 2015:11 3065–3073Neuropsychiatric Disease and Treatment Dove press submit your manuscript | www.dovepress.co m Dove press  3065OrigiNal researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/NDT .S9296 8altered intrinsic regional spontaneous brain  activity in patients with optic neuritis: a resting- state functional magnetic resonance imaging study Yi shao1,* Feng-Qin cai2,* Yu-lin Zhong1 Xin huang1,3 Ying Zhang1 Pei-hong hu1 chong-gang Pei1 Fu-Qing Zhou2 Xian-Jun Zeng2 1Department of Ophthalmology,   2Department of radiology, First  affiliated hospital of Nanchang  University, Nanchang, 3Department  of Ophthalmology, First People’s  hospital of Jiujiang, Jiujiang, People’s  republic of china *These authors contributed equally  to this workObjective:  To investigate the underlying regional homogeneity (ReHo) in brain-activity deficit  in patients with optic neuritis (ON) and its relationship with behavioral performance.",Non-OADS,/arxiv_data1/oa_pdf/b2/af/ndt-11-3065.PMC4686319.pdf
"VEP has been studied in patients with ON, and the VEP features of ON are amplitude  decrease and prolonged latency, which reflect nerve-axon lesions and apoptosis of correspondence: Fu-Qing Zhou;   Xian-Jun Zeng Department of radiology, First  Affiliated Hospital of Nanchang  University, 17 YongWai Zheng street,  Donghu, Nanchang, Jiangxi 330006,  People’s republic of china Tel +86 791 8869 5132 email fq.chou@yahoo.co m;   375135747@qq.co m Journal name: Neuropsychiatric Disease and Treatment Article Designation: Original Research Y ear: 2015 Volume: 11 Running head verso: Shao et al Running head recto: ReHo in brain-activity deficit in optic neuritis DOI: http://dx.doi.org/10.2147/NDT.S92968",Non-OADS,/arxiv_data1/oa_pdf/b2/af/ndt-11-3065.PMC4686319.pdf
The rest of the data were preprocessed using  SPM8 ( http://www.fil.ion.ucl.ac.uk/sp m) and DPARSFA  (http://rfmri.org/DPARS F) software.,OADS,/arxiv_data1/oa_pdf/b2/af/ndt-11-3065.PMC4686319.pdf
"Neuropsychiatric Disease and Treatment Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/neuropsychiatric-disease-and-treatment-journa lNeuropsychiatric Disease and Treatment is an international, peer- reviewed journal of clinical therapeutics and pharmacology focusing   on concise rapid reporting of clinical or pre-clinical studies on a   range of neuropsychiatric and neurological disorders.",Non-OADS,/arxiv_data1/oa_pdf/b2/af/ndt-11-3065.PMC4686319.pdf
Visit http://www.dovepress.com/testimonials.ph p to  read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/b2/af/ndt-11-3065.PMC4686319.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/44/8f/nsa-8-067.PMC4686320.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.ph pNanotechnology, Science and Applications 2015:8 67–80Nanotechnology, Science and Applications Dove press submit your manuscript | www.dovepress.co m Dove press  67ORIGINAL RESEARCHopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/NSA.S9178 5Factors determining the stability, size distribution,  and cellular accumulation of small, monodisperse  chitosan nanoparticles as candidate vectors for  anticancer drug delivery: application to the passive  encapsulation of [14C]-doxorubicin Mas Jaffri Masarudin1 Suzanne M Cutts2 Benny J Evison3 Don R Phillips2 Paul J Pigram4 1Department of Cell and Molecular  Biology, Faculty of Biotechnology and  Biomolecular Sciences, Universiti  Putra Malaysia, Serdang, Malaysia;   2Department of Biochemistry, La  Trobe University, Melbourne, Victoria,   Australia; 3Department of Chemical  Biology and Therapeutics, St Jude  Children’s Hospital, Memphis, TN,   USA; 4Department of Physics, La  Trobe University, Melbourne, Victoria,   Australia Correspondence: Mas Jaffri Masarudin   Department of Cell and Molecular  Biology, Faculty of Biotechnology and  Biomolecular Sciences, Universiti Putra  Malaysia, 43400 UPM Serdang, Selangor,  Malaysia   Tel +60 3 8947 1970   Email masjaffri@upm.edu.m yAbstract:  Development of parameters for the fabrication of nanosized vectors is pivotal for its  successful administration in therapeutic applications.",Non-OADS,/arxiv_data1/oa_pdf/44/8f/nsa-8-067.PMC4686320.pdf
"Nanotechnology, Science and Applications Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/nanotechnology-science-and-applications-journa lNanotechnology, Science and Applications is an international, peer-reviewed, open  access journal that focuses on the science of nanotechnology in a wide range of  industrial and academic applications.",Non-OADS,/arxiv_data1/oa_pdf/44/8f/nsa-8-067.PMC4686320.pdf
Visit http://www.dovepress.com/ testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/44/8f/nsa-8-067.PMC4686320.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/ef/be/hiv-7-277.PMC4686321.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.ph pHIV/AIDS – Research and Palliative Care 2015:7 277–283HIV/AIDS – Research and Palliative Care Dove press submit your manuscript | www.dovepress.co m Dove press  277ORIg InAl ReSeARCHopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/HIV.S9075 5HIV-1 subtype characteristics of infected persons  living in southwestern greece nikolaos Davanos1 george Panos2 Charalambos A gogos2 Athanasia Mouzaki1 1Division of Hematology, Department  of Internal Medicine, Faculty of  Medicine, 2Division of Infectious  Diseases, Department of Internal  Medicine, University Hospital,   University of Patras, Patras, greece Correspondence: Athanasia Mouzaki   Division of Hematology, Department   of Internal Medicine, Faculty of Medicine,  School of Health Sciences, University of   Patras, Asklipiou street, Panepistimioupolis,  Rion, Patras 26500, greece   Tel/fax +30 261 096 9123   email mouzaki@upatras.g rBackground:  The rapid replication rate of HIV -1, coupled with a high mutation rate and  recombination, is the underlying force driving its genetic diversity.",Non-OADS,/arxiv_data1/oa_pdf/ef/be/hiv-7-277.PMC4686321.pdf
"In recent  years, populations of intersubtype circulating recombinant  forms (CRFs; http://www.hiv.lanl.gov/content/sequence/ HIV/CRFs/CRFs.htm l) and multiple unique recombinant  forms have been identified.",Non-OADS,/arxiv_data1/oa_pdf/ef/be/hiv-7-277.PMC4686321.pdf
"HIV/AIDS – Research and Palliative Care 2015:7submit your manuscript | www.dovepress.co m Dove press Dove press 279Determination of HIV-1 subtype prevalence in greece The nucleotide sequences generated were used for  subtype analysis, using the National Center for Biotech - nology Information HIV -subtyping tool ( http://www.ncbi.",Non-OADS,/arxiv_data1/oa_pdf/ef/be/hiv-7-277.PMC4686321.pdf
nlm.nih.gov/projects/genotyping/formpage.cg i) and the  Rega HIV -1-subtyping tool version 2.0 ( http://www.bioaf - rica.net/rega-genotype/htm l).,OADS,/arxiv_data1/oa_pdf/ef/be/hiv-7-277.PMC4686321.pdf
Identification of amino acid  substitutions was performed using the Stanford University  HIV database program ( http://hivdb.stanford.ed u).,OADS,/arxiv_data1/oa_pdf/ef/be/hiv-7-277.PMC4686321.pdf
"HIV/AIDS - Research and Palliative Care Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/hivaids---research-and-palliative-care-journa lHIV/AIDS - Research and Palliative Care is an international, peer- reviewed open-access journal focusing on advances in research in HIV ,  its clinical progression and management options including antiviral  treatment, palliative care and public healthcare policies to control  viral spread.",Non-OADS,/arxiv_data1/oa_pdf/ef/be/hiv-7-277.PMC4686321.pdf
Visit http://www.dovepress.com/   testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/ef/be/hiv-7-277.PMC4686321.pdf
"Official report of the Greek Ministry of Health: HIV/AIDS Surveil - lance in Greece: Available from: http://www.keelpno.gr/Portals/0/ Αρχεια/HIV/2014/Epidimiologiko_2013_final.pd f. Accessed August  31, 2015.",Non-OADS,/arxiv_data1/oa_pdf/ef/be/hiv-7-277.PMC4686321.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/c5/2c/ijn-10-7397.PMC4686322.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpInternational Journal of Nanomedicine 2015:10 7397–7412International Journal of Nanomedicine Dove press submit your manuscript | www.dovepress.co m Dove press  7397OrIg INal researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/IJN.S9269 7a toxic organic solvent-free technology for the  preparation of P egylated paclitaxel  nanosuspension  based on human serum albumin for effective cancer  therapy Tingjie Yin* lihui Dong* Bei cui lei Wang lifang Yin Jianping Zhou Meirong huo state Key laboratory of Natural  Medicines, Department of  Pharmaceutics, china Pharmaceutical  University, Nanjing, People’s republic  of china *These authors contributed equally  to this workAbstract:  Clinically, paclitaxel (PTX) is one of most commonly prescribed therapies against a  wide range of solid neoplasms.",Non-OADS,/arxiv_data1/oa_pdf/c5/2c/ijn-10-7397.PMC4686322.pdf
"This leads to the induction  of cell apoptosis at the late G2/M phase.1 Despite its wide use, the practical applica - tion of PTX is still limited by its poor aqueous solubility and low therapeutic index.2  In its commercial formulations (Taxol®, Bristol-Myers Squibb, New Y ork, NY, USA),  PTX is formulated in a 50:50 mixture of Cremophor EL and dehydrated ethanol.3,4  Unfortunately, Cremophor EL has been attributed to significant side effects, such as  hypersensitivity, neurotoxicity, nephrotoxicity, and cardiotoxicity when intravenously  (IV) administrated at a large dose.5,6 Because of the inherent problems associated with Cremophor EL, a number of  alternative formulations including liposomes,7 lipid emulsions,8 polymeric micelles,9 correspondence: Jianping Zhou; Meirong huo state Key laboratory of Natural  Medicines, Department of Pharmaceutics,  china Pharmaceutical University,   24 Tongjiaxiang, Nanjing 210009,  People’s republic of china Tel +86 25 8327 1102 Fax +86 25 8330 1606 email cpu_zhoujp@163.co m;   huomeirongcpu@163.co mJournal name: International Journal of Nanomedicine Article Designation: Original Research Y ear: 2015 Volume: 10 Running head verso: Yin et al Running head recto: A toxic organic solvent-free technology for preparation of PTX-PEG-HSA DOI: http://dx.doi.org/10.2147/IJN.S92697",Non-OADS,/arxiv_data1/oa_pdf/c5/2c/ijn-10-7397.PMC4686322.pdf
"International Journal of Nanomedicine Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/international-journal-of-nanomedicine-journa lThe International Journal of Nanomedicine is an international, peer- reviewed journal focusing on the application of nanotechnology   in diagnostics, therapeutics, and drug delivery systems throughout   the biomedical field.",Non-OADS,/arxiv_data1/oa_pdf/c5/2c/ijn-10-7397.PMC4686322.pdf
Visit http://www.dovepress.com/ testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/c5/2c/ijn-10-7397.PMC4686322.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/58/ac/ndt-11-3049.PMC4686323.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).Neuropsychiatric Disease and Treatment 2015:11 3049–3064Neuropsychiatric Disease and Treatment Dove press submit your manuscript | www.dovepress.co m Dove press  3049OrigiNal researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/NDT .S9519 0The effects of motivation feedback in patients  with severe mental illness: a cluster randomized  controlled trial eline c Jochems1,2 christina M van der Feltz- cornelis1–3 arno van Dam3,4 hugo J Duivenvoorden5 cornelis l Mulder1,6 1Department of Psychiatry,   epidemiological and social Psychiatric  research institute, erasmus M c  University Medical center, rotterdam,   the Netherlands; 2ggz Breburg, Top  clinical center for Body, Mind and  health, Tilburg, the Netherlands;   3Tilburg University, Faculty of social  sciences, Tranzo Department, Tilburg,   the Netherlands; 4ggZ Westelijk  Noord Brabant, Bergen op Zoom,   the Netherlands; 5erasmus M c  University Medical center, rotterdam,   the Netherlands; 6Bavo europoort,   Parnassia Psychiatric institute,   rotterdam, the NetherlandsObjective:  To evaluate the effectiveness of providing clinicians with regular feedback on the  patient’s motivation for treatment in increasing treatment engagement in patients with severe  mental illness.",Non-OADS,/arxiv_data1/oa_pdf/58/ac/ndt-11-3049.PMC4686323.pdf
"Keywords:  randomized controlled trial, feedback, motivation, adherence, psychotic disorders,  personality disorders Introduction Background A common consideration in clinical practice is that evaluation of the patient’s   motivation may help understand how a patient may best be engaged in treatment.1–5  Patients with severe mental illness (SMI), such as those with psychotic disorders or  severe personality disorders, are often considered not motivated to seek treatment6 or  fail to adhere to treatment programs.7,8 Regular assessment of motivation for engag - ing in treatment and providing this as feedback to the clinician might be a promising  approach to both monitor the patient’s motivation and provide a useful structure correspondence: eline c Jochems Department of Psychiatry,  epidemiological and social Psychiatric  research institute, erasmus Mc  University Medical center, Dr  Molewaterplein 50, 3015 ge, rotterdam,  the Netherlands email e.c.jochems@gmail.co m Journal name: Neuropsychiatric Disease and Treatment Article Designation: Original Research Y ear: 2015 Volume: 11 Running head verso: Jochems et al Running head recto: RCT on the effectiveness of motivation feedback in patients with SMI DOI: http://dx.doi.org/10.2147/NDT.S95190",Non-OADS,/arxiv_data1/oa_pdf/58/ac/ndt-11-3049.PMC4686323.pdf
"Neuropsychiatric Disease and Treatment Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/neuropsychiatric-disease-and-treatment-journa lNeuropsychiatric Disease and Treatment is an international, peer- reviewed journal of clinical therapeutics and pharmacology focusing   on concise rapid reporting of clinical or pre-clinical studies on a   range of neuropsychiatric and neurological disorders.",Non-OADS,/arxiv_data1/oa_pdf/58/ac/ndt-11-3049.PMC4686323.pdf
Visit http://www.dovepress.com/testimonials.ph p to  read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/58/ac/ndt-11-3049.PMC4686323.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/0d/f1/opth-9-2321.PMC4686328.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).Clinical Ophthalmology 2015:9 2321–2323Clinical Ophthalmology Dove press submit your manuscript | www.dovepress.co m Dove press  2321Letteropen access to scientific and medical research Open Access Full text Article http: //dx.doi.org/10.2147/OPTH.S10053 5Comment on “Short-term effects of relaxation  music on patients suffering from primary  open-angle glaucoma” Abdullah Kaya1 Yakup Aksoy2 Mehmet Koray Sevinç3 Oktay Diner4 1Department of Ophthalmology,   Anıttepe Military Dispansery,   Ankara, turkey; 2Department of  Ophthalmology, Girne Military  Hospital, Girne, Cyprus; 3Department  of Ophthalmology, Beytepe Military  Hospital, Ankara, 4Department of  Ophthalmology, erzurum Military  Hospital, erzurum, turkeyDear editor We read the current study “Short-term effects of relaxation music on patients suf - fering from primary open-angle glaucoma” by Bertelmann and Strempel, with great  interest.1 The authors investigated if relaxation music had a positive effect on glaucoma.",Non-OADS,/arxiv_data1/oa_pdf/0d/f1/opth-9-2321.PMC4686328.pdf
"1993;47(2):89–92.Correspondence: Abdullah Kaya Department of Ophhalmology, Anıttepe  Military Dispansery Gençlik Cad 5 Sok,  Anıttepe Mah, Çankaya, Ankara 06280,  turkey tel +90 530 140 9305 email abdullahkayamd@gmail.co m Journal name: Clinical Ophthalmology Article Designation: Letter Y ear: 2015 Volume: 9 Running head verso: Kaya et al Running head recto: Short-term effects of relaxation music on patients suffering DOI: http://dx.doi.org/10.2147/OPTH.S100535",Non-OADS,/arxiv_data1/oa_pdf/0d/f1/opth-9-2321.PMC4686328.pdf
"Clinical Ophthalmology Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/clinical-ophthalmology-journa lClinical Ophthalmology is an international, peer-reviewed journal  covering all subspecialties within ophthalmology.",Non-OADS,/arxiv_data1/oa_pdf/0d/f1/opth-9-2321.PMC4686328.pdf
Visit http://www.dovepress.com/ testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/0d/f1/opth-9-2321.PMC4686328.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/ad/84/opth-9-2305.PMC4686329.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpClinical Ophthalmology 2015:9 2305–2311Clinical Ophthalmology Dove press submit your manuscript | www.dovepress.co m Dove press  2305Original researChopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/OPTH.S9032 2intravitreal pegaptanib for the treatment of ischemic  diabetic macular edema Christine a Kiire rupal Morjaria anna rudenko alexina Fantato lewis smith amy smith Victor Chong Oxford eye hospital, Oxford  University hospitals nhs  Foundation  Trust, Oxford, UKPurpose:  Pegaptanib has been shown to be effective in treating diabetic macular edema (DME).",Non-OADS,/arxiv_data1/oa_pdf/ad/84/opth-9-2305.PMC4686329.pdf
"However, patients with ischemic DME were excluded in the  pivotal study.8 Another pan-VEGF-A blocker, bevacizumab (Avastin), has also been Correspondence: Victor Chong Oxford eye hospital, Oxford University  hospitals nhs Foundation Trust,  John radcliffe hospital, headley Way,  Oxford OX3 9DU, UK email victor@eretina.co mJournal name: Clinical Ophthalmology Article Designation: Original Research Y ear: 2015 Volume: 9 Running head verso: Kiire et al Running head recto: Treatment of ischemic diabetic macular edema with pegaptanib DOI: http://dx.doi.org/10.2147/OPTH.S90322",Non-OADS,/arxiv_data1/oa_pdf/ad/84/opth-9-2305.PMC4686329.pdf
"Clinical Ophthalmology Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/clinical-ophthalmology-journa lClinical Ophthalmology is an international, peer-reviewed journal  covering all subspecialties within ophthalmology.",Non-OADS,/arxiv_data1/oa_pdf/ad/84/opth-9-2305.PMC4686329.pdf
Visit http://www.dovepress.com/ testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/ad/84/opth-9-2305.PMC4686329.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/bf/5c/opth-9-2325.PMC4686330.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpClinical Ophthalmology 2015:9 2325–2328Clinical Ophthalmology Dove press submit your manuscript | www.dovepress.co m Dove press  2325Original researChopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/OPTH.S9365 5Polymerase chain reaction in unilateral cases of  presumed viral anterior uveitis samir s shoughy1 hind M alkatan2,4 abdulelah a al-abdullah2 albarah el-Khani2 Jolanda DF de groot- Mijnes3 Khalid F Tabbara1,4,5 1Department of Ophthalmology,   The eye Center and The eye  Foundation for research in  Ophthalmology, 2Department of  Pathology & laboratory Medicine  and Uveitis Division, King Khaled  eye specialist hospital, riyadh, saudi  arabia; 3Department of Virology  and Ophthalmology, University  Medical Center Utrecht, Utrecht,   the netherlands; 4Department of  Ophthalmology, College of Medicine,   King saud University, riyadh, saudi  arabia; 5The Wilmer Ophthalmological  institute of The Johns hopkins  University school of Medicine,   Baltimore, MD, UsaBackground and objectives:  Anterior uveitis is the most common form of intraocular  inflammation.",Non-OADS,/arxiv_data1/oa_pdf/bf/5c/opth-9-2325.PMC4686330.pdf
"EBV and HSV  type 2 have also been detected in ocular fluids of patients with anterior uveitis, though  less frequently.7 The rubella virus may induce a distinct clinical spectrum of ocular  symptoms similar to the Fuchs heterochromic iridocyclitis.8,9 The chikungunya virus Correspondence: samir s shoughy The eye Center and The eye Foundation  for research in Ophthalmology, PO Box  55307, riyadh 11534, saudi arabia Tel +966 11 464 9614 Fax +966 11 462 9675 email samir.shawki@hotmail.co m Journal name: Clinical Ophthalmology Article Designation: Original Research Y ear: 2015 Volume: 9 Running head verso: Shoughy et al Running head recto: PCR in unilateral cases of presumed viral anterior uveitis DOI: http://dx.doi.org/10.2147/OPTH.S93655",Non-OADS,/arxiv_data1/oa_pdf/bf/5c/opth-9-2325.PMC4686330.pdf
"Clinical Ophthalmology Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/clinical-ophthalmology-journa lClinical Ophthalmology is an international, peer-reviewed journal  covering all subspecialties within ophthalmology.",Non-OADS,/arxiv_data1/oa_pdf/bf/5c/opth-9-2325.PMC4686330.pdf
Visit http://www.dovepress.com/ testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/bf/5c/opth-9-2325.PMC4686330.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/83/00/nss-7-159.PMC4686331.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.ph pNature and Science of Sleep 2015:7 159–169Nature and Science of Sleep Dove press submit your manuscript | www.dovepress.co m Dove press  159Reviewopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/NSS.S9214 0Treatment paradigms for cataplexy in narcolepsy:  past, present, and future T odd J Swick1–4 1Department of Neurology, University  of T exas School of Medicine-Houston,   Houston; 2The Sleep Center at North  Cypress Medical Center, Cypress;   3Apnix Sleep Diagnostics, Houston;   4Neurology and Sleep Medicine  Consultants, Houston, TX, USA Correspondence: Todd J Swick   Neurology and Sleep Medicine  Consultants,  7500 San Felipe, Suite  525,  Houston, TX  77063, USA   Tel +1 713 465 9282  Fax +1 713 467 2954  email tswick@houstonsleepcenter.co mAbstract:  Cataplexy is defined as episodes of sudden loss of voluntary muscle tone triggered  by emotions generally lasting ,2 minutes.",Non-OADS,/arxiv_data1/oa_pdf/83/00/nss-7-159.PMC4686331.pdf
Available from: http://www.ninds.nih.gov/disorders/narcolepsy/ detail_narcolepsy.htm#24121320 1.,Non-OADS,/arxiv_data1/oa_pdf/83/00/nss-7-159.PMC4686331.pdf
"Nature and Science of Sleep Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/nature-and-science-of-sleep-journa lNature and Science of Sleep is an international, peer-reviewed, open  access journal covering all aspects of sleep science and sleep medicine,  including the neurophysiology and functions of sleep, the genetics of  sleep, sleep and society, biological rhythms, dreaming, sleep disorders and  therapy, and strategies to optimize healthy sleep.",Non-OADS,/arxiv_data1/oa_pdf/83/00/nss-7-159.PMC4686331.pdf
Visit http://www.dovepress.com/   testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/83/00/nss-7-159.PMC4686331.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/46/2c/opth-9-2313.PMC4686332.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpClinical Ophthalmology 2015:9 2313–2320Clinical Ophthalmology Dove press submit your manuscript | www.dovepress.co m Dove press  2313Original researChopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/OPTH.S9669 5Prospective, randomized study of one, two,  or three trabecular bypass stents in open- angle glaucoma subjects on topical hypotensive  medication l Jay Katz1 Carl erb2 amadeu Carceller  guillamet3 antonio M Fea4 lilit Voskanyan5 Jeffrey M Wells6 Jane ellen giamporcaro6 1Wills eye hospital, Jefferson  Medical College, Philadelphia, P a,   Usa; 2eye Clinic Wittenbergplatz,   Berlin, germany; 3Department of  Ophthalmology, hospital d’hebron,   Barcelona, spain; 4University eye  Clinic of the University of T urin, T urin,   italy; 5sV Malayan Opthalmology  Centre, Yerevan, armenia; 6glaukos  Corporation, laguna hills, C a, UsaPurpose:  To assess the safety and efficacy of one, two, or three trabecular microbypass stents  in eyes with primary open-angle glaucoma (OAG) not controlled on ocular hypotensive medica - tion.",Non-OADS,/arxiv_data1/oa_pdf/46/2c/opth-9-2313.PMC4686332.pdf
"Keywords:  iStent, MIGS, OAG, intraocular pressure, IOP reduction, multiple stents Introduction Glaucoma, a degenerative progressive disease causing optic nerve damage to approxi - mately 60 million people worldwide, causes bilateral blindness in approximately  8.4 million.1 For many years preceding recent developments with microinvasive glau - coma surgery (MIGS), the standard surgical modality has been trabeculectomy, along  with the various postoperative sequelae of hypotony, progression of cataract, and bleb  and choroidal complications, with concomitant visual loss.2 The development of ab Correspondence: l Jay Katz Wills eye hospital, suite 1110, 11th  floor, 840 Walnut Street, Philadelphia,  Pa 19107, Usa Tel +1 215 928 3197 email ljaykatz@gmail.co m Journal name: Clinical Ophthalmology Article Designation: Original Research Y ear: 2015 Volume: 9 Running head verso: Katz et al Running head recto: One, two, or three trabecular microbypass stents in OAG DOI: http://dx.doi.org/10.2147/OPTH.S96695",Non-OADS,/arxiv_data1/oa_pdf/46/2c/opth-9-2313.PMC4686332.pdf
"Clinical Ophthalmology Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/clinical-ophthalmology-journa lClinical Ophthalmology is an international, peer-reviewed journal  covering all subspecialties within ophthalmology.",Non-OADS,/arxiv_data1/oa_pdf/46/2c/opth-9-2313.PMC4686332.pdf
Visit http://www.dovepress.com/ testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/46/2c/opth-9-2313.PMC4686332.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/93/60/opth-9-2329.PMC4686333.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpClinical Ophthalmology 2015:9 2329–2333Clinical Ophthalmology Dove press submit your manuscript | www.dovepress.co m Dove press  2329Original researChopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/OPTH.S9314 2The effect of cataract surgery on ocular dominance roy schwartz Y ossi Yatziv Ophthalmology Department, Tel  aviv sourasky Medical Center and  The sackler Faculty of Medicine,   T el a viv University, T el aviv, israelPurpose:  The aim of this study is to assess whether eye dominance may change after cataract  surgery.",Non-OADS,/arxiv_data1/oa_pdf/93/60/opth-9-2329.PMC4686333.pdf
"The aim of this  study was to examine whether ocular dominance, as tested by a sighting dominance  technique, is static or may change after cataract surgeries.Correspondence: roy schwartz Ophthalmology Department, Tel aviv  sourasky Medical Center and The  sackler Faculty of Medicine, Tel  aviv University, 6 Weizmann street,  Tel aviv 64239, israel Tel +972 3 697 3408 email royschwartz@gmail.co m Journal name: Clinical Ophthalmology Article Designation: Original Research Y ear: 2015 Volume: 9 Running head verso: Schwartz and Y atziv Running head recto: Effect of cataract surgery on dominance DOI: http://dx.doi.org/10.2147/OPTH.S93142",Non-OADS,/arxiv_data1/oa_pdf/93/60/opth-9-2329.PMC4686333.pdf
"Clinical Ophthalmology Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/clinical-ophthalmology-journa lClinical Ophthalmology is an international, peer-reviewed journal  covering all subspecialties within ophthalmology.",Non-OADS,/arxiv_data1/oa_pdf/93/60/opth-9-2329.PMC4686333.pdf
Visit http://www.dovepress.com/ testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/93/60/opth-9-2329.PMC4686333.pdf
"MED and PTED, a comparative study Asian S pine J ournal 833 Copyright Ⓒ 2015 by Korean Society of Spine Surgery This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/91/d6/asj-9-833.PMC4686386.pdf
"Asian Spine Journal • pISSN 1976-1902 eISSN 1976-7846 • www.asianspinejournal.orgReceived Mar 17, 2015; Revised Apr 9, 2015; Accepted Apr 9, 2015 Corresponding author: Xiao-Tao Wu  Department of Spine Surgery, Zhongda Hospital, Southeast University,  No.87, Dingjiaqiao Road, Nanjing, China, 210009 Tel: +86-25-83262334, Fax: +86-25-83262331, E-mail: wuxiaotao@medmail.com.cn  ASJClinical Study Asian Spine J 2015;9(6):833-840  •  http://dx.doi.org/10.4184/asj.2015.9.6.833 Asian Spine Journal Introduction Lumbar disc herniation (LDH) is the most common cause  of lower back pain and sciatica.",Non-OADS,/arxiv_data1/oa_pdf/91/d6/asj-9-833.PMC4686386.pdf
"Keywords:  Surgical site infection; Posterior lumbar interbody fusion; Treatment; Implant removal; Posterior one stage simultaneous  revision Copyright Ⓒ 2015 by Korean Society of Spine Surgery This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/35/dd/asj-9-841.PMC4686387.pdf
"Asian Spine Journal • pISSN 1976-1902 eISSN 1976-7846 • www.asianspinejournal.orgReceived Apr 21, 2015; Revised May 15, 2015; Accepted May 16, 2015 Corresponding author: Dong Ki Ahn  Department of Orthopedic Surgery, Seoul Sacred Heart General Hospital,  Wangsanrho 259, Dongdaemun-gu, Seoul 02488, Korea TEL: +82-2-966-1616, FAX: +82-2-968-2394, E-mail: adkajs@hanmail.net  ASJClinical Study Asian Spine J 2015;9(6):841-848  •  http://dx.doi.org/10.4184/asj.2015.9.6.841 Asian Spine Journal Introduction In terms of simultaneous anterior reconstruction and  high union rate, posterior lumbar interbody fusion (PLIF)  has many advantages over posterolateral fusion (PLF) [1-4].",Non-OADS,/arxiv_data1/oa_pdf/35/dd/asj-9-841.PMC4686387.pdf
"Keywords:  Cervical myelopathy; Laminoplasty; Plates; Screw; Loosening Copyright Ⓒ 2015 by Korean Society of Spine Surgery This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/a3/5a/asj-9-849.PMC4686388.pdf
"Asian Spine Journal • pISSN 1976-1902 eISSN 1976-7846 • www.asianspinejournal.orgReceived Apr 27, 2015; Accepted May 3, 2015  Corresponding author: Gabriel Liu  Department of Orthopaedic Surgery, Yong Loo Lin School of Medicine, National University Hospital,  Level 11 NUHS Tower Block, 1E Kent Ridge Road, Singapore 119228, Singapore Tel: +65-9233-8520, Fax: +65-6778-0720, E-mail: gabriel_liu@nuhs.edu.sg ASJClinical Study Asian Spine J 2015;9(6):849-854  •  http://dx.doi.org/10.4184/asj.2015.9.6.849 Asian Spine Journal Introduction  Laminoplasty is an accepted treatment for symptomatic  cervical myelopathy resulting from spondylotic disease [1,2] and ossification of the posterior longitudinal liga - ment [3].",Non-OADS,/arxiv_data1/oa_pdf/a3/5a/asj-9-849.PMC4686388.pdf
"Keywords:  Osteoporotic spinal fractures; Traumatic non osteoporotic vertebral fractures; Percutaneous vertebroplasty; Serial cement  injection technique; Cement leak  Copyright Ⓒ 2015 by Korean Society of Spine Surgery This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/4c/42/asj-9-855.PMC4686389.pdf
"Asian Spine Journal • pISSN 1976-1902 eISSN 1976-7846 • www.asianspinejournal.orgReceived Mar 13, 2015; Revised Apr 19, 2015; Accepted Apr 19, 2015 Corresponding author: Hossam Elnoamany  Neurosurgical Department, Faculty of Medicine, University Hospital, Menoufia University,  64 Gamal Abdel Nasser St., Shebin El Kom, Meuoufia, Egypt Tel: +20-1002905305, Fax: +20-48-2233771, E-mail: hae1967@gmail.com  ASJClinical Study Asian Spine J 2015;9(6):855-862  •  http://dx.doi.org/10.4184/asj.2015.9.6.855 Asian Spine Journal Introduction Percutaneous vertebroplasty (PV) was first introduced for  the treatment of vertebral angiomas in 1987 by Galibert et  al.",Non-OADS,/arxiv_data1/oa_pdf/4c/42/asj-9-855.PMC4686389.pdf
"Keywords:  Spine surgery; Surgical site infection; Drain tip culture; Diagnostic value; Bacteria Copyright Ⓒ 2015 by Korean Society of Spine Surgery This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/f4/b3/asj-9-863.PMC4686390.pdf
"Asian Spine Journal • pISSN 1976-1902 eISSN 1976-7846 • www.asianspinejournal.orgReceived Jul 29, 2015; Revised Sep 28, 2015; Accepted Oct 1, 2015 Corresponding author: Ho-Jin Lee Department of Orthopedic Surgery, Chungnam National University School of Medicine,  33 Munwha-ro, Jung-gu, Daejeon 35015, Korea  Tel: +82-42-280-7353, Fax: +82-42-252-7098, E-mail: leeleo98@gmail.com  ASJClinical Study Asian Spine J 2015;9(6):863-868  •  http://dx.doi.org/10.4184/asj.2015.9.6.863 Asian Spine Journal Introduction Closed-suction drainage is an effective tool for minimiz - ing hematoma formation around the surgical site and  reducing the infection rate [1,2].",Non-OADS,/arxiv_data1/oa_pdf/f4/b3/asj-9-863.PMC4686390.pdf
"Keywords:  Metastatic spinal tumor; Liquid nitrogen; Posterior decompression and stabilization; Antitumor immunity  Copyright Ⓒ 2015 by Korean Society of Spine Surgery This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/b2/9f/asj-9-869.PMC4686391.pdf
"Asian Spine Journal • pISSN 1976-1902 eISSN 1976-7846 • www.asianspinejournal.orgReceived Apr 06, 2015; Accepted Apr 28, 2015 Corresponding author: Kazuya Shinmura Department of Orthopaedic Surgery, Graduate School of Medical Sciences, Kanazawa University,  13-1 Takara-machi, Kanazawa, 920-8641, Japan Tel: +81-76-265-2374, Fax: +81-76-234-4261,, E-mail: kazuyashinmura@yahoo.co.jp  ASJClinical Study Asian Spine J 2015;9(6):869-875  •  http://dx.doi.org/10.4184/asj.2015.9.6.869 Asian Spine Journal Introduction The purposes of posterior decompression and stabiliza - tion for metastatic spinal tumors are to maintain quality  of life of the patients and improve paralysis.",Non-OADS,/arxiv_data1/oa_pdf/b2/9f/asj-9-869.PMC4686391.pdf
"Keywords:  Spine; Biomechanical phenomena; Imaging, three-dimensional Copyright Ⓒ 2015 by Korean Society of Spine Surgery This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/65/13/asj-9-876.PMC4686392.pdf
"Asian Spine Journal • pISSN 1976-1902 eISSN 1976-7846 • www.asianspinejournal.orgReceived Mar 23, 2015; Revised Apr 7, 2015; Accepted Apr 10, 2015 Corresponding author: Keita Nakayama Department of Orthopaedic Surgery, Tsukuba University Graduate School of Medicine,  1-1-1, Tennodai, Tuskuba 305-8575, Japan Tel: +81-29-853-3219, Fax: +81-29-853-3214, E-mail: keitanakayma@tsukuba-seikei.jp  ASJClinical Study Asian Spine J 2015;9(6):876-883  •  http://dx.doi.org/10.4184/asj.2015.9.6.876 Asian Spine Journal Introduction  Cervical injuries caused by traffic accidents are commonly reported and include cervical sprain, cervical spinal cord  injuries, cervical spine fractures, and dislocation [1].",Non-OADS,/arxiv_data1/oa_pdf/65/13/asj-9-876.PMC4686392.pdf
"Keywords:  Cortical bone trajectory; Clear zone; Initial fixation Copyright Ⓒ 2015 by Korean Society of Spine Surgery This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/be/02/asj-9-884.PMC4686393.pdf
"Asian Spine Journal • pISSN 1976-1902 eISSN 1976-7846 • www.asianspinejournal.orgReceived Feb 16, 2015; Revised Mar 12, 2015; Accepted Mar 13, 2015 Corresponding author: Koshi Ninomiya  Department of Neurosurgery, Osaka University Graduate School of Medicine,  2-2 Yamadaoka, Suita, Osaka, Japan 565-0871  Tel: +81-6-6879-3652, Fax: +81-6-6879-3659, E-mail: k-ninomiya@nsurg.med.osaka-u.ac.jp ASJClinical Study Asian Spine J 2015;9(6):884-888  •  http://dx.doi.org/10.4184/asj.2015.9.6.884 Asian Spine Journal Introduction The cortical bone trajectory (CBT) technique for lumbar  vertebral fixation was first described by Santoni et al.",Non-OADS,/arxiv_data1/oa_pdf/be/02/asj-9-884.PMC4686393.pdf
"Keywords:  Spinal column; Spinal fracture; Multilevel; Surgery Copyright Ⓒ 2015 by Korean Society of Spine Surgery This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/cf/1a/asj-9-889.PMC4686394.pdf
"Asian Spine Journal • pISSN 1976-1902 eISSN 1976-7846 • www.asianspinejournal.orgReceived Apr 07, 2015; Accepted Apr 23, 2015 Corresponding author: Ali Dalgiç Neurosurgery Clinic, Ankara Numune Research and Training Hospital,  B-Blok, Kat: 3 06100, Altindag, Ankara, Turkey Tel: +90-505-234-2662, Fax: +90-312-311-4340, E-mail: alidalgic@yahoo.com  ASJClinical Study Asian Spine J 2015;9(6):889-894  •  http://dx.doi.org/10.4184/asj.2015.9.6.889 Asian Spine Journal Introduction Multilevel noncontiguous spinal fractures (MNSF) are  rare and have unique characteristics.",Non-OADS,/arxiv_data1/oa_pdf/cf/1a/asj-9-889.PMC4686394.pdf
http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/cf/1a/asj-9-889.PMC4686394.pdf
"Keywords:  Cervical spine; Synostosis; Adjacent segment; Congenital Copyright Ⓒ 2015 by Korean Society of Spine Surgery This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/e7/92/asj-9-895.PMC4686395.pdf
"Asian Spine Journal • pISSN 1976-1902 eISSN 1976-7846 • www.asianspinejournal.orgReceived May 16, 2015; Revised Jul 2, 2015; Accepted Jul 3, 2015 Corresponding author: Min Geun Yoon Department of Orthopaedic Surgery, Cheju Halla General Hospital, Doreongno 65, Jeju 63127, Korea Tel: +82-64-740-5410, Fax: +82-64-743-3110, E-mail: mingy9879@gmail.com  ASJClinical Study Asian Spine J 2015;9(6):895-900  •  http://dx.doi.org/10.4184/asj.2015.9.6.895 Asian Spine Journal Introduction Mono- and multi-segment anterior surgical fusion in any  spinal level causes excessive transfer of the lost motion  and load to the adjacent joints.",Non-OADS,/arxiv_data1/oa_pdf/e7/92/asj-9-895.PMC4686395.pdf
"Keywords:  Validity; Copenhagen Neck Functional Disability Scale; Cervical spondylotic myelopathy; Iran Copyright Ⓒ 2015 by Korean Society of Spine Surgery This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/0c/4a/asj-9-901.PMC4686396.pdf
"Asian Spine Journal • pISSN 1976-1902 eISSN 1976-7846 • www.asianspinejournal.orgReceived Feb 19, 2015; Revised Mar 10, 2015; Accepted Mar 22, 2015 Corresponding author: Parisa Azimi Department of Neurosurgery, Shohada Tajrish Hospital, Functional Neurosurgery Research Center of Shohada Tajrish Hospital,  Shahid Beheshti University of Medical Sciences, Tehran, Iran Tel: 98-21-22-74-9204, Fax: +98-21-88-26-5188, E-mail: parisa.azimi@gmail.com  ASJClinical Study Asian Spine J 2015;9(6):901-908  •  http://dx.doi.org/10.4184/asj.2015.9.6.901 Asian Spine Journal Introduction Cervical spondylotic myelopathy (CSM) includes cervical herniated disc (CHD) and cervical spinal stenosis and is a  progressive spine disease.",Non-OADS,/arxiv_data1/oa_pdf/0c/4a/asj-9-901.PMC4686396.pdf
"Keywords:  Cervical vertebrae; Hemostasis; Postoperative hemorrhage; Floseal matrix; Spinal fusion Copyright Ⓒ 2015 by Korean Society of Spine Surgery This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/63/9c/asj-9-909.PMC4686397.pdf
"Asian Spine Journal • pISSN 1976-1902 eISSN 1976-7846 • www.asianspinejournal.orgReceived Nov 3, 2015; Accepted Nov 13, 2015 Corresponding author: Jin S. Yeom Spine Center and Department of Orthopaedic Surgery, Seoul National University Bundang Hospital,  Seoul National University College of Medicine, 166 Gumi-ro, Bundang-gu, Seongnam 13620, Korea Tel: +82-31-787-7195, Fax: +82-31-787-4056, E-mail: highcervical@gmail.com  ASJClinical Study Asian Spine J 2015;9(6):909-915  •  http://dx.doi.org/10.4184/asj.2015.9.6.909 Asian Spine Journal Introduction One of the most catastrophic complications of anterior  cervical discectomy and fusion (ACDF) is postoperative hemorrhage, which may result in dyspnea, respiratory  arrest, and death [1-6].",Non-OADS,/arxiv_data1/oa_pdf/63/9c/asj-9-909.PMC4686397.pdf
"Keywords:  Autologous conditioned serum; Unilateral lumbar radiculopathy; Epidural perineural injection Copyright Ⓒ 2015 by Korean Society of Spine Surgery This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/f0/67/asj-9-916.PMC4686398.pdf
"Asian Spine Journal • pISSN 1976-1902 eISSN 1976-7846 • www.asianspinejournal.orgReceived Feb 15, 2015; Revised Mar 6, 2015; Accepted Mar 6, 2015 Corresponding author: Ravi Kumar H. S. Department of Orthopaedics, Mandya Institute of Medical Sciences (MIMS),  KL-821, 20th cross v.v.nagar, Kallahalli, Mandya, Karnataka, 571401, India Tel: +919035722667, Fax: +08232-231001, E-mail: drravikumarmmc1110@gmail.com  ASJClinical Study Asian Spine J 2015;9(6):916-922  •  http://dx.doi.org/10.4184/asj.2015.9.6.916 Asian Spine Journal Introduction Low back pain (LBP) is the most common musculoskel - etal disorder of industrialized society, and the most com - mon cause of disability in persons younger than 45 years  of age [1].",Non-OADS,/arxiv_data1/oa_pdf/f0/67/asj-9-916.PMC4686398.pdf
"Keywords:  Adult spinal deformity; Pulmonary function; Restrictive impairment; Obstructive impairment Copyright Ⓒ 2015 by Korean Society of Spine Surgery This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/39/82/asj-9-923.PMC4686399.pdf
"Asian Spine Journal • pISSN 1976-1902 eISSN 1976-7846 • www.asianspinejournal.orgReceived Feb 16, 2015; Revised Mar 10, 2015; Accepted Mar 22, 2015 Corresponding author: Tatsuya Yasuda  Department of Orthopaedic Surgery, Hamamatsu University School of Medicine,  1-20-1 Handayama, Higashi-ku, Hamamatsu 431-3192, Japan Tel: +81-53-435-2299, Fax: +81-53-435-2296, E-mail: t.yasuda@hama-med.ac.jp  ASJClinical Study Asian Spine J 2015;9(6):923-927  •  http://dx.doi.org/10.4184/asj.2015.9.6.923 Asian Spine Journal Introduction Curvature of the chest cage is almost a three-dimensional  distortion in adolescent cases of idiopathic scoliosis.",Non-OADS,/arxiv_data1/oa_pdf/39/82/asj-9-923.PMC4686399.pdf
"Keywords:  Myelography; Complications; Outpatient; Inpatient; Health care costs Copyright Ⓒ 2015 by Korean Society of Spine Surgery This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/37/02/asj-9-928.PMC4686400.pdf
"Asian Spine Journal • pISSN 1976-1902 eISSN 1976-7846 • www.asianspinejournal.orgReceived Feb 3, 2015; Revised Apr 29, 2015; Accepted Apr 29, 2015 Corresponding author: Shiro Imagama Department of Orthopaedic Surgery, Nagoya University Graduate School of Medicine,  65 Tsurumai-cho, Showa-ku, Nagoya city, Aichi 466-8550, Japan Tel: +81-52-741-2111, Fax: +81-52-744-2260, E-mail: imagama@med.nagoya-u.ac.jp  ASJClinical Study Asian Spine J 2015;9(6):928-934  •  http://dx.doi.org/10.4184/asj.2015.9.6.928 Asian Spine Journal Introduction Although magnetic resonance imaging has rapidly devel - oped and is currently widely used, myelography is still an  essential examination, especially for the dynamic evalu -ation of the spine when diagnosing degenerative lumbar  scoliosis in elderly people.",Non-OADS,/arxiv_data1/oa_pdf/37/02/asj-9-928.PMC4686400.pdf
"Keywords:  Glioma; Intramedullary tumor; Outcome; Radiation therapy; Spinal cord Copyright Ⓒ 2015 by Korean Society of Spine Surgery This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/8b/6d/asj-9-935.PMC4686401.pdf
"Asian Spine Journal • pISSN 1976-1902 eISSN 1976-7846 • www.asianspinejournal.orgReceived Mar 11, 2015; Accepted Mar 13, 2015 Corresponding author: Toshitaka Seki  Department of Neurosurgery, Hokkaido University Graduate School of Medicine,  North-15 West-7, Kita-ku, Sapporo 060-8638, Hokkaido, Japan Tel: +81-11-706-5987, Fax: +81-11-708-7737, E-mail: toseki1@hotmail.com  ASJClinical Study Asian Spine J 2015;9(6):935-941  •  http://dx.doi.org/10.4184/asj.2015.9.6.935 Asian Spine Journal Introduction Intramedullary spinal cord tumors are rare entities, ac - counting for 2% to 10% of all central nervous system  tumors [1-3] and for 15% of primary intradural spinal  tumors in adults.",Non-OADS,/arxiv_data1/oa_pdf/8b/6d/asj-9-935.PMC4686401.pdf
"Keywords:  Clinical adjacent segment pathology; Adjacent segment degeneration; Adjacent segment disease; Anterior cervical dis - cectomy; Cervical disc prolapse  Copyright Ⓒ 2015 by Korean Society of Spine Surgery This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/00/50/asj-9-942.PMC4686402.pdf
"Asian Spine Journal • pISSN 1976-1902 eISSN 1976-7846 • www.asianspinejournal.orgReceived Feb 13, 2015; Revised Apr 13, 2015; Accepted Apr 13, 2015 Corresponding author: Srinivasan Sreeramulu Uddanapalli Department of Neurosurgery, MIOT Hospitals, 4/112 Mount Poonamalle Road,  Manapakkam, Chennai–600089, Tamil Nadu, India  Tel: +91-9841294495, Fax: +91-4422324570, E-mail: ussrini@vsnl.net  ASJClinical Study Asian Spine J 2015;9(6):942-951  •  http://dx.doi.org/10.4184/asj.2015.9.6.942 Asian Spine Journal Introduction Adjacent segment degeneration (ASD) is common after  cervical disc surgery.",Non-OADS,/arxiv_data1/oa_pdf/00/50/asj-9-942.PMC4686402.pdf
"Keywords:  Compound muscle action potential; Morphology change; Amplitude Copyright Ⓒ 2015 by Korean Society of Spine Surgery This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/27/3a/asj-9-952.PMC4686403.pdf
"Asian Spine Journal • pISSN 1976-1902 eISSN 1976-7846 • www.asianspinejournal.orgReceived Mar 9, 2015; Revised Apr 24, 2015; Accepted Apr 24, 2015 Corresponding author: Shiro Imagama Department of Orthopaedic Surgery, Nagoya University School of Medicine,  65 Tsurumai Showa-ward, Aichi 466-8550, Japan Tel: +81-52-833-6021, Fax: +81-52-833-6021, E-mail: imagama@med.nagoya-u.ac.jp  ASJClinical Study Asian Spine J 2015;9(6):952-957  •  http://dx.doi.org/10.4184/asj.2015.9.6.952 Asian Spine Journal Introduction Presently, non-compound muscle action potential specific  criteria, such as somatosensory evoked potential (SSEP)  criteria (an amplitude decrease ≥50% and ≥10% latency),  are often used as the criteria for the warning point of  compound muscle action potential (CMAP) [1,2].",Non-OADS,/arxiv_data1/oa_pdf/27/3a/asj-9-952.PMC4686403.pdf
"Keywords:  Osteoid osteoma; Endoscopic surgery; Minimally invasive surgical procedure; Radiculopathy Copyright Ⓒ 2015 by Korean Society of Spine Surgery This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/c5/d7/asj-9-958.PMC4686404.pdf
"Asian Spine Journal • pISSN 1976-1902 eISSN 1976-7846 • www.asianspinejournal.orgReceived Jan 7, 2015; Revised Jan 29, 2015; Accepted Feb 12, 2015 Corresponding author: Katsuhito Yoshioka  Department of Orthopaedic Surgery, Graduate School of Medical Science, Kanazawa University,  13-1 Takara-machi, Kanazawa, 920-8641, Japan Tel: +81-76-265-2374, Fax: +81-76-234-4261, E-mail: ortho0825yoshy@yahoo.co.jp  ASJTechnical Note Asian Spine J 2015;9(6):958-961  •  http://dx.doi.org/10.4184/asj.2015.9.6.958 Asian Spine Journal Introduction Osteoid osteoma is a small benign bone tumor that is  commonly localized in long bones.",Non-OADS,/arxiv_data1/oa_pdf/c5/d7/asj-9-958.PMC4686404.pdf
"Keywords:  Ultra long construct; Minimally invasive stabilization; Percutaneous; Spinal metastasis; Spinal cord compression Copyright Ⓒ 2015 by Korean Society of Spine Surgery This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/71/a9/asj-9-962.PMC4686405.pdf
"Asian Spine Journal • pISSN 1976-1902 eISSN 1976-7846 • www.asianspinejournal.orgReceived Jan 30, 2015; Revised Feb 24, 2015; Accepted Feb 28, 2015 Corresponding author: Chee Kean Lee Department of Orthopaedic Surgery, Faculty of Medicine, University of Malaya, 50603, Lembah Pantai, Kuala Lumpur, Malaysia Tel: +60379492061, Fax: +60379494642, E-mail: kenetto@hotmail.com  ASJTechnical Note Asian Spine J 2015;9(6):962-965  •  http://dx.doi.org/10.4184/asj.2015.9.6.962 Asian Spine Journal Introduction Symptomatic multicentric spinal metastasis in patients  with poor prognostic scores poses a dilemma for sur - geons.",Non-OADS,/arxiv_data1/oa_pdf/71/a9/asj-9-962.PMC4686405.pdf
"Keywords:  Type II odontoid fractures; Internal fixation; C1–C2 fusion Copyright Ⓒ 2015 by Korean Society of Spine Surgery This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/9e/04/asj-9-966.PMC4686406.pdf
"Patil Medical College, Pune 411001, India  Tel: +91-73870-80391, Fax: +91-020-278-05217, E-mail: drabhijitpawar@gmail.com  ASJCase Report Asian Spine J 2015;9(6):966-970  •  http://dx.doi.org/10.4184/asj.2015.9.6.966 Asian Spine Journal Introduction Odontoid fractures are generally rare and account for ap - proximately 15% of all cervical fractures [1-3].",Non-OADS,/arxiv_data1/oa_pdf/9e/04/asj-9-966.PMC4686406.pdf
"Keywords:  Spinopelvic reconstruction; Sacrectomy; Iliac screw fixation; Fresh frozen fibular allograft Copyright Ⓒ 2015 by Korean Society of Spine Surgery This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/cc/2b/asj-9-971.PMC4686407.pdf
"Asian Spine Journal • pISSN 1976-1902 eISSN 1976-7846 • www.asianspinejournal.orgReceived Feb 4, 2015; Revised Feb 27, 2015; Accepted Feb 28, 2015 Corresponding author: Murat Arıkan Department of Orthopedics, Oncology Training and Research Hospital,  Vatan Caddesi No.33 Demetevler, 06200 Ankara, Turkey  Tel: +90-312-336-09-09, Fax: +90-312-336-96-81, E-mail: smuratark@yahoo.com ASJCase Report Asian Spine J 2015;9(6):971-977  •  http://dx.doi.org/10.4184/asj.2015.9.6.971 Asian Spine Journal Introduction Primary sacral tumors are rare, accounting for 7% of all  spinal tumors [1].",Non-OADS,/arxiv_data1/oa_pdf/cc/2b/asj-9-971.PMC4686407.pdf
"Keywords:  Lateral lumbar fusion; Minimally invasive lumbar spine surgery; Spondylolisthesis Copyright Ⓒ 2015 by Korean Society of Spine Surgery This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/01/ab/asj-9-978.PMC4686408.pdf
"Asian Spine Journal • pISSN 1976-1902 eISSN 1976-7846 • www.asianspinejournal.orgReceived Mar 11, 2015; Revised ; Apr 5, 2015 Accepted Apr 5, 2015 Corresponding author: Abhijit Pawar  Department of Orthopedic Surgery, Ruby Hall Clinic and Dr. D. Y. Patil Medical College,  Sant Tukaram Nagar, Pimpri Pune 411018, India Tel: +91-73870-80391, Fax: +91-020-278-05217, E-mail: drabhijitpawar@gmail.com  ASJReview Article Asian Spine J 2015;9(6):978-983  •  http://dx.doi.org/10.4184/asj.2015.9.6.978 Asian Spine Journal Introduction The lateral lumbar interbody fusion (LLIF) technique has  shown encouraging results in patients with degenerative  conditions of the lumbar spine [1,2].",Non-OADS,/arxiv_data1/oa_pdf/01/ab/asj-9-978.PMC4686408.pdf
"Keywords:  Evolution; Thoraco-lumbar; Fracture; Stability Copyright Ⓒ 2015 by Korean Society of Spine Surgery This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/25/61/asj-9-984.PMC4686409.pdf
"Asian Spine Journal • pISSN 1976-1902 eISSN 1976-7846 • www.asianspinejournal.orgReceived Apr 2, 2015; Accepted Apr 26, 2015 Corresponding author:Md Quamar Azam Department of Orthopedics, KFHU, University of Dammam, PO Box- 40071, Al-Khobar-31952, Saudi Arabia Tel: +966-532750228, E-mail: qazam47@gmail.com  ASJReview Article Asian Spine J 2015;9(6):984-994  •  http://dx.doi.org/10.4184/asj.2015.9.6.984 Asian Spine Journal Introduction For more than eight decades, since Boehler’s [1] senti - nel description of the fracture, a universally acceptable  thoracolumbar fracture classification has eluded trauma  and spine surgeons.",Non-OADS,/arxiv_data1/oa_pdf/25/61/asj-9-984.PMC4686409.pdf
"Running title Asian S pine J ournal 995 Comment on the Evaluation of the Effectiveness   of Hyaluronidase in the Selective Nerve   Root Block of Radiculopathy   Laxmaiah Manchikanti1,2, Alan David Kaye3  1Pain Management Center of Paducah, Paducah, KY, USA 2Clinical Professor, Anesthesiology and Perioperative Medicine, University of Louisville, Louisville, KY, USA 3Department of Anesthesia, LSU Health Science Center, New Orleans, LA, USA   Copyright Ⓒ 2015 by Korean Society of Spine Surgery This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/fb/ca/asj-9-995.PMC4686410.pdf
"101, Fax: +1-270-554-8987, E-mail: drlm@thepainmd.com  ASJLetter to the Editor Asian Spine J 2015;9(6):995-996  •  http://dx.doi.org/10.4184/asj.2015.9.6.995 Asian Spine Journal Dear Editor, Ko et al.",Non-OADS,/arxiv_data1/oa_pdf/fb/ca/asj-9-995.PMC4686410.pdf
"Running title Asian S pine J ournal 997 Paravertebral Osteolipoma   Selahattin Ozyurek1, Aziz Atik2  1Department of Orthopaedics and Traumatology, Aksaz Military Hospital, Marmaris, Turkey 2Department of Orthopaedics and Traumatology, Balikesir University Hospital, Balikesir, Turkey Copyright Ⓒ 2015 by Korean Society of Spine Surgery This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/04/ef/asj-9-997.PMC4686411.pdf
"Asian Spine Journal • pISSN 1976-1902 eISSN 1976-7846 • www.asianspinejournal.orgReceived May 4, 2015; Accepted May 5, 2015   Corresponding author: Selahattin Ozyurek Department of Orthopaedics and Traumatology, Aksaz Military Hospital, 48700 Marmaris, Mugla, Turkey Tel: +90-252-4210161, Fax: +90-252-412-1877, E-mail: fsozyurek@yahoo.com  ASJLetter to the Editor Asian Spine J 2015;9(6):997-998  •  http://dx.doi.org/10.4184/asj.2015.9.6.997 Asian Spine Journal Dear Editor, We read with great interest the case report entitled “Cer - vical paravertebral osteolipoma: case report and litera - ture review” in the issue of Asian Spine J 2015;9(2):290- 4 [1].",Non-OADS,/arxiv_data1/oa_pdf/04/ef/asj-9-997.PMC4686411.pdf
"Time course changes in bone metabolic markers Asian S pine J ournal 999 Copyright Ⓒ 2015 by Korean Society of Spine Surgery This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/ea/c7/asj-9-999.PMC4686412.pdf
"Asian Spine Journal • pISSN 1976-1902 eISSN 1976-7846 • www.asianspinejournal.orgThe Time Course Changes in Bone Metabolic Markers  after Administering the Anti-Receptor Activator of  Nuclear Factor-Kappa B Ligand Antibody and Drug  Compliance among Patients with Osteoporosis Kazuhide Inage1, Sumihisa Orita1, Kazuyo Yamauchi1, Y oshihiro Sakuma2,  Go Kubota1, Yasuhiro Oikawa3, T akeshi Sainoh1, Jun Sato1, Kazuki Fujimoto1,  Yasuhiro Shiga1, Kazuhisa T akahashi1, Seiji Ohtori1   1Department of Orthopedic Surgery, Graduate School of Medicine, Chiba University, Chiba, Japan 2Department of Orthopedic Surgery, National Hospital Organization Chiba Medical Center, Chiba, Japan 3Department of Orthopedic Surgery, T eikyo University Chiba Medical Center, Chiba, Japan    Asian Spine J 2015;9(3):338-343   http://dx.doi.org/10.4184/asj.2015.9.3.338 Corrections for Fig.",OADS,/arxiv_data1/oa_pdf/ea/c7/asj-9-999.PMC4686412.pdf
Erratum: Correction of Figures Asian Spine J 2015;9(6):999-1000  •  http://dx.doi.org/10.4184/asj.2015.9.6.999 ASJ Asian Spine Journal • Before correction • After correction Fig.,Non-OADS,/arxiv_data1/oa_pdf/ea/c7/asj-9-999.PMC4686412.pdf
"Clinical Study of TLR4 in Patients with aSAH879 Neurol Med Chir (Tokyo) 55, December, 2015 “Good Clinical Practice” (http://www.goodclinical - practice.com).",Non-OADS,/arxiv_data1/oa_pdf/8e/38/nmc-55-878.PMC4686450.pdf
Additional information Supplementary Information accompanies this paper at http://www.nature.com/ naturecommunications Competing ﬁnancial interests: The authors declare no competing ﬁnancial interests.,Non-OADS,/arxiv_data1/oa_pdf/6a/54/ncomms10032.PMC4686665.pdf
"Reprints and permission information is available online at http://npg.nature.com/ reprintsandpermissions/ How to cite this article: Liu, J. et al.",Non-OADS,/arxiv_data1/oa_pdf/6a/54/ncomms10032.PMC4686665.pdf
"To view a copy of this license, visithttp://creativecommons.org/licenses/by-nc-sa/4.0/PLD1-PH-meditaed EGFR endocytosis MH Park et al 8 Experimental & Molecular Medicine",Non-OADS,/arxiv_data1/oa_pdf/da/e1/emm2015101a.PMC4686693.pdf
"To view a copy of this license, visithttp://creativecommons.org/licenses/by-nc-nd/4.0/Crosstalk between FLS and chondrocytes YH Huh et al 10 Experimental & Molecular Medicine",Non-OADS,/arxiv_data1/oa_pdf/30/0e/emm201588a.PMC4686694.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/4.0/Wnt/β-catenin signaling in airway remodeling HJ Kwak et al 8 Experimental & Molecular Medicine",Non-OADS,/arxiv_data1/oa_pdf/5c/c9/emm201591a.PMC4686695.pdf
"To view a copy of this license, visithttp://creativecommons.org/licenses/by-nc-nd/4.0/mTORC1 in insulin resistance M-S Yoon and CS Choi 6 Experimental & Molecular Medicine",Non-OADS,/arxiv_data1/oa_pdf/ff/6d/emm201593a.PMC4686696.pdf
"To view a copy of this license, visithttp://creativecommons.org/licenses/by-nc-nd/4.0/Regulation of osteoclastogenesis by adseverin M-K Song et al 9 Experimental & Molecular Medicine",Non-OADS,/arxiv_data1/oa_pdf/2a/cd/emm201594a.PMC4686697.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/4.0/ Supplementary Information accompanies the paper on Experimental & Molecular Medicin e website (http://www.nature.com/emm)Aspirin-induced IL-4 production S-K Kong et al 10 Experimental & Molecular Medicine",Non-OADS,/arxiv_data1/oa_pdf/c2/3b/emm201596a.PMC4686698.pdf
"All data capture is electronic, using a purpose-built Open Data Kit-based Android smartphone applica-tion (LINKS, Task Force for Global Health, Atlanta,GA, USA; https://linkssystem.org/ 24).",OADS,/arxiv_data1/oa_pdf/76/d0/iope-22-214.PMC4687001.pdf
Global trachoma mapping project: training for mapping of trachoma (version2) [Available at: http://www.trachomacoalition.org/resources/global-trachoma-mapping-project-training-mapping-trachoma].,Non-OADS,/arxiv_data1/oa_pdf/76/d0/iope-22-214.PMC4687001.pdf
at: http://www.wssinfo.org/fileadmin/user_upload/ resources/1268174016-JMP_Core_Questions.pdf [lastaccessed 1 Sept 2013].,Non-OADS,/arxiv_data1/oa_pdf/76/d0/iope-22-214.PMC4687001.pdf
Available FREE in open access from: http://www.jpathinformatics.org/text.,Non-OADS,/arxiv_data1/oa_pdf/ea/15/JPI-6-62.PMC4687157.pdf
"J Pathol Inform 2015, 1:62  http://www.jpathinformatics.org/content/6/1/62General Hospital, mT uitive xPert© Cancer Reporting  version 3 software (mT uitive Corporation, Centerville  MA, USA) is used by pathologists to complete synoptic  cancer templates with the data transferred via electronic  interface from mT uitive to CCO and also to our  Sunquest CoPath pathology system.",OADS,/arxiv_data1/oa_pdf/ea/15/JPI-6-62.PMC4687157.pdf
"J Pathol Inform 2015, 1:62  http://www.jpathinformatics.org/content/6/1/62the synoptic report in Figure  2, lines found to contain the  text “gender” after splitting would yield gender and age as  the second and fourth data elements, respectively.",Non-OADS,/arxiv_data1/oa_pdf/ea/15/JPI-6-62.PMC4687157.pdf
"J Pathol Inform 2015, 1:62  http://www.jpathinformatics.org/content/6/1/62framework of an integrated QA program.",OADS,/arxiv_data1/oa_pdf/ea/15/JPI-6-62.PMC4687157.pdf
"Commercial parsing  tools (e.g., Datawatch Monarch, http://www.datawatch.",Non-OADS,/arxiv_data1/oa_pdf/ea/15/JPI-6-62.PMC4687157.pdf
"J Pathol Inform 2015, 1:62  http://www.jpathinformatics.org/content/6/1/62primary and secondary Gleason grade, Gleason grade  sum, the number of cores positive, the total number  of cores, percent tissue involved by tumor and, when  present, extraprostatic extension, seminal vesicle invasion,  perineural spread, and optionally lymphatic‑vascular  invasion.",Non-OADS,/arxiv_data1/oa_pdf/ea/15/JPI-6-62.PMC4687157.pdf
Available FREE in open access from: http://www.jpathinformatics.org/text.,Non-OADS,/arxiv_data1/oa_pdf/80/a4/JPI-6-63.PMC4687159.pdf
"J Pathol Inform 2015, 1:63  http://www.jpathinformatics.org/content/6/1/63INTRODUCTION Telepathology refers to the remote practice of  pathology via transmitting digital images.",Non-OADS,/arxiv_data1/oa_pdf/80/a4/JPI-6-63.PMC4687159.pdf
"J Pathol Inform 2015, 1:63  http://www.jpathinformatics.org/content/6/1/63in China.",Non-OADS,/arxiv_data1/oa_pdf/80/a4/JPI-6-63.PMC4687159.pdf
"J Pathol Inform 2015, 1:63  http://www.jpathinformatics.org/content/6/1/63the most cases (23.7%), followed by bone/soft tissue  pathology (21.0%) and gynecologic/breast (20.2%)  subspecialties.",Non-OADS,/arxiv_data1/oa_pdf/80/a4/JPI-6-63.PMC4687159.pdf
"J Pathol Inform 2015, 1:63  http://www.jpathinformatics.org/content/6/1/63primary diagnosis (i.e., the treatment plan was altered,  and/or prognosis differed) in 50.8% of cases [ Table  5],  which included 278 cases of malignancies/cancers.",Non-OADS,/arxiv_data1/oa_pdf/80/a4/JPI-6-63.PMC4687159.pdf
"J Pathol Inform 2015, 1:63  http://www.jpathinformatics.org/content/6/1/63be altered, and/or prognosis differed) in 50.8% of cases.",Non-OADS,/arxiv_data1/oa_pdf/80/a4/JPI-6-63.PMC4687159.pdf
"J Pathol Inform 2015, 1:63  http://www.jpathinformatics.org/content/6/1/637.",Non-OADS,/arxiv_data1/oa_pdf/80/a4/JPI-6-63.PMC4687159.pdf
Available FREE in open access from: http://www.jpathinformatics.org/text.,Non-OADS,/arxiv_data1/oa_pdf/f7/f3/JPI-6-61.PMC4687160.pdf
"J Pathol Inform 2015, 1:61  http://www.jpathinformatics.org/content/6/1/61medicine, from patient monitoring and diagnostics to  more efficient medical education and communication,  smartphones serve a pivotal role in the practice of  medicine today.",Non-OADS,/arxiv_data1/oa_pdf/f7/f3/JPI-6-61.PMC4687160.pdf
"J Pathol Inform 2015, 1:61  http://www.jpathinformatics.org/content/6/1/61molecular pathologist, and neuropathologist are only in  English.",Non-OADS,/arxiv_data1/oa_pdf/f7/f3/JPI-6-61.PMC4687160.pdf
(Oracle Corporation; https://www.mysql.com/).,OADS,/arxiv_data1/oa_pdf/f7/f3/JPI-6-61.PMC4687160.pdf
"J Pathol Inform 2015, 1:61  http://www.jpathinformatics.org/content/6/1/61examination of human specimen’s page, the user will  be able to watch this free available video on Y ouT ube  website.",Non-OADS,/arxiv_data1/oa_pdf/f7/f3/JPI-6-61.PMC4687160.pdf
"J Pathol Inform 2015, 1:61  http://www.jpathinformatics.org/content/6/1/61Financial Support and Sponsorship Nil.",Non-OADS,/arxiv_data1/oa_pdf/f7/f3/JPI-6-61.PMC4687160.pdf
Available FREE in open access from: http://www.jpathinformatics.org/text.,Non-OADS,/arxiv_data1/oa_pdf/56/f0/JPI-6-60.PMC4687161.pdf
"J Pathol Inform 2015, 1:60  http://www.jpathinformatics.org/content/6/1/60INTRODUCTION T umor size is a major determinant for staging and  predicting the outcome for cancer patients.",Non-OADS,/arxiv_data1/oa_pdf/56/f0/JPI-6-60.PMC4687161.pdf
"J Pathol Inform 2015, 1:60  http://www.jpathinformatics.org/content/6/1/60the specimens to avoid the image artifacts.",Non-OADS,/arxiv_data1/oa_pdf/56/f0/JPI-6-60.PMC4687161.pdf
"J Pathol Inform 2015, 1:60  http://www.jpathinformatics.org/content/6/1/60RESULTS 72 female subjects who were diagnosed with primary  invasive breast cancer and subsequently underwent breast  lumpectomy were examined in detail in this study.",Non-OADS,/arxiv_data1/oa_pdf/56/f0/JPI-6-60.PMC4687161.pdf
"J Pathol Inform 2015, 1:60  http://www.jpathinformatics.org/content/6/1/60were measured ≤2 cm by micro‑CT , corresponding  to a sensitivity of 94% (95% CI: 0.83–0.99), a  specificity of 67% (95% CI: 0.38–0.88), a PPV  of 90% (95% CI: 0.79–0.97), and a NPV of 77%  (95% CI: 0.46–0.95).",Non-OADS,/arxiv_data1/oa_pdf/56/f0/JPI-6-60.PMC4687161.pdf
"J Pathol Inform 2015, 1:60  http://www.jpathinformatics.org/content/6/1/60the microscope.",Non-OADS,/arxiv_data1/oa_pdf/56/f0/JPI-6-60.PMC4687161.pdf
"J Pathol Inform 2015, 1:60  http://www.jpathinformatics.org/content/6/1/609.",Non-OADS,/arxiv_data1/oa_pdf/56/f0/JPI-6-60.PMC4687161.pdf
Available	 from:	http://www.epaperbeta.timesofindia.com/Article.,Non-OADS,/arxiv_data1/oa_pdf/72/c3/AYU-36-1.PMC4687227.pdf
Available from: http://www.medical‑dictionary.thefreedictionary.com/ diabetes.,Non-OADS,/arxiv_data1/oa_pdf/da/58/AYU-36-10.PMC4687228.pdf
Available from: http://www.worlddiabetesfoundation.org/composite‑35.,Non-OADS,/arxiv_data1/oa_pdf/da/58/AYU-36-10.PMC4687228.pdf
Available from: http://www.naranorthwest.org/diabetes%20and%20 tobacco.pdf.,Non-OADS,/arxiv_data1/oa_pdf/da/58/AYU-36-10.PMC4687228.pdf
Available from: http://www.ncbi.nlm.nih.gov/pubmed/17266094.,Non-OADS,/arxiv_data1/oa_pdf/da/58/AYU-36-10.PMC4687228.pdf
Available from: http://www.jyoungpharm.in.,Non-OADS,/arxiv_data1/oa_pdf/da/58/AYU-36-10.PMC4687228.pdf
Available from: http://www.healthcaremagic.com/./doctor‑anxiety‑pre‑  diabetes‑United States.,Non-OADS,/arxiv_data1/oa_pdf/da/58/AYU-36-10.PMC4687228.pdf
Available from: http://www.en.wikipedia.org/w/index.php?title=Diabetes_ mellitus.,Non-OADS,/arxiv_data1/oa_pdf/da/58/AYU-36-10.PMC4687228.pdf
Available from: http://www.superhumancoach.com/negative‑effects‑of‑  cottonseed‑oil/.,Non-OADS,/arxiv_data1/oa_pdf/da/58/AYU-36-10.PMC4687228.pdf
Available from: http://www.en.wikipedia.org/w/index.php?title=Diabetes_ mellitus.,Non-OADS,/arxiv_data1/oa_pdf/da/58/AYU-36-10.PMC4687228.pdf
Available from: http://www.medicalindia.org/Diabetes.pdf.,Non-OADS,/arxiv_data1/oa_pdf/da/58/AYU-36-10.PMC4687228.pdf
Available from: http://www.diet.com/g/binge‑eating.,Non-OADS,/arxiv_data1/oa_pdf/da/58/AYU-36-10.PMC4687228.pdf
Available from: http://www.emedicine.,Non-OADS,/arxiv_data1/oa_pdf/07/47/AYU-36-29.PMC4687234.pdf
Available from:  http://www.healthcommunities.com/sciatica/sciatica‑overview.html.,Non-OADS,/arxiv_data1/oa_pdf/55/ef/AYU-36-41.PMC4687237.pdf
Available from: http://www.indianmedicine.nic.in.,Non-OADS,/arxiv_data1/oa_pdf/65/00/AYU-36-5.PMC4687239.pdf
Available from: http://www.healthstatus.sgul.ac.uk/SGRQ_download/ SGRQ%20Manual%20June%202009.pdf 5.,Non-OADS,/arxiv_data1/oa_pdf/e3/91/AYU-36-50.PMC4687240.pdf
[Last  retrieved on 2013 Sep 06 from http://www.who.int/mental_health/ media/68.pdf].,Non-OADS,/arxiv_data1/oa_pdf/96/77/AYU-36-63.PMC4687242.pdf
Available from: http://www.amamayurveda.org/pdf/shelf_life_ notification_241105_.pdf.,Non-OADS,/arxiv_data1/oa_pdf/e6/7d/AYU-36-83.PMC4687246.pdf
Available from: http://www.pantone.co.uk/pages/ pantone/colorfinder.aspx.,Non-OADS,/arxiv_data1/oa_pdf/e6/7d/AYU-36-83.PMC4687246.pdf
Available  from: http://www.who.int/medicines/publications/pharmacopoeia/ Bulk‑tapped‑densityWHO.DocumentQAS/11.450FINAL_ MODIFIEDMarch2012.pdf.,Non-OADS,/arxiv_data1/oa_pdf/e6/7d/AYU-36-83.PMC4687246.pdf
Available from: http://www.pharmainfo.net/reviews/ who‑guidelines‑herbal‑drug‑standardization.,Non-OADS,/arxiv_data1/oa_pdf/e6/7d/AYU-36-83.PMC4687246.pdf
Available  from: http://www.pharmacopeia.cn/v29240/usp29nf24s0_c1174.html.,Non-OADS,/arxiv_data1/oa_pdf/e6/7d/AYU-36-83.PMC4687246.pdf
Available from: http://www.ich.org/fileadmin/PublicWeb_Site/ICH_ Products/Guidelines/Quality/Q1A_R2/Step4/Q1A_R2_Guideline.pdf.,OADS,/arxiv_data1/oa_pdf/e6/7d/AYU-36-83.PMC4687246.pdf
Available from: http://www.pharmacopeia.cn/v29240/ usp29nf24s0_c1191.html.,Non-OADS,/arxiv_data1/oa_pdf/e6/7d/AYU-36-83.PMC4687246.pdf
Available from: https://www.unpa.,Non-OADS,/arxiv_data1/oa_pdf/e6/7d/AYU-36-83.PMC4687246.pdf
Available from: http://www.ema.europa.,Non-OADS,/arxiv_data1/oa_pdf/e6/7d/AYU-36-83.PMC4687246.pdf
Available from: http://www.oulu.fi/spareparts/ebook_topics_ multifunctional/abstracts/huhtala.pdf.,Non-OADS,/arxiv_data1/oa_pdf/64/32/JOVR-10-229.PMC4687254.pdf
Available  from: http://docs.house.gov/meetings/IF/IF02/20141016/102718/HHRG-113-IF02-Wstate- VargaD-20141016.pdf 2.,Non-OADS,/arxiv_data1/oa_pdf/a4/bc/nihms729539.PMC4687403.pdf
Available from: http://hosted.ap.org/dynamic/stories/U/ US_EBOLA_MEDICAL_RECORDS?,Non-OADS,/arxiv_data1/oa_pdf/a4/bc/nihms729539.PMC4687403.pdf
Available from: http://www.nytimes.com/2014/10/11/us/thomas-duncan-had- a-fever-of-103-er-records-show.html?_r=0 5.,Non-OADS,/arxiv_data1/oa_pdf/a4/bc/nihms729539.PMC4687403.pdf
Available from: http://bigstory.ap.org/article/ 17b709cea02d445d9ca2e462bebe37bb/ap-enterprise-records-chronicle-duncans-decline 6.,Non-OADS,/arxiv_data1/oa_pdf/a4/bc/nihms729539.PMC4687403.pdf
Available from: http://www.ama-assn.org/ama/pub/ news/news/2014/2014-09-16-solutions-to-ehr-systems.page 13.,Non-OADS,/arxiv_data1/oa_pdf/a4/bc/nihms729539.PMC4687403.pdf
Available from: http://www.iom.edu/Activities/Quality/PatientSafetyHIT.aspx [cited 2011 May  23].,Non-OADS,/arxiv_data1/oa_pdf/a4/bc/nihms729539.PMC4687403.pdf
Available from: http://www.iom.edu/Activities/Quality/PatientSafetyHIT.aspx 14.,Non-OADS,/arxiv_data1/oa_pdf/a4/bc/nihms729539.PMC4687403.pdf
Available from: http://www.urban.org/UploadedPDF/413104-Placing-Diagnosis-Errors- on-the-Policy-Agenda.pdf 21.,Non-OADS,/arxiv_data1/oa_pdf/a4/bc/nihms729539.PMC4687403.pdf
Supplementary data to this article can be found online at http://dx.doi.org/10.1016/j.scr.2013.09.013 .,OADS,/arxiv_data1/oa_pdf/d8/d5/nihms639234.PMC4687407.pdf
"icSHAPE reactivities for mouse XBP1 mRNA were retrieved from the Gene Expression Omnibus accession GSE64169.The custom tracks (BigWig files) were uploaded into the Universityof California at Santa Cruz (UCSC) Genome browser (http://genome.ucsc.edu, and [36]) and displayed on the 2011 mousegenome assembly (UCSC mm10; Genome Reference ConsortiumGRCm38).",OADS,/arxiv_data1/oa_pdf/f5/cc/EMBR-16-1688.PMC4687415.pdf
"Expanded View for this article is available online: http://embor.embopress.org Acknowledgements We are grateful to Javier Martinez for providing us with a FLAG-RTCB-express-ing HEK 293cell line; Howard Y. Chang and Ryan A. Flynn for help with PARS/ icSHAPE data analysis; Voytek Okreglak for Chaetomium thermophilum cDNA and helpful advice; and Elif Karagöz, Silvia Ramundo, Weihan Li, Han Tran,and members of the Walter Laboratory for insightful discussions.",Non-OADS,/arxiv_data1/oa_pdf/f5/cc/EMBR-16-1688.PMC4687415.pdf
"A–D Differential survival based on LRRC 8A(A, C) or LRRC 8D(B, D) gene expression as extracted from the TCGA database (http://cancergenome.nih.gov/) (A, B) or using the data from Patch et al (2015 ) (C, D).",Non-OADS,/arxiv_data1/oa_pdf/cb/69/EMBJ-34-2993.PMC4687416.pdf
Gene expression and survival analysis based on published data concerning ovarian cancer patients Gene expression data were downloaded from the TCGA (http://cancergenome.nih.gov/).,OADS,/arxiv_data1/oa_pdf/cb/69/EMBJ-34-2993.PMC4687416.pdf
"As time interval definition, we used “days_to_last_follow-up.”This is the time interval from the date of last follow-up to the date of initial pathologic diagnosis, represented as a calculatednumber of days (https://tcga-data.nci.nih.gov/docs/dictionary/).The patients were stratified on the expression levels of LRRC8A or LRRC8D .",OADS,/arxiv_data1/oa_pdf/cb/69/EMBJ-34-2993.PMC4687416.pdf
The microarray data from this publicationhave been submitted to the NCBI GEO database http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE67264.,OADS,/arxiv_data1/oa_pdf/c9/b8/EMBR-16-1656.PMC4687425.pdf
This  is  an  open  access  article  under  the  CC  BY-NC-ND  license  (http://creativecommons.org/ licenses/by-nc-nd/3.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/1b/11/main.PMC4687444.pdf
Seventy-six  single  nucleotide  poly- morphisms  have  been  shown  to  be  signiﬁcantly  associated  with http://dx.doi.org/10.1016/j.ejro.2014.08.002 2352-0477/©  2014  The  Authors.,OADS,/arxiv_data1/oa_pdf/1b/11/main.PMC4687444.pdf
This  is  an  open  access  article  under  the  CC  BY-NC-ND  license  (http://creativecommons.org/licenses/ by-nc-nd/3.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/1b/11/main.PMC4687444.pdf
[11]  http://www.cancerresearchuk.org/cancer-info/cancerstats/incidence/risk/statistics-on-the-risk-of-developing-cancer#Lifetime5.,Non-OADS,/arxiv_data1/oa_pdf/1b/11/main.PMC4687444.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/4.0/ Supplementary Information accompanies this paper on the Oncogene website (http://www.nature.com/onc)MEK-dependent regulation of β-catenin/TCF4 activity E Lemieux et al 4927 © 2015 Macmillan Publishers Limited Oncogene (2015) 4914 –4927",Non-OADS,/arxiv_data1/oa_pdf/60/6a/onc2014416a.PMC4687460.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/c0/f1/main.PMC4687461.pdf
Contents lists available at ScienceDirect Annals of Medicine and Surgery journal homepage: www.annalsjournal.com http://dx.doi.org/10.1016/j.amsu.2015.11.004 2049-0801/ ©2015 Published by Elsevier Ltd on behalf of IJS Publishing Group Limited.,Non-OADS,/arxiv_data1/oa_pdf/c0/f1/main.PMC4687461.pdf
"In mammals, themini review http://www.kidney-international.org © 2015 International Society of Nephrology Correspondence: Christoph Englert, Molecular Genetics, Leibniz Institute for Age Research, Fritz Lipmann Institute, Beutenbergstrasse 11, Jena 07745,Germany.",Non-OADS,/arxiv_data1/oa_pdf/9a/b1/ki2015198a.PMC4687464.pdf
Supplementary material is linked to the online version of the paper at http://www.nature.com/ki REFERENCES 1.,Non-OADS,/arxiv_data1/oa_pdf/9a/b1/ki2015198a.PMC4687464.pdf
"To view a copy ofthis license, visit http://creativecommons.org/licenses/by-nc-sa/4.0/ 690 Kidney International (2015) 88,6 8 4 –690mini review L Dong et al.",Non-OADS,/arxiv_data1/oa_pdf/9a/b1/ki2015198a.PMC4687464.pdf
"Nine cases were identifiedwho fulfilled these criteria and were included in this series.During this same time period, there were also six cases of trueC3 GN in adults aged 440 years (evidence of MPGN with C3-only staining who did not show Ig unmasking onparaffin IF).http://www.kidney-international.org clinical investigation © 2015 International Society of Nephrology Correspondence: Christopher P. Larsen, Nephropath, 10180 Executive Center Drive, Suite 100, Little Rock, Arkansas 72211, USA.E-mail: Chris.larsen@nephropath.com Received 13 February 2015; revised 6 May 2015; accepted 14 May 2015; published online 8 July 2015 Kidney International (2015) 88, 867 –873 867",Non-OADS,/arxiv_data1/oa_pdf/d5/f1/ki2015195a.PMC4687465.pdf
Renal biopsy findings in patient #10 who had histologic features on LM and EM compatible with cryoglobulinemicglomerulonephritis.Supplementary material is linked to the online version of the paper at http://www.nature.com/ki REFERENCES 1.,Non-OADS,/arxiv_data1/oa_pdf/d5/f1/ki2015195a.PMC4687465.pdf
"To view a copy ofthis license, visit http://creativecommons.org/licenses/by-nc-nd/4.0/ Kidney International (2015) 88, 867 –873 873CP Larsen et al.",Non-OADS,/arxiv_data1/oa_pdf/d5/f1/ki2015195a.PMC4687465.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/4.0/ Supplementary Information accompanies this paper on the Leukemia website (http://www.nature.com/leu) Effect of genetic pro ﬁling on prediction of therapeutic resistance and survival in adult acute myeloid leukemia Leukemia (2015) 29,2104 –2107; doi:10.1038/leu.2015.76 Therapeutic resistance, that is failure to achieve complete remission (CR) despite not incurring treatment-related mortality(TRM), or relapse after achieving CR, is the principal cause of failurein acute myeloid leukemia (AML).",Non-OADS,/arxiv_data1/oa_pdf/07/69/leu201567a.PMC4687467.pdf
"See: http://creativecommons.org/ licenses/by-nc/4.0/ REFERENCES 1 Leigh-Smith S, Davies G. Indications for thoracic needle decompression.",Non-OADS,/arxiv_data1/oa_pdf/f0/e5/emermed-2012-201821.PMC4687507.pdf
The full terms of this license are available at https://www.dovepress.com/terms.,Non-OADS,/arxiv_data1/oa_pdf/8d/e4/ahmt-6-189.PMC4687608.pdf
"php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",OADS,/arxiv_data1/oa_pdf/8d/e4/ahmt-6-189.PMC4687608.pdf
"For  permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).Adolescent Health, Medicine and Therapeutics 2015:6 189–196Adolescent Health, Medicine and Therapeutics Dove press submit your manuscript | www.dovepress.co m Dove press  189OriginAl reseArcHopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/AHMT .S9486 5Anemia and iron deficiency among school  adolescents: burden, severity, and determinant  factors in southwest ethiopia Melkam T esfaye1 Tilahun Yemane2 Wondimagegn Adisu2 Yaregal Asres2 lealem gedefaw2 1Department of Clinical Laboratory,   Bonga Hospital, Bonga, 2Department  of Medical Laboratory Science and  Pathology, College of Health Sciences,   Jimma University, Jimma, Ethiopia correspondence: lealem gedefaw   Department of Medical Laboratory  Science and Pathology, College of   Health Sciences, Jimma University,   Jimma, ethiopia   Tel +251 91 302 4541   email lealem.gedefaw@ju.edu.e tBackground:  Adolescence is the period of most rapid growth second to childhood.",Non-OADS,/arxiv_data1/oa_pdf/8d/e4/ahmt-6-189.PMC4687608.pdf
"Available from: http://www.standard.com.tw/standard/t_standard/ system_manager/tw/products/uploadFile/71/Su-fe(IRON).pd f. Accessed  May 01, 2014.",OADS,/arxiv_data1/oa_pdf/8d/e4/ahmt-6-189.PMC4687608.pdf
"Adolescent Health, Medicine and Therapeutics Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/adolescent-health-medicine-and-therapeutics-journa lAdolescent Health, Medicine and Therapeutics is an international,  peer-reviewed, open access journal focusing on health, pathology,  and treatment issues specific to the adolescent age group.",Non-OADS,/arxiv_data1/oa_pdf/8d/e4/ahmt-6-189.PMC4687608.pdf
Visit http://www.dovepress.com/testimonials.ph p to  read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/8d/e4/ahmt-6-189.PMC4687608.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/4a/e4/amep-6-657.PMC4687609.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.ph pAdvances in Medical Education and Practice 2015:6 657–663Advances in Medical Education and Practice Dove press submit your manuscript | www.dovepress.co m Dove press  657OriginAl rEsEArchopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/AMEP .S9656 6simulation training for foundation doctors on the  management of the acutely ill patient Monique cachia1 Michael Pace-Bardon2 gabriella Balzan2 russel Tilney2 Josef Micallef2 Martin Balzan2 1Department of Medicine,   2Department of respiratory Medicine,   Mater Dei hospital, Msida, Malta correspondence: Monique cachia   Department of Medicine, Mater Dei  hospital, Triq Dun Karm, Msida,   MsD 2090, Malta   Tel +356 9989 1786   Email mono488@gmail.co mBackground:  A study evaluating subjective trainee responses to simulation training organized  by the Malta Foundation Program in particular whether this changed their clinical practice.",Non-OADS,/arxiv_data1/oa_pdf/4a/e4/amep-6-657.PMC4687609.pdf
"Advances in Medical Education and Practice Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/advances-in-medical-education-and-practice-journa lAdvances in Medical Education and Practice is an international, peer- reviewed, open access journal that aims to present and publish research  on Medical Education covering medical, dental, nursing and allied  health care professional education.",Non-OADS,/arxiv_data1/oa_pdf/4a/e4/amep-6-657.PMC4687609.pdf
Visit http://www.dovepress.com/testimonials.ph p to read real  quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/4a/e4/amep-6-657.PMC4687609.pdf
Available from: http://www.kcl.,Non-OADS,/arxiv_data1/oa_pdf/4a/e4/amep-6-657.PMC4687609.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/5e/cc/cia-10-1959.PMC4687611.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).Clinical Interventions in Aging 2015:10 1959–1965Clinical Interventions in Aging Dove press submit your manuscript | www.dovepress.co m Dove press  1959OrIg InAl reseArChopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/CIA.S9685 2Mechanical failures after fixation with proximal  femoral nail and risk factors Şemmi Koyuncu1 Taşkın Altay2 Cemil Kayalı2 Fırat Ozan3 Kamil Yamak2 1Department of Orthopedics and  Traumatology, Bayburt State Hospital,   Bayburt, 2Department of Orthopedics  and Traumatology, I.zmir Bozyaka  Training and Research Hospital, I.zmir,   3Department of Orthopedics and  Traumatology, Kayseri Training and  Research Hospital, Kayseri, T urkeyBackground:  This study aims at assessing the clinical results, radiographic findings, and  associated complications after osteosynthesis of trochanteric hip fractures with proximal  femoral nail (PFN).",Non-OADS,/arxiv_data1/oa_pdf/5e/cc/cia-10-1959.PMC4687611.pdf
"Keywords:  trochanteric hip fracture, proximal femoral nail, fracture reduction, complications,  risk factors, intramedullary nail Introduction Trochanteric femoral fractures are often seen in patients aged .65 years; they can  be caused by high-energy or low-energy trauma or may be pathological in nature.1–4  Particularly in the elderly, hip fractures are a major cause of increased mortality and  morbidity.4,5 Because of the decreased physical capacity, concomitant systemic diseases,  and increased vulnerability to environmental dangers, even low-energy trauma can cause  unstable femoral trochanteric fractures in this age group.5–7 Surgical management of  hip fractures is targeted to help patients recover to the closest degree of functionality  they had prior to the trauma; this is achieved by utilizing the most appropriate treatment  methods and early ambulation, thereby preventing potential complications.6,8Correspondence: Semmi Koyuncu Department of Orthopedics and  Traumatology, Bayburt State Hospital,  Şingah Mah I.bni Sina Cad No 25,  Bayburt, Turkey Tel +90 458 2222 300 Fax +90 458 2119 203 email semmi2446@gmail.co m Journal name: Clinical Interventions in Aging Article Designation: Original Research Y ear: 2015 Volume: 10 Running head verso: Koyuncu et al Running head recto: Mechanical failures after fixation with proximal femoral nail and risk factors DOI: http://dx.doi.org/10.2147/CIA.S96852",Non-OADS,/arxiv_data1/oa_pdf/5e/cc/cia-10-1959.PMC4687611.pdf
"Clinical Interventions in Aging Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/clinical-interventions-in-aging-journa lClinical Interventions in Aging is an international, peer-reviewed journal  focusing on evidence-based reports on the value or lack thereof of treatments  intended to prevent or delay the onset of maladaptive correlates of aging  in human beings.",Non-OADS,/arxiv_data1/oa_pdf/5e/cc/cia-10-1959.PMC4687611.pdf
Visit http://www.dovepress.,Non-OADS,/arxiv_data1/oa_pdf/5e/cc/cia-10-1959.PMC4687611.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/af/ab/dddt-9-6489.PMC4687612.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).Drug Design, Development and Therapy 2015:9 6489–6495Drug Design, Development and Therapy Dove press submit your manuscript | www.dovepress.co m Dove press  6489Original researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/DDDT .S9521 8association of systolic blood pressure drop with  intravenous administration of itraconazole in  children with hemato-oncologic disease hyeong Jin lee1,* Bongjin lee2,* June Dong Park2 hyung Joo Jeong2 Yu hyeon choi2 hee Y oung Ju1 che ry hong1 Ji Won lee1 hyery Kim1 Dong in suh3 Kyung Duk Park1 hyoung Jin Kang1 hee Y oung shin1 hyo seop ahn1 1Department of Pediatrics, cancer  research institute, 2Division  of Pediatric intensive care,   Department of Pediatrics, 3Division  of Pulmonology, Department of  Pediatrics, seoul national University  college of Medicine, seoul national  University, seoul, south Korea *These authors contributed equally  to this workPurpose:  Although few adverse effects have been reported for itraconazole, a widely used  antifungal therapy for febrile neutropenia, we found intravenous (IV) itraconazole to be associ - ated with serious cases of blood pressure (BP) drop.",Non-OADS,/arxiv_data1/oa_pdf/af/ab/dddt-9-6489.PMC4687612.pdf
"Itraconazole, a synthetic triazole that covers a broad spectrum of  fungi, including Candida  and Aspergillus spp., was approved in 1992.9 With reports correspondence: June Dong Park Division of Pediatric intensive care,  Department of Pediatrics, seoul national  University college of Medicine, seoul  national University, 101 Daehak-no,  Jongno-gu, seoul 03080, south Korea Tel +82 2 2072 3359 Fax +82 2 762 3359 email jdparkmd@snu.ac.k r Journal name: Drug Design, Development and Therapy Article Designation: Original Research Y ear: 2015 Volume: 9 Running head verso: Lee et al Running head recto: Blood pressure drop and itraconazole DOI: http://dx.doi.org/10.2147/DDDT.S95218",Non-OADS,/arxiv_data1/oa_pdf/af/ab/dddt-9-6489.PMC4687612.pdf
"Drug Design, Development and Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/drug-design-development-and-therapy-journa lDrug Design, Development and Therapy is an international, peer- reviewed open-access journal that spans the spectrum of drug design  and development through to clinical applications.",Non-OADS,/arxiv_data1/oa_pdf/af/ab/dddt-9-6489.PMC4687612.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/af/ab/dddt-9-6489.PMC4687612.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0/ .,Non-OADS,/arxiv_data1/oa_pdf/50/22/dhps-7-175.PMC4687613.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpDrug, Healthcare and Patient Safety 2015:7 175–183Drug, Healthcare and Patient Safety Dovepress submit your manuscript | www.dovepress.co m Dovepress 175Reviewopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/DHPS.S6557 1Safety and tolerability considerations in the use  of sildenafil for children with pulmonary arterial  hypertension Andrew L Dodgen1 Kevin D Hill1,2 1Department of Pediatrics, Duke  University Medical Center, 2Duke  Clinical Research institute, Durham,   NC, USA Correspondence: Kevin D Hill   Duke Clinical Research institute,   2400 Pratt Street, Durham,   NC 27705, USA Tel +1 919 668 8305   Fax +1 919 287 2612   email Kevin.hill@duke.eduAbstract: Sildenafil is a phosphodiesterase type-5 inhibitor approved for treatment of pulmonary  arterial hypertension (P AH) in adults.",Non-OADS,/arxiv_data1/oa_pdf/50/22/dhps-7-175.PMC4687613.pdf
"Acknowledgments KDH is supported in part by a grant KL2TR001115-02 from The National Center for Advancing Translational Sciences of the National Institutes of Health, and a grant from the Mend Table 2 Frequency of adverse events associated with sildenafil  use in adults as reported on the US Food and Drug Administration  Drug Label Adverse Event Percentage of patients reporting  event Sildenafil (n =70) Placebo (n=69) epistaxis 9% 1% Headache 46% 39% Flushing 10% 4% insomnia 7% 1% erythema 6% 1% Dyspnea exacerbated 7% 3% Dyspepsia 13% 7% Rhinitis 4% 0% Diarrhea 9% 6% Myalgia 7% 3% Pyrexia 6% 3% Gastritis 3% 0% Sinusitis 3% 0% Paresthesia 3% 0% Notes: Reproduced from the US Food and Drug Administration.47 Available from:  http://www.accessdata.fda.gov/drugsatfda_docs/label/2014/021845s011,022473s004,   0203109s002lbl.pdf.",Non-OADS,/arxiv_data1/oa_pdf/50/22/dhps-7-175.PMC4687613.pdf
Available from: http://www.ema.europa.eu/docs/ en_GB/document_library/EPAR_-_Assessment_Report_-_Variation/human/000638/WC500107804.pdf.,Non-OADS,/arxiv_data1/oa_pdf/50/22/dhps-7-175.PMC4687613.pdf
Available from: http://www.fda.gov/Drugs/DrugSafety/ucm390876.,Non-OADS,/arxiv_data1/oa_pdf/50/22/dhps-7-175.PMC4687613.pdf
Available from: http://www.fda.gov/Drugs/DevelopmentApprovalProcess/Devel   opmentResources/ucm316937.htm.,Non-OADS,/arxiv_data1/oa_pdf/50/22/dhps-7-175.PMC4687613.pdf
Available from: http://bpca.nichd.nih.gov/prioritization/status/ documents/priority_list_10-26-2012.pdf.,OADS,/arxiv_data1/oa_pdf/50/22/dhps-7-175.PMC4687613.pdf
Available  from: http://labeling.pfizer.com/ShowLabeling.aspx?id= 645.,Non-OADS,/arxiv_data1/oa_pdf/50/22/dhps-7-175.PMC4687613.pdf
"Drug, Healthcare and Patient Safety Publish your work in this journal Submit your manuscript here: http://www.dovepress.com/drug-healthcare-and-patient-safety-journalDrug, Healthcare and Patient Safety is an international, peer-reviewed  open-access journal exploring patient safety issues in the healthcare continuum from diagnostic and screening interventions through to treat-ment, drug therapy and surgery.",Non-OADS,/arxiv_data1/oa_pdf/50/22/dhps-7-175.PMC4687613.pdf
Visit http://www.dovepress.com/   testimonials.php  to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/50/22/dhps-7-175.PMC4687613.pdf
"Available from:  http://www.accessdata.fda.gov/drugsatfda_docs/label/2014/021845s011,022473s004,0203109s002lbl.pdf.",Non-OADS,/arxiv_data1/oa_pdf/50/22/dhps-7-175.PMC4687613.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/09/52/ccid-8-591.PMC4687614.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.ph pClinical, Cosmetic and Investigational Dermatology 2015:8 591–599Clinical, Cosmetic and Investigational Dermatology Dove press submit your manuscript | www.dovepress.co m Dove press  591OrIg Inal researChopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/CCID.S9078 1Phosphatidylcholine liposomes as carriers   to improve topical ascorbic acid treatment   of skin disorders gabriel serrano1,* Patricia almudéver2,* Juan-Manuel serrano1 Javier Milara2–5 ana T orrens1 Inmaculada expósito1 Julio Cortijo2–5 1sesderma laboratorios, 2Department  of Pharmacology, Faculty of Medicine,   University of Valencia, 3Clinical  research Unit, University general  hospital Consortium, 4CIBeres,   health Institute Carlos III, 5research  Foundation of the University general  hospital of Valencia, Valencia, spain *These authors contributed equally to  this work Correspondence: Javier Milara   Clinical research Unit, University general  hospital Consortium, avenida tres   cruces number 2, 46014, Valencia, spain   T el +34 6 2023 1549   Fax +34 9 6197 2145   email xmilara@hotmail.co mAbstract:  Liposomes have been intensively investigated as carriers for different applications  in dermatology and cosmetics.",Non-OADS,/arxiv_data1/oa_pdf/09/52/ccid-8-591.PMC4687614.pdf
"Clinical, Cosmetic and Investigational Dermatology Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/clinical-cosmetic-and-investigational-dermatology-journa lClinical, Cosmetic and Investigational Dermatology is an interna - tional, peer-reviewed, open access, online journal that focuses on  the latest clinical and experimental research in all aspects of skin  disease and cosmetic interventions.",Non-OADS,/arxiv_data1/oa_pdf/09/52/ccid-8-591.PMC4687614.pdf
Visit http://www.dovepress.com/testimonials.ph p to read real quotes  from published authors.,Non-OADS,/arxiv_data1/oa_pdf/09/52/ccid-8-591.PMC4687614.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/c0/06/dddt-9-6475.PMC4687615.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).Drug Design, Development and Therapy 2015:9 6475–6482Drug Design, Development and Therapy Dove press submit your manuscript | www.dovepress.co m Dove press  6475Reviewopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/DDDT .S4069 4Profile of deferasirox for the treatment of patients  with non-transfusion-dependent thalassemia  syndromes Paolo Ricchi1 Maria Marsella1,2 1UOSD Malattie Rare del Globulo  Rosso, Azienda Ospedaliera di Rilievo  Nazionale “Antonio Cardarelli”,   Naples, 2UOC Pediatria, Azienda  Ospedaliera di Rilievo Nazionale  G. Rummo, Benevento, italyAbstract:  It has been clearly shown that iron overload adds progressively significant morbidity  and mortality in patients with non-transfusion-dependent thalassemia (NTDT).",Non-OADS,/arxiv_data1/oa_pdf/c0/06/dddt-9-6475.PMC4687615.pdf
"Ineffective and expanded erythropoiesis are both responsible Correspondence: Paolo Ricchi UOSD Malattie Rare del Globulo Rosso,  Azienda Ospedaliera di Rilievo Nazionale  “Antonio Cardarelli”, via Antonio  Cardarelli 9, 80131 Naples, italy Tel +39 081 747 2256 Fax +39 081 747 2250 email pabloricchi@libero.i t Journal name: Drug Design, Development and Therapy Article Designation: Review Y ear: 2015 Volume: 9 Running head verso: Ricchi and Marsella Running head recto: Deferasirox in NTDT DOI: http://dx.doi.org/10.2147/DDDT.S40694",Non-OADS,/arxiv_data1/oa_pdf/c0/06/dddt-9-6475.PMC4687615.pdf
Available from: http://www.thalassae - mia.org.cy/wp-content/uploads/eBook-publications/guidelines_for_ the_management_of_non_transfusion_dependent_thalassaemia/#/ 0.,Non-OADS,/arxiv_data1/oa_pdf/c0/06/dddt-9-6475.PMC4687615.pdf
"Available from: https://www.pharma.us.novartis.com/product/pi/pdf/ desferal.pd f. Accessed July 27, 2015.",Non-OADS,/arxiv_data1/oa_pdf/c0/06/dddt-9-6475.PMC4687615.pdf
Available from: http://www.ema.europa.,Non-OADS,/arxiv_data1/oa_pdf/c0/06/dddt-9-6475.PMC4687615.pdf
"Drug Design, Development and Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/drug-design-development-and-therapy-journa lDrug Design, Development and Therapy is an international, peer- reviewed open-access journal that spans the spectrum of drug design  and development through to clinical applications.",Non-OADS,/arxiv_data1/oa_pdf/c0/06/dddt-9-6475.PMC4687615.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/c0/06/dddt-9-6475.PMC4687615.pdf
Available from:  https://clinicaltrials.gov/ct2/show/NCT01709838?term =deferasirox +n tdt&rank=1.,Non-OADS,/arxiv_data1/oa_pdf/c0/06/dddt-9-6475.PMC4687615.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/53/6d/dddt-9-6461.PMC4687616.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpDrug Design, Development and Therapy 2015:9 6461–6473Drug Design, Development and Therapy Dove press submit your manuscript | www.dovepress.co m Dove press  6461Original researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/DDDT .S9702 0effects of vitamin c treatment on collar-induced  intimal thickening Mehmet Zuhuri arun1 levent Üstünes1 gülnur sevin1 erdener Özer2 1Department of Pharmacology, Faculty  of Pharmacy, ege University, izmir,   T urkey; 2Department of Pathology,   school of Medicine, Dokuz eylül  University, izmir, T urkeyAbstract:  Vitamin C has efficient antioxidant properties and is involved in important  physiological processes such as collagen synthesis.",Non-OADS,/arxiv_data1/oa_pdf/53/6d/dddt-9-6461.PMC4687616.pdf
"This  model has therefore been used in many studies examining intimal thickening.2 In  this model, the changes at the intima layer are typically observed within 7 days and correspondence: Mehmet Zuhuri arun Faculty of Pharmacy, Department of  Pharmacology, ege University, 35100,  Bornova-izmir, Turkey Tel +90 232 311 3288 Fax +90 232 388 4687 email mehmet.arun@ege.edu.t r Journal name: Drug Design, Development and Therapy Article Designation: Original Research Y ear: 2015 Volume: 9 Running head verso: Arun et al Running head recto: Vitamin C and collar-induced intimal thickening DOI: http://dx.doi.org/10.2147/DDDT.S97020",Non-OADS,/arxiv_data1/oa_pdf/53/6d/dddt-9-6461.PMC4687616.pdf
"Drug Design, Development and Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/drug-design-development-and-therapy-journa lDrug Design, Development and Therapy is an international, peer- reviewed open-access journal that spans the spectrum of drug design  and development through to clinical applications.",Non-OADS,/arxiv_data1/oa_pdf/53/6d/dddt-9-6461.PMC4687616.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/53/6d/dddt-9-6461.PMC4687616.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0/ .,Non-OADS,/arxiv_data1/oa_pdf/bb/ee/bctt-7-389.PMC4687618.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpBreast Cancer: Targets and Therapy 2015:7 389–397Breast Cancer: Targets and Therapy Dovepress submit your manuscript | www.dovepress.co m Dovepress 389Original researChopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/BCTT .S8956 3a gM-CsF and CD40l bystander vaccine is  effective in a murine breast cancer model hatem soliman1 Melanie Mediavilla-Varela2 scott J antonia3 1Department of Women’s Oncology  and experimental Therapeutics,   2Department of immunology,   3Department of Thoracic Oncology,   Moffitt Cancer Center, Tampa, Fl, Usa Correspondence: hatem soliman   Department of Women’s Oncology  and Experimental Therapeutics, Moffitt Cancer Center, 12902 Magnolia Drive, Tampa, Fl 33624, Usa Tel +1 813 745 4933   Fax +1 813 745 7287   email hatem.soliman@moffitt.or gBackground: There is increasing interest in using cancer vaccines to treat breast cancer patients  in the adjuvant setting to prevent recurrence in high risk situations or in combination with other  immunomodulators in the advanced setting.",Non-OADS,/arxiv_data1/oa_pdf/bb/ee/bctt-7-389.PMC4687618.pdf
"Breast Cancer: Targets and Therapy Publish your work in this journal Submit your manuscript here: http://www.dovepress.com/breast-cancer---targets-and-therapy-journalBreast Cancer: Targets and Therapy is an international, peer-   reviewed open access journal focusing on breast cancer research,  identification of therapeutic targets and the optimal use of preven - tative and integrated treatment interventions to achieve improved outcomes, enhanced survival and quality of life for the cancer patient.",Non-OADS,/arxiv_data1/oa_pdf/bb/ee/bctt-7-389.PMC4687618.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/19/ec/cia-10-1947.PMC4687619.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).Clinical Interventions in Aging 2015:10 1947–1958Clinical Interventions in Aging Dove press submit your manuscript | www.dovepress.co m Dove press  1947RevIewopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/CIA.S6963 2Depression and frailty in later life: a systematic  review Leslie vaughan1 Akeesha L Corbin1 Joseph S Goveas2 1Department of Social Sciences and  Health Policy, wake Forest School  of Medicine, winston-Salem, NC,   USA; 2Department of Psychiatry and  Behavioral Medicine, Medical College  of wisconsin, MI, USAAbstract:  Frailty and depression are important issues affecting older adults.",Non-OADS,/arxiv_data1/oa_pdf/19/ec/cia-10-1947.PMC4687619.pdf
"It was first operationalized and measured over  3 and 7 years in noninstitutionalized women and men of ages 65–101 years in the  Cardiovascular Health Study at baseline as $3 of the following criteria present: unin - tentional weight loss of $10 lbs/$5% of body weight accompanied by sarcopenia in  the prior year; weakness (grip strength), slowness (walking time), low activity (kcals  per week) in the 20th percentile; and self-reported “exhaustion” from two items on  the Center for Epidemiological Studies Depression (CES-D) Scale.2 The initial study  excluded those with a history of probable dementia, stroke, mini-mental scores ,18,  and taking antidepressants, the rationale being that “these conditions could potentially Correspondence: Leslie vaughan Department of Social Sciences and Health  Policy, wake Forest University School  of Medicine, Medical Center Boulevard,  winston-Salem, NC 27157, USA email alvaugha@wakehealth.ed u Journal name: Clinical Interventions in Aging Article Designation: Review Y ear: 2015 Volume: 10 Running head verso: Vaughan et al Running head recto: A systematic review of depression and frailty during aging DOI: http://dx.doi.org/10.2147/CIA.S69632",Non-OADS,/arxiv_data1/oa_pdf/19/ec/cia-10-1947.PMC4687619.pdf
"Clinical Interventions in Aging Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/clinical-interventions-in-aging-journa lClinical Interventions in Aging is an international, peer-reviewed journal  focusing on evidence-based reports on the value or lack thereof of treatments  intended to prevent or delay the onset of maladaptive correlates of aging  in human beings.",Non-OADS,/arxiv_data1/oa_pdf/19/ec/cia-10-1947.PMC4687619.pdf
Visit http://www.dovepress.,Non-OADS,/arxiv_data1/oa_pdf/19/ec/cia-10-1947.PMC4687619.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/ba/ad/copd-10-2675.PMC4687620.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).International Journal of COPD 2015:10 2675International Journal of COPD Dove press submit your manuscript | www.dovepress.co m Dove press  International Journal of COPD Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/international-journal-of-chronic-obstructive-pulmonary-disease-journa lThe International Journal of COPD is an international, peer-reviewed  journal of therapeutics and pharmacology focusing on concise rapid  reporting of clinical studies and reviews in COPD.",Non-OADS,/arxiv_data1/oa_pdf/ba/ad/copd-10-2675.PMC4687620.pdf
"Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.Dove pres s 2675COrrIgenDumopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/COPD.S10141 7Endoscopic bronchial valve treatment: patient selection and special  considerations [Corrigendum]Journal name: International Journal of COPD Article Designation: Corrigendum Y ear: 2015 Volume: 10 Running head verso: Eberhardt et al Running head recto: Endoscopic bronchial valve treatment DOI: http://dx.doi.org/10.2147/COPD.S101417 Eberhardt R, Gompelmann D, Herth FJ, Schuhmann M.  Int J Chron Obstruct Pulmon Dis .",Non-OADS,/arxiv_data1/oa_pdf/ba/ad/copd-10-2675.PMC4687620.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/80/e5/ccide-7-125.PMC4687621.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.ph pClinical, Cosmetic and Investigational Dentistry 2015:7 125–131Clinical, Cosmetic and Investigational Dentistry Dove press submit your manuscript | www.dovepress.co m Dove press  125OrIg Inal researChopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/CCIDE.S9581 4scanning electron microscopy analysis   of the growth of dental plaque on the surfaces   of removable orthodontic aligners after   the use of different cleaning methods luca levrini Francesca novara silvia Margherini Camilla T enconi Mario raspanti Department of surgical and  Morphological sciences, Dental  hygiene school, research Centre  Cranio Facial Disease and Medicine,   University of Insubria, Varese, Italy Correspondence: luca levrini   Dental hygiene school, University of  Insubria, Via Piatti 10, 21100 Varese, Italy   email luca.levrini@uninsubria.i tBackground:  Advances in orthodontics are leading to the use of minimally invasive technolo - gies, such as transparent removable aligners, and are able to meet high demands in terms of  performance and esthetics.",Non-OADS,/arxiv_data1/oa_pdf/80/e5/ccide-7-125.PMC4687621.pdf
"Clinical, Cosmetic and Investigational Dentistry Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/clinical-cosmetic-and-investigational-dentistry-journa lClinical, Cosmetic and Investigational Dentistry is an international,  peer-reviewed, open access, online journal focusing on the latest clini - cal and experimental research in dentistry with specific emphasis on  cosmetic interventions.",Non-OADS,/arxiv_data1/oa_pdf/80/e5/ccide-7-125.PMC4687621.pdf
Visit http://www.dovepress.,Non-OADS,/arxiv_data1/oa_pdf/80/e5/ccide-7-125.PMC4687621.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/f8/21/dddt-9-6509.PMC4687622.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).Drug Design, Development and Therapy 2015:9 6509Drug Design, Development and Therapy Dove press submit your manuscript | www.dovepress.co m Dove press  Drug Design, Development and Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/drug-design-development-and-therapy-journa lDrug Design, Development and Therapy is an international, peer- reviewed open-access journal that spans the spectrum of drug design  and development through to clinical applications.",Non-OADS,/arxiv_data1/oa_pdf/f8/21/dddt-9-6509.PMC4687622.pdf
"Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.Dove pres s 6509CorrigenDumopen access to scientific and medical research open Access Full T ext Article http: //dx.doi.org/10.2147/DDDT .S10119 4Brivaracetam: review of its pharmacology and potential use as adjunctive  therapy in patients with partial onset seizures [Corrigendum]Journal name: Drug Design, Development and Therapy Article Designation: Corrigendum Y ear: 2015 Volume: 9 Running head verso: Mumoli et al Running head recto: Review of its pharmacology and potential use as adjunctive therapy DOI: http://dx.doi.org/10.2147/DDDT.S101194 Mumoli L, Palleria C, Gasparini S, et al.",Non-OADS,/arxiv_data1/oa_pdf/f8/21/dddt-9-6509.PMC4687622.pdf
"On page 5724, the first sentence of the Conclusion should  read “BRV is a novel AED whose efficacy in partial epi - lepsies has been studied and established in six randomized  controlled trials;30–35 furthermore, two recent meta-analyses  have confirmed significant effects for BRV in patients with  refractory partial seizures.29,43” In the reference list, page 5725, reference 34 (Klein et al),  the link should be: http://www.abstracts2view.com/aan/ view.php?nu=AAN15L1_S31.00 9, which links directly to  the abstract text.",Non-OADS,/arxiv_data1/oa_pdf/f8/21/dddt-9-6509.PMC4687622.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/9f/e5/ceor-7-637.PMC4687623.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.ph pClinicoEconomics and Outcomes Research 2015:7 637–642ClinicoEconomics and Outcomes Research Dove press submit your manuscript | www.dovepress.co m Dove press  637ORIGINAL RESEARCHopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/CEOR.S8726 1The impact of ribavirin on real-world adherence  rates in hepatitis C patients treated with  sofosbuvir plus simeprevir David R Walker Timothy R Juday Shivaji R Manthena Y onghua Jing Vipan Sood Health Economics and Outcomes  Research, AbbVie Inc., North Chicago,   IL, USA Correspondence: Timothy R Juday   Health Economics and Outcomes  Research, AbbVie Inc., 1 North Waukegan   Road,  AP31-01 Department GMH1,  Chicago, IL, 60064, USA   T el +1 847 935 1616   Fax +1 847 937 3440   Email timothy.juday@abbvie.co m Background:  Combination therapy with sofosbuvir (SOF) and simeprevir (SIM) is used to treat  patients with hepatitis C virus infection.",Non-OADS,/arxiv_data1/oa_pdf/9f/e5/ceor-7-637.PMC4687623.pdf
Or use: http://youtu.be/dJ4Xv4DZkM U,Non-OADS,/arxiv_data1/oa_pdf/9f/e5/ceor-7-637.PMC4687623.pdf
"ClinicoEconomics and Outcomes Research Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/clinicoeconomics-and-outcomes-research-journa lClinicoEconomics & Outcomes Research is an international, peer- reviewed open-access journal focusing on Health Technology Assess - ment, Pharmacoeconomics and Outcomes Research in the areas of  diagnosis, medical devices, and clinical, surgical and pharmacological  intervention.",Non-OADS,/arxiv_data1/oa_pdf/9f/e5/ceor-7-637.PMC4687623.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/9f/e5/ceor-7-637.PMC4687623.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/4e/ac/dddt-9-6445.PMC4687624.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).Drug Design, Development and Therapy 2015:9 6445–6460Drug Design, Development and Therapy Dove press submit your manuscript | www.dovepress.co m Dove press  6445Original researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/DDDT .S9348 1The study on the preparation and characterization  of gene-loaded immunomagnetic albumin  nanospheres and their anti-cell proliferative effect  combined with magnetic fluid hyperthermia on  glc-82 cells hao Zhang,1 Xinxin hou,2  Mei lin,3 ling Wang,1  hongbo li,4 chenyan Yuan,1  chen liang,1 Jia Zhang,5  Dongsheng Zhang1,6  1Medical school of southeast  University, nanjing, Jiangsu, People’s  republic of china; 2Medical school  of henan Polytechnic University,   Jiaozuo, henan, People’s republic  of china; 3Taizhou People’s hospital  affiliated to nantong University,   Taizhou, Jiangsu, People’s republic of  china; 4Department of Ultrasound  in Medicine, The First affiliated  hospital (Jiangsu Province hospital  of TcM), nanjing University of  chinese Medicine, n anjing, Jiangsu,   People’s republic of china; 5Jiangsu  cancer hospital, nanjing, Jiangsu,   People’s republic of china; 6Jiangsu  Key laboratory For Biomaterials and  Devices, nanjing, Jiangsu, People’s  republic of chinaAbstract:  As one of the most common malignant tumors, the clinical and socio-economic  consequences of lung cancer are significant.",Non-OADS,/arxiv_data1/oa_pdf/4e/ac/dddt-9-6445.PMC4687624.pdf
"Therefore, identifying a new method or combination of  different methods that have mild side effects and accurately target lung cancer have correspondence: Dongsheng Zhang Medical school of southeast University,  no 87 Dingjiaqiao road, nanjing, 210009,  Jiangsu Province, People’s republic of  china email zdszds1222@163.co m Journal name: Drug Design, Development and Therapy Article Designation: Original Research Y ear: 2015 Volume: 9 Running head verso: Zhang et al Running head recto: Study of gene-loaded immunomagnetic albumin nanospheres DOI: http://dx.doi.org/10.2147/DDDT.S93481",Non-OADS,/arxiv_data1/oa_pdf/4e/ac/dddt-9-6445.PMC4687624.pdf
"Drug Design, Development and Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/drug-design-development-and-therapy-journa lDrug Design, Development and Therapy is an international, peer- reviewed open-access journal that spans the spectrum of drug design  and development through to clinical applications.",Non-OADS,/arxiv_data1/oa_pdf/4e/ac/dddt-9-6445.PMC4687624.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/4e/ac/dddt-9-6445.PMC4687624.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/f9/16/dddt-9-6497.PMC4687625.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpDrug Design, Development and Therapy 2015:9 6497–6508Drug Design, Development and Therapy Dove press submit your manuscript | www.dovepress.co m Dove press  6497Original researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/DDDT .S9620 7study of bone-like hydroxyapatite/polyamino  acid com posite materials for their biological  properties and effects on the reconstruction of  long bone defects correspondence: Dian-ming Jiang Department of Orthopedic surgery,  The First Affiliated Hospital, Chongqing  Medical University, no 1 Youyi road,  Yuzhong District, Chongqing 400016,  People’s republic of china Tel +86 139 8383 6636 Fax +86 23 8901 1212 email jdm571026@vip.163.co m Journal name: Drug Design, Development and Therapy Article Designation: Original Research Y ear: 2015 Volume: 9 Running head verso: Y an and Jiang Running head recto: Study of BHA/PAA composite materials DOI: http://dx.doi.org/10.2147/DDDT.S96207 ling Yan1 Dian-ming Jiang2 1Department of Orthopedics surgery,   The First People’s hospital of Zunyi  city, Zunyi, People’s republic of  china; 2Department of Orthopedic  surgery, The First affiliated hospital,   Chongqing Medical University,   Chongqing, People’s Republic of ChinaPurpose:  The purpose of this study was to investigate the effect of bone-like hydroxyapatite/ polyamino acid (BHA/PAA) in the osteogenesis and reconstruction of long segmental bone  defects.",Non-OADS,/arxiv_data1/oa_pdf/f9/16/dddt-9-6497.PMC4687625.pdf
"Drug Design, Development and Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/drug-design-development-and-therapy-journa lDrug Design, Development and Therapy is an international, peer- reviewed open-access journal that spans the spectrum of drug design  and development through to clinical applications.",Non-OADS,/arxiv_data1/oa_pdf/f9/16/dddt-9-6497.PMC4687625.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/f9/16/dddt-9-6497.PMC4687625.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0/ .,Non-OADS,/arxiv_data1/oa_pdf/0b/b6/dhps-7-169.PMC4687626.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpDrug, Healthcare and Patient Safety 2015:7 169–174Drug, Healthcare and Patient Safety Dovepress submit your manuscript | www.dovepress.co m Dovepress 169Original reSearcHopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/DHPS.S9711 3Safety profile of dalfampridine extended release  in multiple sclerosis: 5-year postmarketing  experience in the United States Michele Jara Thomas aquilina Peter aupperle adrian l rabinowicz acorda Therapeutics, inc.,    ardsley, nY, USa correspondence: Michele Jara   acorda Therapeutics, inc., 420 Saw Mill  river road, ardsley, nY 10502, USa   Tel +1 914 326 5368   Fax +1 914 347 4560   email mjara@acorda.co mBackground: Dalfampridine extended release tablets (dalfampridine-ER; prolonged-, modi- fied, or sustained-release fampridine outside the US), 10 mg twice daily, was approved by the  US Food and Drug Administration (FDA) in January 2010 to improve walking in people with  multiple sclerosis, as determined by an increase in walking speed.",Non-OADS,/arxiv_data1/oa_pdf/0b/b6/dhps-7-169.PMC4687626.pdf
"Drug, Healthcare and Patient Safety Publish your work in this journal Submit your manuscript here: http://www.dovepress.com/drug-healthcare-and-patient-safety-journalDrug, Healthcare and Patient Safety is an international, peer-reviewed  open-access journal exploring patient safety issues in the healthcare continuum from diagnostic and screening interventions through to treat-ment, drug therapy and surgery.",Non-OADS,/arxiv_data1/oa_pdf/0b/b6/dhps-7-169.PMC4687626.pdf
Visit http://www.dovepress.com/   testimonials.php  to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/0b/b6/dhps-7-169.PMC4687626.pdf
"Silver Spring, MD:  Food and Drug Administration; 2013. http://www.accessdata.fda.gov/ drugsatfda_docs/appletter/2013/022250Orig1s008ltr.pdf .",OADS,/arxiv_data1/oa_pdf/0b/b6/dhps-7-169.PMC4687626.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/a3/89/cia-10-1967.PMC4687627.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpClinical Interventions in Aging 2015:10 1967–1970Clinical Interventions in Aging Dove press submit your manuscript | www.dovepress.co m Dove press  1967CAse reportopen access to scientific and medical research open Access Full text Article http: //dx.doi.org/10.2147/CIA.S9723 0periprosthetic proximal medial femoral cortical  destruction caused by a femoral arterial  pseudoaneurysm Ug ˘ur Tiftikçi sancar serbest Department of orthopaedics and  traumatology, Faculty of Medicine,   Kırıkkale University, Kırıkkale, T urkeyAbstract:  A femoral artery aneurysm is a very rare complication of hip surgery treatment.",Non-OADS,/arxiv_data1/oa_pdf/a3/89/cia-10-1967.PMC4687627.pdf
"In the anamnesis, it was found that Correspondence: sancar serbest Department of orthopaedics and traumatology, Faculty of Medicine, Kırıkkale University, Yahşiyan, 71100 Kırıkkale, Turkey tel +90 533 554 5080 Fax +90 318 225 2819 email dr.sancarserbest@hotmail.co m Journal name: Clinical Interventions in Aging Article Designation: Case report Y ear: 2015 Volume: 10 Running head verso: Tiftikçi and Serbest Running head recto: Periprosthetic proximal medial femoral cortical destruction DOI: http://dx.doi.org/10.2147/CIA.S97230",Non-OADS,/arxiv_data1/oa_pdf/a3/89/cia-10-1967.PMC4687627.pdf
"Clinical Interventions in Aging Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/clinical-interventions-in-aging-journa lClinical Interventions in Aging is an international, peer-reviewed journal  focusing on evidence-based reports on the value or lack thereof of treatments  intended to prevent or delay the onset of maladaptive correlates of aging  in human beings.",Non-OADS,/arxiv_data1/oa_pdf/a3/89/cia-10-1967.PMC4687627.pdf
Visit http://www.dovepress.,Non-OADS,/arxiv_data1/oa_pdf/a3/89/cia-10-1967.PMC4687627.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/85/19/ceor-7-629.PMC4687628.pdf
"Information on how to request permission may be found at: http://www.dovepress.com/permissions.ph pClinicoEconomics and Outcomes Research 2015:7 629–636ClinicoEconomics and Outcomes Research Dove press submit your manuscript | www.dovepress.co m Dove press  629MEthO dOlOgyopen access to scientific and medical research Open Access Full text Article http: //dx.doi.org/10.2147/CEOR.S9328 0Adjustment of foreign EQ-5d-3l utilities   can increase their transferability lars Oddershede1,2 Karin dam Petersen1 1danish Center for healthcare  Improvements, Faculty of Social  Sciences, Faculty of health Sciences,   Aalborg University, Aalborg East,   2hEOR Consult ApS, Copenhagen,   denmark Correspondence: lars Oddershede   danish Center for healthcare  Improvements, Faculty of Social Sciences,  Faculty of health Sciences, Aalborg  University, Fibigerstraede 11 room 70,  9220 Aalborg East, denmark   tel +45 4060 9448   Email lars.oddershede@gmail.co mBackground:  Foreign utilities of the EQ-5D-3L (3-level version of the EuroQol-5 Dimension  of health questionnaire) are not readily transferrable to economic evaluations conducted from  a national perspective.",Non-OADS,/arxiv_data1/oa_pdf/85/19/ceor-7-629.PMC4687628.pdf
"ClinicoEconomics and Outcomes Research Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/clinicoeconomics-and-outcomes-research-journa lClinicoEconomics & Outcomes Research is an international, peer- reviewed open-access journal focusing on Health Technology Assess - ment, Pharmacoeconomics and Outcomes Research in the areas of  diagnosis, medical devices, and clinical, surgical and pharmacological  intervention.",Non-OADS,/arxiv_data1/oa_pdf/85/19/ceor-7-629.PMC4687628.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/85/19/ceor-7-629.PMC4687628.pdf
To viewplease visit the journal online(http://dx.doi.org/10.1136/ oemed-2014-102468).,OADS,/arxiv_data1/oa_pdf/04/5b/oemed-2014-102468.PMC4687690.pdf
See: http://creativecommons.org/ licenses/by-nc/4.0/ REFERENCES 1W H O .,Non-OADS,/arxiv_data1/oa_pdf/04/5b/oemed-2014-102468.PMC4687690.pdf
"doi:10.1136/bmjqs-2015-004403 539▸http://dx.doi.org/10.1136/ bmjqs-2014-003702 ▸http://dx.doi.org/10.1136/ bmjqs-2015-004461 To cite: Vincent C, Amalberti R. BMJ Qual Saf 2015; 24:539 –540.",Non-OADS,/arxiv_data1/oa_pdf/d1/62/bmjqs-2015-004403.PMC4687691.pdf
"See: http://creativecommons.org/licenses/by- nc/4.0/ REFERENCES 1 Sharpe V A, Faden AI.",Non-OADS,/arxiv_data1/oa_pdf/d1/62/bmjqs-2015-004403.PMC4687691.pdf
"Risk factors which predispose ﬁrst-time traumatic anterior shoulder dislocations to recurrent instability in adults: a systematic review and meta-analysis M Olds,1R Ellis,2K Donaldson,1P Parmar,1P Kersten3 1Auckland University of Technology, Auckland,New Zealand 2Health and Rehabilitation Research Institute, Auckland University of Technology,Auckland, New Zealand 3Centre for Person Centred Research, Auckland University of Technology, Auckland,New Zealand Correspondence to M Olds, Auckland University of Technology, Private Bag 92006, Auckland,New Zealand;Margie.olds@aut.ac.nz Accepted 19 March 2015 Published Online First21 April 2015 ▸http://dx.doi.org/10.1136/ bjsports-2015-094584 To cite: Olds M, Ellis R, Donaldson K, et al.Br J Sports Med Published Online First: [ please include Day Month Year] doi:10.1136/bjsports-2014-094342ABSTRACT Background Recurrent instability following a ﬁrst-time anterior traumatic shoulder dislocation may exceed 26%.We systematically reviewed risk factors which predisposethis population to events of recurrence.Methods A systematic review of studies published before 1 July 2014.",Non-OADS,/arxiv_data1/oa_pdf/07/88/bjsports-2014-094342.PMC4687692.pdf
"Bob McCormack ’s podcast on ﬁrst time shoulder dislocation: http://tinyurl.com/ozqkmy7 Contributors MO designed the study, collected and extracted and appraised data, designed the statistical analysis, analysed the data and drafted and revised thepaper.",Non-OADS,/arxiv_data1/oa_pdf/07/88/bjsports-2014-094342.PMC4687692.pdf
"See: http://creativecommons.org/licenses/by-nc/4.0/ REFERENCES 1 Zacchilli MA, Owens BD.",Non-OADS,/arxiv_data1/oa_pdf/07/88/bjsports-2014-094342.PMC4687692.pdf
"SIGN, 2012. http://www.sign.ac.uk/ methodology/checklists.html 22 Perestelo-Perez L. Standards on how to develop and report systematic reviews in Psychology and Health.",Non-OADS,/arxiv_data1/oa_pdf/07/88/bjsports-2014-094342.PMC4687692.pdf
"SIGN, 2011. http://www.sign.ac.",Non-OADS,/arxiv_data1/oa_pdf/07/88/bjsports-2014-094342.PMC4687692.pdf
"The Cochrane Collaboration, 2009. http://www.cochrane-handbook.org 26 Borenstein M, Hedges L, Higgins J, et al.Comprehensive meta-analysis version 2 .",OADS,/arxiv_data1/oa_pdf/07/88/bjsports-2014-094342.PMC4687692.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/f5/2f/ijn-10-7455.PMC4687718.pdf
Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpInternational Journal of Nanomedicine 2015:10 7455–7466International Journal of Nanomedicine Dove press submit your manuscript | www.dovepress.co m Dove press  7455OrIg INal researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/IJN.S9263 8liquid crystal precursor mucoadhesive system  as a strategy to improve the prophylactic action  of Syngonanthus nitens  (Bong.),Non-OADS,/arxiv_data1/oa_pdf/f5/2f/ijn-10-7455.PMC4687718.pdf
"Keywords:  precursor system of mucoadhesive liquid crystal, nanostructured system,   prophylaxis, Candida kruseicorrespondence: Taís Maria Bauab Faculdade de ciências Farmacêuticas,  UNesP - Univ estadual Paulista, campus  araraquara, Departamento de ciências  Biológicas, araraquara-Jaú, km 01,  araraquara, sP ceP: 14801-902, Brazil Tel +55 16 3301 6955 Fax +55 16 3301 6940 email bauabtm@fcfar.unesp.b r Journal name: International Journal of Nanomedicine Article Designation: Original Research Y ear: 2015 Volume: 10 Running head verso: dos Santos Ramos et al Running head recto: New antifungal prophylactic strategy with nanostructured system DOI: http://dx.doi.org/10.2147/IJN.S92638",Non-OADS,/arxiv_data1/oa_pdf/f5/2f/ijn-10-7455.PMC4687718.pdf
"International Journal of Nanomedicine Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/international-journal-of-nanomedicine-journa lThe International Journal of Nanomedicine is an international, peer- reviewed journal focusing on the application of nanotechnology   in diagnostics, therapeutics, and drug delivery systems throughout   the biomedical field.",Non-OADS,/arxiv_data1/oa_pdf/f5/2f/ijn-10-7455.PMC4687718.pdf
Visit http://www.dovepress.com/ testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/f5/2f/ijn-10-7455.PMC4687718.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0/ .,Non-OADS,/arxiv_data1/oa_pdf/9b/89/jaa-8-135.PMC4687719.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpJournal of Asthma and Allergy 2015:8 135–137Journal of Asthma and Allergy Dovepress submit your manuscript | www.dovepress.co m Dovepress 135Corrigendumopen access to scientific and medical research open Access Full T ext Article http: //dx.doi.org/10.2147/JAA.S10041 1Morning and evening efficacy evaluation of rupatadine (10 and 20 mg),  compared with cetirizine 10 mg in perennial allergic rhinitis: a randomized,  double-blind, placebo-controlled trial [Corrigendum] Marmouz F , Giralt J, Izquierdo I.",Non-OADS,/arxiv_data1/oa_pdf/9b/89/jaa-8-135.PMC4687719.pdf
"Journal of Asthma and Allergy Publish your work in this journal Submit your manuscript here: http://www.dovepress.com/journal-of-asthma-and-allergy-journalThe Journal of Asthma and Allergy is an international, peer-reviewed  open-access journal publishing original research, reports, editorials and commentaries on the following topics: Asthma; Pulmonary physi-ology; Asthma related clinical health; Clinical immunology and the immunological basis of disease; Pharmacological interventions and new therapies.",Non-OADS,/arxiv_data1/oa_pdf/9b/89/jaa-8-135.PMC4687719.pdf
Visit http://www.dovepress.com/testimonials.php to read  real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/9b/89/jaa-8-135.PMC4687719.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/56/87/ijn-10-7467.PMC4687720.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).International Journal of Nanomedicine 2015:10 7467–7475International Journal of Nanomedicine Dove press submit your manuscript | www.dovepress.co m Dove press  7467OrIg INal researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/IJN.S9762 2antioxidant and hepatoprotective role of  gold nanoparticles against murine hepatic  schistosomiasis Mohamed a Dkhil1,2 amira a Bauomy2,3 Marwa sM Diab4 saleh al-Quraishy2 1Department of Zoology, college  of science, King saud University,   riyadh, saudi arabia; 2Department  of Zoology and entomology, Faculty  of science, helwan University, cairo,   egypt; 3Department of laboratory  sciences, college of science & arts,   Qassim University, Buraydah, saudi  arabia; 4Molecular Drug evaluation  Department, National Organization  for Drug control & research  (NODcar), giza, egyptAbstract:  In recent years, gold nanoparticles (AuNPs) have become the focus of much attention  in biomedical research, especially in the context of nanomedicine, due to their distinctive  physicochemical properties.",Non-OADS,/arxiv_data1/oa_pdf/56/87/ijn-10-7467.PMC4687720.pdf
"Chrysotherapy, the use of gold to treat diseases such as smallpox, skin ulcers,  syphilis, and measles, is attested in ancient cultures in Egypt, India, and the People’s  Republic of China.2 More recently, gold complexes have also showed potential  antileishmanial and antimalarial activity,3 with an interesting role against Leishmania   promastigotes in culture media, and apparently larvicidal properties against a mosquito  vector of malaria.4,5 They are also promising for use as “band-aids” to treat skin lesions.6 correspondence: Marwa sM Diab Molecular Drug evaluation Department,  National Organization for Drug control  & research (NODcar), 6 abou hazem  st., Madkour station, Pyramids ave,  PO Box 29, giza 12553, egypt Tel +2 02 3585 0005 Fax +2 02 3585 5582 email marwa.db@gmail.co m Journal name: International Journal of Nanomedicine Article Designation: Original Research Y ear: 2015 Volume: 10 Running head verso: Dkhil et al Running head recto: Effect of gold nanoparticles on hepatic schistosomiasis DOI: http://dx.doi.org/10.2147/IJN.S97622",Non-OADS,/arxiv_data1/oa_pdf/56/87/ijn-10-7467.PMC4687720.pdf
"International Journal of Nanomedicine Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/international-journal-of-nanomedicine-journa lThe International Journal of Nanomedicine is an international, peer- reviewed journal focusing on the application of nanotechnology   in diagnostics, therapeutics, and drug delivery systems throughout   the biomedical field.",Non-OADS,/arxiv_data1/oa_pdf/56/87/ijn-10-7467.PMC4687720.pdf
Visit http://www.dovepress.com/ testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/56/87/ijn-10-7467.PMC4687720.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0/ .,Non-OADS,/arxiv_data1/oa_pdf/0d/bf/jbm-6-285.PMC4687721.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpJournal of Blood Medicine 2015:6 285–290Journal of Blood Medicine Dovepress submit your manuscript | www.dovepress.co m Dovepress 285Original researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/JBM.S9740 5hydroxyurea decreases hospitalizations in  pediatric patients with hb sc and hb sB +  thalassemia Jeffrey D lebensburger rakeshkumar J Patel Prasannalaxmi Palabindela christina J Bemrich-stolzThomas h howard lee M hilliard Division of Pediatric hematology  Oncology, University of alabama at  Birmingham, Birmingham, al, Usa correspondence: Jeffrey D lebensburger   Division of Pediatric hematology  Oncology, University of alabama at Birmingham, 1600 7th ave south, lowder  512, Birmingham, al 35233, Usa Tel +1 205 638 9285   Fax +1 205 975 1949   email jlebensburger@peds.uab.ed uPurpose: Patients with hemoglobin SC (Hb SC) and hemoglobin SB+ (Hb SB+) thalassemia  suffer from frequent hospitalizations yet strong evidence of a clinical benefit of hydroxyurea  (HU) in this population is lacking.",Non-OADS,/arxiv_data1/oa_pdf/0d/bf/jbm-6-285.PMC4687721.pdf
Sample size calculations were completed using G*power data  analysis (http://www.ats.ucla.edu/stat/ gpower/indepsamps.htm ).,OADS,/arxiv_data1/oa_pdf/0d/bf/jbm-6-285.PMC4687721.pdf
"Journal of Blood Medicine Publish your work in this journal Submit your manuscript here: http://www.dovepress.com/Journal-of-blood-medicine-journalThe Journal of Blood Medicine is an international, peer-reviewed, open  access, online journal publishing laboratory, experimental and clinical aspects  of all topics pertaining to blood based medicine including but not limited to:  Transfusion Medicine; Blood collection, Donor issues, Transmittable diseases, and Blood banking logistics; Immunohematology; Artificial and alternative blood based therapeutics; Hematology; Biotechnology/nanotechnology of blood related medicine; Legal aspects of blood medicine; Historical perspec-tives.",Non-OADS,/arxiv_data1/oa_pdf/0d/bf/jbm-6-285.PMC4687721.pdf
Visit http://www.dovepress.com/   testimonials.php  to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/0d/bf/jbm-6-285.PMC4687721.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/83/eb/ijn-10-7425.PMC4687722.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpInternational Journal of Nanomedicine 2015:10 7425–7441International Journal of Nanomedicine Dove press submit your manuscript | www.dovepress.co m Dove press  7425OrIg INal researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/IJN.S9381 0In vitro controlled release of cisplatin from gold- carbon nanobottles via cleavable linkages Jian li1 sia lee Y oong2 Wei Jiang goh2 Bertrand czarny1 Zhi Yang1 Kingshuk Poddar2,3 Michal M Dykas2,3 abhijeet Patra2,3 T Venkatesan2,3 T omasz Panczyk4 chengkuo lee5 giorgia Pastorin1–3 1Department of Pharmacy, National  University of singapore, 2NUs  graduate school for Integrative  sciences and engineering, centre  for life sciences (cels), 3NUsNNI- Nano core, National University of  singapore, singapore; 4Institute of  catalysis and surface chemistry,  Polish academy of sciences, cracow,  Poland; 5Department of electrical  and computer engineering, National  University of singapore, singaporeAbstract:  Carbon nanotubes’ (CNTs) hollow interior space has been explored for biomedical  applications, such as drug repository against undesirable inactivation.",Non-OADS,/arxiv_data1/oa_pdf/83/eb/ijn-10-7425.PMC4687722.pdf
"It can also be modulated by nanovalves or nanogates that are responsive to certain  environmental changes.19,23correspondence: chengkuo lee Department of electrical and computer  engineering, National University of  singapore, 4 engineering Drive 3,  singapore 117576 Tel +65 6516 5865 email elelc@nus.edu.s g  giorgia Pastorin Department of Pharmacy,  National University of singapore,  science Drive 2, s15#05-PI-03,   singapore 117543 Tel +65 6516 1876 Fax +65 6779 1554 email phapg@nus.edu.s g Journal name: International Journal of Nanomedicine Article Designation: Original Research Y ear: 2015 Volume: 10 Running head verso: Li et al Running head recto: In vitro controlled release of cisplatin from gold-carbon nanobottles DOI: http://dx.doi.org/10.2147/IJN.S93810",Non-OADS,/arxiv_data1/oa_pdf/83/eb/ijn-10-7425.PMC4687722.pdf
"International Journal of Nanomedicine Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/international-journal-of-nanomedicine-journa lThe International Journal of Nanomedicine is an international, peer- reviewed journal focusing on the application of nanotechnology   in diagnostics, therapeutics, and drug delivery systems throughout   the biomedical field.",Non-OADS,/arxiv_data1/oa_pdf/83/eb/ijn-10-7425.PMC4687722.pdf
Visit http://www.dovepress.com/ testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/83/eb/ijn-10-7425.PMC4687722.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/ad/8d/ijn-10-7413.PMC4687723.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpInternational Journal of Nanomedicine 2015:10 7413–7423International Journal of Nanomedicine Dove press submit your manuscript | www.dovepress.co m Dove press  7413OrIg INal researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/IJN.S9683 1Mechanistic study of decreased skin penetration  using a combination of sonophoresis with sodium  fluorescein-loaded PEGylated liposomes with  d-limonene Worranan rangsimawong Praneet Opanasopit Theerasak rojanarata Tanasait Ngawhirunpat Faculty of Pharmacy, Silpakorn  University, Nakhon Pathom, ThailandAbstract:  The effect of low frequency sonophoresis (SN, 20 kHz) on the skin transport of  sodium fluorescein (NaFI)-loaded liposomes was investigated.",Non-OADS,/arxiv_data1/oa_pdf/ad/8d/ijn-10-7413.PMC4687723.pdf
"It can easily be coupled with other transdermal drug delivery  techniques such as tape stripping,8 microneedle,9 electroporation,10 iontophoresis,11  and chemical enhancement to produce a synergistic effect on transdermal correspondence: Tanasait Ngawhirunpat Faculty of Pharmacy, Silpakorn University,  6 Racchamakka Nai Road, Nakhon  Pathom 73000, Thailand Fax +66 3 425 5801 email ngawhirunpat_t@su.ac.t h Journal name: International Journal of Nanomedicine Article Designation: Original Research Y ear: 2015 Volume: 10 Running head verso: Rangsimawong et al Running head recto: Mechanistic study of decreased skin penetration DOI: http://dx.doi.org/10.2147/IJN.S96831",Non-OADS,/arxiv_data1/oa_pdf/ad/8d/ijn-10-7413.PMC4687723.pdf
"International Journal of Nanomedicine Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/international-journal-of-nanomedicine-journa lThe International Journal of Nanomedicine is an international, peer- reviewed journal focusing on the application of nanotechnology   in diagnostics, therapeutics, and drug delivery systems throughout   the biomedical field.",Non-OADS,/arxiv_data1/oa_pdf/ad/8d/ijn-10-7413.PMC4687723.pdf
Visit http://www.dovepress.com/ testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/ad/8d/ijn-10-7413.PMC4687723.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/9c/24/ijn-10-7477.PMC4687724.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpInternational Journal of Nanomedicine 2015:10 7477–7490International Journal of Nanomedicine Dove press submit your manuscript | www.dovepress.co m Dove press  7477OrIg INal researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/IJN.S9157 9Novel platinum–palladium bimetallic nanoparticles  synthesized by Dioscorea bulbifera : anticancer and  antioxidant activities sougata ghosh1 rahul Nitnavare1 ankush Dewle1 geetanjali B T omar1 rohan chippalkatti1 Piyush More1 rohini Kitture2 sangeeta Kale2 Jayesh Bellare3 Balu a chopade4 1Institute of Bioinformatics and  Biotechnology, University of Pune,   2Department of applied Physics,   Defense Institute of advanced  T echnology, Pune, 3Department of  chemical engineering, Indian Institute  of T echnology Bombay, Mumbai,   4Department of Microbiology,   University of Pune, Pune, IndiaAbstract:  Medicinal plants serve as rich sources of diverse bioactive phytochemicals that  might even take part in bioreduction and stabilization of phytogenic nanoparticles with immense  therapeutic properties.",Non-OADS,/arxiv_data1/oa_pdf/9c/24/ijn-10-7477.PMC4687724.pdf
"Pt nanocubes  and nano-octahedra are recently reported to exhibit efficient catalytic activity for correspondence: Balu a chopade Vice-Chancellor’s Office, Dr Babasaheb  ambedkar Marathwada University,  Jaisingpura, aurangabad 431004, India Tel +91 20 2569 0643 Fax +91 20 2569 0087 email vc@bamu.ac.i n Journal name: International Journal of Nanomedicine Article Designation: Original Research Y ear: 2015 Volume: 10 Running head verso: Ghosh et al Running head recto: Anticancer and antioxidant Pt–PdNPs synthesized by Dioscorea bulbifera DOI: http://dx.doi.org/10.2147/IJN.S91579",Non-OADS,/arxiv_data1/oa_pdf/9c/24/ijn-10-7477.PMC4687724.pdf
"International Journal of Nanomedicine Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/international­journal­of­nanomedicine­journa lThe International Journal of Nanomedicine is an international, peer- reviewed journal focusing on the application of nanotechnology   in diagnostics, therapeutics, and drug delivery systems throughout   the biomedical field.",Non-OADS,/arxiv_data1/oa_pdf/9c/24/ijn-10-7477.PMC4687724.pdf
Visit http://www.dovepress.com/ testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/9c/24/ijn-10-7477.PMC4687724.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/46/ed/ijgm-8-373.PMC4687725.pdf
Information on  how to request permission may be found at: http://www.dovepress.com/permissions.ph pInternational Journal of General Medicine 2015:8 373–380International Journal of General Medicine Dove press submit your manuscript | www.dovepress.co m Dove press  373OrIGInal researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/IJGM.S9364 9Video abstract Point your Smar tPhone at the code abo ve.,Non-OADS,/arxiv_data1/oa_pdf/46/ed/ijgm-8-373.PMC4687725.pdf
"Or use: http://youtu.be/GyFvoojuZM oassessment of preclinical students’ academic  motivation before and after a three-day   academic affair program Myo nyein aung1 Juraiporn somboonwong2 Vorapol Jaroonvanichkul1 Pongsak Wannakrairot3 1Medical education Unit, 2Quality  Management Division and  Department of Physiology, 3academic  affairs Division, Faculty of Medicine,   chulalongkorn University, Bangkok,   Thailand correspondence: Myo nyein aung   WhO collaborating center for Medical  education, Medical education Unit,  ananda Mahidol Building, Faculty of  Medicine, chulalongkorn University,  1873 henri Dunant road, Pathumwan,  Bangkok 10330, Thailand   email dr.myonyeinaung@gmail.co mBackground:  Medical students’ motivation is an important driving factor for academic perfor - mance, and therefore medical teachers and educators are often highly interested in this topic.",Non-OADS,/arxiv_data1/oa_pdf/46/ed/ijgm-8-373.PMC4687725.pdf
Available  from: http://www.who.int/substance_abuse/research_tools/translation/ en/.,Non-OADS,/arxiv_data1/oa_pdf/46/ed/ijgm-8-373.PMC4687725.pdf
"Available from: http://www.er.uqam.ca/nobel/ r26710/LRCS/echelles_en.ht m. Accessed May 26, 2015.",Non-OADS,/arxiv_data1/oa_pdf/46/ed/ijgm-8-373.PMC4687725.pdf
"International Journal of General Medicine Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/international-journal-of-general-medicine-journa lThe International Journal of General Medicine is an international,  peer-reviewed open-access journal that focuses on general and internal  medicine, pathogenesis, epidemiology, diagnosis, monitoring and treat - ment protocols.",Non-OADS,/arxiv_data1/oa_pdf/46/ed/ijgm-8-373.PMC4687725.pdf
Visit http://www.dovepress.com/   testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/46/ed/ijgm-8-373.PMC4687725.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0/ .,Non-OADS,/arxiv_data1/oa_pdf/db/9d/ijgm-8-381.PMC4687726.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpInternational Journal of General Medicine 2015:8 381–390International Journal of General Medicine Dovepress submit your manuscript | www.dovepress.co m Dovepress 381RevIewopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/IJGM.S8685 4The why and wherefore of hepatic encephalopathy vijay PB Grover Joshua M T ognarelli Nicolas Massie Mary M e Crossey Nicola A CookSimon D Taylor-Robinson Liver Unit, Division of Diabetes,   endocrinology and Metabolism,  Department of Medicine, Imperial College London, London, UK Correspondence: Joshua M Tognarelli   Liver Unit, Division of Diabetes,  endocrinology and Metabolism, Department of Medicine, 10th Floor Queen elizabeth the Queen Mother wing, St Mary’s Hospital Campus, Imperial College London, Praed Street, London w2 1NY, UK   Tel +44 20 7886 6454   Fax +44 20 7402 2796   email jt2110@imperial.ac.ukAbstract: Hepatic encephalopathy is a common neuropsychiatric abnormality, which compli- cates the course of patients with liver disease.",Non-OADS,/arxiv_data1/oa_pdf/db/9d/ijgm-8-381.PMC4687726.pdf
"International Journal of General Medicine Publish your work in this journal Submit your manuscript here: http://www.dovepress.com/international-journal-of-general-medicine-journalThe International Journal of General Medicine is an international,  peer-reviewed open-access journal that focuses on general and internal medicine, pathogenesis, epidemiology, diagnosis, monitoring and treat-ment protocols.",Non-OADS,/arxiv_data1/oa_pdf/db/9d/ijgm-8-381.PMC4687726.pdf
Visit http://www.dovepress.com/   testimonials.php  to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/db/9d/ijgm-8-381.PMC4687726.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/2e/a7/ijn-10-7443.PMC4687727.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpInternational Journal of Nanomedicine 2015:10 7443–7454International Journal of Nanomedicine Dove press submit your manuscript | www.dovepress.co m Dove press  7443OrIg INal researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/IJN.S9100 8Therapeutic and scintigraphic applications of  polymeric micelles: combination of chemotherapy  and radiotherapy in hepatocellular carcinoma Ying-hsia shih1,2 cheng-liang Peng2 Ping-Fang chiang1,2 Wuu-Jyh lin2 Tsai-Yueh luo2,3 Ming-Jium shieh1,4 1Institute of Biomedical engineering,   National Taiwan University, Taipei,   Taiwan; 2Isotope application  Division, Institute of Nuclear  energy research, Taoyuan, Taiwan;   3Institute of radiological science,   central University, Taichung, Taiwan;   4Department of Oncology, National  Taiwan University hospital, college of  Medicine, National Taiwan University,   Taipei, TaiwanAbstract:  This study evaluated a multifunctional micelle simultaneously loaded with  doxorubicin (Dox) and labeled with radionuclide rhenium-188 (188Re) as a combined  radiotherapy and chemotherapy treatment for hepatocellular carcinoma.",Non-OADS,/arxiv_data1/oa_pdf/2e/a7/ijn-10-7443.PMC4687727.pdf
"However, clinical studies have shown its serious side effects, such as dose-dependent  cardiotoxicity and hepatotoxicity.3 Previous researches recently have revealed that  nano-sized carrier enhance the accumulation of Dox in the tumor site and decrease  the side effect.4,5 Intra-arterial administration of therapeutic radiopharmaceuticals and chemothera - peutic agents can deliver a tumoricidal dose with less non-tumorous hepatic tissue  damage.6,7 However, transcatheter arterial embolization of yttrium-90 (90Y)-mico - spheres requires accurate skill and the use of specialized equipment, and the skeletal  accumulation of 90Y could result in bone marrow depression.8correspondence: Ming-Jium shieh Institute of Biomedical engineering,  National Taiwan University, 1 Jen-ai  road, section 1, Taipei 100, Taiwan Tel +886 2 2312 3456 ext 1444 Fax +886 2 2394 0049 email soloman@ntu.edu.t w  Tsai-Yueh luo Isotope application Division, Institute of  Nuclear energy research, 1,000 Wenhua  road, Jiaan Village, longtan District,  Taoyuan 32546, Taiwan Tel +886 3 471 1400 ext 7004 Fax +886 3 471 1416 email tylo@iner.gov.t w Journal name: International Journal of Nanomedicine Article Designation: Original Research Y ear: 2015 Volume: 10 Running head verso: Shih et al Running head recto: 188Re-Dox micelles study in murine HCC model DOI: http://dx.doi.org/10.2147/IJN.S91008",Non-OADS,/arxiv_data1/oa_pdf/2e/a7/ijn-10-7443.PMC4687727.pdf
"International Journal of Nanomedicine Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/international-journal-of-nanomedicine-journa lThe International Journal of Nanomedicine is an international, peer- reviewed journal focusing on the application of nanotechnology   in diagnostics, therapeutics, and drug delivery systems throughout   the biomedical field.",Non-OADS,/arxiv_data1/oa_pdf/2e/a7/ijn-10-7443.PMC4687727.pdf
Visit http://www.dovepress.com/ testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/2e/a7/ijn-10-7443.PMC4687727.pdf
"Diabetol Metab Syndr  2012; 4: 2, http://www.dmsjournal.",Non-OADS,/arxiv_data1/oa_pdf/31/b6/10.1177_2050312113495195.PMC4687761.pdf
"The full questionnaires EQ-5D and  CROQ can be viewed online at the following websites,  respectively: 1. http://www.euroqol.org/fileadmin/user_upload/ Documenten/PDF/Products/Sample_UK__ English__EQ-5D-3L.pdf 2. http://heart.bmj.com/content/90/12/1460/suppl/DC1 Conduct of the focus groups Each participant was asked to give his or her opinion on each  of the questions in turn to ensure that everyone’s views were  captured.",Non-OADS,/arxiv_data1/oa_pdf/ab/d3/10.1177_2050312113503956.PMC4687762.pdf
"Patient Reported Outcome Measures  (PROMS) in England: a methodology for identifying poten - tial outliers, https://www.gov.uk/government/uploads/system/ uploads/attachment_data/file/216651/dh_128447.pdf (2011).",Non-OADS,/arxiv_data1/oa_pdf/ab/d3/10.1177_2050312113503956.PMC4687762.pdf
"Hos- pital Episodes Statistics , November 2011, http://www.hqip.org.",Non-OADS,/arxiv_data1/oa_pdf/ab/d3/10.1177_2050312113503956.PMC4687762.pdf
"London: Ataxia UK,  http://www.ataxia.org.uk/data/files/ataxia_guidelines_web.pdf  (accessed 12 September 2013)  2.",Non-OADS,/arxiv_data1/oa_pdf/1d/e5/10.1177_2050312113505560.PMC4687766.pdf
Avail - able at: http://www.wma.net/en/20activities/10ethics/10helsi nki/ (accessed February 2013).,Non-OADS,/arxiv_data1/oa_pdf/69/6f/10.1177_2050312113507921.PMC4687768.pdf
"Study finds much of private- sector consumer medication information not consistently useful (News release, 16 December 2008), http://www.fda.",Non-OADS,/arxiv_data1/oa_pdf/9d/ec/10.1177_2050312113490420.PMC4687769.pdf
"OECD Publishing, http://dx.doi.",Non-OADS,/arxiv_data1/oa_pdf/11/71/10.1177_2050312113510001.PMC4687771.pdf
"Inter-society  consensus for the management of peripheral arterial disease (TASC II),  http://www.jvascsurg.org (accessed October 2007).",Non-OADS,/arxiv_data1/oa_pdf/86/75/10.1177_2050312113516110.PMC4687773.pdf
"Renal  adverse reactions (ESUR Guidelines 7), http://www.esur.org/ guidelines/  (2008).",Non-OADS,/arxiv_data1/oa_pdf/86/75/10.1177_2050312113516110.PMC4687773.pdf
Available at: http://www.ghp.org.uk/login.,Non-OADS,/arxiv_data1/oa_pdf/cc/96/10.1177_2050312113502959.PMC4687774.pdf
"Making pregnancy safer: the critical role of the skilled  attendant, http://www.who.int/maternal_child_adolescent/ documents/9241591692/en/ (accessed 17 March 2013).",Non-OADS,/arxiv_data1/oa_pdf/0d/c3/10.1177_2050312113508388.PMC4687775.pdf
"The World Health Report 2005-make every mother  and child count, http://www.who.int/whr/2005/en/index.html  (accessed 4 June 2011).",Non-OADS,/arxiv_data1/oa_pdf/0d/c3/10.1177_2050312113508388.PMC4687775.pdf
"The Millennium Development Goal Report 2010, Addendum  2, http://mdgs.un.org/unsd/mdg/Resources/Static/Products/ Progress2010/2010_Addendum_Goal5.pdf  29.",Non-OADS,/arxiv_data1/oa_pdf/0d/c3/10.1177_2050312113508388.PMC4687775.pdf
"The World Bank country classification, http://data.worldbank.",Non-OADS,/arxiv_data1/oa_pdf/0d/c3/10.1177_2050312113508388.PMC4687775.pdf
"Maternal mortality country profiles, http://www.who.",Non-OADS,/arxiv_data1/oa_pdf/0d/c3/10.1177_2050312113508388.PMC4687775.pdf
"Nanomedicine, 2006, http://nihroadmap.nih.gov/nanomedicine/  4.",OADS,/arxiv_data1/oa_pdf/8f/b8/10.1177_2050312113513759.PMC4687778.pdf
"Nanotechnology in medical applications: the  global market, 2010, http://www.bccresearch.com/market- research/healthcare/nanotechnology-medical-applications- hlc069a.html  5.",Non-OADS,/arxiv_data1/oa_pdf/8f/b8/10.1177_2050312113513759.PMC4687778.pdf
"3rd ed.,  2006, https://www.idf.org/sites/default/files/Diabetes%20 Atlas%203rd%20edition.pdf  2.",Non-OADS,/arxiv_data1/oa_pdf/22/a3/10.1177_2050312113508390.PMC4687781.pdf
"5th ed.,  2009, http://www.idf.org/diabetesatlas/5e/the-globalburden  8.",Non-OADS,/arxiv_data1/oa_pdf/22/a3/10.1177_2050312113508390.PMC4687781.pdf
http://www.cdc.gov/pcd/issues/2008/jul/07_0086.htm  10.,Non-OADS,/arxiv_data1/oa_pdf/22/a3/10.1177_2050312113508390.PMC4687781.pdf
"Muscat Daily , http://www.muscatdaily.com (2003  accessed 20 August 2013).",Non-OADS,/arxiv_data1/oa_pdf/22/a3/10.1177_2050312113508390.PMC4687781.pdf
"Expert paper  no 2011/3, http://www.un.org/esa/population/publications/ expertpapers/2011-3-shetty.pdf  16.",Non-OADS,/arxiv_data1/oa_pdf/22/a3/10.1177_2050312113508390.PMC4687781.pdf
"Global guideline for type  2 diabetes, 2010, http://www.idf.org/webdata/docs/IDF%20 GGT2D.pdf  64.",Non-OADS,/arxiv_data1/oa_pdf/22/a3/10.1177_2050312113508390.PMC4687781.pdf
"ESRD patients in 2011: a global per - spective, http://www.vision-fmc.com/files/download/ESRD/ ESRD_Patients (accessed 6 June 2012).",Non-OADS,/arxiv_data1/oa_pdf/37/f3/10.1177_2050312113516111.PMC4687783.pdf
"National Kidney Center, Health Care Foundation—Nepal,  http://www.hecaf.org/hecaf+nkc.html  (accessed 4 June 2012).",Non-OADS,/arxiv_data1/oa_pdf/37/f3/10.1177_2050312113516111.PMC4687783.pdf
"Reality  sandwich, http://www.realitysandwich.com/how_shipibo_ healers_treated_my_brain_tumor (2009, accessed 1 March  2013).",Non-OADS,/arxiv_data1/oa_pdf/3b/5e/10.1177_2050312113508389.PMC4687784.pdf
"For reprints and permission queries, plea se visit SAGE’s Web site at http://www.sagepub.com/journalsPermissions.nav.",Non-OADS,/arxiv_data1/oa_pdf/ad/8b/10.1177_2325967115613988.PMC4687830.pdf
http://www.seniam.org.,Non-OADS,/arxiv_data1/oa_pdf/ad/8b/10.1177_2325967115613988.PMC4687830.pdf
"For reprints and permission queries, plea se visit SAGE’s Web site at http://www.sagepub.com/journalsPermissions.nav.",Non-OADS,/arxiv_data1/oa_pdf/fe/43/10.1177_2325967115618914.PMC4687831.pdf
2012. http://www.cebm.net/oxford-centre-evidence-based-medicine- levels-evidence-march-2009/.,Non-OADS,/arxiv_data1/oa_pdf/fe/43/10.1177_2325967115618914.PMC4687831.pdf
The University of York Center for Reviews and Dissemination Iprosr-v. http://www.crd.york.ac.uk/PROSPERO/.,Non-OADS,/arxiv_data1/oa_pdf/fe/43/10.1177_2325967115618914.PMC4687831.pdf
"For reprints and permission queries, plea se visit SAGE’s Web site at http://www.sagepub.com/journalsPermissions.nav.",Non-OADS,/arxiv_data1/oa_pdf/6d/c6/10.1177_2325967115612416.PMC4687832.pdf
Data Collection Data were obtained from official event records that are in the public domain and freely accessible from the Nevada Athletic Commission website (http://boxing.nv.gov/).,OADS,/arxiv_data1/oa_pdf/6d/c6/10.1177_2325967115612416.PMC4687832.pdf
"For reprints and permission queries, plea se visit SAGE’s Web site at http://www.sagepub.com/journalsPermissions.nav.",Non-OADS,/arxiv_data1/oa_pdf/ff/91/10.1177_2325967115616783.PMC4687833.pdf
"For reprints and permission queries, plea se visit SAGE’s Web site at http://www.sagepub.com/journalsPermissions.nav.",Non-OADS,/arxiv_data1/oa_pdf/e3/bb/10.1177_2325967115617728.PMC4687834.pdf
"For reprints and permission queries, plea se visit SAGE’s Web site at http://www.sagepub.com/journalsPermissions.nav.",Non-OADS,/arxiv_data1/oa_pdf/b4/a0/10.1177_2325967115616582.PMC4687835.pdf
http://m.mlb.com/pitchsmart/.,Non-OADS,/arxiv_data1/oa_pdf/b4/a0/10.1177_2325967115616582.PMC4687835.pdf
http://www.ncaapublications.com/productdownloads/ PR2014.pdf.,Non-OADS,/arxiv_data1/oa_pdf/b4/a0/10.1177_2325967115616582.PMC4687835.pdf
http://www.esrl.noaa.gov/psd/data/usclimate/ tmp.state.19712000.climo.,OADS,/arxiv_data1/oa_pdf/b4/a0/10.1177_2325967115616582.PMC4687835.pdf
USA Baseball Medical and Safety Advisory Committee guidelines: May 2006. http://www.massgeneral.org/ortho/services/sports/pdfs/ usa-baseball-medical-position-statement.pdf.,Non-OADS,/arxiv_data1/oa_pdf/b4/a0/10.1177_2325967115616582.PMC4687835.pdf
"For reprints and permission queries, plea se visit SAGE’s Web site at http://www.sagepub.com/journalsPermissions.nav.",Non-OADS,/arxiv_data1/oa_pdf/47/0d/10.1177_2325967115616581.PMC4687836.pdf
"For reprints and permission queries, plea se visit SAGE’s Web site at http://www.sagepub.com/journalsPermissions.nav.",Non-OADS,/arxiv_data1/oa_pdf/d3/9d/10.1177_2325967115620770.PMC4687837.pdf
"For reprints and permission queries, plea se visit SAGE’s Web site at http://www.sagepub.com/journalsPermissions.nav.",Non-OADS,/arxiv_data1/oa_pdf/6f/38/10.1177_2325967115620365.PMC4687838.pdf
"Spe- cifically, data on concussion in the NFL were obtained from the Public Broadcasting Service (PBS) FRONTLINE Con- cussion Watch (http://www.pbs.org/wgbh/pages/frontline/ sports/concussion-watch/ about-concussion-watch/),22-24 and variables for styles of play, along with performance measures, by the NFL teams described below were obtained from Pro-Football-Reference.com28,29,32and NFL.com.16-18 Numbers of concussions reported during these 3 seasons were stratified by each team and each position.",OADS,/arxiv_data1/oa_pdf/6f/38/10.1177_2325967115620365.PMC4687838.pdf
http://www.nfl.com/news/story/0ap 1000000235494/article/nfl-explayers-agree-to-765m-settlement-in- concussions-suit.,Non-OADS,/arxiv_data1/oa_pdf/6f/38/10.1177_2325967115620365.PMC4687838.pdf
http://www.nfl.com/stats/ team?seasonId ¼2012&seasonType ¼PRE.,Non-OADS,/arxiv_data1/oa_pdf/6f/38/10.1177_2325967115620365.PMC4687838.pdf
http://www.nfl.com/stats/ team?seasonId ¼2013&seasonType ¼PRE.,Non-OADS,/arxiv_data1/oa_pdf/6f/38/10.1177_2325967115620365.PMC4687838.pdf
http://www.nfl.com/stats/ team?seasonId ¼2014&seasonType ¼PRE.,Non-OADS,/arxiv_data1/oa_pdf/6f/38/10.1177_2325967115620365.PMC4687838.pdf
http://www.pbs.org/wgbh/pages/frontline/ concussion-watch/#positions_2012.,Non-OADS,/arxiv_data1/oa_pdf/6f/38/10.1177_2325967115620365.PMC4687838.pdf
http://www.pbs.org/wgbh/pages/frontline/ concussion-watch/#positions_2013.,Non-OADS,/arxiv_data1/oa_pdf/6f/38/10.1177_2325967115620365.PMC4687838.pdf
http://www.pbs.org/wgbh/pages/frontline/ concussion-watch/#positions_2014.,Non-OADS,/arxiv_data1/oa_pdf/6f/38/10.1177_2325967115620365.PMC4687838.pdf
http://www.pro-football-reference.com/years/2012/.,Non-OADS,/arxiv_data1/oa_pdf/6f/38/10.1177_2325967115620365.PMC4687838.pdf
http://www.pro-football-r eference.com/years/2013/.,Non-OADS,/arxiv_data1/oa_pdf/6f/38/10.1177_2325967115620365.PMC4687838.pdf
http://www.pro- football-reference.com/teams/chi/2014.htm.,Non-OADS,/arxiv_data1/oa_pdf/6f/38/10.1177_2325967115620365.PMC4687838.pdf
http://www.pro-football-reference.com/years/2014/.,Non-OADS,/arxiv_data1/oa_pdf/6f/38/10.1177_2325967115620365.PMC4687838.pdf
http://www.pro-football-reference.com/about/glossary.htm.,Non-OADS,/arxiv_data1/oa_pdf/6f/38/10.1177_2325967115620365.PMC4687838.pdf
http://www.sports- reference.com/blog/2012/03/features-expected-points/.,Non-OADS,/arxiv_data1/oa_pdf/6f/38/10.1177_2325967115620365.PMC4687838.pdf
http://www.sports-reference.com/ blog/2013/07/p-f-r-help-wanted-help -us-identify-hist orical-teams- offensive-defensive-schemes/.,Non-OADS,/arxiv_data1/oa_pdf/6f/38/10.1177_2325967115620365.PMC4687838.pdf
The relatively profound differences in injury risk estimation accuracy and their potential implications for risk screening suggest the need for additional training and outreach (see http://www.ACL-IQ.org).,Non-OADS,/arxiv_data1/oa_pdf/52/79/10.1177_2325967115614799.PMC4687839.pdf
"For reprints and permission queries, plea se visit SAGE’s Web site at http://www.sagepub.com/journalsPermissions.nav.",Non-OADS,/arxiv_data1/oa_pdf/52/79/10.1177_2325967115614799.PMC4687839.pdf
"Building on this work, Petushek and colleagues23devel- oped and validated a brief test of ACL injury risk estima- tion skill: the ACL Injury Risk Estimation Quiz (ACL-IQ; http://www.ACL-IQ.org).",Non-OADS,/arxiv_data1/oa_pdf/52/79/10.1177_2325967115614799.PMC4687839.pdf
"Procedures Participants completed the web-based, 5-item ACL-IQ (see http://www.ACL-IQ.org and Petushek et al23for develop- ment, reliability, and validation).",OADS,/arxiv_data1/oa_pdf/52/79/10.1177_2325967115614799.PMC4687839.pdf
"Individuals can assess their ACL injury risk prediction ability with a short, free, and online (http://www.ACL-IQ.org) tool.",Non-OADS,/arxiv_data1/oa_pdf/52/79/10.1177_2325967115614799.PMC4687839.pdf
"6 © Ekihiro Seki *Correspondence to: Ekihiro Seki; Email: ekseki@ucsd.eduSubmitted: 08/19/2014; Revised: 08/20/2014; Accepted: 08/20/2014 http://dx.doi.org/10.4161/23723548.2014.968507 This is an Open Access article distributed under the terms of the Creative Commons Attribution-Non-Commercial License (http://creativecommons.o rg/licenses/ by-nc/3.0/), which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/2c/43/kmco-01-04-968507.PMC4687902.pdf
J Gastroenterol 2014; 49:185- 194; PMID:24443058; http://dx.doi.org/10.1007/s00535-013-0931-x 2.,Non-OADS,/arxiv_data1/oa_pdf/2c/43/kmco-01-04-968507.PMC4687902.pdf
Cancer Cell 2010; 17:481-496; PMID:20478530; http://dx.doi.org/10.1016/j.ccr.2010.03.0214.,Non-OADS,/arxiv_data1/oa_pdf/2c/43/kmco-01-04-968507.PMC4687902.pdf
EMBO J 2009; 28:677-685; PMID:19197243; http://dx.doi.org/10.1038/emboj.2009.8 5.,Non-OADS,/arxiv_data1/oa_pdf/2c/43/kmco-01-04-968507.PMC4687902.pdf
J Clin Invest2014; 124:3566-3578; PMID:24983318; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/2c/43/kmco-01-04-968507.PMC4687902.pdf
EMBO J 2010;29:619-631; PMID:19959994; http://dx.doi.org/10.1038/emboj.2009.364 8.,Non-OADS,/arxiv_data1/oa_pdf/2c/43/kmco-01-04-968507.PMC4687902.pdf
Nature 2010;468:1100- 1104; PMID:21179166; http://dx.doi.org/10.1038/ nature09584 9.,Non-OADS,/arxiv_data1/oa_pdf/2c/43/kmco-01-04-968507.PMC4687902.pdf
Mol Cell 2013;51:618-631; PMID:24011591; http://dx.doi.org/ 10.1016/j.molcel.2013.08.003 www.landesbioscience.com e968507-3 Molecular & Cellular Oncology,OADS,/arxiv_data1/oa_pdf/2c/43/kmco-01-04-968507.PMC4687902.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/98/56/tcrm-11-1853.PMC4687952.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpTherapeutics and Clinical Risk Management 2015:11 1853–1861Therapeutics and Clinical Risk Management Dove press submit your manuscript | www.dovepress.co m Dove press  1853ORiginal ReseaRChopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/TCRM.S9401 0USP18  downregulation in peripheral blood  mononuclear cells predicts nonresponse to  interferon-based triple therapy in patients with  chronic hepatitis C, genotype 1: a pilot study sona Frankova1 Milan Jirsa2 Dusan Merta3 Magdalena neroldova2 Petr Urbanek4 Renata senkerikova1 Julius spicak1 Jan sperl1 1Department of hepatogastroenterology,  2laboratory of experimental  hepatology, 3Department of  anesthesiology, Resuscitation  and intensive Care, institute for  Clinical and experimental Medicine,   4Department of internal Medicine,   Central Military hospital, First  Medical school, Prague, Czech  RepublicBackground and aims:  Patients with advanced liver fibrosis owing to chronic hepatitis C virus  genotype 1 represent a difficult-to-treat group even if a protease inhibitor is added to pegylated  interferon alpha and ribavirin.",Non-OADS,/arxiv_data1/oa_pdf/98/56/tcrm-11-1853.PMC4687952.pdf
"In the last 4 years, new direct-acting antivirals  (DAAs), inhibiting directly the viral enzymes crucial for its replication, have entered  into clinical practice, together with pegylated interferon alpha and RBV (P/R) or in Correspondence: Jan sperl Department of hepatogastroenterology,  institute for Clinical and experimental  Medicine, Videnska 1958/9, 140 21  Prague 4, Czech Republic Tel +420 261 364 003 Fax +420 261 362 602 email jan.sperl@ikem.c z Journal name: Therapeutics and Clinical Risk Management Article Designation: Original Research Y ear: 2015 Volume: 11 Running head verso: Frankova et al Running head recto: USP18  expression as a predictor of treatment outcome in HCV DOI: http://dx.doi.org/10.2147/TCRM.S94010",Non-OADS,/arxiv_data1/oa_pdf/98/56/tcrm-11-1853.PMC4687952.pdf
"Therapeutics and Clinical Risk Management Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/therapeutics-and-clinical-risk-management-journa lTherapeutics and Clinical Risk Management is an international, peer- reviewed journal of clinical therapeutics and risk management, focusing  on concise rapid reporting of clinical studies in all therapeutic areas,  outcomes, safety, and programs for the effective, safe, and sustained  use of medicines.",Non-OADS,/arxiv_data1/oa_pdf/98/56/tcrm-11-1853.PMC4687952.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/98/56/tcrm-11-1853.PMC4687952.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/8b/9a/tcrm-11-1837.PMC4687953.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).Therapeutics and Clinical Risk Management 2015:11 1837–1842Therapeutics and Clinical Risk Management Dove press submit your manuscript | www.dovepress.co m Dove press  1837ORiginal ReseaRChopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/TCRM.S9216 9enema reduction of intussusception: the success  rate of hydrostatic and pneumatic reduction Jiraporn Khorana1 Jesda singhavejsakul1 nuthapong Ukarapol2 Mongkol laohapensang3 Junsujee Wakhanrittee4 Jayanton Patumanond5 1Division of Pediatric surgery,   Department of surgery, 2Division  of gastroenterology, Department  of Pediatrics, Chiang Mai University  hospital, Chiang Mai, 3Division of  Pediatric surgery, Department of  surgery, siriraj hospital, Mahidol  University, Bangkok, 4Division of  Pediatric surgery, Department of  surgery, Thammasat University  hospital, 5Center of excellence in  applied epidemiology, Thammasat  University hospital, Pathumthani,   ThailandPurpose:  Intussusception is a common surgical emergency in infants and children.",Non-OADS,/arxiv_data1/oa_pdf/8b/9a/tcrm-11-1837.PMC4687953.pdf
"The level 2 diagnostic certainty is  the clinical criteria which include two major criteria or one major with three minor Correspondence: Jiraporn Khorana Division of Pediatric surgery, Department  of surgery, Chiang Mai University  hospital, Chiang Mai, Thailand Tel +66 8 1992 9767 email nanji22@gmail.co m Journal name: Therapeutics and Clinical Risk Management Article Designation: Original Research Y ear: 2015 Volume: 11 Running head verso: Khorana et al Running head recto: Enema reduction of intussusception DOI: http://dx.doi.org/10.2147/TCRM.S92169",Non-OADS,/arxiv_data1/oa_pdf/8b/9a/tcrm-11-1837.PMC4687953.pdf
"Therapeutics and Clinical Risk Management Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/therapeutics­and­clinical­risk­management­journa lTherapeutics and Clinical Risk Management is an international, peer- reviewed journal of clinical therapeutics and risk management, focusing  on concise rapid reporting of clinical studies in all therapeutic areas,  outcomes, safety, and programs for the effective, safe, and sustained  use of medicines.",Non-OADS,/arxiv_data1/oa_pdf/8b/9a/tcrm-11-1837.PMC4687953.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/8b/9a/tcrm-11-1837.PMC4687953.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/a8/c3/tcrm-11-1843.PMC4687954.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).Therapeutics and Clinical Risk Management 2015:11 1843–1852Therapeutics and Clinical Risk Management Dove press submit your manuscript | www.dovepress.co m Dove press  1843ORiginal ReseaRChopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/TCRM.S9153 2are atrophic long-bone nonunions associated  with low-grade infections?",Non-OADS,/arxiv_data1/oa_pdf/a8/c3/tcrm-11-1843.PMC4687954.pdf
uni-heidelberg.d eJournal name: Therapeutics and Clinical Risk Management Article Designation: Original Research Y ear: 2015 Volume: 11 Running head verso: Dapunt et al Running head recto: Bacterial infection and atrophic nonunions DOI: http://dx.doi.org/10.2147/TCRM.S91532,Non-OADS,/arxiv_data1/oa_pdf/a8/c3/tcrm-11-1843.PMC4687954.pdf
"Therapeutics and Clinical Risk Management Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/therapeutics-and-clinical-risk-management-journa lTherapeutics and Clinical Risk Management is an international, peer- reviewed journal of clinical therapeutics and risk management, focusing  on concise rapid reporting of clinical studies in all therapeutic areas,  outcomes, safety, and programs for the effective, safe, and sustained  use of medicines.",Non-OADS,/arxiv_data1/oa_pdf/a8/c3/tcrm-11-1843.PMC4687954.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/a8/c3/tcrm-11-1843.PMC4687954.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/7f/b9/rmhp-8-225.PMC4687955.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.ph pRisk Management and Healthcare Policy 2015:8 225–233Risk Management and Healthcare Policy Dove press submit your manuscript | www.dovepress.co m Dove press  225Reviewopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/RMHP .S6209 1Female genital mutilation/cutting: risk management  and strategies for social workers and health care  professionals Susan Costello School of Global, Urban and Social  Studies, RM iT University, Melbourne,   viC, Australia Correspondence: Susan Costello   School of Global, Urban and Social  Studies, RMiT University, 360 Swanston  Street, Melbourne 3001, viC, Australia   email susan.costello@rmit.edu.a uAbstract:  Female genital mutilation/cutting (FGM/C) is a traditional practice originating  in Africa.",Non-OADS,/arxiv_data1/oa_pdf/7f/b9/rmhp-8-225.PMC4687955.pdf
"Available from: http://www.fpv.org.au/fg c. Accessed  February 8, 2014.",Non-OADS,/arxiv_data1/oa_pdf/7f/b9/rmhp-8-225.PMC4687955.pdf
Available from: http://www.who.int/reproductivehealth/publications/ fgm/9789241596442/en /.,Non-OADS,/arxiv_data1/oa_pdf/7f/b9/rmhp-8-225.PMC4687955.pdf
Available from: http://www.who.,Non-OADS,/arxiv_data1/oa_pdf/7f/b9/rmhp-8-225.PMC4687955.pdf
Available from: https://www.academia.edu/8817976/ Female_   genital_mutilation_FGM_and_male_circumcision :_Should_there_ be_a_ separate_ ethical_discours e?,Non-OADS,/arxiv_data1/oa_pdf/7f/b9/rmhp-8-225.PMC4687955.pdf
"Available from: http://www.unicef-irc.org/ publications/pdf/fgm_eng.pd f. Accessed July 24, 2013.",Non-OADS,/arxiv_data1/oa_pdf/7f/b9/rmhp-8-225.PMC4687955.pdf
Available from: http://eige.europa.eu/sites/ default/files/EIGE-Report-FGM-in-the-EU-and-Croatia.pdf.,Non-OADS,/arxiv_data1/oa_pdf/7f/b9/rmhp-8-225.PMC4687955.pdf
"Risk Management and Healthcare Policy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/risk-management-and-healthcare-policy-journa lRisk Management and Healthcare Policy is an international, peer- reviewed, open access journal focusing on all aspects of public health,  policy, and preventative measures to promote good health and improve  morbidity and mortality in the population.",Non-OADS,/arxiv_data1/oa_pdf/7f/b9/rmhp-8-225.PMC4687955.pdf
Visit http://www.dovepress.com/   testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/7f/b9/rmhp-8-225.PMC4687955.pdf
"A vailable  from: http://www.iom.int/jahia/webdav/shared/shared/m ainsit e/projects/ documents/fgm_infosheet.pd f. Accessed July 20, 2013.",Non-OADS,/arxiv_data1/oa_pdf/7f/b9/rmhp-8-225.PMC4687955.pdf
"Available from: http://openaccess.city.ac.uk/12382 /  Accessed October 8, 2015.",Non-OADS,/arxiv_data1/oa_pdf/7f/b9/rmhp-8-225.PMC4687955.pdf
Available  from: http://mobile.abc.net.au/news/2015-01-20/uk-holds-first-trial- over-female-genital-mutilation/602680 8.,Non-OADS,/arxiv_data1/oa_pdf/7f/b9/rmhp-8-225.PMC4687955.pdf
"Available from: http://www.un.org/popin/icpd/ conference/offeng/poa.htm l. Accessed June 29, 2015.",Non-OADS,/arxiv_data1/oa_pdf/7f/b9/rmhp-8-225.PMC4687955.pdf
"Available from:  http://www.serc.mb.ca/sites/default/files/resources/ Our_Se lves_Our_ Daughters_Engagement_Consultations_Report_2009.pd f. Accessed  October 12, 2013.",Non-OADS,/arxiv_data1/oa_pdf/7f/b9/rmhp-8-225.PMC4687955.pdf
Available from: http://www.health.,Non-OADS,/arxiv_data1/oa_pdf/7f/b9/rmhp-8-225.PMC4687955.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/24/e5/jmdh-8-535.PMC4687956.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.ph pJournal of Multidisciplinary Healthcare 2015:8 535–545Journal of Multidisciplinary Healthcare Dove press submit your manuscript | www.dovepress.co m Dove press  535Original researcHopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/JMDH.S9074 4riding a roller coaster: narrative typologies   of patients with neuroendocrine tumors alessia Miconi1 Daniele De nuzzo1 solfrid Vatne2 Paola Pierantognetti1 1Faculty of Medicine and Psychology,   sapienza Università di roma, rome,   italy; 2Molde University college,   Molde, norway correspondence: solfrid Vatne   Molde University college, PO Box 2110,  nO-6402 Molde, norway   Tel +47 9051 5649   email solfrid.vatne@himolde.n oBackground and objective:  Illness stories have attracted growing attention in health care  research in the context of learning from looking at the world through the patients’ eyes.",Non-OADS,/arxiv_data1/oa_pdf/24/e5/jmdh-8-535.PMC4687956.pdf
"Journal of Multidisciplinary Healthcare Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/journal-of-multidisciplinary-healthcare-journa lThe Journal of Multidisciplinary Healthcare is an international, peer- reviewed open-access journal that aims to represent and publish research  in healthcare areas delivered by practitioners of different disciplines.",Non-OADS,/arxiv_data1/oa_pdf/24/e5/jmdh-8-535.PMC4687956.pdf
Visit http://www.dove - press.com/testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/24/e5/jmdh-8-535.PMC4687956.pdf
The full terms of this license are available at https://www.dovepress.com/terms.,Non-OADS,/arxiv_data1/oa_pdf/5a/31/jpr-8-879.PMC4687958.pdf
"php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/ ).",OADS,/arxiv_data1/oa_pdf/5a/31/jpr-8-879.PMC4687958.pdf
"For  permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php ).Journal of Pain Research 2015:8 879–884Journal of Pain Research Dovepress submit your manuscript | www.dovepress.co m Dovepress 879ORiginal ReseaRchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/JPR.S9662 5Voluntary warnings and the limits of good  prescribing behavior: the case for de-adoption   of meperidine Kevin J Friesen Jamie Falk shawn Bugden college of Pharmacy, Faculty of  health sciences, University of  Manitoba, Winnipeg, MB, canada correspondence: shawn Bugden   college of Pharmacy, Faculty of health  sciences, University of Manitoba,   750 McDermot avenue, Winnipeg,   MB R3e 0T5, canada   Tel +1 204 803 9093   Fax +1 877 776 8332   email shawn.bugden@umanitoba.c aBackground: Meperidine (pethidine) offers little to no therapeutic advantage over other opioids,  may be more prone to abuse, and produces a neurotoxic metabolite with a long half-life.",Non-OADS,/arxiv_data1/oa_pdf/5a/31/jpr-8-879.PMC4687958.pdf
"Journal of Pain Research Publish your work in this journal Submit your manuscript here: http://www.dovepress.com/journal-of-pain-research-journalThe Journal of Pain Research is an international, peer-reviewed, open  access, online journal that welcomes laboratory and clinical findings in the fields of pain research and the prevention and management of pain.",Non-OADS,/arxiv_data1/oa_pdf/5a/31/jpr-8-879.PMC4687958.pdf
Visit http://www.dovepress.com/testimonials.php to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/5a/31/jpr-8-879.PMC4687958.pdf
ISMP Canada Safety Bulletin – Meperidine (Demerol ®): Issues in  Medication Safety; 2004. http://www.ismp-canada.org/download/safetyBulletins/ISMPCSB2004-08.pdf.,Non-OADS,/arxiv_data1/oa_pdf/5a/31/jpr-8-879.PMC4687958.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/fe/77/prbm-8-287.PMC4687981.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.ph pPsychology Research and Behavior Management 2015:8 287–294Psychology Research and Behavior Management Dove press submit your manuscript | www.dovepress.co m Dove press  287O R I G I N A L  R E S E A R C H open access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/PRBM.S9664 7Measuring workplace trauma response in Australian  paramedics: an investigation into the psychometric  properties of the Impact of Event Scale Nicola Hogan1 Shane Costello1 Malcolm Boyle2 Brett Williams2 1Faculty of Education, Monash  University, Clayton, VIC, Australia;   2Department of Community  Emergency Health and Paramedic  Practice, Monash University,   Frankston, VIC, Australia Correspondence: Brett Williams   Department of Community Emergency  Health and Paramedic Practice, Monash  University, Peninsula Campus,   PO Box 527, McMahons Road,   Frankston, VIC 3199, Australia   Tel +61 3 9904 4283   Fax +61 3 9904 4168   Email brett.williams@monash.ed uIntroduction:  Investigation into the psychological effects of violence toward health care work - ers and its associated trauma is increasing.",Non-OADS,/arxiv_data1/oa_pdf/fe/77/prbm-8-287.PMC4687981.pdf
"Psychology Research and Behavior Management Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/psychology-research-and-behavior-management-journa lPsychology Research and Behavior Management is an international, peer- reviewed, open access journal focusing on the science of psychology and  its application in behavior management to develop improved outcomes  in the clinical, educational, sports and business arenas.",Non-OADS,/arxiv_data1/oa_pdf/fe/77/prbm-8-287.PMC4687981.pdf
Visit http://www.dovepress.,Non-OADS,/arxiv_data1/oa_pdf/fe/77/prbm-8-287.PMC4687981.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.php  and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/).",Non-OADS,/arxiv_data1/oa_pdf/35/2b/jpr-8-885.PMC4687984.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php).Journal of Pain Research 2015:8 885–887Journal of Pain Research Dove press submit your manuscript | www.dovepress.co m Dove press  885Edito Rialopen access to scientific and medical research open access Full text article http: //dx.doi.org/10.2147/JPR.S10209 0the american chronic pain crisis and the media:  about time to get it right?",Non-OADS,/arxiv_data1/oa_pdf/35/2b/jpr-8-885.PMC4687984.pdf
Available from: http://www.wsj.com/articles/new-help-for-back- pain- 1448311243?,Non-OADS,/arxiv_data1/oa_pdf/35/2b/jpr-8-885.PMC4687984.pdf
"Journal of Pain Research Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/journal-of-pain-research-journa lThe Journal of Pain Research is an international, peer-reviewed, open  access, online journal that welcomes laboratory and clinical findings  in the fields of pain research and the prevention and management  of pain.",Non-OADS,/arxiv_data1/oa_pdf/35/2b/jpr-8-885.PMC4687984.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/35/2b/jpr-8-885.PMC4687984.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/b1/96/lra-8-119.PMC4687985.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.ph pLocal and Regional Anesthesia 2015:8 119–122Local and Regional Anesthesia Dove press submit your manuscript | www.dovepress.co m Dove press  119ORiginAL  ReseARchopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/LRA.S9532 9effect of a combined continuous and intermittent  transcutaneous electrical nerve stimulation on  pain perception of burn patients evaluated by  visual analog scale: a pilot study irma Pérez-Ruvalcaba1 Viridiana sánchez- hernández1 Arieh R Mercado-sesma2,3 1Burn Unit, hospital de especialidades,   centro Médico nacional de  Occidente, Mexican institute of  social security,  2health sciences  Department, centro Universitario  de T onalá, University of guadalajara,   guadalajara, Mexico;  3Diabetes sin  complicaciones, Zapopan, Mexico correspondence: Arieh R Mercado- sesma   Diabetes sin complicaciones,   Avenida nicolás copérnico  3730,  colonia Arboledas, Zapopan,   Jalisco,  45070, Mexico   Tel +52 33 3631 7250  email roldan_mercado@hotmail.co mAim:  The aim of this study was to assess the effect of continuous and intermittent electrical  transcutaneous nerve stimulation on the perception of pain in patients with burns of different  types.",Non-OADS,/arxiv_data1/oa_pdf/b1/96/lra-8-119.PMC4687985.pdf
"Local and Regional Anesthesia Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/local-and-regional-anesthesia-journa lLocal and Regional Anesthesia is an international, peer-reviewed,  open access journal publishing on the development, pharmacology,  delivery and targeting and clinical use of local and regional anesthet - ics and analgesics.",Non-OADS,/arxiv_data1/oa_pdf/b1/96/lra-8-119.PMC4687985.pdf
Visit http://www.dovepress.com/testimonials.ph p to read real  quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/b1/96/lra-8-119.PMC4687985.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/99/43/lra-8-129.PMC4687986.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.ph pLocal and Regional Anesthesia 2015:8 129–134Local and Regional Anesthesia Dove press submit your manuscript | www.dovepress.co m Dove press  129ORiginAL  ReseARchopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/LRA.S9199 1A retrospective study to correlate breech  presentation and enhanced risk of postspinal  hypotension during cesarean delivery Anshul Jain1 shivali Pandey1 Roopesh Kumar1 chavi sethi1 sanjya sharma2 1Department of Anaesthesiology,   2Department of gynecology and  Obstetrics, Maharani Laxmi Bai  Medical college, Jhansi, india correspondence: shivali Pandey   Department of Anaesthesiology,   Maharani Laxmi Bai Medical college,  Kanpur Road, Jhansi, 284128, india   Tel +91 510 232 0143   Fax +91 510 232 0858   email dr.shivalipandey22@gmail.co mBackground:  Subarachnoid blockade for cesarean section still poses a threat of profound  hypotension and can result in uns table  maternal and fetal hemodynamics.",Non-OADS,/arxiv_data1/oa_pdf/99/43/lra-8-129.PMC4687986.pdf
"Local and Regional Anesthesia Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/local-and-regional-anesthesia-journa lLocal and Regional Anesthesia is an international, peer-reviewed,  open access journal publishing on the development, pharmacology,  delivery and targeting and clinical use of local and regional anesthet - ics and analgesics.",Non-OADS,/arxiv_data1/oa_pdf/99/43/lra-8-129.PMC4687986.pdf
Visit http://www.dovepress.com/testimonials.ph p to read real  quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/99/43/lra-8-129.PMC4687986.pdf
"Accession Numbers 5ECG Baldock et al., 2015, Cell Reports 13, 2081–2089 December 15, 2015 ª2015 The Authors http://dx.doi.org/10.1016/j.celrep.2015.10.074",OADS,/arxiv_data1/oa_pdf/40/fd/main.PMC4688034.pdf
http://dx.doi.org/10.1016/j.celrep.2015.10.074 This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/40/fd/main.PMC4688034.pdf
"SUPPLEMENTAL INFORMATION Supplemental Information includes Supplemental Experimental Procedures, four ﬁgures, one table, and three movies and can be found with this articleonline at http://dx.doi.org/10.1016/j.celrep.2015.10.074 .",Non-OADS,/arxiv_data1/oa_pdf/40/fd/main.PMC4688034.pdf
"Key Words : Degenerative disc disease · Total disc displacement · Lumbar spine · Outcome · Complications.Review Article • Received : June 8, 2015  • Revised : August 11, 2015  • Accepted : August 12, 2015 • Address for reprints : Chun Kun Park, M.D., Ph.D.  Good Doctor Teun Teun Hospital, 775 Gyeongsu-daero, Dongan-gu, Anyang 14041, Korea  Tel : +82-31-8086-8357,  Fax : +82-31-429-6712,  E-mail : ckpmd@catholic.ac.kr • This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0 )     which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.J Korean Neurosurg Soc 58  (5) : 401-411, 2015http://dx.doi.org/10.3340/jkns.2015.58.5.401 Copyright © 2015 The Korean Neurosurgical Society  Print ISSN 2005-3711  On-line ISSN 1598-7876 www.jkns.or.kr",Non-OADS,/arxiv_data1/oa_pdf/38/63/jkns-58-401.PMC4688308.pdf
"Key Words : Dynamic stabilization · Implant rigidity · Axial loading · Spinal kinematics · Cadaveric study · Robotic testing.Laboratory Investigation • Received : October 17, 2014  • Revised : May 2, 2015  • Accepted : July 3, 2015 • Address for reprints : Dosang Cho, M.D., Ph.D.  Department of Neurosurgery, Ewha Womans University College of Medicine, 1071 Anyangcheon-ro, Yangcheon-gu, Seoul 07985, Korea  Tel : +82-2-2650-2651,  Fax : +82-2-2650-2652,  E-mail : drcho@ewha.ac.kr • This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0 )     which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.J Korean Neurosurg Soc 58  (5) : 412-418, 2015http://dx.doi.org/10.3340/jkns.2015.58.5.412 Copyright © 2015 The Korean Neurosurgical Society  Print ISSN 2005-3711  On-line ISSN 1598-7876 www.jkns.or.kr",Non-OADS,/arxiv_data1/oa_pdf/ab/ec/jkns-58-412.PMC4688309.pdf
"Department of Neurosurgery, Keimyung University School of Medicine, 56 Dalseong-ro, Jung-gu, Daegu 41931, Korea  Tel : +82-53-250-7730,  Fax : +82-53-250-7356,  E-mail : ppori2k@naver.com • This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0 )     which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.J Korean Neurosurg Soc 58  (5) : 419-425, 2015http://dx.doi.org/10.3340/jkns.2015.58.5.419 Copyright © 2015 The Korean Neurosurgical Society  Print ISSN 2005-3711  On-line ISSN 1598-7876 www.jkns.or.kr",Non-OADS,/arxiv_data1/oa_pdf/66/f9/jkns-58-419.PMC4688310.pdf
"Key Words : Glioblastoma · Temozolomide · Metronomic chemotherapy · Microvessel density.Clinical Article • Received : February 2, 2015  • Revised : June 23, 2015  • Accepted : July 8, 2015 • Address for reprints : Yong Kil Hong, M.D., Ph.D.  Department of Neurosurgery, Seoul St. Mary’s Hospital, The Catholic University of Korea, 222 Banpo-daero, Seocho-gu, Seoul 06591, Korea  Tel : +82-2-2588-6123,  Fax : +82-2-594-2732,  E-mail : hongyk@catholic.ac.kr • This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0 )     which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.J Korean Neurosurg Soc 58  (5) : 426-431, 2015http://dx.doi.org/10.3340/jkns.2015.58.5.426 Copyright © 2015 The Korean Neurosurgical Society  Print ISSN 2005-3711  On-line ISSN 1598-7876 www.jkns.or.kr",Non-OADS,/arxiv_data1/oa_pdf/aa/a3/jkns-58-426.PMC4688311.pdf
"Department of Neurological Surgery, Asan Medical Center, University of Ulsan College of Medicine, 88 Olympic-ro 43-gil, Songpa-gu, Seoul 05505, Korea  Tel : +82-2-3010-3556,  Fax : +82-2-476-6738,  E-mail : cjkim@amc.seoul.kr • This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0 )     which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.J Korean Neurosurg Soc 58  (5) : 432-441, 2015http://dx.doi.org/10.3340/jkns.2015.58.5.432 Copyright © 2015 The Korean Neurosurgical Society  Print ISSN 2005-3711  On-line ISSN 1598-7876 www.jkns.or.kr",Non-OADS,/arxiv_data1/oa_pdf/24/dd/jkns-58-432.PMC4688312.pdf
"Key Words : Ossification of ligamentum nuchae · Ossification of posterior longitudinal ligament · Spinal ligament ossification syndrome · Cervical spine.Clinical Article • Received : December 3, 2014  • Revised : March 21, 2015  • Accepted : April 20, 2015 • Address for reprints : Young-Min Oh, M.D., Ph.D.   Department of Neurosurgery, Research Institute of Clinical Medicine of Chonbuk National University, Biomedical Research Institute of Chonbuk National University Hospital,  20 Geonji-ro, Deokjin-gu, Jeonju 54907, Korea   Tel : +82-63-250-1870,  Fax : +82-63-277-3273,  E-mail : timoh@jbnu.ac.kr • This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0 )     which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.J Korean Neurosurg Soc 58  (5) : 442-447, 2015http://dx.doi.org/10.3340/jkns.2015.58.5.442 Copyright © 2015 The Korean Neurosurgical Society  Print ISSN 2005-3711  On-line ISSN 1598-7876 www.jkns.or.kr",Non-OADS,/arxiv_data1/oa_pdf/55/5a/jkns-58-442.PMC4688313.pdf
"Key Words : Spinal metastasis · Hepatocellular carcinoma · Prognostic factor.Clinical Article • Received : February 5, 2015  • Revised : July 7, 2015  • Accepted : July 8, 2015 • Address for reprints : Sun-Ho Lee, M.D., Ph.D.  Department of Neurosurgery, Spine Center, Samsung Medical Center, Sungkyunkwan University School of Medicine, 81 Irwon-ro, Gangnam-gu, Seoul 06351, Korea  Tel : +82-2-3410-3499,  Fax : +82-2-3410-0048,  E-mail : sobotta72@hotmail.com • This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0 )     which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.J Korean Neurosurg Soc 58  (5) : 448-453, 2015http://dx.doi.org/10.3340/jkns.2015.58.5.448 Copyright © 2015 The Korean Neurosurgical Society  Print ISSN 2005-3711  On-line ISSN 1598-7876 www.jkns.or.kr",Non-OADS,/arxiv_data1/oa_pdf/b6/74/jkns-58-448.PMC4688314.pdf
"Key Words : Cavalieri method · Morphometry · Chiari malformation · MRI.Clinical Article • Received : February 12, 2015  • Revised : August 7, 2015  • Accepted : August 31, 2015 • Address for reprints : Yücel Gönül, Ph.D.  Department of Anatomy, Faculty of Medicine, Afyon Kocatepe University, Afyon, Afyonkarahisar 03200, Turkey  Tel : +90-505-5715259,  Fax : +90-272-246 3300,  E-mail : yucel94@hotmail.com • This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0 )     which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.J Korean Neurosurg Soc 58  (5) : 454-461, 2015http://dx.doi.org/10.3340/jkns.2015.58.5.454 Copyright © 2015 The Korean Neurosurgical Society  Print ISSN 2005-3711  On-line ISSN 1598-7876 www.jkns.or.kr",Non-OADS,/arxiv_data1/oa_pdf/86/49/jkns-58-454.PMC4688315.pdf
"• Address for reprints : Young Seob Chung, M.D., Ph.D.  Department of Neurosurgery, Seoul National University College of Medicine, Seoul National University Boramae Hospital, 20 Boramae-ro 5-gil, Dongjak-gu, Seoul 07061, Korea  Tel : +82-2-870-2301,  Fax : +82-2-870-3863,  E-mail : yschung@snu.ac.kr • This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0 )     which permits unrestricted non-commercial use,  distribution, and reproduction in any medium, provided the original work is properly cited.J Korean Neurosurg Soc 58  (5) : 462-466, 2015http://dx.doi.org/10.3340/jkns.2015.58.5.462 Copyright © 2015 The Korean Neurosurgical Society  Print ISSN 2005-3711  On-line ISSN 1598-7876 www.jkns.or.kr",Non-OADS,/arxiv_data1/oa_pdf/a8/ba/jkns-58-462.PMC4688316.pdf
"Department of Neurosurgery, College of Medicine, Kyung Hee University, Kyungheedae-ro, Dongdaemun-gu, Seoul 02447, Korea   Tel : +82-2-958-8385,  Fax : +82-2-958-8380,  E-mail : nscsk@hanmail.net • This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0 )     which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.J Korean Neurosurg Soc 58  (5) : 467-470, 2015http://dx.doi.org/10.3340/jkns.2015.58.5.467 Copyright © 2015 The Korean Neurosurgical Society  Print ISSN 2005-3711  On-line ISSN 1598-7876 www.jkns.or.kr",Non-OADS,/arxiv_data1/oa_pdf/16/5f/jkns-58-467.PMC4688317.pdf
"Key Words : Aneurysm ruptured · Basal ganglia hemorrhage · Lenticulostriate artery.Case Report • Received : February 4, 2014  • Revised : August 8, 2014  • Accepted : August 31, 2014 • Address for reprints : Jin Yang Joo, M.D., Ph.D.  Department of Neurosurgery, Gangnam Severance Hospital, College of Medicine, Yonsei University, 211 Eonju-ro, Gangnam-gu, Seoul 06273, Korea   Tel : +82-2-2019-3390,  Fax : +82-2-3461-9229,  E-mail : JYJOO@yuhs.ac • This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0 )     which permits unrestricted non-commercial use,  distribution, and reproduction in any medium, provided the original work is properly cited.J Korean Neurosurg Soc 58  (5) : 471-475, 2015http://dx.doi.org/10.3340/jkns.2015.58.5.471 Copyright © 2015 The Korean Neurosurgical Society  Print ISSN 2005-3711  On-line ISSN 1598-7876 www.jkns.or.kr",Non-OADS,/arxiv_data1/oa_pdf/6c/a6/jkns-58-471.PMC4688318.pdf
"Key Words : Cortical vein thrombosis · Cord sign · Hemorrhagic infarction.Case Report • Received : May 8, 2015  • Revised : October 5, 2015  • Accepted : October 6, 2015 • Address for reprints : Young Seob Chung, M.D., Ph.D.   Department of Neurosurgery, Seoul National University College of Medicine, Seoul National University Boramae Hospital, 20 Boramae-ro 5-gil, Dongjak-gu, Seoul 07061,  Korea  Tel : +82-2-870-2301,  Fax : +82-2-870-3863,  E-mail : yschung@snu.ac.kr • This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0 )     which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.J Korean Neurosurg Soc 58  (5) : 476-478, 2015http://dx.doi.org/10.3340/jkns.2015.58.5.476 Copyright © 2015 The Korean Neurosurgical Society  Print ISSN 2005-3711  On-line ISSN 1598-7876 www.jkns.or.kr",Non-OADS,/arxiv_data1/oa_pdf/52/db/jkns-58-476.PMC4688319.pdf
"Key Words : Glioblastoma multiforme · Pineal region · Leptomeningeal dissemination · Spinal metastasis.Case Report • Received : January 15, 2014  • Revised : September 10, 2014  • Accepted : September 16, 2014 • Address for reprints : Ryosuke Matsuda, M.D., Ph.D.  Department of Neurosurgery, Nara Medical University, 840 Shijo-cho, Kashihara, Nara 634-8522, Japan   Tel : +81-744223051,  Fax : +81-744290818,  E-mail : cak93500@pop02.odn.ne.jp • This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0 )     which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.J Korean Neurosurg Soc 58  (5) : 479-482, 2015http://dx.doi.org/10.3340/jkns.2015.58.5.479 Copyright © 2015 The Korean Neurosurgical Society  Print ISSN 2005-3711  On-line ISSN 1598-7876 www.jkns.or.kr",Non-OADS,/arxiv_data1/oa_pdf/9c/22/jkns-58-479.PMC4688320.pdf
"Key Words : Subdural spinal hematoma · Cervical transforaminal epidural block · Quadriparesis.Case Report • Received : September 2, 2014  • Revised : January 19, 2015  • Accepted : January 23, 2015 • Address for reprints : Chang Il Ju, M.D., Ph.D.  Department of Neurosurgery, College of Medicine, Chosun University, 365 Pilmun-daero, Dong-gu, Gwangju 61453, Korea  Tel : +82-62-220-3126,  Fax : +82-62-227-4575,  E-mail : jchangil@chosun.ac.kr • This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0 )     which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.J Korean Neurosurg Soc 58  (5) : 483-486, 2015http://dx.doi.org/10.3340/jkns.2015.58.5.483 Copyright © 2015 The Korean Neurosurgical Society  Print ISSN 2005-3711  On-line ISSN 1598-7876 www.jkns.or.kr",Non-OADS,/arxiv_data1/oa_pdf/f4/42/jkns-58-483.PMC4688321.pdf
"Key Words : Biopsy · β-2 microglobulin · Chronic lymphocytic inflammation with pontine perivascular enhancement responsive to steroids ·  Diagnosis · malignant lymphoma.Case Report • Received : April 10, 2014  • Revised : August 18, 2014  • Accepted : September 15, 2014 • Address for reprints : Soichi Oya, M.D., Ph.D.  Department of Neurosurgery, Saitama Medical Center, Saitama Medical University, Kamoda 1981, Kawagoe, Saitama 350-8550, Japan  Tel : +81-49-228-3671,  Fax : +81-49-228-3671,  E-mail : sooya-tky@umin.ac.jp • This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0 )     which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.J Korean Neurosurg Soc 58  (5) : 487-490, 2015http://dx.doi.org/10.3340/jkns.2015.58.5.487 Copyright © 2015 The Korean Neurosurgical Society  Print ISSN 2005-3711  On-line ISSN 1598-7876 www.jkns.or.kr",Non-OADS,/arxiv_data1/oa_pdf/54/3b/jkns-58-487.PMC4688322.pdf
"Key Words : Neuralgic amyotrophy · Brachial plexus neuritis · Posterior interosseous nerve · Entrapment syndrome · Magnetic resonance neurography.Case Report • Received : May 21, 2014  • Revised : December 1, 2014  • Accepted : December 2, 2014 • Address for reprints : Yong Jun Cho, M.D., Ph.D.  Department of Neurosurgery, Chuncheon Sacred Heart Hospital, College of Medicine, Hallym University, 77 Sakju-ro, Chuncheon 24253, Korea  Tel : +82-33-240-5173,  Fax : +82-33-242-9970,  E-mail : nssur771@hallym.or.kr • This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0 )     which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.J Korean Neurosurg Soc 58  (5) : 491-493, 2015http://dx.doi.org/10.3340/jkns.2015.58.5.491 Copyright © 2015 The Korean Neurosurgical Society  Print ISSN 2005-3711  On-line ISSN 1598-7876 www.jkns.or.kr Fig.",Non-OADS,/arxiv_data1/oa_pdf/3e/e2/jkns-58-491.PMC4688323.pdf
"Key Words : Spinous process-splitting hemilaminoplasty · Physiological integrity · Intradural and posterior extradural lesion.Technical Note • Received : March 16, 2015  • Revised : July 6, 2015  • Accepted : August 7, 2015 • Address for reprints : Young-Baeg Kim, M.D., Ph.D.  Department of Neurosurgery, Chung-Ang University College of Medicine, 102 Heukseok-ro, Dongjak-gu, Seoul 06973, Korea  Tel : +82-2-6299-1607,  Fax : +82-2-6299-2069,  E-mail : ybkim1218@cau.ac.kr • This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0 )     which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.J Korean Neurosurg Soc 58  (5) : 494-498, 2015http://dx.doi.org/10.3340/jkns.2015.58.5.494 Copyright © 2015 The Korean Neurosurgical Society  Print ISSN 2005-3711  On-line ISSN 1598-7876 www.jkns.or.kr",Non-OADS,/arxiv_data1/oa_pdf/48/dc/jkns-58-494.PMC4688324.pdf
"Genetics of Autism Spectrum Disorder:   Current Status and Possible Clinical Applications Heejeong Y oo * Department of Psychiatry, Seoul National University Bundang Hospital,   Seoul National University College of Medicine, Seongnam 13620, Koreahttp://dx.doi.org/10.5607/en.2015.24.4.257 Exp Neurobiol.",OADS,/arxiv_data1/oa_pdf/1c/d8/en-24-257.PMC4688327.pdf
"TEL: 82-31-787-7436, FAX: 82-31-787-4058 e-mail: hjyoo@snu.ac.kr Copyright © Experimental Neurobiology 2015. www.enjournal.orgThis is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License  (http://creativecommons.org/licenses/by-nc/ 4.0) which permits unrestricted non-commercial use, distribution, and  reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/1c/d8/en-24-257.PMC4688327.pdf
"258 www.enjournal.org http://dx.doi.org/10.5607/en.2015.24.4.257Heejeong Y oo GENETIC VARIANTS Common variants The genetic architecture of ASD is diverse in frequency  (common vs. rare variation), mode of inheritance (inherited vs.  de novo  variation), type of variation (single nucleotide, indel, or  copy number variation [CNV]) and mode of action (dominant,  recessive, or additive) [3, 7].",OADS,/arxiv_data1/oa_pdf/1c/d8/en-24-257.PMC4688327.pdf
"259 www.enjournal.org http://dx.doi.org/10.5607/en.2015.24.4.257Genetics of Autism ASD have identifiable, causative, and protein-disrupting rare  genetic mutations [5].",Non-OADS,/arxiv_data1/oa_pdf/1c/d8/en-24-257.PMC4688327.pdf
"260 www.enjournal.org http://dx.doi.org/10.5607/en.2015.24.4.257Heejeong Y oo Copy number variation  Copy number variants (CNVs) are variations (duplication  or deletion) in chromosomal structure of greater than 1,000  nucleotides, usually a section of DNA with a length from 1 kb to  several Mb.",OADS,/arxiv_data1/oa_pdf/1c/d8/en-24-257.PMC4688327.pdf
NLGNs are known to act as splice site-specific ligands for beta- neurexins and be involved in the formation and remodeling of  central nervous system synapses (http://www.ncbi.nlm.nih.gov/ gene/54413).,Non-OADS,/arxiv_data1/oa_pdf/1c/d8/en-24-257.PMC4688327.pdf
"A second family of genes possibly associated with ASD is the  SHANK genes ( SHANK1 , SHANK2 , and SHANK3 ), encoding  synaptic proteins that may function as molecular scaffolds in the  postsynaptic density of excitatory synapses (http://www.ncbi.nlm.",Non-OADS,/arxiv_data1/oa_pdf/1c/d8/en-24-257.PMC4688327.pdf
261 www.enjournal.org http://dx.doi.org/10.5607/en.2015.24.4.257Genetics of Autism neurexins [60].,Non-OADS,/arxiv_data1/oa_pdf/1c/d8/en-24-257.PMC4688327.pdf
"262 www.enjournal.org http://dx.doi.org/10.5607/en.2015.24.4.257Heejeong Y oo (PTEN-ASD); compared to subjects with idiopathic (non-PTEN)  ASD and healthy controls, subjects with PTEN-ASD showed  prominent cognitive dysfunction and white-matter abnormalities,  mediated by reductions in the PTEN protein [89].",OADS,/arxiv_data1/oa_pdf/1c/d8/en-24-257.PMC4688327.pdf
"263 www.enjournal.org http://dx.doi.org/10.5607/en.2015.24.4.257Genetics of Autism GENETICS USED FOR DIAGNOSIS AND THERAPEUTIC TARGETS:  CLINICAL REALM The ultimate goal of the evaluation of genetic etiology in complex  disorders is the discovery of biomarkers for risk assessment,  diagnosis, and prediction of therapeutic responses and prognoses,  and the development of therapeutic components.",Non-OADS,/arxiv_data1/oa_pdf/1c/d8/en-24-257.PMC4688327.pdf
"264 www.enjournal.org http://dx.doi.org/10.5607/en.2015.24.4.257Heejeong Y oo FMR1  genes, and are refining potential therapeutic mechanisms  [78, 102-106].",OADS,/arxiv_data1/oa_pdf/1c/d8/en-24-257.PMC4688327.pdf
265 www.enjournal.org http://dx.doi.org/10.5607/en.2015.24.4.257Genetics of Autism REFERENCES 1.,Non-OADS,/arxiv_data1/oa_pdf/1c/d8/en-24-257.PMC4688327.pdf
"266 www.enjournal.org http://dx.doi.org/10.5607/en.2015.24.4.257Heejeong Y oo LO, W right HH, Abramson RK, DeLong GR, Cuccaro ML,  Pericak-V ance MA (2000) Analysis of linkage disequilibrium  in gamma-aminobutyric acid receptor subunit genes in  autistic disorder.",OADS,/arxiv_data1/oa_pdf/1c/d8/en-24-257.PMC4688327.pdf
"267 www.enjournal.org http://dx.doi.org/10.5607/en.2015.24.4.257Genetics of Autism R, Howe JL, Hughes G, Hus V , Igliozzi R, Kim C, Klauck  SM, Kolevzon A, Korvatska O, Kustanovich V , Lajonchere  CM, Lamb JA, Laskawiec M, Leboyer M, Le Couteur A,  Leventhal BL, Lionel AC, Liu XQ, Lord C, Lotspeich L,  Lund SC, Maestrini E, Mahoney W , Mantoulan C, Marshall  CR, McConachie H, McDougle CJ, McGrath J, McMahon  WM, Melhem NM, Merikangas A, Migita O, Minshew NJ,  Mirza GK, Munson J, Nelson SF , Noakes C, Noor A, Nygren  G, Oliveira G, Papanikolaou K, Parr JR, Parrini B, Paton T ,  Pickles A, Piven J, Posey DJ, Poustka A, Poustka F , Prasad  A, Ragoussis J, Renshaw K, Rickaby J, Roberts W , Roeder K,  Roge B, Rutter ML, Bierut LJ, Rice JP , Salt J, Sansom K, Sato  D, Segurado R, Senman L, Shah N, Sheffield VC, Soorya L,  Sousa I, Stoppioni V , Strawbridge C, T ancredi R, T ansey K,  Thiruvahindrapduram B, Thompson AP , Thomson S, T ryfon  A, T siantis J, V an Engeland H, Vincent JB, V olkmar F , W allace  S, W ang K, W ang Z, W assink TH, Wing K, Wittemeyer K,  W ood S, Y aspan BL, Zurawiecki D, Zwaigenbaum L, Betancur  C, Buxbaum JD, Cantor RM, Cook EH, Coon H, Cuccaro  ML, Gallagher L, Geschwind DH, Gill M, Haines JL, Miller  J, Monaco AP , Nurnberger JI Jr, Paterson AD, Pericak-V ance  MA, Schellenberg GD, Scherer SW , Sutcliffe JS, Szatmari P ,  Vicente AM, Vieland VJ, Wijsman EM, Devlin B, Ennis S,  Hallmayer J (2010) A genome-wide scan for common alleles  affecting risk for autism.",Non-OADS,/arxiv_data1/oa_pdf/1c/d8/en-24-257.PMC4688327.pdf
"268 www.enjournal.org http://dx.doi.org/10.5607/en.2015.24.4.257Heejeong Y oo K, Y amamoto T (2009) A newly recognised microdeletion  syndrome of 2p15-16.1 manifesting moderate developmental  delay, autistic behaviour, short stature, microcephaly, and  dysmorphic features: a new patient with 3.2 Mb deletion.",Non-OADS,/arxiv_data1/oa_pdf/1c/d8/en-24-257.PMC4688327.pdf
269 www.enjournal.org http://dx.doi.org/10.5607/en.2015.24.4.257Genetics of Autism and regulatory components.,Non-OADS,/arxiv_data1/oa_pdf/1c/d8/en-24-257.PMC4688327.pdf
270 www.enjournal.org http://dx.doi.org/10.5607/en.2015.24.4.257Heejeong Y oo 73.,OADS,/arxiv_data1/oa_pdf/1c/d8/en-24-257.PMC4688327.pdf
271 www.enjournal.org http://dx.doi.org/10.5607/en.2015.24.4.257Genetics of Autism 93.,Non-OADS,/arxiv_data1/oa_pdf/1c/d8/en-24-257.PMC4688327.pdf
272 www.enjournal.org http://dx.doi.org/10.5607/en.2015.24.4.257Heejeong Y oo implicates novel and candidate genes.,OADS,/arxiv_data1/oa_pdf/1c/d8/en-24-257.PMC4688327.pdf
"It is believed that ASD is a highly  heritable disorder and that genetic susceptibility interacts with Characteristics of Brains in Autism Spectrum  Disorder: Structure, Function and Connectivity  across the Lifespan Sungji Ha1, In-Jung Sohn1,2, Namwook Kim1,2, Hyeon Jeong Sim1 and Keun-Ah Cheon1,2* 1Department of Psychiatry, Institute of Behavioral Science in Medicine and Yonsei Autism Laboratory, Yonsei University  College of Medicine, Seoul 03722, 2Division of Child and Adolescent Psychiatry, Severance Children’s Hospital,   Yonsei University College of Medicine, Seoul 03722, Koreahttp://dx.doi.org/10.5607/en.2015.24.4.273 Exp Neurobiol.",Non-OADS,/arxiv_data1/oa_pdf/6d/2f/en-24-273.PMC4688328.pdf
"TEL: 82-2-2228-1633, FAX: 82-2-313-0891 e-mail: kacheon@yuhs.ac Copyright © Experimental Neurobiology 2015. www.enjournal.orgThis is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License  (http://creativecommons.org/licenses/by-nc/ 4.0) which permits unrestricted non-commercial use, distribution, and  reproduction in any medium, provided the original work is properly cited.Review Article: Autism Spectrum Disorders",Non-OADS,/arxiv_data1/oa_pdf/6d/2f/en-24-273.PMC4688328.pdf
"274 www.enjournal.org http://dx.doi.org/10.5607/en.2015.24.4.273Sungji Ha, et al.",OADS,/arxiv_data1/oa_pdf/6d/2f/en-24-273.PMC4688328.pdf
"275 www.enjournal.org http://dx.doi.org/10.5607/en.2015.24.4.273Characteristics of Brains in Autism Spectrum Disorder and seem to be common in other disorders such as obsessive- compulsive disorder, general anxiety disorders, and schizophrenia  [22-24].",Non-OADS,/arxiv_data1/oa_pdf/6d/2f/en-24-273.PMC4688328.pdf
"276 www.enjournal.org http://dx.doi.org/10.5607/en.2015.24.4.273Sungji Ha, et al.",OADS,/arxiv_data1/oa_pdf/6d/2f/en-24-273.PMC4688328.pdf
277 www.enjournal.org http://dx.doi.org/10.5607/en.2015.24.4.273Characteristics of Brains in Autism Spectrum Disorder have been reported through several studies [51].,Non-OADS,/arxiv_data1/oa_pdf/6d/2f/en-24-273.PMC4688328.pdf
"278 www.enjournal.org http://dx.doi.org/10.5607/en.2015.24.4.273Sungji Ha, et al.",OADS,/arxiv_data1/oa_pdf/6d/2f/en-24-273.PMC4688328.pdf
"279 www.enjournal.org http://dx.doi.org/10.5607/en.2015.24.4.273Characteristics of Brains in Autism Spectrum Disorder in ASD brains in language [68], visuomotor processing [85],  selective attention [69].",Non-OADS,/arxiv_data1/oa_pdf/6d/2f/en-24-273.PMC4688328.pdf
"280 www.enjournal.org http://dx.doi.org/10.5607/en.2015.24.4.273Sungji Ha, et al.",OADS,/arxiv_data1/oa_pdf/6d/2f/en-24-273.PMC4688328.pdf
281 www.enjournal.org http://dx.doi.org/10.5607/en.2015.24.4.273Characteristics of Brains in Autism Spectrum Disorder minicolumns in autism.,Non-OADS,/arxiv_data1/oa_pdf/6d/2f/en-24-273.PMC4688328.pdf
"282 www.enjournal.org http://dx.doi.org/10.5607/en.2015.24.4.273Sungji Ha, et al.",OADS,/arxiv_data1/oa_pdf/6d/2f/en-24-273.PMC4688328.pdf
"283 www.enjournal.org http://dx.doi.org/10.5607/en.2015.24.4.273Characteristics of Brains in Autism Spectrum Disorder and high functioning autism: a promising path of research  that needs refined models, methodological convergence, and  stronger behavioral links.",Non-OADS,/arxiv_data1/oa_pdf/6d/2f/en-24-273.PMC4688328.pdf
"284 www.enjournal.org http://dx.doi.org/10.5607/en.2015.24.4.273Sungji Ha, et al.",OADS,/arxiv_data1/oa_pdf/6d/2f/en-24-273.PMC4688328.pdf
"Like any other animal models of neurologic  disorders, ASD animal models were developed to gain insight Exploring the Validity of Valproic Acid Animal  Model of Autism Darine Froy N. Mabunga1, Edson Luck T. Gonzales1, Ji-woon Kim1,   Ki Chan Kim1 and Chan Y oung Shin1,2* 1Department of Neuroscience, School of Medicine, and Neuroscience Research Center, SMART-IABS and KU Open Innovation  Center, Konkuk University, 2Department of Pharmacology, School of Medicine, Konkuk University, Seoul 05029, Koreahttp://dx.doi.org/10.5607/en.2015.24.4.285 Exp Neurobiol.",OADS,/arxiv_data1/oa_pdf/d6/c6/en-24-285.PMC4688329.pdf
"TEL: 82-2-2030-7834, FAX: 82-2-2049-7899 e-mail: chanyshin@kku.ac.kr Copyright © Experimental Neurobiology 2015. www.enjournal.orgThis is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License  (http://creativecommons.org/licenses/by-nc/ 4.0) which permits unrestricted non-commercial use, distribution, and  reproduction in any medium, provided the original work is properly cited.Review Article: Autism Spectrum Disorders",Non-OADS,/arxiv_data1/oa_pdf/d6/c6/en-24-285.PMC4688329.pdf
"286 www.enjournal.org http://dx.doi.org/10.5607/en.2015.24.4.285Darine Froy N. Mabunga, et al.",OADS,/arxiv_data1/oa_pdf/d6/c6/en-24-285.PMC4688329.pdf
287 www.enjournal.org http://dx.doi.org/10.5607/en.2015.24.4.285Exploring the Validity of Valproic Acid Animal Model of Autism 5-methoxytryptamine (5-MT) are also used to generate models  of autism.,OADS,/arxiv_data1/oa_pdf/d6/c6/en-24-285.PMC4688329.pdf
"288 www.enjournal.org http://dx.doi.org/10.5607/en.2015.24.4.285Darine Froy N. Mabunga, et al.",Non-OADS,/arxiv_data1/oa_pdf/d6/c6/en-24-285.PMC4688329.pdf
"289 www.enjournal.org http://dx.doi.org/10.5607/en.2015.24.4.285Exploring the Validity of Valproic Acid Animal Model of Autism that VPA exposure in male offspring led to time-specific increases  in postsynaptic density as well as excitatory neuronal markers  within four weeks of age, which can be rooted to changes in  MeCP2 levels [21].",Non-OADS,/arxiv_data1/oa_pdf/d6/c6/en-24-285.PMC4688329.pdf
"290 www.enjournal.org http://dx.doi.org/10.5607/en.2015.24.4.285Darine Froy N. Mabunga, et al.",Non-OADS,/arxiv_data1/oa_pdf/d6/c6/en-24-285.PMC4688329.pdf
"291 www.enjournal.org http://dx.doi.org/10.5607/en.2015.24.4.285Exploring the Validity of Valproic Acid Animal Model of Autism treated mice were also observed to display increased repetitive- stereotyped movements [87] and self-grooming time [76, 88] in  an open field.",Non-OADS,/arxiv_data1/oa_pdf/d6/c6/en-24-285.PMC4688329.pdf
"292 www.enjournal.org http://dx.doi.org/10.5607/en.2015.24.4.285Darine Froy N. Mabunga, et al.",Non-OADS,/arxiv_data1/oa_pdf/d6/c6/en-24-285.PMC4688329.pdf
"293 www.enjournal.org http://dx.doi.org/10.5607/en.2015.24.4.285Exploring the Validity of Valproic Acid Animal Model of Autism reliability and potency of resveratrol as a therapeutic compound,  unless target identification studies will be conducted.",Non-OADS,/arxiv_data1/oa_pdf/d6/c6/en-24-285.PMC4688329.pdf
"294 www.enjournal.org http://dx.doi.org/10.5607/en.2015.24.4.285Darine Froy N. Mabunga, et al.",Non-OADS,/arxiv_data1/oa_pdf/d6/c6/en-24-285.PMC4688329.pdf
295 www.enjournal.org http://dx.doi.org/10.5607/en.2015.24.4.285Exploring the Validity of Valproic Acid Animal Model of Autism 4.,Non-OADS,/arxiv_data1/oa_pdf/d6/c6/en-24-285.PMC4688329.pdf
"296 www.enjournal.org http://dx.doi.org/10.5607/en.2015.24.4.285Darine Froy N. Mabunga, et al.",Non-OADS,/arxiv_data1/oa_pdf/d6/c6/en-24-285.PMC4688329.pdf
297 www.enjournal.org http://dx.doi.org/10.5607/en.2015.24.4.285Exploring the Validity of Valproic Acid Animal Model of Autism Prenatal exposure to valproic acid increases the neural  progenitor cell pool and induces macrocephaly in rat brain  via a mechanism involving the GSK-3β/β-catenin pathway.,Non-OADS,/arxiv_data1/oa_pdf/d6/c6/en-24-285.PMC4688329.pdf
"298 www.enjournal.org http://dx.doi.org/10.5607/en.2015.24.4.285Darine Froy N. Mabunga, et al.",Non-OADS,/arxiv_data1/oa_pdf/d6/c6/en-24-285.PMC4688329.pdf
299 www.enjournal.org http://dx.doi.org/10.5607/en.2015.24.4.285Exploring the Validity of Valproic Acid Animal Model of Autism to an enriched environment 15 days after focal brain  ischemia.,Non-OADS,/arxiv_data1/oa_pdf/d6/c6/en-24-285.PMC4688329.pdf
"300 www.enjournal.org http://dx.doi.org/10.5607/en.2015.24.4.285Darine Froy N. Mabunga, et al.",Non-OADS,/arxiv_data1/oa_pdf/d6/c6/en-24-285.PMC4688329.pdf
"Despite the absence of targeted treatments, it is  believed that as many as 75% of patients with ASD receive some  kind of pharmacological treatment, which are mainly directed  to treat non-core associated symptoms such as hyperactivity, New Therapeutic Options for Autism Spectrum  Disorder: Experimental Evidences Olga Peñagarikano * Department of Pharmacology, School of Medicine, University of the Basque Country, Sarriena s/n, Leioa 48940, Spainhttp://dx.doi.org/10.5607/en.2015.24.4.301 Exp Neurobiol.",Non-OADS,/arxiv_data1/oa_pdf/85/50/en-24-301.PMC4688330.pdf
"TEL: 34-94-6015560, FAX: 34-94-6013400 e-mail: olga.penagarikano@ehu.eus Copyright © Experimental Neurobiology 2015. www.enjournal.orgThis is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License  (http://creativecommons.org/licenses/by-nc/ 4.0) which permits unrestricted non-commercial use, distribution, and  reproduction in any medium, provided the original work is properly cited.Review Article: Autism Spectrum Disorders",Non-OADS,/arxiv_data1/oa_pdf/85/50/en-24-301.PMC4688330.pdf
"302 www.enjournal.org http://dx.doi.org/10.5607/en.2015.24.4.301Olga Peñagarikano irritability, aggression and self-injury [6].",Non-OADS,/arxiv_data1/oa_pdf/85/50/en-24-301.PMC4688330.pdf
"303 www.enjournal.org http://dx.doi.org/10.5607/en.2015.24.4.301ASD Treatments According to the fifth edition of the American Psychiatric  Association's Diagnostic and Statistical Manual (DMS-V), ASD  and ADHD are no longer mutually exclusive [1], therefore patients  with autism no longer need to be treated off-label for ADHD  symptoms.",Non-OADS,/arxiv_data1/oa_pdf/85/50/en-24-301.PMC4688330.pdf
"304 www.enjournal.org http://dx.doi.org/10.5607/en.2015.24.4.301Olga Peñagarikano in dendritic spines, including spine density, morphology and/ or dynamics have been identified in postmortem studies of ASD  patients, as well as in studies of animal models of autism [26].",OADS,/arxiv_data1/oa_pdf/85/50/en-24-301.PMC4688330.pdf
"305 www.enjournal.org http://dx.doi.org/10.5607/en.2015.24.4.301ASD Treatments directions, or interestingly, when mice are bred to carry both  mutations [43].",Non-OADS,/arxiv_data1/oa_pdf/85/50/en-24-301.PMC4688330.pdf
"306 www.enjournal.org http://dx.doi.org/10.5607/en.2015.24.4.301Olga Peñagarikano review of the published randomized controlled trials until 2013  reports that 85% of them found statistically significant differences  in outcome related to social behavior between placebo and OXT  treated groups, with eye gaze and facial emotion recognition  being the domains more frequently improved [75].",Non-OADS,/arxiv_data1/oa_pdf/85/50/en-24-301.PMC4688330.pdf
307 www.enjournal.org http://dx.doi.org/10.5607/en.2015.24.4.301ASD Treatments 5.,Non-OADS,/arxiv_data1/oa_pdf/85/50/en-24-301.PMC4688330.pdf
"308 www.enjournal.org http://dx.doi.org/10.5607/en.2015.24.4.301Olga Peñagarikano Dawson G, Duketis E, Fernandez BA, Gallagher L, Geller E,  Guter SJ, Hill RS, Ionita-Laza J, Jimenz Gonzalez P , Kilpinen  H, Klauck SM, Kolevzon A, Lee I, Lei I, Lei J, Lehtimäki  T , Lin CF , Ma'ayan A, Marshall CR, McInnes AL, Neale B,  Owen MJ, Ozaki N, Parellada M, Parr JR, Purcell S, Puura  K, Rajagopalan D, Rehnström K, Reichenberg A, Sabo A,  Sachse M, Sanders SJ, Schafer C, Schulte-Rüther M, Skuse D,  Stevens C, Szatmari P , T ammimies K, V alladares O, V oran A,  Li-San W , W eiss LA, Willsey AJ, Y u TW , Y uen RK; DDD Study;  Homozygosity Mapping Collaborative for Autism; UK10K  Consortium, Cook EH, Freitag CM, Gill M, Hultman CM,  Lehner T , Palotie A, Schellenberg GD, Sklar P , State MW ,  Sutcliffe JS, W alsh CA, Scherer SW , Zwick ME, Barett JC,  Cutler DJ, Roeder K, Devlin B, Daly MJ, Buxbaum JD (2014)  Synaptic, transcriptional and chromatin genes disrupted in  autism.",Non-OADS,/arxiv_data1/oa_pdf/85/50/en-24-301.PMC4688330.pdf
309 www.enjournal.org http://dx.doi.org/10.5607/en.2015.24.4.301ASD Treatments sclerosis and Autism spectrum disorders.,Non-OADS,/arxiv_data1/oa_pdf/85/50/en-24-301.PMC4688330.pdf
310 www.enjournal.org http://dx.doi.org/10.5607/en.2015.24.4.301Olga Peñagarikano mechanisms regulating social cognition and affiliative  behavior.,Non-OADS,/arxiv_data1/oa_pdf/85/50/en-24-301.PMC4688330.pdf
311 www.enjournal.org http://dx.doi.org/10.5607/en.2015.24.4.301ASD Treatments 87.,Non-OADS,/arxiv_data1/oa_pdf/85/50/en-24-301.PMC4688330.pdf
"Seung Yup Lee1, Ah Rah Lee2, Ram Hwangbo3, Juhee Han3, Minha Hong4 and Geon Ho Bahn5* 1Graduate School of Medicine, Kyung Hee University, Seoul 02543, 2Kyung Hee University School of Medicine, Seoul 02543,   3Department of Psychiatry, Kyung Hee University Hospital, Seoul 02447,   4Department of Psychiatry, Seonam University, College of Medicine, Myongji Hospital, Goyang 10475,   5Department of Psychiatry, Kyung Hee University School of Medicine, Seoul 02447, Koreahttp://dx.doi.org/10.5607/en.2015.24.4.312 Exp Neurobiol.",Non-OADS,/arxiv_data1/oa_pdf/f7/e0/en-24-312.PMC4688331.pdf
"TEL: 82-2-958-8556, FAX: 82-2-957-1997 e-mail: mompeian@khu.ac.kr Copyright © Experimental Neurobiology 2015. www.enjournal.orgThis is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License  (http://creativecommons.org/licenses/by-nc/ 4.0) which permits unrestricted non-commercial use, distribution, and  reproduction in any medium, provided the original work is properly cited.Review Article: Autism Spectrum Disorders",Non-OADS,/arxiv_data1/oa_pdf/f7/e0/en-24-312.PMC4688331.pdf
313 www.enjournal.org http://dx.doi.org/10.5607/en.2015.24.4.312Oxytocin and Autism Spectrum Disorder no approved drugs for the treatment of core symptoms of ASD  [6].,Non-OADS,/arxiv_data1/oa_pdf/f7/e0/en-24-312.PMC4688331.pdf
"314 www.enjournal.org http://dx.doi.org/10.5607/en.2015.24.4.312Seung Yup Lee, et al.",OADS,/arxiv_data1/oa_pdf/f7/e0/en-24-312.PMC4688331.pdf
"315 www.enjournal.org http://dx.doi.org/10.5607/en.2015.24.4.312Oxytocin and Autism Spectrum Disorder children, early genetic studies were designed to attempt to find  genetic evidence for such differences.",Non-OADS,/arxiv_data1/oa_pdf/f7/e0/en-24-312.PMC4688331.pdf
"316 www.enjournal.org http://dx.doi.org/10.5607/en.2015.24.4.312Seung Yup Lee, et al.",OADS,/arxiv_data1/oa_pdf/f7/e0/en-24-312.PMC4688331.pdf
317 www.enjournal.org http://dx.doi.org/10.5607/en.2015.24.4.312Oxytocin and Autism Spectrum Disorder Table 2.,Non-OADS,/arxiv_data1/oa_pdf/f7/e0/en-24-312.PMC4688331.pdf
"318 www.enjournal.org http://dx.doi.org/10.5607/en.2015.24.4.312Seung Yup Lee, et al.",OADS,/arxiv_data1/oa_pdf/f7/e0/en-24-312.PMC4688331.pdf
319 www.enjournal.org http://dx.doi.org/10.5607/en.2015.24.4.312Oxytocin and Autism Spectrum Disorder in social cognition following treatment as rated by caregivers  and clinicians [83].,Non-OADS,/arxiv_data1/oa_pdf/f7/e0/en-24-312.PMC4688331.pdf
"320 www.enjournal.org http://dx.doi.org/10.5607/en.2015.24.4.312Seung Yup Lee, et al.",OADS,/arxiv_data1/oa_pdf/f7/e0/en-24-312.PMC4688331.pdf
321 www.enjournal.org http://dx.doi.org/10.5607/en.2015.24.4.312Oxytocin and Autism Spectrum Disorder disorders.,Non-OADS,/arxiv_data1/oa_pdf/f7/e0/en-24-312.PMC4688331.pdf
"322 www.enjournal.org http://dx.doi.org/10.5607/en.2015.24.4.312Seung Yup Lee, et al.",OADS,/arxiv_data1/oa_pdf/f7/e0/en-24-312.PMC4688331.pdf
323 www.enjournal.org http://dx.doi.org/10.5607/en.2015.24.4.312Oxytocin and Autism Spectrum Disorder 3:101-112.,Non-OADS,/arxiv_data1/oa_pdf/f7/e0/en-24-312.PMC4688331.pdf
"324 www.enjournal.org http://dx.doi.org/10.5607/en.2015.24.4.312Seung Yup Lee, et al.",OADS,/arxiv_data1/oa_pdf/f7/e0/en-24-312.PMC4688331.pdf
"The Role of Oxidative Stress in Neurodegenerative  Diseases Geon Ha Kim1,2, Jieun E. Kim1,3, Sandy Jeong Rhie1,4 and Sujung Y oon1* 1Ewha Brain Institute, Ewha Womans University,   2Department of Neurology, Ewha Womans University Mokdong Hospital, Ewha Womans University School of Medicine,   3Department of Brain and Cognitive Sciences,   4College of Pharmacy, Graduate School of Pharmaceutical Sciences, Ewha Womans University, Seoul 03760, Koreahttp://dx.doi.org/10.5607/en.2015.24.4.325 Exp Neurobiol.",Non-OADS,/arxiv_data1/oa_pdf/ce/81/en-24-325.PMC4688332.pdf
"TEL: 82-2-3277-2466, FAX: 82-2-3277-6562 e-mail: sujungjyoon@ewha.ac.kr Copyright © Experimental Neurobiology 2015. www.enjournal.orgThis is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License  (http://creativecommons.org/licenses/by-nc/ 4.0) which permits unrestricted non-commercial use, distribution, and  reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/ce/81/en-24-325.PMC4688332.pdf
"326 www.enjournal.org http://dx.doi.org/10.5607/en.2015.24.4.325Geon Ha Kim, et al.",OADS,/arxiv_data1/oa_pdf/ce/81/en-24-325.PMC4688332.pdf
"327 www.enjournal.org http://dx.doi.org/10.5607/en.2015.24.4.325Oxidative Stress in Neurodegeneration chain (ETC) consists of five multi-subunit complexes including  NADH-coenzyme Q (CoQ) reductase (NADH dehydrogenase,  Complex I), succinate dehydrogenase (Complex II), coenzyme  Q-cytochrome c reductase (Complex III), cytochrome C oxidase  (Complex IV), and ATP synthase (Complex V) [3, 10].",OADS,/arxiv_data1/oa_pdf/ce/81/en-24-325.PMC4688332.pdf
"328 www.enjournal.org http://dx.doi.org/10.5607/en.2015.24.4.325Geon Ha Kim, et al.",OADS,/arxiv_data1/oa_pdf/ce/81/en-24-325.PMC4688332.pdf
"329 www.enjournal.org http://dx.doi.org/10.5607/en.2015.24.4.325Oxidative Stress in Neurodegeneration oxidative stress [56, 57].",Non-OADS,/arxiv_data1/oa_pdf/ce/81/en-24-325.PMC4688332.pdf
"330 www.enjournal.org http://dx.doi.org/10.5607/en.2015.24.4.325Geon Ha Kim, et al.",OADS,/arxiv_data1/oa_pdf/ce/81/en-24-325.PMC4688332.pdf
331 www.enjournal.org http://dx.doi.org/10.5607/en.2015.24.4.325Oxidative Stress in Neurodegeneration in PD [89].,Non-OADS,/arxiv_data1/oa_pdf/ce/81/en-24-325.PMC4688332.pdf
"332 www.enjournal.org http://dx.doi.org/10.5607/en.2015.24.4.325Geon Ha Kim, et al.",OADS,/arxiv_data1/oa_pdf/ce/81/en-24-325.PMC4688332.pdf
333 www.enjournal.org http://dx.doi.org/10.5607/en.2015.24.4.325Oxidative Stress in Neurodegeneration Table 1.,Non-OADS,/arxiv_data1/oa_pdf/ce/81/en-24-325.PMC4688332.pdf
"334 www.enjournal.org http://dx.doi.org/10.5607/en.2015.24.4.325Geon Ha Kim, et al.",OADS,/arxiv_data1/oa_pdf/ce/81/en-24-325.PMC4688332.pdf
335 www.enjournal.org http://dx.doi.org/10.5607/en.2015.24.4.325Oxidative Stress in Neurodegeneration results.,Non-OADS,/arxiv_data1/oa_pdf/ce/81/en-24-325.PMC4688332.pdf
"336 www.enjournal.org http://dx.doi.org/10.5607/en.2015.24.4.325Geon Ha Kim, et al.",OADS,/arxiv_data1/oa_pdf/ce/81/en-24-325.PMC4688332.pdf
337 www.enjournal.org http://dx.doi.org/10.5607/en.2015.24.4.325Oxidative Stress in Neurodegeneration astrocytes and neurons in the defense against reactive oxygen  species.,Non-OADS,/arxiv_data1/oa_pdf/ce/81/en-24-325.PMC4688332.pdf
"338 www.enjournal.org http://dx.doi.org/10.5607/en.2015.24.4.325Geon Ha Kim, et al.",OADS,/arxiv_data1/oa_pdf/ce/81/en-24-325.PMC4688332.pdf
339 www.enjournal.org http://dx.doi.org/10.5607/en.2015.24.4.325Oxidative Stress in Neurodegeneration 108.,Non-OADS,/arxiv_data1/oa_pdf/ce/81/en-24-325.PMC4688332.pdf
"340 www.enjournal.org http://dx.doi.org/10.5607/en.2015.24.4.325Geon Ha Kim, et al.",OADS,/arxiv_data1/oa_pdf/ce/81/en-24-325.PMC4688332.pdf
"The definitive pathophysiological Rosmarinic Acid Alleviates Neurological  Symptoms in the G93A-SOD1 Transgenic Mouse  Model of Amyotrophic Lateral Sclerosis Ji-Seon Seo1, Juli Choi1, Y ea-Hyun Leem2,3 and Pyung-Lim Han1,2,3* 1Department of Brain & Cognitive Sciences, 2Department of Chemistry & Nano Science, and 3Brain Disease Research  Institute, Ewha Womans University, Seoul 03760, Koreahttp://dx.doi.org/10.5607/en.2015.24.4.341 Exp Neurobiol.",Non-OADS,/arxiv_data1/oa_pdf/2b/cb/en-24-341.PMC4688333.pdf
"TEL: 82-2-3277-4130, FAX: 82-2-3277-3419 e-mail: plhan@ewha.ac.kr Copyright © Experimental Neurobiology 2015. www.enjournal.orgThis is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License  (http://creativecommons.org/licenses/by-nc/ 4.0) which permits unrestricted non-commercial use, distribution, and  reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/2b/cb/en-24-341.PMC4688333.pdf
"342 www.enjournal.org http://dx.doi.org/10.5607/en.2015.24.4.341Ji-Seon Seo, et al.",OADS,/arxiv_data1/oa_pdf/2b/cb/en-24-341.PMC4688333.pdf
343 www.enjournal.org http://dx.doi.org/10.5607/en.2015.24.4.341Neuroprotective Effects of Rosmarinic Acid in ALS Mice described [31].,Non-OADS,/arxiv_data1/oa_pdf/2b/cb/en-24-341.PMC4688333.pdf
"344 www.enjournal.org http://dx.doi.org/10.5607/en.2015.24.4.341Ji-Seon Seo, et al.",OADS,/arxiv_data1/oa_pdf/2b/cb/en-24-341.PMC4688333.pdf
345 www.enjournal.org http://dx.doi.org/10.5607/en.2015.24.4.341Neuroprotective Effects of Rosmarinic Acid in ALS Mice mg/kg.,Non-OADS,/arxiv_data1/oa_pdf/2b/cb/en-24-341.PMC4688333.pdf
"346 www.enjournal.org http://dx.doi.org/10.5607/en.2015.24.4.341Ji-Seon Seo, et al.",OADS,/arxiv_data1/oa_pdf/2b/cb/en-24-341.PMC4688333.pdf
347 www.enjournal.org http://dx.doi.org/10.5607/en.2015.24.4.341Neuroprotective Effects of Rosmarinic Acid in ALS Mice mice by 1~2 weeks [32].,Non-OADS,/arxiv_data1/oa_pdf/2b/cb/en-24-341.PMC4688333.pdf
"348 www.enjournal.org http://dx.doi.org/10.5607/en.2015.24.4.341Ji-Seon Seo, et al.",OADS,/arxiv_data1/oa_pdf/2b/cb/en-24-341.PMC4688333.pdf
349 www.enjournal.org http://dx.doi.org/10.5607/en.2015.24.4.341Neuroprotective Effects of Rosmarinic Acid in ALS Mice 19:31-37.,Non-OADS,/arxiv_data1/oa_pdf/2b/cb/en-24-341.PMC4688333.pdf
"350 www.enjournal.org http://dx.doi.org/10.5607/en.2015.24.4.341Ji-Seon Seo, et al.",OADS,/arxiv_data1/oa_pdf/2b/cb/en-24-341.PMC4688333.pdf
"Most ALS patients show focal onset of upper and lower  motor neuron signs and spread of symptoms to other regions or Pattern of Respiratory Deterioration in Sporadic  Amyotrophic Lateral Sclerosis According to Onset  Lesion by Using Respiratory Function Tests Dong-Gun Kim1, Y oon-Ho Hong2#, Je-Y oung Shin3, Kwang-Woo Lee3,   Kyung Seok Park1, Seung-Y ong Seong4 and Jung-Joon Sung3*# 1Department of Neurology, Seoul National University College of Medicine, Seoul National University Bundang Hospital,   2Department of Neurology,  Seoul National University College of Medicine, Seoul Metropolitan Government Boramae Medical  Center, 3Department of Neurology, Seoul National University College of Medicine, Seoul National University Hospital,  4Wide River Institute of Immunology, Department of Microbiology and Immunology, Department of Biomedical Sciences,  Seoul National University College of Medicine, Seoul 03080, Koreahttp://dx.doi.org/10.5607/en.2015.24.4.351 Exp Neurobiol.",Non-OADS,/arxiv_data1/oa_pdf/c8/ae/en-24-351.PMC4688334.pdf
"Copyright © Experimental Neurobiology 2015. www.enjournal.orgThis is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License  (http://creativecommons.org/licenses/by-nc/ 4.0) which permits unrestricted non-commercial use, distribution, and  reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/c8/ae/en-24-351.PMC4688334.pdf
"352 www.enjournal.org http://dx.doi.org/10.5607/en.2015.24.4.351Dong-Gun Kim, et al.",OADS,/arxiv_data1/oa_pdf/c8/ae/en-24-351.PMC4688334.pdf
"353 www.enjournal.org http://dx.doi.org/10.5607/en.2015.24.4.351MIP:MEP Ratio in ALS Forced vital capacity  FVC was measured in the sitting position with a spirometer  (Flowscreen® CT; ERT , Philadelphia, PA, USA).",OADS,/arxiv_data1/oa_pdf/c8/ae/en-24-351.PMC4688334.pdf
"354 www.enjournal.org http://dx.doi.org/10.5607/en.2015.24.4.351Dong-Gun Kim, et al.",OADS,/arxiv_data1/oa_pdf/c8/ae/en-24-351.PMC4688334.pdf
355 www.enjournal.org http://dx.doi.org/10.5607/en.2015.24.4.351MIP:MEP Ratio in ALS patients without respiratory failure because the aim of this study  was to evaluate changes in MIP and MEP between patients with  different onset regions.,Non-OADS,/arxiv_data1/oa_pdf/c8/ae/en-24-351.PMC4688334.pdf
"356 www.enjournal.org http://dx.doi.org/10.5607/en.2015.24.4.351Dong-Gun Kim, et al.",OADS,/arxiv_data1/oa_pdf/c8/ae/en-24-351.PMC4688334.pdf
357 www.enjournal.org http://dx.doi.org/10.5607/en.2015.24.4.351MIP:MEP Ratio in ALS Neurol Sci 169:13-21.,Non-OADS,/arxiv_data1/oa_pdf/c8/ae/en-24-351.PMC4688334.pdf
"In recent years, The Effect of Donor-Dependent Administration  of Human Umbilical Cord Blood-Derived  Mesenchymal Stem Cells following Focal Cerebral  Ischemia in Rats Hyung Woo Park1,2,3, Jong Wook Chang5, Y oon Sun Y ang4, Wonil Oh4,   Jae Ha Hwang1,2,3, Dong Gyu Kim1,2,3 and Sun Ha Paek1,2,3* 1Department of Neurosurgery, 2Cancer Research Institute, 3Ischemic/Hypoxic Disease Institute,   Seoul National University College of Medicine, Seoul 03082,   4Biomedical Research Institute, MEDIPOST Co., Ltd, Seoul 13494, 5Stem Cell & Regenerative Medicine Center,   Research Institute for Future Medicine, Samsung Medical Center, Seoul 06351, Koreahttp://dx.doi.org/10.5607/en.2015.24.4.358 Exp Neurobiol.",Non-OADS,/arxiv_data1/oa_pdf/3f/24/en-24-358.PMC4688335.pdf
"TEL: 82-2-2072-3993, FAX: 82-2-744-8459 e-mail: paeksh@snu.ac.kr Copyright © Experimental Neurobiology 2015. www.enjournal.orgThis is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License  (http://creativecommons.org/licenses/by-nc/ 4.0) which permits unrestricted non-commercial use, distribution, and  reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/3f/24/en-24-358.PMC4688335.pdf
359 www.enjournal.org http://dx.doi.org/10.5607/en.2015.24.4.358Effect of Donor-Dependent UCB-MSCs for Ischemia the use of mesenchymal stem cells (MSCs) has received attention  as a new alternative for treating this disease.,Non-OADS,/arxiv_data1/oa_pdf/3f/24/en-24-358.PMC4688335.pdf
"360 www.enjournal.org http://dx.doi.org/10.5607/en.2015.24.4.358Hyung Woo Park, et al.",OADS,/arxiv_data1/oa_pdf/3f/24/en-24-358.PMC4688335.pdf
361 www.enjournal.org http://dx.doi.org/10.5607/en.2015.24.4.358Effect of Donor-Dependent UCB-MSCs for Ischemia HeNe 543 and HeNe 633).,Non-OADS,/arxiv_data1/oa_pdf/3f/24/en-24-358.PMC4688335.pdf
"362 www.enjournal.org http://dx.doi.org/10.5607/en.2015.24.4.358Hyung Woo Park, et al.",OADS,/arxiv_data1/oa_pdf/3f/24/en-24-358.PMC4688335.pdf
"363 www.enjournal.org http://dx.doi.org/10.5607/en.2015.24.4.358Effect of Donor-Dependent UCB-MSCs for Ischemia ration enhanced angiogenesis in endothelial cells or endogenous  astroglia, we performed double-labeled immunohistochemistry  with GFAP and anti-human nuclei, and laminin and anti-human  nuclei.",Non-OADS,/arxiv_data1/oa_pdf/3f/24/en-24-358.PMC4688335.pdf
"364 www.enjournal.org http://dx.doi.org/10.5607/en.2015.24.4.358Hyung Woo Park, et al.",OADS,/arxiv_data1/oa_pdf/3f/24/en-24-358.PMC4688335.pdf
365 www.enjournal.org http://dx.doi.org/10.5607/en.2015.24.4.358Effect of Donor-Dependent UCB-MSCs for Ischemia 6.,Non-OADS,/arxiv_data1/oa_pdf/3f/24/en-24-358.PMC4688335.pdf
"Here, we firstly report a case of ICVS without intracranial  hemorrhage that was caused by acute spontaneous spinal SDH.Intracranial Vasospasm without Intracranial  Hemorrhage due to Acute Spontaneous Spinal  Subdural Hematoma Jung-Hwan Oh1, Seung-Joo Jwa1, Tae Ki Y ang2, Chang Sub Lee2,   Kyungmi Oh3 and Ji-Hoon Kang1* Departments of 1Neurology and 2Neurosurgery, Jeju National University Hospital, Jeju 63241,   3Department of Neurology, Korea University Medical Center, Seoul 02841, Koreahttp://dx.doi.org/10.5607/en.2015.24.4.366 Exp Neurobiol.",Non-OADS,/arxiv_data1/oa_pdf/0e/35/en-24-366.PMC4688336.pdf
"TEL: 82-64-717-1620, FAX: 82-64-757-8276 e-mail: jhkang@jejunu.ac.kr Copyright © Experimental Neurobiology 2015. www.enjournal.orgThis is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License  (http://creativecommons.org/licenses/by-nc/ 4.0) which permits unrestricted non-commercial use, distribution, and  reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/0e/35/en-24-366.PMC4688336.pdf
367 www.enjournal.org http://dx.doi.org/10.5607/en.2015.24.4.366ICVS due to Spinal SDH CASE A 41-year-old woman was admitted to our hospital with a  complaint of severe headache.,Non-OADS,/arxiv_data1/oa_pdf/0e/35/en-24-366.PMC4688336.pdf
"368 www.enjournal.org http://dx.doi.org/10.5607/en.2015.24.4.366Jung-Hwan Oh, et al.",OADS,/arxiv_data1/oa_pdf/0e/35/en-24-366.PMC4688336.pdf
369 www.enjournal.org http://dx.doi.org/10.5607/en.2015.24.4.366ICVS due to Spinal SDH was larger than the left side ( Fig.,Non-OADS,/arxiv_data1/oa_pdf/0e/35/en-24-366.PMC4688336.pdf
"370 www.enjournal.org http://dx.doi.org/10.5607/en.2015.24.4.366Jung-Hwan Oh, et al.",OADS,/arxiv_data1/oa_pdf/0e/35/en-24-366.PMC4688336.pdf
"Martin et al., using a TaqMan  Low Density Array, discovered a total of 41 differentially  expressed miRNAs (DE-miRs) between 12 RB samples and  three healthy retina samples in humans, including 13 previ - ously identified miRNAs ( miR-17 , miR-20b , miR-22 , miR-25 ,  miR-34a , miR-34c-5p , miR-106a , miR-106b , miR-93 , miR-129 , Molecular Vision  2015; 21:1307-1317 <http://www.molvis.org/molvis/v 21/1307 > Received 22 September 2015 | Accepted 12 December 2015 | Published 14 December 2015© 2015 Molecular Vision 1307miRNA signature identification of retinoblastoma and the  correlations between differentially expressed miRNAs during  retinoblastoma progression Yang Yang,1 Qi Mei2 1Department of Ophthalmology, Renmin Hospital of Wuhan University, Wuhan, China; 2Department of Oncology, Tongji Hospital,  Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China Purpose:  Retinoblastoma (RB) is a common pediatric cancer.",Non-OADS,/arxiv_data1/oa_pdf/96/ba/mv-v21-1307.PMC4688417.pdf
"Molecular Vision  2015; 21:1307-1317 <http://www.molvis.org/molvis/v 21/1307 > © 2015 Molecular Vision  1308miR-193–5p , miR-342–5p , miR-370 ) in human and mouse RB  and many novel miRNAs, such as miR-18a , miR-138 , miR-155 ,  miR-382 , and miR-504  [14].",Non-OADS,/arxiv_data1/oa_pdf/96/ba/mv-v21-1307.PMC4688417.pdf
Molecular Vision  2015; 21:1307-1317 <http://www.molvis.org/molvis/v 21/1307 > © 2015 Molecular Vision  1309mapped into the TRASFAC  database [ 23] to further screen  the potential transcription factors (TFs).,OADS,/arxiv_data1/oa_pdf/96/ba/mv-v21-1307.PMC4688417.pdf
"Molecular Vision  2015; 21:1307-1317 <http://www.molvis.org/molvis/v 21/1307 > © 2015 Molecular Vision  1310predominant correlated miRNA interactions were hsa-let-7b   and hsa-miR-125b  (the common target genes were CDC25A ,  LIN28A , and CDK6 ); and hsa-miR-18a , hsa-miR-20a , and  hsa-miR-25  (the common target gene was BCL2L11 ).",Non-OADS,/arxiv_data1/oa_pdf/96/ba/mv-v21-1307.PMC4688417.pdf
Molecular Vision  2015; 21:1307-1317 <http://www.molvis.org/molvis/v 21/1307 > © 2015 Molecular Vision  1311the prognosis and prediction of RB development.,Non-OADS,/arxiv_data1/oa_pdf/96/ba/mv-v21-1307.PMC4688417.pdf
"Molecular Vision  2015; 21:1307-1317 <http://www.molvis.org/molvis/v 21/1307 > © 2015 Molecular Vision  1312shared the common target gene BCL2L11 ; hsa-let-7b  and hsa- miR-125b  targeted three genes, CDC25A , CDK6 , and LIN28A .",Non-OADS,/arxiv_data1/oa_pdf/96/ba/mv-v21-1307.PMC4688417.pdf
Molecular Vision  2015; 21:1307-1317 <http://www.molvis.org/molvis/v 21/1307 > © 2015 Molecular Vision  1313 Figure 4.,Non-OADS,/arxiv_data1/oa_pdf/96/ba/mv-v21-1307.PMC4688417.pdf
"Molecular Vision  2015; 21:1307-1317 <http://www.molvis.org/molvis/v 21/1307 > © 2015 Molecular Vision  1314has been demonstrated to be the downstream of miR-125b ,  and by binding to the 3′ untranslated region (UTR) region of  LIN28B , miR-125b  successfully inhibited the cell growth in  hepatocellular carcinoma [ 42].",Non-OADS,/arxiv_data1/oa_pdf/96/ba/mv-v21-1307.PMC4688417.pdf
"Molecular Vision  2015; 21:1307-1317 <http://www.molvis.org/molvis/v 21/1307 > © 2015 Molecular Vision  1315In conclusion, a set of critical miRNA signatures was  identified in RB progression.",Non-OADS,/arxiv_data1/oa_pdf/96/ba/mv-v21-1307.PMC4688417.pdf
Molecular Vision  2015; 21:1307-1317 <http://www.molvis.org/molvis/v 21/1307 > © 2015 Molecular Vision  131623.,Non-OADS,/arxiv_data1/oa_pdf/96/ba/mv-v21-1307.PMC4688417.pdf
Molecular Vision  2015; 21:1307-1317 <http://www.molvis.org/molvis/v 21/1307 > © 2015 Molecular Vision  1317control the alternative splicing of apoptotic regulators.,Non-OADS,/arxiv_data1/oa_pdf/96/ba/mv-v21-1307.PMC4688417.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/af/eb/main.PMC4688430.pdf
"Production and hosting by ElsevierThe Saudi Dental Journal (2016) 28,4 4–48 King Saud University The Saudi Dental Journal www.ksu.edu.sa www.sciencedirect.com http://dx.doi.org/10.1016/j.sdentj.2015.01.005 1013-9052 ª2015 The Authors.",Non-OADS,/arxiv_data1/oa_pdf/af/eb/main.PMC4688430.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/af/eb/main.PMC4688430.pdf
http://dx.doi.org/10.4103/0974- 7761.121264 .,Non-OADS,/arxiv_data1/oa_pdf/af/eb/main.PMC4688430.pdf
"Production and hosting by ElsevierThe Saudi Dental Journal (2016) 28,1 8–23 King Saud University The Saudi Dental Journal www.ksu.edu.sa www.sciencedirect.com http://dx.doi.org/10.1016/j.sdentj.2015.05.003 1013-9052 /C2112015 The Authors.",Non-OADS,/arxiv_data1/oa_pdf/e9/3a/main.PMC4688431.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/e9/3a/main.PMC4688431.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/e9/3a/main.PMC4688431.pdf
"Production and hosting by ElsevierThe Saudi Dental Journal (2016) 28,4 9–55 King Saud University The Saudi Dental Journal www.ksu.edu.sa www.sciencedirect.com http://dx.doi.org/10.1016/j.sdentj.2015.09.001 1013-9052 /C2112015 The Authors.",Non-OADS,/arxiv_data1/oa_pdf/c7/11/main.PMC4688433.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/c7/11/main.PMC4688433.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/c7/11/main.PMC4688433.pdf
"Production and hosting by ElsevierThe Saudi Dental Journal (2016) 28,3 6–43 King Saud University The Saudi Dental Journal www.ksu.edu.sa www.sciencedirect.com http://dx.doi.org/10.1016/j.sdentj.2015.05.004 1013-9052 /C2112015 The Authors.",Non-OADS,/arxiv_data1/oa_pdf/3f/c5/main.PMC4688435.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/3f/c5/main.PMC4688435.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/3f/c5/main.PMC4688435.pdf
"2013 Available at: < http://www.ada.org/~/media/CODA/ Files/predoc_2013.ashx > (accessed 31.10.14) Derous, E., Ryan, A.M., 2008.",OADS,/arxiv_data1/oa_pdf/3f/c5/main.PMC4688435.pdf
"Available at:<http://nsse.iub.edu/NSSE_2011_Results/pdf/NSSE_2011_Annual Results.pdf#page=11 > (accessed 31.10.14) Pau, A., Rowland, M.L., Naidoo, S., et al, 2007.",OADS,/arxiv_data1/oa_pdf/3f/c5/main.PMC4688435.pdf
"Production and hosting by ElsevierThe Saudi Dental Journal (2016) 28,2 4–30 King Saud University The Saudi Dental Journal www.ksu.edu.sa www.sciencedirect.com http://dx.doi.org/10.1016/j.sdentj.2015.03.005 1013-9052 /C2112015 The Authors.",Non-OADS,/arxiv_data1/oa_pdf/49/13/main.PMC4688436.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/49/13/main.PMC4688436.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/49/13/main.PMC4688436.pdf
"BMC Public Health 9(12), 855. http://dx.doi.org/10.1186/1471-2458-12-855 .",Non-OADS,/arxiv_data1/oa_pdf/49/13/main.PMC4688436.pdf
"Production and hosting by ElsevierThe Saudi Dental Journal (2016) 28,5 6–61 King Saud University The Saudi Dental Journal www.ksu.edu.sa www.sciencedirect.com http://dx.doi.org/10.1016/j.sdentj.2015.08.003 1013-9052 /C2112015 The author.",Non-OADS,/arxiv_data1/oa_pdf/2a/86/main.PMC4688437.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/2a/86/main.PMC4688437.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/2a/86/main.PMC4688437.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/9a/19/main.PMC4688438.pdf
"Production and hosting by ElsevierThe Saudi Dental Journal (2016) 28,3–11 King Saud University The Saudi Dental Journal www.ksu.edu.sa www.sciencedirect.com http://dx.doi.org/10.1016/j.sdentj.2015.01.006 1013-9052 ª2015 The Author.",Non-OADS,/arxiv_data1/oa_pdf/9a/19/main.PMC4688438.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/9a/19/main.PMC4688438.pdf
http://dx.doi.org/ 10.1590/S2176-94512013000600021 (SPECIAL ARTICLE).,Non-OADS,/arxiv_data1/oa_pdf/9a/19/main.PMC4688438.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/4c/a1/main.PMC4688439.pdf
http://dx.doi.org/10.1016/j.fob.2015.10.004 2211-5463/ /C2112015 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/4c/a1/main.PMC4688439.pdf
"This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).Abbreviations: MRSA, methicillin-resistant Staphylococcus aureus ; MDR, multi-drug resistant; VipTx-I and VipTx-II, viperatoxins I and II; PLA 2, phospholipase A 2; MTXs, myotoxins; MALDI-TOF/MS, matrix-assisted laser desorption ionization-time of ﬂight/mass spectrometer; MH, Mueller Hinton; TS, Tryptic Soya; MI Cs, minimum inhibitory concentrations; SEM, scanning electron microscopy; TEM, transmission electron microscopy ⇑Corresponding author at: Department of Physiology, NUS Immunology Programme, Centre for Life Sciences, Yong Loo Lin School of Medicine, National Un iversity Health System, National University of Singapore, Singapore 117456.",Non-OADS,/arxiv_data1/oa_pdf/4c/a1/main.PMC4688439.pdf
The resulting amino acid (AA) sequences were submitted to Basic Local Alignment Search Tool (BLAST) forsequence similarity search ( http://web.expasy.org/cgi-bin/blast/ blast.pl ) by using the ExPASy World Wide Web (WWW) molecular biology server of the Swiss Institute of Bioinformatics (SIB).,OADS,/arxiv_data1/oa_pdf/4c/a1/main.PMC4688439.pdf
"Supplementary data Supplementary data associated with this article can be found, in the online version, at http://dx.doi.org/10.1016/j.fob.2015.10.004 .",OADS,/arxiv_data1/oa_pdf/4c/a1/main.PMC4688439.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/ee/9f/main.PMC4688443.pdf
"Further, to http://dx.doi.org/10.1016/j.fob.2015.11.003 2211-5463/ /C2112015 The Authors.",Non-OADS,/arxiv_data1/oa_pdf/ee/9f/main.PMC4688443.pdf
"This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).Abbreviations: GRAVY, grand average of hydropathicity; Hop, Hsp70/90 orga- nizing protein; Hsps, heat shock proteins; M domain, middle domain; ML,Maximum Likelihood; MSA, multiple sequence analysis; NJ, Neighbor Joining ⇑Corresponding author.",Non-OADS,/arxiv_data1/oa_pdf/ee/9f/main.PMC4688443.pdf
"Supplementary data Supplementary data associated with this article can be found, in the online version, at http://dx.doi.org/10.1016/j.fob.2015.11.003 .",OADS,/arxiv_data1/oa_pdf/ee/9f/main.PMC4688443.pdf
"5, 1–3, http://dx.doi.org/10.2174/1874104501105010001 .",Non-OADS,/arxiv_data1/oa_pdf/ee/9f/main.PMC4688443.pdf
"4, 727–740, http://dx.doi.org/10.1038/nrd1824 .",Non-OADS,/arxiv_data1/oa_pdf/ee/9f/main.PMC4688443.pdf
"Acta 1823, 707–711, http://dx.doi.org/10.1016/j.bbamcr.2011.12.003 .",OADS,/arxiv_data1/oa_pdf/ee/9f/main.PMC4688443.pdf
"278, 18336–18345, http://dx.doi.org/10.1074/jbc.",Non-OADS,/arxiv_data1/oa_pdf/ee/9f/main.PMC4688443.pdf
"17, 1527–1533, http://dx.doi.org/10.1016/j.",Non-OADS,/arxiv_data1/oa_pdf/ee/9f/main.PMC4688443.pdf
"79, 129–168,http://dx.doi.org/10.1016/S0163-7258(98)00013-8 .",Non-OADS,/arxiv_data1/oa_pdf/ee/9f/main.PMC4688443.pdf
"9, 92–101 (http://www.ncbi.nlm.nih.gov/pubmed/10047588) .",Non-OADS,/arxiv_data1/oa_pdf/ee/9f/main.PMC4688443.pdf
"285, 37964–37975, http://dx.doi.org/10.1074/jbc.M110.155317 .",Non-OADS,/arxiv_data1/oa_pdf/ee/9f/main.PMC4688443.pdf
"53, 3552–3557, http://dx.doi.org/10.1021/ jm901796s .",Non-OADS,/arxiv_data1/oa_pdf/ee/9f/main.PMC4688443.pdf
"33, 511–518, http://dx.doi.org/10.1093/nar/gki198 .",Non-OADS,/arxiv_data1/oa_pdf/ee/9f/main.PMC4688443.pdf
"Bioinformatics 25, 1189–1191, http://dx.doi.org/10.1093/ bioinformatics/btp033 .",Non-OADS,/arxiv_data1/oa_pdf/ee/9f/main.PMC4688443.pdf
"28,2731–2739, http://dx.doi.org/10.1093/molbev/msr121 .",Non-OADS,/arxiv_data1/oa_pdf/ee/9f/main.PMC4688443.pdf
"Evol., 65–73, http://dx.doi.org/10.1007/ s00236-001-2304-y .",Non-OADS,/arxiv_data1/oa_pdf/ee/9f/main.PMC4688443.pdf
"25, 1307–1320, http://dx.doi.org/10.1093/molbev/ msn067 .",Non-OADS,/arxiv_data1/oa_pdf/ee/9f/main.PMC4688443.pdf
"47, 583–621, http://dx.doi.org/10.1080/ 01621459.1952.10483441 .",Non-OADS,/arxiv_data1/oa_pdf/ee/9f/main.PMC4688443.pdf
"294, 1351–1362, http://dx.doi.org/10.1006/jmbi.1999.3310 .",Non-OADS,/arxiv_data1/oa_pdf/ee/9f/main.PMC4688443.pdf
"234, 779–815, http://dx.doi.org/10.1006/ jmbi.1993.1626 .",Non-OADS,/arxiv_data1/oa_pdf/ee/9f/main.PMC4688443.pdf
"33, 244–248, http://dx.doi.org/10.1093/nar/gki408 .",Non-OADS,/arxiv_data1/oa_pdf/ee/9f/main.PMC4688443.pdf
"37, W202–W208, http://dx.doi.org/10.1093/nar/gkp335 .",Non-OADS,/arxiv_data1/oa_pdf/ee/9f/main.PMC4688443.pdf
"110, 141–145 (http://www.ncbi.nlm.nih.gov/pubmed/1939021) .",Non-OADS,/arxiv_data1/oa_pdf/ee/9f/main.PMC4688443.pdf
"Genomics 86, 627–637, http://dx.doi.org/10.1016/j.",OADS,/arxiv_data1/oa_pdf/ee/9f/main.PMC4688443.pdf
"322, 359–378, http://dx.doi.org/10.1002/jez.b.22541 .",Non-OADS,/arxiv_data1/oa_pdf/ee/9f/main.PMC4688443.pdf
"Cell 90, 65–75, http://dx.doi.org/ 10.1016/S0092-8674(00)80314-1 .",OADS,/arxiv_data1/oa_pdf/ee/9f/main.PMC4688443.pdf
"283, 11677–11688, http://dx.doi.org/10.1074/jbc.M709516200 .",Non-OADS,/arxiv_data1/oa_pdf/ee/9f/main.PMC4688443.pdf
"284, 22559– 22567, http://dx.doi.org/10.1074/jbc.M109.031658 .",Non-OADS,/arxiv_data1/oa_pdf/ee/9f/main.PMC4688443.pdf
"4, 155–161, http://dx.doi.org/10.1093/protein/4.2.155 .",OADS,/arxiv_data1/oa_pdf/ee/9f/main.PMC4688443.pdf
"88, 1895–1898 (http://www.ncbi.nlm.nih.gov/pubmed/7462208) .",Non-OADS,/arxiv_data1/oa_pdf/ee/9f/main.PMC4688443.pdf
"157, 105–132, http://dx.doi.",Non-OADS,/arxiv_data1/oa_pdf/ee/9f/main.PMC4688443.pdf
"281, 14361–14369, http://dx.doi.org/10.1074/jbc.M512613200 .",Non-OADS,/arxiv_data1/oa_pdf/ee/9f/main.PMC4688443.pdf
"Biochemistry 43, 15510–15519, http://dx.doi.org/10.1021/bi048736m .",Non-OADS,/arxiv_data1/oa_pdf/ee/9f/main.PMC4688443.pdf
"18, 61–66, http://dx.doi.org/10.1038/nsmb.1965 .",Non-OADS,/arxiv_data1/oa_pdf/ee/9f/main.PMC4688443.pdf
"Cell Cycle 9, 2310–2316, http://dx.doi.org/10.4161/ cc.9.12.12054 .",Non-OADS,/arxiv_data1/oa_pdf/ee/9f/main.PMC4688443.pdf
"Acta 1823, 648–655, http://dx.doi.org/10.1016/j.bbamcr.2011.07.018 .",OADS,/arxiv_data1/oa_pdf/ee/9f/main.PMC4688443.pdf
"2012, 648–655, http://dx.doi.org/10.1016/j.bbamcr.2011.07.018 .",OADS,/arxiv_data1/oa_pdf/ee/9f/main.PMC4688443.pdf
"290, 17029– 17040, http://dx.doi.org/10.1074/jbc.M114.624106 .",Non-OADS,/arxiv_data1/oa_pdf/ee/9f/main.PMC4688443.pdf
"278, 37344–37351,http://dx.doi.org/10.1074/jbc.M301508200 .",Non-OADS,/arxiv_data1/oa_pdf/ee/9f/main.PMC4688443.pdf
"89, 866–873, http://dx.doi.org/10.1161/ hh2201.100319 .",Non-OADS,/arxiv_data1/oa_pdf/ee/9f/main.PMC4688443.pdf
"57, 2524–2535, http://dx.doi.org/10.1021/jm401801 .",Non-OADS,/arxiv_data1/oa_pdf/ee/9f/main.PMC4688443.pdf
"Nature 386, 414–417, http://dx.doi.org/10.1038/ 386414a0 .",Non-OADS,/arxiv_data1/oa_pdf/ee/9f/main.PMC4688443.pdf
"Cell 131, 1190–1203, http://dx.doi.org/10.1016/j.cell.2007.11.025 .",OADS,/arxiv_data1/oa_pdf/ee/9f/main.PMC4688443.pdf
"USA 105, 10762–10767, http://dx.doi.org/10.1073/ pnas.0805139105 .",Non-OADS,/arxiv_data1/oa_pdf/ee/9f/main.PMC4688443.pdf
"278, 2066–2071, http://dx.doi.org/ 10.1074/jbc.M206697200 .",Non-OADS,/arxiv_data1/oa_pdf/ee/9f/main.PMC4688443.pdf
"Science 316, 1160–1166, http://dx.doi.",Non-OADS,/arxiv_data1/oa_pdf/ee/9f/main.PMC4688443.pdf
"Cell 127, 635–648, http://dx.doi.org/10.1016/j.cell.2006.09.026 .",OADS,/arxiv_data1/oa_pdf/ee/9f/main.PMC4688443.pdf
"Production and hosting by ElsevierThe Saudi Dental Journal (2016) 28,1–2 King Saud University The Saudi Dental Journal www.ksu.edu.sa www.sciencedirect.com http://dx.doi.org/10.1016/j.sdentj.2015.05.001 1013-9052 ª2015 The Author.",Non-OADS,/arxiv_data1/oa_pdf/59/63/main.PMC4688445.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/59/63/main.PMC4688445.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/13/ca/main.PMC4688450.pdf
"Production and hosting by ElsevierThe Saudi Dental Journal (2016) 28,3 1–35 King Saud University The Saudi Dental Journal www.ksu.edu.sa www.sciencedirect.com http://dx.doi.org/10.1016/j.sdentj.2015.08.001 1013-9052 /C2112015 The Authors.",Non-OADS,/arxiv_data1/oa_pdf/13/ca/main.PMC4688450.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/13/ca/main.PMC4688450.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/09/2e/main.PMC4688451.pdf
"Production and hosting by ElsevierThe Saudi Dental Journal (2016) 28,1 2–17 King Saud University The Saudi Dental Journal www.ksu.edu.sa www.sciencedirect.com http://dx.doi.org/10.1016/j.sdentj.2015.08.004 1013-9052 /C2112015 The Authors.",Non-OADS,/arxiv_data1/oa_pdf/09/2e/main.PMC4688451.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/09/2e/main.PMC4688451.pdf
1476-5586http://dx.doi.org/10.1016/j.neo.2015.11.006,OADS,/arxiv_data1/oa_pdf/72/ee/main.PMC4688562.pdf
1476-5586http://dx.doi.org/10.1016/j.neo.2015.11.007,OADS,/arxiv_data1/oa_pdf/35/00/main.PMC4688563.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/15/0d/main.PMC4688564.pdf
1476-5586 http://dx.doi.org/10.1016/j.neo.2015.11.005,OADS,/arxiv_data1/oa_pdf/15/0d/main.PMC4688564.pdf
"http://dx.doi.org/10.1038/nrc867 [Epub 2002/08/03, PubMed PMID: 12154351].",OADS,/arxiv_data1/oa_pdf/15/0d/main.PMC4688564.pdf
http://dx.doi.org/10.1038/ nrc1098 [PubMed PMID: 12778135].,OADS,/arxiv_data1/oa_pdf/15/0d/main.PMC4688564.pdf
http://dx.doi.org/10.,Non-OADS,/arxiv_data1/oa_pdf/15/0d/main.PMC4688564.pdf
http://dx.doi.org/10.1002/jcb.,Non-OADS,/arxiv_data1/oa_pdf/15/0d/main.PMC4688564.pdf
http://dx.doi.org/10.1007/s13277-013-1109-0 [PubMed PMID: 24026883].,OADS,/arxiv_data1/oa_pdf/15/0d/main.PMC4688564.pdf
http://dx.doi.org/10.1038/nature04524 [PubMed PMID: 16572175].,OADS,/arxiv_data1/oa_pdf/15/0d/main.PMC4688564.pdf
http://dx.doi.org/10.1002/jcb.21382 [PubMed PMID: 17471510].,OADS,/arxiv_data1/oa_pdf/15/0d/main.PMC4688564.pdf
"Breast Cancer Res Treat 126(1), 73 –83.http://dx.doi.org/10.1007/s10549-010-0889-9 [Epub 2010/04/20, PubMed PMID: 20401631].",Non-OADS,/arxiv_data1/oa_pdf/15/0d/main.PMC4688564.pdf
http://dx.doi.org/10.1007/s10585-013-9622-5 [PubMed PMID: 24173696].,OADS,/arxiv_data1/oa_pdf/15/0d/main.PMC4688564.pdf
"http://dx.doi.org/10.1007/s10549-011-1753-2 [Epub 2011/09/07, PubMed PMID: 21894461].",OADS,/arxiv_data1/oa_pdf/15/0d/main.PMC4688564.pdf
"BoneKEy rep 4, 689. http://dx.doi.org/10.1038/bonekey.2015.57 [PubMed PMID: 26029360; PMCID: 4440229].",OADS,/arxiv_data1/oa_pdf/15/0d/main.PMC4688564.pdf
http://dx.doi.org/10.,Non-OADS,/arxiv_data1/oa_pdf/15/0d/main.PMC4688564.pdf
"Nat Rev Cancer 1(1), 46 –54.http://dx.doi.org/10.1038/35094059 [Epub 2002/03/20, PubMed PMID: 11900251; PMCID: 2975572].",Non-OADS,/arxiv_data1/oa_pdf/15/0d/main.PMC4688564.pdf
"http://dx.doi.org/10.1038/nrc2618 [Epub 2009/03/13, PubMed PMID: 19279573; PMCID: 3251309].",OADS,/arxiv_data1/oa_pdf/15/0d/main.PMC4688564.pdf
"Breast Cancer Res 13(6), 227. http://dx.doi.org/10.1186/bcr2912 [Epub 2011/11/15, PubMed PMID: 22078026; PMCID: 3326543].",Non-OADS,/arxiv_data1/oa_pdf/15/0d/main.PMC4688564.pdf
http://dx.doi.org/10.1210/jc.2012-3634 [PubMed PMID: 23393168; PMCID: 3590487].,OADS,/arxiv_data1/oa_pdf/15/0d/main.PMC4688564.pdf
http://dx.doi.org/10.1111/nyas.12327 [PubMed PMID: 24650218; PMCID: 4049420].,OADS,/arxiv_data1/oa_pdf/15/0d/main.PMC4688564.pdf
"http://dx.doi.org/10.1007/s10555-013- 9484-y [Epub 2014/01/09, PubMed PMID: 24398857; PMCID: 4154371].",OADS,/arxiv_data1/oa_pdf/15/0d/main.PMC4688564.pdf
"http://dx.doi.org/10.1007/s11307-013-0685-0 [Epub 2013/09/07, PubMed PMID: 24008275].Neoplasia Vol.",Non-OADS,/arxiv_data1/oa_pdf/15/0d/main.PMC4688564.pdf
"J Vis Exp 97(e52656), 1–10.http://dx.doi.org/10.3791/52656 .",Non-OADS,/arxiv_data1/oa_pdf/15/0d/main.PMC4688564.pdf
"http://dx.doi.org/10.1016/j.ajpath.2011.10.036 [Epub 2011/12/23, PubMed PMID: 22189618; PMCID: 3349876].",OADS,/arxiv_data1/oa_pdf/15/0d/main.PMC4688564.pdf
http://dx.doi.org/10.1007/s12026-014-8491-6 [PubMed PMID: 24522699; PMCID: 4332596].,OADS,/arxiv_data1/oa_pdf/15/0d/main.PMC4688564.pdf
http://dx.doi.org/10.1016/j.bbrc.2010.,OADS,/arxiv_data1/oa_pdf/15/0d/main.PMC4688564.pdf
"Endocr Relat Cancer 21(2), 327– 341. http://dx.doi.org/10.1530/ERC-13-0158 [PubMed PMID: 24413608].",Non-OADS,/arxiv_data1/oa_pdf/15/0d/main.PMC4688564.pdf
http://dx.doi.org/10.1007/ s00256-007-0309-3 [PubMed PMID: 17492443].,OADS,/arxiv_data1/oa_pdf/15/0d/main.PMC4688564.pdf
http://dx.doi.org/10.1038/sj.onc.,Non-OADS,/arxiv_data1/oa_pdf/15/0d/main.PMC4688564.pdf
http://dx.doi.org/10.4161/adip.23645 [PubMed PMID: 23991363; PMCID: 3756105].,OADS,/arxiv_data1/oa_pdf/15/0d/main.PMC4688564.pdf
http://dx.doi.org/10.1016/j.ydbio.2010.,OADS,/arxiv_data1/oa_pdf/15/0d/main.PMC4688564.pdf
http://dx.doi.org/10.1158/0008-5472.CAN-10-3323 [PubMed PMID: 21459803].,OADS,/arxiv_data1/oa_pdf/15/0d/main.PMC4688564.pdf
http://dx.doi.org/10.1038/nrendo.2014.94 [PubMed PMID: 24935119; PMCID: 4374431].,OADS,/arxiv_data1/oa_pdf/15/0d/main.PMC4688564.pdf
http://dx.doi.org/10.1016/j.cy- togfr.2013.10.001 [PubMed PMID: 24210902].,OADS,/arxiv_data1/oa_pdf/15/0d/main.PMC4688564.pdf
"J Interferon Cytokine Res 33(12), 717– 727. http://dx.doi.org/10.1089/jir.2012.0168 [Epub 2013/07/23, PubMed PMID: 23869900].",OADS,/arxiv_data1/oa_pdf/15/0d/main.PMC4688564.pdf
http://dx.doi.org/10.1371/journal.pone.0067349 [PubMed PMID: 23826274; PMCID: 3694967].,OADS,/arxiv_data1/oa_pdf/15/0d/main.PMC4688564.pdf
http://dx.doi.org/10.1007/s10911-013-9308-2 [PubMed PMID: 24214584].,OADS,/arxiv_data1/oa_pdf/15/0d/main.PMC4688564.pdf
http://dx.doi.org/10.,Non-OADS,/arxiv_data1/oa_pdf/15/0d/main.PMC4688564.pdf
"http://dx.doi.org/10.1016/j.clbc.2013.08.001 [Epub 2013/10/03, PubMed PMID: 24084031].",OADS,/arxiv_data1/oa_pdf/15/0d/main.PMC4688564.pdf
http://dx.doi.org/10.1016/j.lfs.2015.04.012 [PubMed PMID: 25957709].,OADS,/arxiv_data1/oa_pdf/15/0d/main.PMC4688564.pdf
http://dx.doi.org/10.1158/1078-0432.,Non-OADS,/arxiv_data1/oa_pdf/15/0d/main.PMC4688564.pdf
http://dx.doi.org/10.1158/1078-0432.CCR-03-0749 [PubMed PMID: 15240518].,OADS,/arxiv_data1/oa_pdf/15/0d/main.PMC4688564.pdf
http://dx.doi.org/10.1002/ijc.21543 [PubMed PMID: 16206269].,OADS,/arxiv_data1/oa_pdf/15/0d/main.PMC4688564.pdf
"http://dx.doi.org/10.1530/ERC-11-0102 [Epub 2011/06/04, PubMed PMID: 21636700; PMCID: 3197719].",OADS,/arxiv_data1/oa_pdf/15/0d/main.PMC4688564.pdf
"http://dx.doi.org/10.1677/ERC- 09-0340 [Epub 2010/04/23, PubMed PMID:20410173].",OADS,/arxiv_data1/oa_pdf/15/0d/main.PMC4688564.pdf
http://dx.doi.org/10.3892/mmr.,Non-OADS,/arxiv_data1/oa_pdf/15/0d/main.PMC4688564.pdf
"Breast Cancer Res 17, 112. http://dx.doi.org/10.",Non-OADS,/arxiv_data1/oa_pdf/15/0d/main.PMC4688564.pdf
"http://dx.doi.org/10.1080/01635581.2014.894104 [Epub 2014/04/18, PubMed PMID: 24738610].",OADS,/arxiv_data1/oa_pdf/15/0d/main.PMC4688564.pdf
http://dx.doi.org/10.1093/carcin/bgq267 [PubMed PMID: 21163886; PMCID: 3105585].,OADS,/arxiv_data1/oa_pdf/15/0d/main.PMC4688564.pdf
http://dx.doi.org/10.1080/ 15384047.2015.1056409 [PubMed PMID: 26121010].,OADS,/arxiv_data1/oa_pdf/15/0d/main.PMC4688564.pdf
http://dx.doi.org/10.1158/1078-0432.CCR-05-1603 [PubMed PMID: 16489061].,OADS,/arxiv_data1/oa_pdf/15/0d/main.PMC4688564.pdf
http://dx.doi.org/10.,Non-OADS,/arxiv_data1/oa_pdf/15/0d/main.PMC4688564.pdf
http://dx.doi.org/10.1038/sj.ijo.0802142 [PubMed PMID: 12439643].,OADS,/arxiv_data1/oa_pdf/15/0d/main.PMC4688564.pdf
http://dx.doi.org/10.5897/ JDBTE2013.0065 [PubMed PMID: 24013643; PMCID: 3765027].,OADS,/arxiv_data1/oa_pdf/15/0d/main.PMC4688564.pdf
http://dx.doi.org/10.1359/jbmr.2001.16.8.1426 [PubMed PMID: 11499865].,OADS,/arxiv_data1/oa_pdf/15/0d/main.PMC4688564.pdf
http://dx.doi.org/10.1373/- clinchem.2010.146118 [PubMed PMID: 20530731].,OADS,/arxiv_data1/oa_pdf/15/0d/main.PMC4688564.pdf
http://dx.doi.org/10.1038/nm.,OADS,/arxiv_data1/oa_pdf/15/0d/main.PMC4688564.pdf
"http://dx.doi.org/10.1016/j.bbalip.2013.02.010 [Epub 2013/03/19, PubMed PMID: 23500888; PMCID: 3742583].",OADS,/arxiv_data1/oa_pdf/15/0d/main.PMC4688564.pdf
"http://dx.doi.org/10.1007/s10911-013- 9301-9 [Epub 2013/10/05, PubMed PMID: 24091864; PMCID: 3874287].",OADS,/arxiv_data1/oa_pdf/15/0d/main.PMC4688564.pdf
"http://dx.doi.org/10.1158/1078-0432 [Epub 2013/08/21, PubMed PMID: 23958744; PMCID: 3891839].",OADS,/arxiv_data1/oa_pdf/15/0d/main.PMC4688564.pdf
http://dx.doi.org/10.1158/1055-9965.EPI-12-1444 PubMed PMID: 23651666; PMCID: 4417498.,OADS,/arxiv_data1/oa_pdf/15/0d/main.PMC4688564.pdf
http://dx.doi.org/10.4143/crt.2013.45.3.210 [PubMed PMID: 24155680; PMCID: 3804733].,OADS,/arxiv_data1/oa_pdf/15/0d/main.PMC4688564.pdf
http://dx.doi.org/10.1093/jnci/djv169 [PubMed PMID: 26185195].Neoplasia Vol.,Non-OADS,/arxiv_data1/oa_pdf/15/0d/main.PMC4688564.pdf
1476-5586http://dx.doi.org/10.1016/j.neo.2015.11.008,OADS,/arxiv_data1/oa_pdf/ba/54/main.PMC4688565.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/e1/a0/main.PMC4688573.pdf
Kidney Research and Clinical Practice journal homepage: http://www.krcp-ksn.com Contents lists available at ScienceDirect http://dx.doi.org/10.1016/j.krcp.2015.10.002 2211-9132/Copyright ©2015.,Non-OADS,/arxiv_data1/oa_pdf/e1/a0/main.PMC4688573.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).Kidney Res Clin Pract 34 (2015) 207 e211,Non-OADS,/arxiv_data1/oa_pdf/e1/a0/main.PMC4688573.pdf
Some improvement in objective sleep parameters and mood were found in http://dx.doi.org/10.1016/j.slsci.2015.10.001 1984-0063/ &2015 Brazilian Association of Sleep.,Non-OADS,/arxiv_data1/oa_pdf/0c/05/main.PMC4688574.pdf
"This is an open access article under the CC BY- NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).Abbreviations: CFS, Chronic Fatigue Syndrome; CNS, central nervous system; FMA, faecal microbiota analysis; HPA, hypothalamic-pituitary adrenal; POMS, Pro ﬁle of Mood States; SFI, sleep fragmentation index; SOL, sleep onset latency; TST, total sleep time; WASO, wake after sleep onset; MALDI-TOF MS, matrix assisted laser desorption ionization –time of ﬂight mass spectrometry.",Non-OADS,/arxiv_data1/oa_pdf/0c/05/main.PMC4688574.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/0c/05/main.PMC4688574.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/43/af/main.PMC4688575.pdf
"One survey estimated that 7% of sleep problems were related to an uncomfortable mattress [5] contributing to poor quality of sleep or physical discomfort.Moreover, several studies indicate that a mattress withergonomic standards could improve the quality of sleep http://dx.doi.org/10.1016/j.slsci.2015.08.004 1984-0063/ &2015 Brazilian Association of Sleep.",Non-OADS,/arxiv_data1/oa_pdf/43/af/main.PMC4688575.pdf
This is an open access article under the CC BY- NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/43/af/main.PMC4688575.pdf
Available from: 〈http://www.ehow.com/info_12107876_vinyl- mattress-covers-make-sweat.html 〉; [accessed 02.01.15].,Non-OADS,/arxiv_data1/oa_pdf/43/af/main.PMC4688575.pdf
Available from: http://www.rti.org/rtipress .Sleep Science 8 (2015) 115–120 120,Non-OADS,/arxiv_data1/oa_pdf/43/af/main.PMC4688575.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/15/8a/main.PMC4688576.pdf
Kidney Research and Clinical Practice journal homepage: http://www.krcp-ksn.com Contents lists available at ScienceDirect http://dx.doi.org/10.1016/j.krcp.2015.10.006 2211-9132/ ©2015.,Non-OADS,/arxiv_data1/oa_pdf/15/8a/main.PMC4688576.pdf
Kidney Research and Clinical Practice journal homepage: http://www.krcp-ksn.com Contents lists available at ScienceDirect Kidney Res Clin Pract 34 (2015) 191 e193 http://dx.doi.org/10.1016/j.krcp.2015.08.007 2211-9132/Copyright ©2015.,Non-OADS,/arxiv_data1/oa_pdf/71/c5/main.PMC4688577.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/71/c5/main.PMC4688577.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/c2/75/main.PMC4688578.pdf
Kidney Research and Clinical Practice journal homepage: http://www.krcp-ksn.com Contents lists available at ScienceDirect http://dx.doi.org/10.1016/j.krcp.2015.09.002 2211-9132/Copyright ©2015.,Non-OADS,/arxiv_data1/oa_pdf/c2/75/main.PMC4688578.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).Kidney Res Clin Pract 34 (2015) 201 e206,Non-OADS,/arxiv_data1/oa_pdf/c2/75/main.PMC4688578.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/e9/c0/main.PMC4688579.pdf
"That is, the PPN inhibits the reticular thalamic nucleus (RTN) (which decreasesslow waves during sleep), and excites speci ﬁct h a l a m i cr e l a y http://dx.doi.org/10.1016/j.slsci.2015.09.004 1984-0063/ &2015 Brazilian Association of Sleep.",Non-OADS,/arxiv_data1/oa_pdf/e9/c0/main.PMC4688579.pdf
This is an open access article under the CC BY- NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/e9/c0/main.PMC4688579.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/7d/d2/main.PMC4688580.pdf
http://dx.doi.org/10.1016/j.slsci.2015.12.001 ☆Peer review under responsibility of Brazilian Association of Sleep.Sleep Science 8 (2015) 107,Non-OADS,/arxiv_data1/oa_pdf/7d/d2/main.PMC4688580.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/bb/f4/main.PMC4688581.pdf
"While there is strong evidence highlighting the cardiovascular riskof OSA [6,7], it has been proposed that other forms of sleep http://dx.doi.org/10.1016/j.slsci.2015.08.003 1984-0063/ &2015 Brazilian Association of Sleep.",Non-OADS,/arxiv_data1/oa_pdf/bb/f4/main.PMC4688581.pdf
This is an open access article under the CC BY- NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/bb/f4/main.PMC4688581.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/b1/74/main.PMC4688582.pdf
Kidney Research and Clinical Practice journal homepage: http://www.krcp-ksn.com Contents lists available at ScienceDirect http://dx.doi.org/10.1016/j.krcp.2015.06.001 2211-9132/Copyright ©2015.,Non-OADS,/arxiv_data1/oa_pdf/b1/74/main.PMC4688582.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).Kidney Res Clin Pract 34 (2015) 237 e240,Non-OADS,/arxiv_data1/oa_pdf/b1/74/main.PMC4688582.pdf
Kidney Research and Clinical Practice journal homepage: http://www.krcp-ksn.com Contents lists available at ScienceDirect http://dx.doi.org/10.1016/j.krcp.2015.10.001 2211-9132/Copyright ©2015.,Non-OADS,/arxiv_data1/oa_pdf/51/5b/main.PMC4688583.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).Kidney Res Clin Pract 34 (2015) 245 e246,Non-OADS,/arxiv_data1/oa_pdf/51/5b/main.PMC4688583.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/d3/7f/main.PMC4688584.pdf
Kidney Research and Clinical Practice journal homepage: http://www.krcp-ksn.com Contents lists available at ScienceDirect http://dx.doi.org/10.1016/j.krcp.2015.10.005 2211-9132/Copyright ©2015.,Non-OADS,/arxiv_data1/oa_pdf/d3/7f/main.PMC4688584.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).Kidney Res Clin Pract 34 (2015) 228 e232,Non-OADS,/arxiv_data1/oa_pdf/d3/7f/main.PMC4688584.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/d6/01/main.PMC4688585.pdf
The close http://dx.doi.org/10.1016/j.slsci.2015.09.002 1984-0063/ &2015 Brazilian Association of Sleep.,Non-OADS,/arxiv_data1/oa_pdf/d6/01/main.PMC4688585.pdf
This is an open access article under the CC BY- NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/d6/01/main.PMC4688585.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/e3/a3/main.PMC4688586.pdf
Kidney Research and Clinical Practice journal homepage: http://www.krcp-ksn.com Contents lists available at ScienceDirect http://dx.doi.org/10.1016/j.krcp.2015.05.007 2211-9132/Copyright ©2015.,Non-OADS,/arxiv_data1/oa_pdf/e3/a3/main.PMC4688586.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).Kidney Res Clin Pract 34 (2015) 233 e236,Non-OADS,/arxiv_data1/oa_pdf/e3/a3/main.PMC4688586.pdf
"” Available at: http://www.forest.go.kr/newkfsweb/cop/bbs/ selectBoardArticle.do?nttId ¼2978898 &bbsId ¼BBSMSTR_1036 &pa geUnit ¼10&pageIndex ¼2&searchtitle ¼title&searchcont ¼&search key¼&searchwriter ¼&searchWrd ¼&ctgryLrcls ¼CTGRY150 &ctgry Mdcls ¼&ctgrySmcls ¼&ntcStartDt ¼&ntcEndDt ¼&mn¼KFS_14_ 06_02 &orgId ¼kfri[Date accessed: 18 July 2014] [in Korean] [2]Ahn BM, Lee DS, Lee KM, Kang SB, Yang JM, Park YM, Lee YS, Chung KW, Sun HS, Park DH, Rho HJ, Kang YM, Lee JM, Hur JW,Choi SG, Kim JH, Lee SI, Choi SO, Choi HY, Kwon OS, Koo CD, Seok SJ, Kim YS: Amatoxins poisonings in Korea.",Non-OADS,/arxiv_data1/oa_pdf/e3/a3/main.PMC4688586.pdf
http://dx.doi.org/10.1016/j.slsci.2015.09.003 1984-0063/ &2015 Brazilian Association of Sleep.,Non-OADS,/arxiv_data1/oa_pdf/d4/97/main.PMC4688587.pdf
"This is an open access article under the CC BY- NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).Abbreviations: SlD, Sleep Disorders; OSA, obstructive sleep apnea; CSHQ-PT, Portuguese Children Sleep Habits Questionnaire; PHCC, Primary Health Care Center; BTR, bedtime resistance; SOD, sleep onset delay; SDur, sleep duration; PS, parasomnia;NW, night awakenings; SA, sleep anxiety; SDB, sleep disordered breathing; DTS, daytime sleepiness; BMI, body mass index;PSG, polysomnography ☆This work was done in Monte Abraão Primary Health Care Center and Hospital Professor Doutor Fernando Fonseca, in the Pediatric Department.",Non-OADS,/arxiv_data1/oa_pdf/d4/97/main.PMC4688587.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/d4/97/main.PMC4688587.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/cb/75/main.PMC4688588.pdf
http://dx.doi.org/10.1016/j.slsci.2015.08.002 1984-0063/ &2015 Brazilian Association of Sleep.,Non-OADS,/arxiv_data1/oa_pdf/cb/75/main.PMC4688588.pdf
"This is an open access article under the CC BY- NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).☆All the authors declare that there are no actual or potential con ﬂicts of interest, including ﬁnancial or personal interests or related to individuals or organizations that could have inﬂuenced the present study.",Non-OADS,/arxiv_data1/oa_pdf/cb/75/main.PMC4688588.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/85/ed/main.PMC4688589.pdf
It is worth noting that stimulation of the region of the PPN dates to the earliest http://dx.doi.org/10.1016/j.slsci.2015.09.001 1984-0063/ &2015 Brazilian Association of Sleep.,Non-OADS,/arxiv_data1/oa_pdf/85/ed/main.PMC4688589.pdf
"This is an open access article under the CC BY- NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).Abbreviations: DBS, deep brain stimulation; EEG, electroencephalogram; LC, locus coeruleus; PD, Parkinson's disease; PGO, ponto-geniculo-occipital; PPN, pedunculopontine nucleus; REM, rapid eye movement; RAS, reticular activating system;SN, substantia nigra; STN, subthalamic nucleus; SubCD, subcoeruleus nucleus dorsalis nCorrespondence to: Center for Translational Neuroscience, Department of Neurobiology and Developmental Sciences, University of Arkansas for Medical Sciences, Slot 847, 4301 West Markham St., Little Rock, AR 72205, USA.",Non-OADS,/arxiv_data1/oa_pdf/85/ed/main.PMC4688589.pdf
The gene expression data ob-tained in this work are available as a public Web page ( https://helixweb.nih.gov/ ESBL/Database/NephronRNAseq/ ) and can be used to explore the transcriptomic landscape of the nephron.,OADS,/arxiv_data1/oa_pdf/02/b3/main.PMC4688590.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/02/b3/main.PMC4688590.pdf
Kidney Research and Clinical Practice journal homepage: http://www.krcp-ksn.com Contents lists available at ScienceDirect http://dx.doi.org/10.1016/j.krcp.2015.08.008 2211-9132/Copyright ©2015.,Non-OADS,/arxiv_data1/oa_pdf/02/b3/main.PMC4688590.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).Kidney Res Clin Pract 34 (2015) 219 e227,Non-OADS,/arxiv_data1/oa_pdf/02/b3/main.PMC4688590.pdf
"For more general information on RNA-seq, the author would like to recommend a well-curated online Web site available athttp://rnaseq.uoregon.edu/ .",Non-OADS,/arxiv_data1/oa_pdf/02/b3/main.PMC4688590.pdf
5 forceps ( https://www.dumonttweezers.com/Tweezer/ Tweezer/469 ).,Non-OADS,/arxiv_data1/oa_pdf/02/b3/main.PMC4688590.pdf
"This graph was created using FastQC, a quality assessment tool available at http://www.bioinformatics.",OADS,/arxiv_data1/oa_pdf/02/b3/main.PMC4688590.pdf
(B) A snapshot of the Integrated Genome Viewer ( https://www.broadinstitute.org/igv/ ) shows RNA-seq reads mapping to Aqp2 in a sample prepared from microdissected cortical collecting ducts.,OADS,/arxiv_data1/oa_pdf/02/b3/main.PMC4688590.pdf
The annotation ﬁles are available at Ensembl ( http:// ensembl.org ) or University of California at Santa Cruz (UCSC) database ( http://genome.ucsc.edu ) in the general feature format (GTF) or browser extensible data (BED) format.,OADS,/arxiv_data1/oa_pdf/02/b3/main.PMC4688590.pdf
"The raw FASTQ sequences obtained from 105 samples of glomeruli and renal tubule segments are available at Gene Expression Omnibus (GSE56743, http://www.ncbi.nlm.",OADS,/arxiv_data1/oa_pdf/02/b3/main.PMC4688590.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/f7/4e/main.PMC4688591.pdf
Kidney Research and Clinical Practice journal homepage: http://www.krcp-ksn.com Contents lists available at ScienceDirect http://dx.doi.org/10.1016/j.krcp.2014.11.004 2211-9132/Copyright ©2015.,Non-OADS,/arxiv_data1/oa_pdf/f7/4e/main.PMC4688591.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).Kidney Res Clin Pract 34 (2015) 241 e244,Non-OADS,/arxiv_data1/oa_pdf/f7/4e/main.PMC4688591.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/39/6a/main.PMC4688592.pdf
Kidney Research and Clinical Practice journal homepage: http://www.krcp-ksn.com Contents lists available at ScienceDirect http://dx.doi.org/10.1016/j.krcp.2015.10.004 2211-9132/Copyright ©2015.,Non-OADS,/arxiv_data1/oa_pdf/39/6a/main.PMC4688592.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).Kidney Res Clin Pract 34 (2015) 194 e200,Non-OADS,/arxiv_data1/oa_pdf/39/6a/main.PMC4688592.pdf
"This is an open-access article distributed under the terms of the Creative Com - mons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material  just in noncommercial usages, provided the original work is properly cited.1.",Non-OADS,/arxiv_data1/oa_pdf/69/99/aapm-05-06-29299.PMC4688808.pdf
"This is an open-access article distributed under the terms of the Creative Com - mons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material  just in noncommercial usages, provided the original work is properly cited.1.",Non-OADS,/arxiv_data1/oa_pdf/48/cf/aapm-05-06-31640.PMC4688809.pdf
"This is an open-access article distributed under the terms of the Creative Com - mons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material  just in noncommercial usages, provided the original work is properly cited.1.",Non-OADS,/arxiv_data1/oa_pdf/56/d4/aapm-05-06-29366.PMC4688810.pdf
"This is an open-access article distributed under the terms of the Creative Com - mons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material  just in noncommercial usages, provided the original work is properly cited.1.",Non-OADS,/arxiv_data1/oa_pdf/2e/a4/aapm-05-06-31111.PMC4688811.pdf
"It was pro - spectively registered with clinicaltrials.gov (NCT01696188)  on September 13, 2012 (available at https://clinicaltrials.gov/ ct2/show/NCT01696188?term=interscalene+catheters&rank)  (8) in accordance with our institutional review board regu - lations.",Non-OADS,/arxiv_data1/oa_pdf/2e/a4/aapm-05-06-31111.PMC4688811.pdf
"This is an open-access article distributed under the terms of the Creative Com - mons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material  just in noncommercial usages, provided the original work is properly cited.1.",Non-OADS,/arxiv_data1/oa_pdf/47/64/aapm-05-06-32140.PMC4688812.pdf
"This is an open-access article distributed under the terms of the Creative Com - mons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material  just in noncommercial usages, provided the original work is properly cited.1.",Non-OADS,/arxiv_data1/oa_pdf/8c/bf/aapm-05-06-29698.PMC4688813.pdf
"This is an open-access article distributed under the terms of the Creative Com - mons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material  just in noncommercial usages, provided the original work is properly cited.1.",Non-OADS,/arxiv_data1/oa_pdf/65/8d/aapm-05-06-32299.PMC4688814.pdf
"This is an open-access article distributed under the terms of the Creative Com - mons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material  just in noncommercial usages, provided the original work is properly cited.1.",Non-OADS,/arxiv_data1/oa_pdf/43/06/aapm-05-06-28849.PMC4688815.pdf
"This is an open-access article distributed under the terms of the Creative Com - mons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material  just in noncommercial usages, provided the original work is properly cited.1.",Non-OADS,/arxiv_data1/oa_pdf/1a/aa/aapm-05-06-28804.PMC4688816.pdf
"This is an open-access article distributed under the terms of the Creative Com - mons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material  just in noncommercial usages, provided the original work is properly cited.1.",Non-OADS,/arxiv_data1/oa_pdf/eb/89/aapm-05-06-30062.PMC4688817.pdf
"This is an open-access article distributed under the terms of the Creative Com - mons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material  just in noncommercial usages, provided the original  work is properly cited.1.",Non-OADS,/arxiv_data1/oa_pdf/26/f9/aapm-05-06-32697.PMC4688818.pdf
"This is an open-access article distributed under the terms of the Creative Com - mons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material  just in noncommercial usages, provided the original work is properly cited.1.",Non-OADS,/arxiv_data1/oa_pdf/ba/74/aapm-05-06-32105.PMC4688819.pdf
"This is an open-access article distributed under the terms of the Creative Com - mons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material  just in noncommercial usages, provided the original work is properly cited.1.",Non-OADS,/arxiv_data1/oa_pdf/33/cd/aapm-05-06-31524.PMC4688820.pdf
"This is an open-access article distributed under the terms of the Creative Com - mons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material  just in noncommercial usages, provided the original work is properly cited.1.",Non-OADS,/arxiv_data1/oa_pdf/55/92/aapm-05-06-24025.PMC4688821.pdf
"This is an open-access article distributed under the terms of the Creative Com - mons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material  just in noncommercial usages, provided the original work is properly cited.1.",Non-OADS,/arxiv_data1/oa_pdf/9b/75/aapm-05-06-30643.PMC4688822.pdf
"However, we believe that http://dx.doi.org/10.1016/j.gore.2015.04.003 2352-5789/© 2015 The Authors.",Non-OADS,/arxiv_data1/oa_pdf/bb/91/main.PMC4688823.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/bb/91/main.PMC4688823.pdf
http://dx.doi.org/10.1111/cyt.12027 .,Non-OADS,/arxiv_data1/oa_pdf/bb/91/main.PMC4688823.pdf
Contents lists available at ScienceDirect Gynecologic Oncology Reports journal homepage: www.elsevier.com/locate/gore http://dx.doi.org/10.1016/j.gore.2015.07.004 2352-5789/© 2015 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/f2/ee/main.PMC4688824.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/f2/ee/main.PMC4688824.pdf
"The International In ﬂammatory Brain Disease Outcome Study Retrieved from: bhttp://www.sickkids.ca/pdfs/Research/BrainWorks/62062- Antibody%20IBrainD.pdf N. Dalmau, J., Tüzün, E., 2007.",Non-OADS,/arxiv_data1/oa_pdf/f2/ee/main.PMC4688824.pdf
"After the last cycle, the patient had worsening abdominal pain and a Contents lists available at ScienceDirect Gynecologic Oncology Reports journal homepage: www.elsevier.com/locate/gore http://dx.doi.org/10.1016/j.gore.2015.08.002 2352-5789/© 2015 The Authors.",Non-OADS,/arxiv_data1/oa_pdf/3b/cd/main.PMC4688825.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/3b/cd/main.PMC4688825.pdf
"Clear, straw-colored ascites Contents lists available at ScienceDirect Gynecologic Oncology Reports journal homepage: www.elsevier.com/locate/gore http://dx.doi.org/10.1016/j.gore.2015.08.001 2352-5789/© 2015 The Authors.",Non-OADS,/arxiv_data1/oa_pdf/a9/49/main.PMC4688826.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/a9/49/main.PMC4688826.pdf
Based on the World Health Organiza- tion revised criteria this patient's original tumor met criteria for the smooth muscle tumor of uncertain malignant potential (STUMP) sub- group of ‘atypical leiomyoma with limited experience ’due to lack of tumor cell necrosis and less than 10 mitotic ﬁgures per high powered Contents lists available at ScienceDirect Gynecologic Oncology Reports journal homepage: www.elsevier.com/locate/gore http://dx.doi.org/10.1016/j.gore.2015.07.006 2352-5789/© 2015 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/77/06/main.PMC4688827.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/77/06/main.PMC4688827.pdf
30 September 2014Gynecologic Oncology Reports 14 (2015) 41 http://dx.doi.org/10.1016/j.gore.2014.10.005 2352-5789/© 2014 The Author.,Non-OADS,/arxiv_data1/oa_pdf/88/da/main.PMC4688828.pdf
This is an open access article under the CC BY-NC-ND 4.0 license ( http://creativecommons.org/licenses/by/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/88/da/main.PMC4688828.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/be/e4/main.PMC4688829.pdf
Contents lists available at ScienceDirect Gynecologic Oncology Reports journal homepage: www.elsevier.com/locate/gore http://dx.doi.org/10.1016/j.gore.2015.08.003 2352-5789/© 2015 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/be/e4/main.PMC4688829.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/be/e4/main.PMC4688829.pdf
(Mar 21. http://dx.doi.org/10.1016/j.ygyno.2015.03.041 [Epub ahead of print]).,Non-OADS,/arxiv_data1/oa_pdf/be/e4/main.PMC4688829.pdf
Available from: http://www.nccn.org /).,Non-OADS,/arxiv_data1/oa_pdf/be/e4/main.PMC4688829.pdf
http://dx.doi.org/10.1016/j.gore.2015.08.004 2352-5789/© 2015 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/d9/06/main.PMC4688864.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/d9/06/main.PMC4688864.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/32/ec/main.PMC4688880.pdf
Contents lists available at ScienceDirect Gynecologic Oncology Reports journal homepage: www.elsevier.com/locate/gore http://dx.doi.org/10.1016/j.gore.2015.10.003 2352-5789/© 2015 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/32/ec/main.PMC4688880.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/32/ec/main.PMC4688880.pdf
Contents lists available at ScienceDirect Gynecologic Oncology Reports journal homepage: www.elsevier.com/locate/gore http://dx.doi.org/10.1016/j.gore.2015.10.002 2352-5789/© 2015 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/69/9a/main.PMC4688881.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/69/9a/main.PMC4688881.pdf
Contents lists available at ScienceDirect Gynecologic Oncology Reports journal homepage: www.elsevier.com/locate/gore http://dx.doi.org/10.1016/j.gore.2015.09.004 2352-5789/© 2015 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/13/f4/main.PMC4688882.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/13/f4/main.PMC4688882.pdf
"http://www.cancer.gov/cancertopics/pdq/treatment/cervical/ HealthProfessional/page1 (accessed 5/13/2015) Chiantera, V., Rossi, M., De Iaco, P., Koehler, C., Marnitz, S., Ferrandina, G., et al., 2014.",Non-OADS,/arxiv_data1/oa_pdf/13/f4/main.PMC4688882.pdf
Contents lists available at ScienceDirect Gynecologic Oncology Reports journal homepage: www.elsevier.com/locate/gynor http://dx.doi.org/10.1016/j.gore.2015.11.001 2352-5789/© 2015 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/65/ed/main.PMC4688883.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/65/ed/main.PMC4688883.pdf
Contents lists available at ScienceDirect Gynecologic Oncology Reports journal homepage: www.elsevier.com/locate/gore http://dx.doi.org/10.1016/j.gore.2015.09.002 2352-5789/© 2015 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/3f/79/main.PMC4688884.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/3f/79/main.PMC4688884.pdf
"JOP 13 (4), 372 –375http://www.ncbi.nlm.nih.gov/pubmed/22797392 .30 J. Novo et al.",OADS,/arxiv_data1/oa_pdf/3f/79/main.PMC4688884.pdf
http://dx.doi.org/10.1016/j.gore.2015.09.001 2352-5789/© 2015 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/3e/d5/main.PMC4688885.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/3e/d5/main.PMC4688885.pdf
Frozen section was negative for malignancy Contents lists available at ScienceDirect Gynecologic Oncology Reports journal homepage: www.elsevier.com/locate/gore http://dx.doi.org/10.1016/j.gore.2015.09.003 2352-5789/© 2015 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/ba/71/main.PMC4688886.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/ba/71/main.PMC4688886.pdf
"1 October 2015 DOIs of original article: http://dx.doi.org/ 10.1016/j.ygyno.2014.09.009 ,http://dx.doi.org/ 10.1016/j.gore.2015.10.001 .",OADS,/arxiv_data1/oa_pdf/d1/95/main.PMC4688887.pdf
http://dx.doi.org/10.1016/j.gore.2015.10.004 2352-5789/© 2015 Published by Elsevier Inc.,Non-OADS,/arxiv_data1/oa_pdf/d1/95/main.PMC4688887.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/d1/95/main.PMC4688887.pdf
We believe that a blanket recom- mendation against offering genetic testing to young adult women com- promises their autonomy and may deter them from pursuing genetic counseling.Gynecologic Oncology Reports 14 (2015) 44 –45 DOI of original article: http://dx.doi.org/10.1016/j.ygyno.2014.09.009 .,Non-OADS,/arxiv_data1/oa_pdf/d2/3f/main.PMC4688888.pdf
http://dx.doi.org/10.1016/j.gore.2015.10.001 2352-5789/© 2015 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/d2/3f/main.PMC4688888.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/d2/3f/main.PMC4688888.pdf
"International Journal of Preventive Medicine 2015, 6:117 http://www.ijpvmjournal.net/content/6/1/117with a life course perspective have major implications  for health promotion, as they suggest previously  unrecognized opportunities to intervene for health  promotion of populations.",Non-OADS,/arxiv_data1/oa_pdf/04/ce/IJPVM-6-117.PMC4689094.pdf
"International Journal of Preventive Medicine 2015, 6:117 http://www.ijpvmjournal.net/content/6/1/117Data analysis We used SPSS 20 (IBM Corporation NY, USA) for our data  analysis.",Non-OADS,/arxiv_data1/oa_pdf/04/ce/IJPVM-6-117.PMC4689094.pdf
"International Journal of Preventive Medicine 2015, 6:117 http://www.ijpvmjournal.net/content/6/1/117life.",Non-OADS,/arxiv_data1/oa_pdf/04/ce/IJPVM-6-117.PMC4689094.pdf
"International Journal of Preventive Medicine 2015, 6:117 http://www.ijpvmjournal.net/content/6/1/117neighborhood and three health outcomes including  self‑assessed health status, chronic conditions, and  emotional distress in Canada.",Non-OADS,/arxiv_data1/oa_pdf/04/ce/IJPVM-6-117.PMC4689094.pdf
"International Journal of Preventive Medicine 2015, 6:117 http://www.ijpvmjournal.net/content/6/1/117victimization showed less benefit associated with moving  to a better neighborhood.",Non-OADS,/arxiv_data1/oa_pdf/04/ce/IJPVM-6-117.PMC4689094.pdf
"International Journal of Preventive Medicine 2015, 6:117 http://www.ijpvmjournal.net/content/6/1/117early conditions on health status among elderly Puerto Ricans.",Non-OADS,/arxiv_data1/oa_pdf/04/ce/IJPVM-6-117.PMC4689094.pdf
"International Journal of Preventive Medicine 2015, 6:117 http://www.ijpvmjournal.net/content/6/1/117Appendix 1: Items used in this  study What is your birthdate?",Non-OADS,/arxiv_data1/oa_pdf/04/ce/IJPVM-6-117.PMC4689094.pdf
"International Journal of Preventive Medicine 2015, 6:116 http://www.ijpvmjournal.net/content/6/1/116with a worker without interfering the activity and its  reflection.",Non-OADS,/arxiv_data1/oa_pdf/b5/87/IJPVM-6-116.PMC4689095.pdf
"International Journal of Preventive Medicine 2015, 6:116 http://www.ijpvmjournal.net/content/6/1/116Oral temperatures reliably range from 0.3°C to 0.7°C  lower than the core body temperature, averaging around  0.5°C lower than core body temperature.",Non-OADS,/arxiv_data1/oa_pdf/b5/87/IJPVM-6-116.PMC4689095.pdf
"International Journal of Preventive Medicine 2015, 6:116 http://www.ijpvmjournal.net/content/6/1/116physiological heat strain during exercise‑heat stress, based  on normalized increases in body core temperature and  HR, is matched by its perceptual analog.",Non-OADS,/arxiv_data1/oa_pdf/b5/87/IJPVM-6-116.PMC4689095.pdf
"International Journal of Preventive Medicine 2015, 6:116 http://www.ijpvmjournal.net/content/6/1/1162.",Non-OADS,/arxiv_data1/oa_pdf/b5/87/IJPVM-6-116.PMC4689095.pdf
"International Journal of Preventive Medicine 2015, 6:114 http://www.ijpvmjournal.net/content/6/1/114algorithms.",Non-OADS,/arxiv_data1/oa_pdf/3e/30/IJPVM-6-114.PMC4689096.pdf
"International Journal of Preventive Medicine 2015, 6:114 http://www.ijpvmjournal.net/content/6/1/114be allowed to choose where, when, and how they are  tested for HIV .",Non-OADS,/arxiv_data1/oa_pdf/3e/30/IJPVM-6-114.PMC4689096.pdf
"International Journal of Preventive Medicine 2015, 6:112 http://www.ijpvmjournal.net/content/6/1/112highest contribution among cardiovascular diseases in  Iran.",Non-OADS,/arxiv_data1/oa_pdf/7e/08/IJPVM-6-112.PMC4689097.pdf
"International Journal of Preventive Medicine 2015, 6:112 http://www.ijpvmjournal.net/content/6/1/112of Health and Medical Education.",Non-OADS,/arxiv_data1/oa_pdf/7e/08/IJPVM-6-112.PMC4689097.pdf
"International Journal of Preventive Medicine 2015, 6:112 http://www.ijpvmjournal.net/content/6/1/112all higher than survived patients.",Non-OADS,/arxiv_data1/oa_pdf/7e/08/IJPVM-6-112.PMC4689097.pdf
"International Journal of Preventive Medicine 2015, 6:112 http://www.ijpvmjournal.net/content/6/1/112of the factors associated with hospital mortality in  multilevel analysis.",Non-OADS,/arxiv_data1/oa_pdf/7e/08/IJPVM-6-112.PMC4689097.pdf
"International Journal of Preventive Medicine 2015, 6:112 http://www.ijpvmjournal.net/content/6/1/112in deceased patients due to MI than survived patients.",Non-OADS,/arxiv_data1/oa_pdf/7e/08/IJPVM-6-112.PMC4689097.pdf
"International Journal of Preventive Medicine 2015, 6:112 http://www.ijpvmjournal.net/content/6/1/112at risk of diseases.",Non-OADS,/arxiv_data1/oa_pdf/7e/08/IJPVM-6-112.PMC4689097.pdf
Available  from: http://www.ehr2.behdasht.gov.ir/miregistry.,Non-OADS,/arxiv_data1/oa_pdf/7e/08/IJPVM-6-112.PMC4689097.pdf
Available from: http://www.irimo.ir/eng/wd/720‑Products‑Services.html.,OADS,/arxiv_data1/oa_pdf/7e/08/IJPVM-6-112.PMC4689097.pdf
"International Journal of Preventive Medicine 2015, 6:112 http://www.ijpvmjournal.net/content/6/1/11227.",Non-OADS,/arxiv_data1/oa_pdf/7e/08/IJPVM-6-112.PMC4689097.pdf
"International Journal of Preventive Medicine 2015, 6:113 http://www.ijpvmjournal.net/content/6/1/113Globally, hearing loss is the most common sensory  deficit in human beings.",Non-OADS,/arxiv_data1/oa_pdf/99/35/IJPVM-6-113.PMC4689099.pdf
"International Journal of Preventive Medicine 2015, 6:113 http://www.ijpvmjournal.net/content/6/1/113done to detect hearing impairment.",Non-OADS,/arxiv_data1/oa_pdf/99/35/IJPVM-6-113.PMC4689099.pdf
Available from:  http://www.who.int/pbd/deafness/hearing_impairment_grades/en/index.html.,Non-OADS,/arxiv_data1/oa_pdf/99/35/IJPVM-6-113.PMC4689099.pdf
Available from: http://www.who.int/pbd/deafness/WHO_GE_HL.pdf.,Non-OADS,/arxiv_data1/oa_pdf/99/35/IJPVM-6-113.PMC4689099.pdf
Available from: http://www.who.int/healthinfo/statistics/bod_ hearingloss.pdf.,Non-OADS,/arxiv_data1/oa_pdf/99/35/IJPVM-6-113.PMC4689099.pdf
"International Journal of Preventive Medicine 2015, 6:113 http://www.ijpvmjournal.net/content/6/1/1134.",Non-OADS,/arxiv_data1/oa_pdf/99/35/IJPVM-6-113.PMC4689099.pdf
"International Journal of Preventive Medicine 2015, 6:115 http://www.ijpvmjournal.net/content/6/1/115INTRODUCTION Osteoporosis is a disease characterized by decreased  bone density and or loss of bone microstructure, which  can lead to an increased risk of fracture.",Non-OADS,/arxiv_data1/oa_pdf/a9/f7/IJPVM-6-115.PMC4689100.pdf
"International Journal of Preventive Medicine 2015, 6:115 http://www.ijpvmjournal.net/content/6/1/115five public health experts was done.",Non-OADS,/arxiv_data1/oa_pdf/a9/f7/IJPVM-6-115.PMC4689100.pdf
"International Journal of Preventive Medicine 2015, 6:115 http://www.ijpvmjournal.net/content/6/1/115action (resources including family and friends, doctors  and health workers, mass media, books and magazines,  internet and other patients with osteoporosis that  encourage the subjects toward prevention behaviors  of osteoporosis); and 3 questions on internal cues to  action (including the fear of suffering from complications  of osteoporosis and a sense of inner peace following  preventive behaviors); all questions are based on the  standard 5‑point Likert scale ranging from strongly  disagree to strongly agree (scores of 1–5).",Non-OADS,/arxiv_data1/oa_pdf/a9/f7/IJPVM-6-115.PMC4689100.pdf
"International Journal of Preventive Medicine 2015, 6:115 http://www.ijpvmjournal.net/content/6/1/115demographic data.",Non-OADS,/arxiv_data1/oa_pdf/a9/f7/IJPVM-6-115.PMC4689100.pdf
"International Journal of Preventive Medicine 2015, 6:115 http://www.ijpvmjournal.net/content/6/1/115After intervention, the perceived severity of the  experimental group significantly increased compared  to the control group.",Non-OADS,/arxiv_data1/oa_pdf/a9/f7/IJPVM-6-115.PMC4689100.pdf
"International Journal of Preventive Medicine 2015, 6:115 http://www.ijpvmjournal.net/content/6/1/115and health workers.",Non-OADS,/arxiv_data1/oa_pdf/a9/f7/IJPVM-6-115.PMC4689100.pdf
"International Journal of Preventive Medicine 2015, 6:115 http://www.ijpvmjournal.net/content/6/1/115Six months after intervention, the value of lumbar spine  BMD T‑score in the experimental group increased to  0.127, while in the control group it reduced to −0.043.",Non-OADS,/arxiv_data1/oa_pdf/a9/f7/IJPVM-6-115.PMC4689100.pdf
"International Journal of Preventive Medicine 2015, 6:115 http://www.ijpvmjournal.net/content/6/1/11518.",Non-OADS,/arxiv_data1/oa_pdf/a9/f7/IJPVM-6-115.PMC4689100.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/3d/96/main.PMC4689149.pdf
Sul ﬁte oxidation is the ﬁnal step in the metabolism of sulfur derived from sulfurContents lists available at ScienceDirect journal homepage: www.elsevier.com/locate/bbrepBiochemistry and Biophysics Reports http://dx.doi.org/10.1016/j.bbrep.2015.11.025 2405-5808/ &2015 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/3d/96/main.PMC4689149.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/3d/96/main.PMC4689149.pdf
Supplementary material Supplementary data associated with this article can be found in the online version at http://dx.doi.org/10.1016/j.bbrep.2015.11.025 .,OADS,/arxiv_data1/oa_pdf/3d/96/main.PMC4689149.pdf
Clinical Trial Registration—URL: https://www.clinicaltrials.gov.,Non-OADS,/arxiv_data1/oa_pdf/8d/16/str-47-143.PMC4689175.pdf
The online-only Data Supplement is available with this article at http://stroke.ahajournals.org/lookup/suppl/doi:10.1161/STROKEAHA.,OADS,/arxiv_data1/oa_pdf/8d/16/str-47-143.PMC4689175.pdf
Stroke is available at http://stroke.ahajournals.org DOI: 10.1161/STROKEAHA.115.010477,Non-OADS,/arxiv_data1/oa_pdf/8d/16/str-47-143.PMC4689175.pdf
The trial  was registered on clinicaltrials.gov (NCT01669161) and the protocol  is at http://www.microtransponder.com/?page_id=972.,Non-OADS,/arxiv_data1/oa_pdf/8d/16/str-47-143.PMC4689175.pdf
http://www.brainstimjrnl.com/article/S1935-861X(15)01125-0/ pdf.,Non-OADS,/arxiv_data1/oa_pdf/8d/16/str-47-143.PMC4689175.pdf
Stroke is available at http://stroke.ahajournals.org DOI: 10.1161/STROKEAHA.115.010528,Non-OADS,/arxiv_data1/oa_pdf/7e/37/str-47-113.PMC4689176.pdf
Clinical Trial Registration—URL: http://www.clinicaltrialsregister.eu.,Non-OADS,/arxiv_data1/oa_pdf/a7/53/str-47-151.PMC4689177.pdf
The online-only Data Supplement is available with this article at http://stroke.ahajournals.org/lookup/suppl/doi:10.1161/STROKEAHA.,OADS,/arxiv_data1/oa_pdf/a7/53/str-47-151.PMC4689177.pdf
Stroke is available at http://stroke.ahajournals.org DOI: 10.1161/STROKEAHA.115.009416,Non-OADS,/arxiv_data1/oa_pdf/a7/53/str-47-151.PMC4689177.pdf
The Cochrane Collaboration; 2011. http://www.cochrane-handbook.org.,OADS,/arxiv_data1/oa_pdf/a7/53/str-47-151.PMC4689177.pdf
"Guest Editor for this article was Giuseppe Lanzino, MD.The online-only Data Supplement is available with this article at http://stroke.ahajournals.org/lookup/suppl/doi:10.1161/STROKEAHA.",Non-OADS,/arxiv_data1/oa_pdf/20/e6/str-47-180.PMC4689178.pdf
Stroke is available at http://stroke.ahajournals.org DOI: 10.1161/STROKEAHA.115.010898,Non-OADS,/arxiv_data1/oa_pdf/20/e6/str-47-180.PMC4689178.pdf
"The working group was created and coordinated by the International Consortium for Health Outcomes Measurement (ICHOM, http://www.ICHOM.org), a nonprofit organization focused on the devel- opment of standard sets of outcomes and related risk factors for  individual medical conditions.",Non-OADS,/arxiv_data1/oa_pdf/20/e6/str-47-180.PMC4689178.pdf
"Discharge, 90 days Patient-reported    Ability to return to usual activities Simplified modified Rankin Scale Questionnaire(smRSq)PROMIS-1090 days90 daysClinical Patient-reported   Nonmotor functioning    Pain and other unpleasant sensations PROMIS-10 90 days Patient-reported    Fatigue PROMIS-10 90 days Patient-reported   Social functioning    Ability to communicate Do you have problems with  communication or understanding?Discharge, 90 days Patient-reported    Social participation PROMIS-10 90 days Patient-reported   General health status PROMIS-10 90 days Patient-reported   Health-related quality of life PROMIS-10 90 days Patient-reported ICH indicates intracerebral hemorrhage; and PROMIS-10, Patient Reported Outcomes Measurement Information System 10-Question Short Form  (PROMIS SF v.1.1 Global Health; http://www.nihpromis.org).",Non-OADS,/arxiv_data1/oa_pdf/20/e6/str-47-180.PMC4689178.pdf
"Implementation A complete data specification and collection manual is avail-able on the ICHOM website (http://www.ichom.org/medical-conditions/stroke), which describes each domain and subdomain, their definitions and corresponding measures, and their potential data sources.",OADS,/arxiv_data1/oa_pdf/20/e6/str-47-180.PMC4689178.pdf
http://phi.uhce.ox.ac.uk/pdf/PROMs_Oxford_ Stroke_17092010.pdf.,Non-OADS,/arxiv_data1/oa_pdf/20/e6/str-47-180.PMC4689178.pdf
"Published by Oxford University Press on behalf of the British Occupational Hygiene Society.•  27 This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivs licence (http://creativecommons.org/ licenses/by-nc-nd/3.0/), which permits non-commercial reproduction and distribution of the work, in any medium, provided the original work is not altered or  transformed in any way, and that the work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/dc/d9/mev062.PMC4689185.pdf
Available at http://www.ehjournal.net/content/13/1/59 .,Non-OADS,/arxiv_data1/oa_pdf/dc/d9/mev062.PMC4689185.pdf
Available at https://www.gov.uk/govern- ment/publications/asbestos-management-in-schools .,Non-OADS,/arxiv_data1/oa_pdf/dc/d9/mev062.PMC4689185.pdf
Available  at https://www.gov.uk/government/publications/asbes - tos-in-schools-policy-review .,Non-OADS,/arxiv_data1/oa_pdf/dc/d9/mev062.PMC4689185.pdf
Available at https://www.gov.uk/gov - ernment/uploads/system/uploads/attachment_data/ file/417033/asbestos_managament_guidance.pdf .,OADS,/arxiv_data1/oa_pdf/dc/d9/mev062.PMC4689185.pdf
Available at http://shop.bsigroup.com.,Non-OADS,/arxiv_data1/oa_pdf/dc/d9/mev062.PMC4689185.pdf
Available at  http://pubs.healtheffects.org .,Non-OADS,/arxiv_data1/oa_pdf/dc/d9/mev062.PMC4689185.pdf
Available at http://pubs.healtheffects.,Non-OADS,/arxiv_data1/oa_pdf/dc/d9/mev062.PMC4689185.pdf
Available at http://www.hse.gov.uk/ pubns/mdhs/pdfs/mdhs87.pdf .,Non-OADS,/arxiv_data1/oa_pdf/dc/d9/mev062.PMC4689185.pdf
Available at http://www.hse.gov.uk/pubns/books/hsg248.htm .,Non-OADS,/arxiv_data1/oa_pdf/dc/d9/mev062.PMC4689185.pdf
Available at http://www.hse.gov.uk/services/education/ asbestos-system-buildings.pdf .,Non-OADS,/arxiv_data1/oa_pdf/dc/d9/mev062.PMC4689185.pdf
Available at http://www.hse.gov.uk/services/edu- cation/asbestos-schools-inspections13-14-evaluation.pdf .,Non-OADS,/arxiv_data1/oa_pdf/dc/d9/mev062.PMC4689185.pdf
Available at: https://archive.org/details/reportofroyasbes t02onta .Accessed 20 March 2015.,Non-OADS,/arxiv_data1/oa_pdf/dc/d9/mev062.PMC4689185.pdf
Available from: http://www.idf.org/diabetesatlas.,Non-OADS,/arxiv_data1/oa_pdf/c6/8d/cm-88-449.PMC4689234.pdf
Available from: http://www.medscape.org/viewarticle/418568.,Non-OADS,/arxiv_data1/oa_pdf/c6/8d/cm-88-449.PMC4689234.pdf
2014 Available from: http://www.pharmacytimes.com/ publications/issue/2014/august2014/ketamine-reinventing- chronic-pain-management/,Non-OADS,/arxiv_data1/oa_pdf/8f/51/cm-88-457.PMC4689236.pdf
Available from:  http://www.equator-network.org/wp-content/uploads/2013/07/ SAMPL-Guidelines-6-27-13.pdf.,Non-OADS,/arxiv_data1/oa_pdf/9d/a8/cm-88-483.PMC4689241.pdf
Available from: http://www.clujulmedical.,Non-OADS,/arxiv_data1/oa_pdf/9d/a8/cm-88-483.PMC4689241.pdf
"SEER Cancer  Statistics Review, 1975–2005, National Cancer Institute Bethesda,  MD, http://seer.cancer.gov/csr/1975-2005/, based on November  2007 SEER data submission, posted to the SEER web site, 2008.",Non-OADS,/arxiv_data1/oa_pdf/be/67/cm-88-550.PMC4689250.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/46/f9/ott-8-3767.PMC4689259.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpOncoTargets and Therapy 2015:8 3767–3774OncoTargets and Therapy Dove press submit your manuscript | www.dovepress.co m Dove press  3767Reviewopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/OTT .S9384 3epidermal growth factor, latrophilin, and seven  transmembrane domain-containing protein 1  marker, a novel angiogenesis marker Florentina Serban Stefan-Alexandru Artene Ada Maria Georgescu Stefana Oana Purcaru Daniela elise Tache Oana Alexandru Anica Dricu Department of Biochemistry,   University of Medicine and Pharmacy  of Craiova, Craiova, RomaniaAbstract:  Epidermal growth factor, latrophilin, and seven transmembrane domain-containing  protein 1 on chromosome 1 (ELTD1), an orphan adhesion G-protein coupled receptor, was  reported as a regulator of angiogenesis, also involved in cancer progression and development.",Non-OADS,/arxiv_data1/oa_pdf/46/f9/ott-8-3767.PMC4689259.pdf
"The vascular endothelial growth factor receptor family is a well-studied angiogenic  class of receptors9–11 that have been constantly used to develop new cancer therapies  for quite a while now.12–14 The therapeutic results, however, for many malignant dis - eases, in which vascular endothelial growth factor receptor dysfunction is believed Correspondence:  Anica Dricu Department of Biochemistry, University  of Medicine and Pharmacy of Craiova,  Petru Rares 2, 200349, Craiova, Romania email anica.dricu@live.co.u k Journal name: OncoTargets and Therapy Article Designation: Review Y ear: 2015 Volume: 8 Running head verso: Serban et al Running head recto: ELTD1 structure, function, and its role in angiogenesis DOI: http://dx.doi.org/10.2147/OTT.S93843",Non-OADS,/arxiv_data1/oa_pdf/46/f9/ott-8-3767.PMC4689259.pdf
"Data were obtained  from the Biogps online database ( http://biogps.org/#goto=genereport&id=170,75 7, accessed October 17, 2015).64 Results are represented as the 20 most highly expressed  gene levels for each probe in order to highlight the most relevant data.",OADS,/arxiv_data1/oa_pdf/46/f9/ott-8-3767.PMC4689259.pdf
"Results were obtained from  the Human Protein Atlas Database ( http://www.proteinatlas.org/eNSG00000162618-eLTD1/cell/HPA02522 9, accessed October 17, 2015).77 Abbreviation:  eLTD1, epidermal growth factor, latrophilin, and seven transmembrane domain-containing protein 1 on chromosome 1.",OADS,/arxiv_data1/oa_pdf/46/f9/ott-8-3767.PMC4689259.pdf
"The results were obtained from  the BioPortal for Cancer Genomics database ( http://bit.ly/1PyuYc R, accessed October 17, 2015).78 Abbreviations:  eLTD1, epidermal growth factor, latrophilin, and seven transmembrane domain-containing protein 1 on chromosome 1; lung SC, lung squamous cells.",OADS,/arxiv_data1/oa_pdf/46/f9/ott-8-3767.PMC4689259.pdf
"OncoTargets and Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/oncotargets-and-therapy-journa lOncoTargets and Therapy is an international, peer-reviewed, open  access journal focusing on the pathological basis of all cancers, potential  targets for therapy and treatment protocols employed to improve the  management of cancer patients.",Non-OADS,/arxiv_data1/oa_pdf/46/f9/ott-8-3767.PMC4689259.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/46/f9/ott-8-3767.PMC4689259.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/cf/31/ott-8-3783.PMC4689260.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpOncoTargets and Therapy 2015:8 3783–3792OncoTargets and Therapy Dove press submit your manuscript | www.dovepress.co m Dove press  3783Reviewopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/OTT .S9547 0The role of CD44 in epithelial–mesenchymal  transition and cancer development Hanxiao Xu1 Yijun Tian1 Xun Yuan1 Hua wu1 Qian Liu1 Richard G Pestell2 Kongming wu1 1Department of Oncology, Tongji  Hospital, T ongji Medical College,   Huazhong University of Science and  Technology, wuhan, People’s Republic  of China; 2Sidney Kimmel Cancer  Center, Thomas Jefferson University,   Philadelphia, PA, USAAbstract:  CD44, a multi-structural and multifunctional transmembrane glycoprotein, was  initially identified as a receptor for hyaluronan that participates in both physiological and  pathological processes.",Non-OADS,/arxiv_data1/oa_pdf/cf/31/ott-8-3783.PMC4689260.pdf
"Multiple CD44v is produced by insertion of variant exons (v1–v10) at the  proximal plasma membrane external region (Figure 1).4 CD44s is found in most cells,5  while CD44v is expressed primarily on cells during inflammation and on tumor cells.6–8  CD44 protein consists of a short C-terminal cytoplasmic domain, a transmembrane  domain, and seven extracellular domains which contains an N-terminal HA-binding  link-homology module and stem region (Figure 2).9,10 CD44 was initially identified as a receptor for HA and lymphocyte-homing recep - tor11 that participates in both physiological and pathological processes, including  cell adhesion, angiogenesis, inflammation, and tumor development.12,13 Since CD44  expression in several tumor types was found to be different from that in normal  counterparts, studies have been subsequently carried out to investigate the role of Correspondence: Kongming wu Department of Oncology, Tongji  Hospital, Tongji Medical College,  Huazhong University of Science and  Technology, 1095 Jiefang Avenue, wuhan  430030, People’s Republic of China email kmwu@tjh.tjmu.edu.c n Journal name: OncoTargets and Therapy Article Designation: Review Y ear: 2015 Volume: 8 Running head verso: Xu et al Running head recto: Role of CD44 in EMT and cancer DOI: http://dx.doi.org/10.2147/OTT.S95470",Non-OADS,/arxiv_data1/oa_pdf/cf/31/ott-8-3783.PMC4689260.pdf
"Available from: http://journal.frontiersin.org/article/10.3389/ fimmu.2015.00201/abstrac t. Copyright: © 2015 Misra, Hascall, Markwald and Ghatak.4 Abbreviations:  HA, hyaluronic acid; CD44s, CD44 standard; CD44v, CD44 variant;   SS, disulfide bond; v, variant.",Non-OADS,/arxiv_data1/oa_pdf/cf/31/ott-8-3783.PMC4689260.pdf
"OncoTargets and Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/oncotargets-and-therapy-journa lOncoTargets and Therapy is an international, peer-reviewed, open  access journal focusing on the pathological basis of all cancers, potential  targets for therapy and treatment protocols employed to improve the  management of cancer patients.",Non-OADS,/arxiv_data1/oa_pdf/cf/31/ott-8-3783.PMC4689260.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/cf/31/ott-8-3783.PMC4689260.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/8a/38/ott-8-3749.PMC4689261.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpOncoTargets and Therapy 2015:8 3749–3756OncoTargets and Therapy Dove press submit your manuscript | www.dovepress.co m Dove press  3749Original researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/OTT .S9494 5Prognostic impact of initial maximum standardized  uptake value of 18F-FDg PeT/cT on treatment  response in patients with metastatic lung  adenocarcinoma treated with erlotinib T ulay Kus1 gokmen aktas1 alper sevinc1 Mehmet emin Kalender1 Mustafa Yilmaz2 seval Kul3 serdar Oztuzcu4 cemil Oktay5 celaletdin camci1 1Department of internal Medicine,   Division of Medical Oncology,   gaziantep Oncology hospital,   2Department of n uclear Medicine,   3Department of Biostatistics,   Faculty of Medicine, 4Department of  Medical Biology, Faculty of Medicine,   University of gaziantep, gaziantep,   5Department of radiology, Faculty  of Medicine, University of akdeniz,   antalya, T urkeyPurpose:  To investigate whether the initial maximum standardized uptake value (SUVmax) on  fluorine-18 fluorodeoxyglucose positron emission tomography/computed tomography (18F-FDG  PET/CT) has a prognostic significance in metastatic lung adenocarcinoma.",Non-OADS,/arxiv_data1/oa_pdf/8a/38/ott-8-3749.PMC4689261.pdf
"In  advanced non-small cell lung cancer (NSCLC), several pretherapeutic  prognostic factors have been identified, such as performance status (PS), age, sex,  weight loss, neutrophil counts, C-reactive protein, albumin, serum calcium level.1–3 correspondence: Tulay Kus Department of internal Medicine,  Division of Medical Oncology, gaziantep  Oncology hospital, Faculty of Medicine,  University of gaziantep, 104050 Kizilhisar  street, Tr-27310 gaziantep, Turkey email drtulaykus83@hotmail.co m Journal name: OncoTargets and Therapy Article Designation: Original Research Y ear: 2015 Volume: 8 Running head verso: Kus et al Running head recto: Metastatic lung adenocarcinoma treated with erlotinib DOI: http://dx.doi.org/10.2147/OTT.S94945",Non-OADS,/arxiv_data1/oa_pdf/8a/38/ott-8-3749.PMC4689261.pdf
"OncoTargets and Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/oncotargets-and-therapy-journa lOncoTargets and Therapy is an international, peer-reviewed, open  access journal focusing on the pathological basis of all cancers, potential  targets for therapy and treatment protocols employed to improve the  management of cancer patients.",Non-OADS,/arxiv_data1/oa_pdf/8a/38/ott-8-3749.PMC4689261.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/8a/38/ott-8-3749.PMC4689261.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/a8/87/ppa-9-1771.PMC4689262.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpPatient Preference and Adherence 2015:9 1771–1779Patient Preference and Adherence Dove press submit your manuscript | www.dovepress.co m Dove press  1771OriginAl reseArchopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/PPA.S8863 0Drug holidays: the most frequent type of  noncompliance with calcium plus vitamin D  supplementation in persistent patients with  osteoporosis T ereza T ouskova1 Magda Vytrisalova1 Vladimir Palicka2 T ereza hendrychova1 leos Fuksa1 radka holcova1 Jana Konopacova1 Ales Antonin Kubena1 1Department of social and clinical  Pharmacy, Faculty of Pharmacy in  hradec Kralove, charles University  in Prague, 2Osteocentre, institute of  clinical Biochemistry and Diagnostics,   charles University in Prague, Faculty  of Medicine and University hospital  in hradec Kralove, hradec Kralove,   czech republicPurpose:  All current recommendations include calcium and vitamin D (Ca–D) as an integrated  part of osteoporosis treatment.",Non-OADS,/arxiv_data1/oa_pdf/a8/87/ppa-9-1771.PMC4689262.pdf
"The bisphos - phonates alendronate, ibandronate, risedronate, and zoledronic acid; raloxifene; agents  derived from parathyroid hormone; and denosumab and strontium ranelate are most correspondence: Magda Vytrisalova Department of social and clinical  Pharmacy, Faculty of Pharmacy in hradec  Kralove, charles University in Prague,  heyrovskeho 1203, 500 05 hradec  Kralove, czech republic Tel +420 49 506 7648 Fax +420 49 506 7161 email v ytrm7aa@faf.cuni.c z Journal name: Patient Preference and Adherence Article Designation: Original Research Y ear: 2015 Volume: 9 Running head verso: Touskova et al Running head recto: Compliance with calcium plus vitamin D supplementation DOI: http://dx.doi.org/10.2147/PPA.S88630",Non-OADS,/arxiv_data1/oa_pdf/a8/87/ppa-9-1771.PMC4689262.pdf
"Patient Preference and Adherence Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/patient-preference-and-adherence-journa lPatient Preference and Adherence is an international, peer-reviewed,  open access journal that focuses on the growing importance of patient   preference  and adherence throughout the therapeutic continuum.",Non-OADS,/arxiv_data1/oa_pdf/a8/87/ppa-9-1771.PMC4689262.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/56/ed/ott-8-3803.PMC4689263.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpOncoTargets and Therapy 2015:8 3803–3815OncoTargets and Therapy Dove press submit your manuscript | www.dovepress.co m Dove press  3803Original researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/OTT .S8712 6correlation of 18F-fluoroethyl tyrosine positron- emission tomography uptake values and  histomorphological findings by stereotactic serial  biopsy in newly diagnosed brain tumors using a  refined software tool William Omar contreras  lopez,1,2 Joacir graciolli  cordeiro,1 Ulrich Albicker,3  soroush Doostkam,4  guido nikkhah,1,5 Robert  D Kirch,6 Michael Trippel,1  Thomas  reithmeier1,7 1Department of stereotactic and  Functional neurosurgery, University  Medical Center Freiburg, Freiburg  im Breisgau, germany; 2Division of  Functional neurosurgery, Department  of neurology, hospital das clinicas,  University of são Paulo Medical  school, são Paulo, Brazil; 3inomed,  emmendingen, 4Department of  neuropathology, University Medical  Center Freiburg, Freiburg im Breisgau,  5Department of neurosurgery,  University clinic erlangen, erlangen,  6neuroelectronic systems, Department  of neurosurgery, University Medical  Center Freiburg, Freiburg im Breisgau,  7Department of neurosurgery,  Schwabing Academic Teaching Hospital  of Technical University and ludwig  Maximilian University of Munich,  Munich, germanyBackground:  Magnetic resonance imaging (MRI) is the standard neuroimaging method to diag - nose neoplastic brain lesions, as well as to perform stereotactic biopsy surgical planning.",Non-OADS,/arxiv_data1/oa_pdf/56/ed/ott-8-3803.PMC4689263.pdf
"Low cell density in tissue samples was found to have a significant negative correlation  with the measured cortical uptake rate ( r=-0.43, P=0.02), as well as moderate cell density correspondence: William Omar  contreras lopez hospital das clinicas, University of são  Paulo Medical school, r. Dr. Ovídio Pires  de campos, 785 – são Paulo 01060-970,  Brazil email wyllcon@gmail.co m Journal name: OncoTargets and Therapy Article Designation: Original Research Y ear: 2015 Volume: 8 Running head verso: Lopez et al Running head recto: New hot spot-detection software for stereotactic biopsy DOI: http://dx.doi.org/10.2147/OTT.S87126",Non-OADS,/arxiv_data1/oa_pdf/56/ed/ott-8-3803.PMC4689263.pdf
"OncoTargets and Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/oncotargets-and-therapy-journa lOncoTargets and Therapy is an international, peer-reviewed, open  access journal focusing on the pathological basis of all cancers, potential  targets for therapy and treatment protocols employed to improve the  management of cancer patients.",Non-OADS,/arxiv_data1/oa_pdf/56/ed/ott-8-3803.PMC4689263.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/56/ed/ott-8-3803.PMC4689263.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/33/1b/opth-9-2355.PMC4689264.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).Clinical Ophthalmology 2015:9 2355–2371Clinical Ophthalmology Dove press submit your manuscript | www.dovepress.co m Dove press  2355Reviewopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/OPTH.S8004 0Aflibercept: a review of its use in the treatment  of choroidal neovascularization due to age-related  macular degeneration Chandrakumar  Balaratnasingam1–3 Elona Dhrami-Gavazi1,2,4 Jesse T McCann1,2,4,5 Quraish Ghadiali1,2 K Bailey Freund1,2,4,5 1Vitreous-Retina-Macula Consultants  of New Y ork, NY, USA; 2Luesther  T Mertz Retinal Research Center,   Manhattan eye, ear and Throat  Hospital, New Y ork, NY, USA;   3Centre for Ophthalmology and  Visual Sciences, Lions Eye Institute,   University of Western Australia,   Perth, WA, Australia; 4Department of  Ophthalmology, Edward S Harkness  Eye Institute, Columbia University  College of Physicians and Surgeons,   New Y ork, NY, USA; 5Department of  Ophthalmology, New Y ork University  School of Medicine, New Y ork,   NY, USAAbstract:  Choroidal neovascularization (CNV) due to age-related macular degeneration  (AMD) is an important cause of visual morbidity globally.",Non-OADS,/arxiv_data1/oa_pdf/33/1b/opth-9-2355.PMC4689264.pdf
"Keywords:  age-related macular degeneration, aflibercept, choroidal neovascularization, vascular  endothelial growth factor, clinical trial Introduction Age-related macular degeneration (AMD) is the leading cause of severe visual loss in  people over the age of 65 years in the industrialized world.1 It is a bilateral, progres - sive disease that demonstrates great interindividual variability with respect to the rate  of visual loss over time.2 The global burden of AMD is projected to increase over the  next two decades, and thus, there is an urgent need to clarify the pathophysiology of  this disease and to identify viable treatment strategies that will arrest disease-induced  vision loss.3 Choroidal neovascularization (CNV) is a complication that may occur during the  natural course of AMD.4 In a study of individuals who were diagnosed with early  or intermediate AMD at baseline visit, approximately 10% developed CNV over  a median follow-up period of 6.3 years.5 Fortunately, significant progress has been Correspondence: K Bailey Freund Vitreous Retina Macula Consultants of  New York, 460 Park Avenue, 5th Floor,  New York, NY 10022, USA Tel +1 212 861 9797 Fax +1 212 628 0698 email kbfnyf@aol.co m Journal name: Clinical Ophthalmology Article Designation: Review Y ear: 2015 Volume: 9 Running head verso: Balaratnasingam et al Running head recto: Aflibercept and choroidal neovascularization DOI: http://dx.doi.org/10.2147/OPTH.S80040",Non-OADS,/arxiv_data1/oa_pdf/33/1b/opth-9-2355.PMC4689264.pdf
"Clinical Ophthalmology Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/clinical-ophthalmology-journa lClinical Ophthalmology is an international, peer-reviewed journal  covering all subspecialties within ophthalmology.",Non-OADS,/arxiv_data1/oa_pdf/33/1b/opth-9-2355.PMC4689264.pdf
Visit http://www.dovepress.com/ testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/33/1b/opth-9-2355.PMC4689264.pdf
"Available from: http://www.fda.gov/downloads/AdvisoryCommit - tees/CommitteesMeetingMaterials/Drugs/DermatologicandOphthal - micDrugsAdvisoryCommittee/UCM259143.pd f. Accessed November  17, 2015.",Non-OADS,/arxiv_data1/oa_pdf/33/1b/opth-9-2355.PMC4689264.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/6b/9b/ppa-9-1751.PMC4689265.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpPatient Preference and Adherence 2015:9 1751–1761Patient Preference and Adherence Dove press submit your manuscript | www.dovepress.co m Dove press  1751OriginAl reseArchopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/PPA.S9199 2self-monitoring of lower leg skin temperature:  accuracy of self-reported data and adherence to a  cooling protocol for the prevention of venous leg  ulcers T eresa J Kelechi Mohan Madisetti Martina Mueller Mary Dooley Margaret Prentice college of nursing, Medical University  of south carolina, charleston, sc,   UsABackground:  For intervention studies that require the use of participant self-reports, the quality  and accuracy of recorded data and variability in participant adherence rates to the treatment can  cause significant outcome bias.",Non-OADS,/arxiv_data1/oa_pdf/6b/9b/ppa-9-1751.PMC4689265.pdf
"Keywords:  self care, lower leg, symptoms, prevention intervention, diary logs, chronic illnesscorrespondence: Teresa J Kelechi college of nursing, Medical University of  south carolina, 99 Jonathan lucas street,  Msc 160, charleston, sc 29425-1600,  UsA Tel +1 843 792 4602 Fax +1 843 792 2104 email kelechtj@musc.ed u Journal name: Patient Preference and Adherence Article Designation: Original Research Y ear: 2015 Volume: 9 Running head verso: Kelechi et al Running head recto: Self-monitoring of leg skin temperature for venous ulcer prevention DOI: http://dx.doi.org/10.2147/PPA.S91992",Non-OADS,/arxiv_data1/oa_pdf/6b/9b/ppa-9-1751.PMC4689265.pdf
"Patient Preference and Adherence Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/patient-preference-and-adherence-journa lPatient Preference and Adherence is an international, peer-reviewed,  open access journal that focuses on the growing importance of patient   preference  and adherence throughout the therapeutic continuum.",Non-OADS,/arxiv_data1/oa_pdf/6b/9b/ppa-9-1751.PMC4689265.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/49/84/ppa-9-1763.PMC4689266.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpPatient Preference and Adherence 2015:9 1763–1770Patient Preference and Adherence Dove press submit your manuscript | www.dovepress.co m Dove press  1763OriginAl reseArchopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/PPA.S8838 5Factors related to changes in the quality of life  among Polish adolescents and adults with cystic  fibrosis over a 1-year period Grażyna Dębska1 Henryk Mazurek2 1Faculty of Health and Medical  Studies, Andrzej Frycz Modrzewski  Krakow University, Krakow,   2Department of Pneumonology and  Cystic Fibrosis, National Tuberculosis  and Lung Diseases Research Institute,   Rabka, PolandBackground:  The aim of this study was to determine the effects of clinical factors, physical  activity, and sociodemographic variables on 1-year changes in health-related quality of life  (HRQoL) in Polish adolescents and adults with cystic fibrosis (CF).",Non-OADS,/arxiv_data1/oa_pdf/49/84/ppa-9-1763.PMC4689266.pdf
"The deterioration in lung function is marked not only by a decrease in the forced  expiratory volume in the 1st second (FEV1) of expiration, but also by the frequent  occurrence of exacerbations and complications (eg, hemoptysis and pneumothorax).1,3,4 Correspondence: Grażyna Dębska Faculty of Health and Medical Studies,  Andrzej Frycz Modrzewski Krakow  University, Herlinga-Grudzińskiego 1,  30-705 Krakow, Poland Tel +48 12 252 4520 Fax +48 12 252 4523 email gdebska@afm.edu.p l Journal name: Patient Preference and Adherence Article Designation: Original Research Y ear: 2015 Volume: 9 Running head verso: D ębska and Mazurek Running head recto: HRQoL in cystic fibrosis DOI: http://dx.doi.org/10.2147/PPA.S88385",Non-OADS,/arxiv_data1/oa_pdf/49/84/ppa-9-1763.PMC4689266.pdf
"Patient Preference and Adherence Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/patient-preference-and-adherence-journa lPatient Preference and Adherence is an international, peer-reviewed,  open access journal that focuses on the growing importance of patient   preference  and adherence throughout the therapeutic continuum.",Non-OADS,/arxiv_data1/oa_pdf/49/84/ppa-9-1763.PMC4689266.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/34/70/ott-8-3775.PMC4689267.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).OncoTargets and Therapy 2015:8 3775–3781OncoTargets and Therapy Dove press submit your manuscript | www.dovepress.co m Dove press  3775Original researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/OTT .S9393 9impact of age on the prognosis after liver  transplantation for patients with hepatocellular  carcinoma: a single-center experience Pusen Wang1,* chunguang Wang1,* hao li1 Baojie shi1 Jianning Wang2 lin Zhong1 1Department of general surgery,   shanghai general hospital, shanghai  Jiaotong University school of  Medicine, shanghai, 2Department  of Urology, affiliated Qianfoshan  hospital, shandong University, Jinan,   People’s republic of china *These authors contributed equally  to this workBackground:  Liver transplantation (LT) offers the most effective treatment for hepatocellular  carcinoma patients.",Non-OADS,/arxiv_data1/oa_pdf/34/70/ott-8-3775.PMC4689267.pdf
"Keywords:  age, hepatocellular carcinoma, liver transplantation, prognosis Introduction Hepatocellular carcinoma (HCC) is the fifth most common malignancy and the third  leading cause of cancer-related deaths worldwide.1 It is estimated that there were 782,000  liver cancer cases and 746,000 liver cancer-related deaths worldwide in 2012.2 Despite  various therapeutic options such as liver resection, radiofrequency ablation, and transcath - eter hepatic arterial chemoembolization, the prognosis remains generally poor, leading  to 500,000 deaths per year.3 The incidence of HCC is increasing rapidly worldwide.4,5 Liver transplantation (LT) remains the most effective treatment for small HCC  with chronic liver disease and the best chance for end-stage liver disease.6–8 Sequential  development from hepatitis B to liver cirrhosis and HCC is a typical phenomenon correspondence: lin Zhong Department of general surgery,  shanghai general hospital, shanghai  Jiaotong University school of Medicine,  100 haining road, hongkou District,  shanghai 200080, People's republic of  china Tel +86 21 6324 0090 ext 3133 Fax +86 21 6324 2903 email zhongl_3284@hotmail.co m  Jianning Wang Department of Urology, Affiliated  Qianfoshan hospital, shandong  University, 16766 Jingshi road, Jinan city  250014, People's republic of china Tel +86 531 8228 7327 email guowz_wps@hotmail.co m Journal name: OncoTargets and Therapy Article Designation: Original Research Y ear: 2015 Volume: 8 Running head verso: Wang et al Running head recto: Age and prognosis after LT DOI: http://dx.doi.org/10.2147/OTT.S93939",Non-OADS,/arxiv_data1/oa_pdf/34/70/ott-8-3775.PMC4689267.pdf
"OncoTargets and Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/oncotargets-and-therapy-journa lOncoTargets and Therapy is an international, peer-reviewed, open  access journal focusing on the pathological basis of all cancers, potential  targets for therapy and treatment protocols employed to improve the  management of cancer patients.",Non-OADS,/arxiv_data1/oa_pdf/34/70/ott-8-3775.PMC4689267.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/34/70/ott-8-3775.PMC4689267.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/f3/f9/ott-8-3827.PMC4689268.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpOncoTargets and Therapy 2015:8 3827–3835OncoTargets and Therapy Dove press submit your manuscript | www.dovepress.co m Dove press  3827Original researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/OTT .S9231 4Microrna-125a-5p regulates cancer cell  proliferation and migration through naiF1 in  prostate carcinoma Yi Fu Fuhua cao Department of Urology, The Oilfield  general hospital of Daqing, Daqing,   People’s republic of chinaBackground:  We investigated the functional roles of microRNA-125a-5p in regulating human  prostate carcinoma.",Non-OADS,/arxiv_data1/oa_pdf/f3/f9/ott-8-3827.PMC4689268.pdf
"MicroRNAs (miRNAs) are groups of noncoding small RNAs that transcription - ally or posttranslationally degrade genes or proteins by binding the 3 ′-untranslated  regions (3 ′-UTR) of targeted genes.5 In human prostate cancer, miRNAs are broadly  involved in many aspects of cancer development, such as prostate cancer pathogenesis, correspondence: Yi Fu Department of Urology, The Oilfield  general hospital of Daqing, 9 Middle  8th road, Daqing 163001, People’s  republic of china Tel +86 139 3678 6622 email yi.fu@aol.co m Journal name: OncoTargets and Therapy Article Designation: Original Research Y ear: 2015 Volume: 8 Running head verso: Fu and Cao Running head recto: miR-125a-5p modulates prostate cancer DOI: http://dx.doi.org/10.2147/OTT.S92314",Non-OADS,/arxiv_data1/oa_pdf/f3/f9/ott-8-3827.PMC4689268.pdf
"OncoTargets and Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/oncotargets-and-therapy-journa lOncoTargets and Therapy is an international, peer-reviewed, open  access journal focusing on the pathological basis of all cancers, potential  targets for therapy and treatment protocols employed to improve the  management of cancer patients.",Non-OADS,/arxiv_data1/oa_pdf/f3/f9/ott-8-3827.PMC4689268.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/f3/f9/ott-8-3827.PMC4689268.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/f8/b1/ott-8-3817.PMC4689269.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).OncoTargets and Therapy 2015:8 3817–3825OncoTargets and Therapy Dove press submit your manuscript | www.dovepress.co m Dove press  3817Original researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/OTT .S9554 3Validation of a quantitative 12-multigene  expression assay (Oncotype DX® colon cancer  assay) in Korean patients with stage ii colon  cancer: implication of ethnic differences  contributing to differences in gene expression Duck hyoun Jeong1 Woo ram Kim1 Byung soh Min1 Y oung Wan Kim2 Mi Kyung song3 nam Kyu Kim1 1Department of surgery, Yonsei  University college of Medicine,   seoul, 2Department of surgery,   Wonju college of Medicine, Wonju,   3Department of research affairs,   Biostatistics collaboration Unit,   Y onsei University college of Medicine,   seoul, KoreaPurpose:  To evaluate the Recurrence Score® of the quantitative 12-multigene expression assay  and to determine risk groups based on the continuous Recurrence Score® in Korean patients.",Non-OADS,/arxiv_data1/oa_pdf/f8/b1/ott-8-3817.PMC4689269.pdf
"The cur - rent National Comprehensive Cancer Network guidelines recommend adjuvant che - motherapy for stage II colon cancer when patients have a pathological (p)T4 lesion,  intestinal perforation or obstruction, lymphovascular invasion, perineural invasion,  poorly differentiated histology, or fewer than 12 lymph nodes examined.8 However, correspondence: nam Kyu Kim Department of surgery, Yonsei University  college of Medicine, 250 seongsanro,  seodaemun-Ku, seoul, 120-752, Korea Tel +82 2 2228 2105 Fax +82 2 313 8289 email namkyuk@yuhs.a c Journal name: OncoTargets and Therapy Article Designation: Original Research Y ear: 2015 Volume: 8 Running head verso: Jeong et al Running head recto: Ethnic differences contributing to differences in gene expression DOI: http://dx.doi.org/10.2147/OTT.S95543",Non-OADS,/arxiv_data1/oa_pdf/f8/b1/ott-8-3817.PMC4689269.pdf
Available  from: http://www.nccn.org/professionals/physician_gls/pdf/colon.pdf.,Non-OADS,/arxiv_data1/oa_pdf/f8/b1/ott-8-3817.PMC4689269.pdf
"OncoTargets and Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/oncotargets-and-therapy-journa lOncoTargets and Therapy is an international, peer-reviewed, open  access journal focusing on the pathological basis of all cancers, potential  targets for therapy and treatment protocols employed to improve the  management of cancer patients.",Non-OADS,/arxiv_data1/oa_pdf/f8/b1/ott-8-3817.PMC4689269.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/f8/b1/ott-8-3817.PMC4689269.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/4f/b2/opth-9-2345.PMC4689270.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpClinical Ophthalmology 2015:9 2345–2353Clinical Ophthalmology Dove press submit your manuscript | www.dovepress.co m Dove press  2345Original researChopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/OPTH.S9229 6Microcurrent stimulation in the treatment of dry  and wet macular degeneration laurie Chaikin1  Kellen Kashiwa2 Michael Bennet2 george Papastergiou3 Walter gregory4 1Private practice, alameda, C a,   Usa; 2retina institute of hawaii,   honolulu, hi, Usa; 3California retinal  associates, san Diego, C a, Usa;   4Clinical Trials research Unit, Faculty  of Medicine and health, University of  leeds, leeds, UKPurpose:  To determine the safety and efficacy of the application of transcutaneous  (transpalpebral) microcurrent stimulation to slow progression of dry and wet macular degenera - tion or improve vision in dry and wet macular degeneration.",Non-OADS,/arxiv_data1/oa_pdf/4f/b2/opth-9-2345.PMC4689270.pdf
"Henry Dor, MD, an ophthalmologist in Germany,  used electrical currents to help individuals with amblyopia, retinochoroiditis, glau - coma, and optic atrophy in 1873.1 In a summary paper by Gekeler and Bartz-Schmidt,  subthreshold visual stimulation in inactive retinal implants leading to improvements in  residual areas of vision was stated to be the result of a release of neurotrophic factors.2  Twenty peer-reviewed publications in PubMed over the last 5 years reflect renewed  interest in microcurrent therapy.3 Since then, transcorneal electrical stimulation (TES)  and transpalpebral electrical stimulation (TPES)  placement of the electrodes over the Correspondence: laurie Chaikin Private practice, 420 F Cola Ballena  alameda, Ca 94501, Usa Tel +1 510 693 8053 Fax +1 510 995 8376 email laurie.chaikin@gmail.co mJournal name: Clinical Ophthalmology Article Designation: Original Research Y ear: 2015 Volume: 9 Running head verso: Chaikin et al Running head recto: Microcurrent stimulation for macular degeneration treatment DOI: http://dx.doi.org/10.2147/OPTH.S92296",Non-OADS,/arxiv_data1/oa_pdf/4f/b2/opth-9-2345.PMC4689270.pdf
"Clinical Ophthalmology Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/clinical-ophthalmology-journa lClinical Ophthalmology is an international, peer-reviewed journal  covering all subspecialties within ophthalmology.",Non-OADS,/arxiv_data1/oa_pdf/4f/b2/opth-9-2345.PMC4689270.pdf
Visit http://www.dovepress.com/ testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/4f/b2/opth-9-2345.PMC4689270.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/da/7e/ott-8-3757.PMC4689271.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpOncoTargets and Therapy 2015:8 3757–3765OncoTargets and Therapy Dove press submit your manuscript | www.dovepress.co m Dove press  3757Original researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/OTT .S8634 3role of nsc319726 in ovarian cancer based on  the bioinformatics analyses Ji Xue1 guang Yang1 hong Ding1 Pu Wang2 changhong Wang3 1Department of chinese Medicine,   The second hospital of Jilin  University, 2The clinical Medical  college of Jilin University ( grade  2013), 3Department of chinese  Medicine, china–Japan Union hospital  of Jilin University, changchun city,   People’s republic of chinaAim:  This study aimed to explore the molecular mechanisms of NSC319726 in ovarian cancer  by bioinformatics analyses.",Non-OADS,/arxiv_data1/oa_pdf/da/7e/ott-8-3757.PMC4689271.pdf
"This compound has been found to kill p53R172H knock-in mice correspondence: changhong Wang Department of chinese Medicine,  china–Japan Union hospital of Jilin  University, Xiantai street, changchun  city 130033, People’s republic of china Tel +86 431 8499 5840 email chhwangsfd@hotmail.co m Journal name: OncoTargets and Therapy Article Designation: Original Research Y ear: 2015 Volume: 8 Running head verso: Xue et al Running head recto: Ovarian cancer treated with NSC319726 DOI: http://dx.doi.org/10.2147/OTT.S86343",Non-OADS,/arxiv_data1/oa_pdf/da/7e/ott-8-3757.PMC4689271.pdf
"Data and methods affymetrix microarray data The microarray expression profile data set GSE35972 was  downloaded from National Center of Biotechnology Information  Gene Expression Omnibus ( http://www.ncbi.nlm.nih.gov/geo /)  database, which is based on the GPL570 [HG-U133_Plus_2]  Affymetrix Human Genome U133 Plus 2.0 Array platform.",OADS,/arxiv_data1/oa_pdf/da/7e/ott-8-3757.PMC4689271.pdf
"OncoTargets and Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/oncotargets-and-therapy-journa lOncoTargets and Therapy is an international, peer-reviewed, open  access journal focusing on the pathological basis of all cancers, potential  targets for therapy and treatment protocols employed to improve the  management of cancer patients.",Non-OADS,/arxiv_data1/oa_pdf/da/7e/ott-8-3757.PMC4689271.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/da/7e/ott-8-3757.PMC4689271.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/e1/db/ott-8-3793.PMC4689272.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpOncoTargets and Therapy 2015:8 3793–3801OncoTargets and Therapy Dove press submit your manuscript | www.dovepress.co m Dove press  3793Original researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/OTT .S9329 7Prognostic and clinicopathological significance  of serum interleukin-6 expression in colorectal  cancer: a systematic review and meta-analysis Zhen Wang1 Pin Wu1,2 Dang Wu1 Zhigang Zhang3 guoming hu1 shuai Zhao1 Yucheng lai1 Jian huang1,4 1cancer institute, Key laboratory of  cancer Prevention and intervention,   Key laboratory of Molecular Biology  in Medical sciences, china national  Ministry of education, 2Department  of Thoracic surgery, 3Department of  gynecology, 4Department of surgical  Oncology, The second affiliated  hospital, Zhejiang University school  of Medicine, Zhejiang University,   hangzhou, Zhejiang Province, People’s  republic of chinaPurpose:  Interleukin-6 (IL-6) plays an important role in human colorectal cancer (CRC)  development.",Non-OADS,/arxiv_data1/oa_pdf/e1/db/ott-8-3793.PMC4689272.pdf
"Moreover, IL-6 expression level is gradually elevated during  the progression from colorectal adenoma to carcinoma.6correspondence: Jian huang Department of surgical Oncology,  The Second Affiliated Hospital, Zhejiang  University school of Medicine, Zhejiang  University, 88 Jiefang road, hangzhou  310009, Zhejiang Province, People’s  republic of china email drhuangjian@zju.edu.c n Journal name: OncoTargets and Therapy Article Designation: Original Research Y ear: 2015 Volume: 8 Running head verso: Wang et al Running head recto: Serum interleukin-6 expression in colorectal cancer DOI: http://dx.doi.org/10.2147/OTT.S93297",Non-OADS,/arxiv_data1/oa_pdf/e1/db/ott-8-3793.PMC4689272.pdf
"If  included articles only provided survival data in a Kaplan– Meier curve, the software GetDataGraph Digitizer 2.24  (http://getdata-graph-digitizer.com /) was used to extract  the data.",OADS,/arxiv_data1/oa_pdf/e1/db/ott-8-3793.PMC4689272.pdf
"Available from: http://www.ohri.ca/programs/clinical_   epidemiology/oxford.as p. Accessed July 29, 2015.",Non-OADS,/arxiv_data1/oa_pdf/e1/db/ott-8-3793.PMC4689272.pdf
"OncoTargets and Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/oncotargets-and-therapy-journa lOncoTargets and Therapy is an international, peer-reviewed, open  access journal focusing on the pathological basis of all cancers, potential  targets for therapy and treatment protocols employed to improve the  management of cancer patients.",Non-OADS,/arxiv_data1/oa_pdf/e1/db/ott-8-3793.PMC4689272.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/e1/db/ott-8-3793.PMC4689272.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/b5/cc/ott-8-3731.PMC4689273.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).OncoTargets and Therapy 2015:8 3731–3742OncoTargets and Therapy Dove press submit your manuscript | www.dovepress.co m Dove press  3731Original researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/OTT .S9671 5giT1 is a novel prognostic biomarker and  facilitates tumor progression via activating erK/ MMP9 signaling in hepatocellular carcinoma Junyi chen1,* Pinghua Yang2,* Jue Yang2 Zhijian Wen2 Baohua Zhang2 Xin Zheng1,3 1Department of general surgery,   Branch of the First People’s hospital  of shanghai, 2Department of hepatic  surgery, the eastern hepatobiliary  surgery hospital, second Military  Medical University, 3Department of  Traditional chinese Medicine, Branch  of the first People’s hospital of  shanghai, shanghai, People’s republic  of china *These authors contributed equally  to this workAim:  Multiple studies have revealed that G-protein-coupled receptor kinase-interacting protein  1  (GIT1) is overexpressed in many cancers and facilitates tumor progression.",Non-OADS,/arxiv_data1/oa_pdf/b5/cc/ott-8-3731.PMC4689273.pdf
"G-protein-coupled receptor kinase-interacting protein 1 (GIT1) was originally  considered as a multifunctional scaffold protein, and was suggested to be associ - ated with paxillin and capable of binding and regulating various proteins.10,11 As a correspondence: Xin Zheng Department of Traditional chinese  Medicine, Branch of the First People’s  hospital of shanghai, north sichuan  road 1878, shanghai 200081,  People’s republic of china Tel +86 21 5666 3031 Fax +86 21 5666 0851 email zx918163@163.co m  Baohua Zhang Department of hepatic surgery, the  eastern hepatobiliary surgery hospital,  second Military Medical University,  225 changhai road, shanghai, 200433,  People’s republic of china Tel +86 21 8187 5005 Fax +86 21 6556 2400 email zhangbh68@163.co m Journal name: OncoTargets and Therapy Article Designation: Original Research Y ear: 2015 Volume: 8 Running head verso: Chen et al Running head recto: GIT1 facilitates hepatocellular carcinoma progression DOI: http://dx.doi.org/10.2147/OTT.S96715",Non-OADS,/arxiv_data1/oa_pdf/b5/cc/ott-8-3731.PMC4689273.pdf
"OncoTargets and Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/oncotargets-and-therapy-journa lOncoTargets and Therapy is an international, peer-reviewed, open  access journal focusing on the pathological basis of all cancers, potential  targets for therapy and treatment protocols employed to improve the  management of cancer patients.",Non-OADS,/arxiv_data1/oa_pdf/b5/cc/ott-8-3731.PMC4689273.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/b5/cc/ott-8-3731.PMC4689273.pdf
Agricultural statistics 2012. http://www.nass.u sda.gov/Publications/Ag_Sta- tistics/2012/2012_Final.pdf.,OADS,/arxiv_data1/oa_pdf/b0/64/tov250.PMC4689275.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/26/08/ndt-11-3085.PMC4689284.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpNeuropsychiatric Disease and Treatment 2015:11 3085–3093Neuropsychiatric Disease and Treatment Dove press submit your manuscript | www.dovepress.co m Dove press  3085OrigiNal researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/NDT .S9522 4Functional connectivity of paired default mode  network subregions in primary insomnia Xiao Nie1,* Yi shao2,* si-yu liu3 hai-jun li1 ai-lan Wan4 si Nie1 De-chang Peng1 Xi-jian Dai1,5 1Department of radiology, The First  affiliated hospital of Nanchang  University, Nangchang, Jiangxi, People’s  republic of china; 2Department of  Ophthalmology,The First affiliated  hospital of Nanchang University,   Nangchang, Jiangxi, People’s republic  of china; 3Medical college of  Nanchang University, Nangchang,   Jiangxi, People’s republic of china;   4Department of Psychosomatic  Medicine, The First affiliated hospital  of Nanchang University, Nangchang,   Jiangxi, People’s republic of china;   5Brain cognition and Brain Disease  institute, shenzhen institutes of  advanced T echnology, chinese  academy of sciences, shenzhen,   People’s republic of china *These authors contributed equally  to this workObjective:  The aim of this study is to explore the resting-state functional connectivity (FC)  differences between the paired default mode network (DMN) subregions in patients with pri - mary insomnia (PIs).",Non-OADS,/arxiv_data1/oa_pdf/26/08/ndt-11-3085.PMC4689284.pdf
"Altena et al concluded that patients with PI (PIs) are cognitively compromised, as  shown by hypoactivation in the left prefrontal cortex and left inferior frontal gyrus  during task performance.11 Drummond et al12 further investigated the cognitive impair - ments in the PIs, they found less activation in the thalamus, fronto-parietal cortex, and  cerebellum, and these brain regions normally associated with the working memory and  the motor and visual processing during the cognitive tasks compared with the good  sleepers (GSs).12 Previous study found that the aberrant activation of the insula, which correspondence: Xi-jian Dai; De-chang Peng Department of radiology, The First  Affiliated Hospital of Nanchang  University, No 17, Yongwai Zheng street,  Donghu District, Nanchang 330006,  Jiangxi, People’s republic of china Tel +86 791 8869 4457 email daixjdoctor@126.co m;  pengdcdoctor@163.co mJournal name: Neuropsychiatric Disease and Treatment Article Designation: Original Research Y ear: 2015 Volume: 11 Running head verso: Nie et al Running head recto: Functional connectivity of paired DMN subregions in primary insomnia DOI: http://dx.doi.org/10.2147/NDT.S95224",Non-OADS,/arxiv_data1/oa_pdf/26/08/ndt-11-3085.PMC4689284.pdf
Neuropsychiatric Disease and Treatment 2015:11submit your manuscript | www.dovepress.co m Dove press Dove press 3087Functional connectivity of paired DMN subregions in primary insomnia PIs were asked to wear a Fitbit Flex tracker ( http://help.fitbit.,Non-OADS,/arxiv_data1/oa_pdf/26/08/ndt-11-3085.PMC4689284.pdf
"On the  basis of MATLAB2010a (Mathworks, Natick, MA, USA),  the rest of the data pre-processing was performed by the DPARSFA ( http://rfmri.org/DPARS F) software, including  digital imaging and communications in medicine form trans - formation, slice timing, head-motion correction, spatial nor - malization, and smooth with a Gaussian kernel of 6 ×6×6 mm3  full-width at half-maximum.",OADS,/arxiv_data1/oa_pdf/26/08/ndt-11-3085.PMC4689284.pdf
"Neuropsychiatric Disease and Treatment Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/neuropsychiatric-disease-and-treatment-journa lNeuropsychiatric Disease and Treatment is an international, peer- reviewed journal of clinical therapeutics and pharmacology focusing   on concise rapid reporting of clinical or pre-clinical studies on a   range of neuropsychiatric and neurological disorders.",Non-OADS,/arxiv_data1/oa_pdf/26/08/ndt-11-3085.PMC4689284.pdf
Visit http://www.dovepress.com/testimonials.ph p to  read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/26/08/ndt-11-3085.PMC4689284.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/72/59/ndt-11-3095.PMC4689285.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpNeuropsychiatric Disease and Treatment 2015:11 3095–3104Neuropsychiatric Disease and Treatment Dove press submit your manuscript | www.dovepress.co m Dove press  3095OrigiNal researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/NDT .S9191 7lack of tolerable treatment options for patients  with schizophrenia leslie citrome1 anna eramo2 clement Francois2 ruth Duffy3 susan N legacy3 steve J Offord3 holly B Krasa3 stephen s Johnston4 alice guiraud-Diawara5 siddhesh a Kamat3 Patricia rohman3 1Department of Psychiatry and  Behavioral sciences, New York  Medical college, Valhalla, NY,   2lundbeck, Deerfield, il, 3Otsuka  america Pharmaceuticals, Princeton,   NJ, 4Truven health analytics,   Bethesda,  MD, Usa; 5lundbeck  sas, issy-les-Moulineaux, FrancePurpose:  Atypical antipsychotics (AAs), an effective treatment for schizophrenia, have a range  of pharmacologic properties leading to differences in tolerability as well as heterogeneity in  treatment response.",Non-OADS,/arxiv_data1/oa_pdf/72/59/ndt-11-3095.PMC4689285.pdf
"Keywords:  schizophrenia, atypical antipsychotics, tolerability, comorbidities, treatment Background Schizophrenia is a chronic and disabling psychiatric disorder affecting an estimated  1.1% of adults (2.6 million) in the US, with onset commonly occurring in early  adulthood.1,2 Schizophrenia is also associated with significant medical comorbidities  and excess mortality; compared with healthy controls, patients with schizophrenia have  a nearly twofold increase in mortality rate.3 Antipsychotic therapy remains the main - stay of schizophrenia treatment, with patients requiring lifelong use of antipsychotic  medication to manage their disease.4 Antipsychotics are beneficial in controlling many  of the symptoms of schizophrenia, but are also associated with side effects.5,6 While correspondence: leslie citrome 11 Medical Park Drive, suite 106,  Pomona, NY 10970, Usa Tel +1 845 362 2081 Fax +1 845 362 8745 email citrome@cnsconsultant.co m Journal name: Neuropsychiatric Disease and Treatment Article Designation: Original Research Y ear: 2015 Volume: 11 Running head verso: Citrome et al Running head recto: Schizophrenia treatment options DOI: http://dx.doi.org/10.2147/NDT.S91917",Non-OADS,/arxiv_data1/oa_pdf/72/59/ndt-11-3095.PMC4689285.pdf
"Available from: http://www.nimh.nih.gov/health/publications/the-num - bers-count-mental-disorders-in-america/index.shtml#Schizophreni a.  Accessed March 6, 2015.",Non-OADS,/arxiv_data1/oa_pdf/72/59/ndt-11-3095.PMC4689285.pdf
"Available from:  https://www.pharma.us.novartis.com/product/pi/pdf/Clozaril.pd f.  Accessed May 11, 2015.",Non-OADS,/arxiv_data1/oa_pdf/72/59/ndt-11-3095.PMC4689285.pdf
"Available  from: http://www1.astrazeneca-us.com/pi/Seroquel.pd f. Accessed  March 6, 2015.",Non-OADS,/arxiv_data1/oa_pdf/72/59/ndt-11-3095.PMC4689285.pdf
Available from:  http://pi.actavis.com/data_stream.asp?product_group =1908&p =  pi&language =E.,OADS,/arxiv_data1/oa_pdf/72/59/ndt-11-3095.PMC4689285.pdf
"Available from:  http://www.janssencns.com/sites/default/files/pdf/invega/invega.pd f.  Accessed March 17, 2015.",OADS,/arxiv_data1/oa_pdf/72/59/ndt-11-3095.PMC4689285.pdf
"Available  from: http://www.janssenpharmaceuticalsinc.com/assets/risperdal.pd f.  Accessed March 6, 2015.",OADS,/arxiv_data1/oa_pdf/72/59/ndt-11-3095.PMC4689285.pdf
"Available from:  http://www.fanapt.com/product/pi/pdf/fanapt.pd f. Accessed March 10,  2015.",Non-OADS,/arxiv_data1/oa_pdf/72/59/ndt-11-3095.PMC4689285.pdf
"Available  from: http://www.otsuka-us.com/Documents/Abilify.PI.pd f. Accessed  March 6, 2015.",Non-OADS,/arxiv_data1/oa_pdf/72/59/ndt-11-3095.PMC4689285.pdf
Available from: http://labeling.pfizer.,Non-OADS,/arxiv_data1/oa_pdf/72/59/ndt-11-3095.PMC4689285.pdf
Available from: http://www.latuda.com/LatudaPrescribingInformation.,Non-OADS,/arxiv_data1/oa_pdf/72/59/ndt-11-3095.PMC4689285.pdf
"Neuropsychiatric Disease and Treatment Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/neuropsychiatric-disease-and-treatment-journa lNeuropsychiatric Disease and Treatment is an international, peer- reviewed journal of clinical therapeutics and pharmacology focusing   on concise rapid reporting of clinical or pre-clinical studies on a   range of neuropsychiatric and neurological disorders.",Non-OADS,/arxiv_data1/oa_pdf/72/59/ndt-11-3095.PMC4689285.pdf
Visit http://www.dovepress.com/testimonials.ph p to  read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/72/59/ndt-11-3095.PMC4689285.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/f3/69/opth-9-2335.PMC4689286.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpClinical Ophthalmology 2015:9 2335–2338Clinical Ophthalmology Dove press submit your manuscript | www.dovepress.co m Dove press  2335Original researChopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/OPTH.S8922 1effect of selective laser trabeculoplasty on macular  thickness Mustafa Koc1 irfan Durukan2 Yaran Koban3 Basak Bastanci Ceran1 Orhan ayar4 Metin ekinci3 Pelin Yilmazbas1 1Department of Ophthalmology,   Ulucanlar eye Training and research  hospital, ankara, 2Ophthalmology  Clinic, Kayserigoz hospital Kayseri,   3Department of Ophthalmology,   Faculty of Medicine, Kafkas University,   Kars, 4Department of Ophthalmology,   Faculty of Medicine, Bulent ecevit  University, Zonguldak, T urkeyBackground:  To investigate the effects of selective laser trabeculoplasty (SLT) on macular  thickness change.",Non-OADS,/arxiv_data1/oa_pdf/f3/69/opth-9-2335.PMC4689286.pdf
"In this method, Correspondence: Yaran Koban Kafkas Universitesi Tip Fakultesi, goz  hastaliklari aD, Turan Celik street,  Merkez, 36100 Kars, Turkey Tel +90 50 7707 8180 Fax +90 47 4225 1193  email yarankoban@yahoo.c om.au Journal name: Clinical Ophthalmology Article Designation: Original Research Y ear: 2015 Volume: 9 Running head verso: Koc et al Running head recto: Selective laser trabeculoplasty and macula DOI: http://dx.doi.org/10.2147/OPTH.S89221",Non-OADS,/arxiv_data1/oa_pdf/f3/69/opth-9-2335.PMC4689286.pdf
"Clinical Ophthalmology Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/clinical-ophthalmology-journa lClinical Ophthalmology is an international, peer-reviewed journal  covering all subspecialties within ophthalmology.",Non-OADS,/arxiv_data1/oa_pdf/f3/69/opth-9-2335.PMC4689286.pdf
Visit http://www.dovepress.com/ testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/f3/69/opth-9-2335.PMC4689286.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/13/6b/ndt-11-3075.PMC4689287.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpNeuropsychiatric Disease and Treatment 2015:11 3075–3083Neuropsychiatric Disease and Treatment Dove press submit your manuscript | www.dovepress.co m Dove press  3075OrigiNal researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/NDT .S9249 7Disturbed spontaneous brain-activity pattern in  patients with optic neuritis using amplitude of  low-frequency fluctuation: a functional magnetic  resonance imaging study Xin huang1,2,* Feng-Qin cai3,* Pei-hong hu1 Yu-lin Zhong1 Ying Zhang1 rong Wei1 chong-gang Pei1 Fu-Qing Zhou3 Yi shao1 1Department of Ophthalmology,   Jiangxi Province clinical  Ophthalmology institute, First  affiliated hospital of Nanchang  University, Nanchang, 2Department of  Ophthalmology, First People’s hospital  of Jiujiang, Jiujiang, 3Department of  radiology, First affiliated hospital  of Nanchang University, Nanchang,   People’s  republic of china *These authors contributed equally  to this workObjective:  To use the amplitude of low-frequency fluctuation (ALFF) technique to investigate  the local features of spontaneous brain activity in optic neuritis (ON) and their relationship with  behavioral performance.",Non-OADS,/arxiv_data1/oa_pdf/13/6b/ndt-11-3075.PMC4689287.pdf
"Clinically, it can occur as an isolated condition or as correspondence: Fu-Qing Zhou Department of radiology, First  Affiliated Hospital of Nanchang  University, 17 Yongwai Zheng street,  Donghu, Nanchang, Jiangxi 330006,  People’s republic of china Tel +86 791 8869 5132 email f q.chou@yahoo.co m  Yi shao Department of Ophthalmology, Jiangxi  Province clinical Ophthalmology  Institute, First Affiliated Hospital of  Nanchang University, 17 Yongwai Zheng  street, Donghu, Nanchang, Jiangxi  330006, People’s republic of china Tel +86 791 8869 2520 email freebee99@163.co m Journal name: Neuropsychiatric Disease and Treatment Article Designation: Original Research Y ear: 2015 Volume: 11 Running head verso: Huang et al Running head recto: Disturbed brain activity in optic neuritis DOI: http://dx.doi.org/10.2147/NDT.S92497",Non-OADS,/arxiv_data1/oa_pdf/13/6b/ndt-11-3075.PMC4689287.pdf
"The rest of the data preprocessing was performed by  DPARSFA ( http://rfmri.org/DPARS F) software, including  Digital Imaging and Communications in Medicine form  transformation, slice timing, head-motion correction, spatial  normalization, and smoothening with a Gaussian kernel of  6×6×6 mm3 full width at half maximum.",OADS,/arxiv_data1/oa_pdf/13/6b/ndt-11-3075.PMC4689287.pdf
"Neuropsychiatric Disease and Treatment Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/neuropsychiatric-disease-and-treatment-journa lNeuropsychiatric Disease and Treatment is an international, peer- reviewed journal of clinical therapeutics and pharmacology focusing   on concise rapid reporting of clinical or pre-clinical studies on a   range of neuropsychiatric and neurological disorders.",Non-OADS,/arxiv_data1/oa_pdf/13/6b/ndt-11-3075.PMC4689287.pdf
Visit http://www.dovepress.com/testimonials.ph p to  read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/13/6b/ndt-11-3075.PMC4689287.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/d3/23/nss-7-171.PMC4689288.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.ph pNature and Science of Sleep 2015:7 171–184Nature and Science of Sleep Dove press submit your manuscript | www.dovepress.co m Dove press  171COMMENTARYopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/NSS.S5403 6Sleep, recovery, and metaregulation: explaining   the benefits of sleep Vladyslav V Vyazovskiy Department of Physiology, Anatomy,   and Genetics, University of Oxford,   Oxford, UK Correspondence: Vladyslav V Vyazovskiy   Department of Physiology, Anatomy,   and Genetics, University of Oxford,   Parks Road, Oxford OX1  3PT, UK   Email vladyslav.vyazovskiy@dpag.ox.ac.u kAbstract:  A commonly held view is that extended wakefulness is causal for a broad spectrum of  deleterious effects at molecular, cellular, network, physiological, psychological, and behavioral  levels.",Non-OADS,/arxiv_data1/oa_pdf/d3/23/nss-7-171.PMC4689288.pdf
"Nature and Science of Sleep Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/nature-and-science-of-sleep-journa lNature and Science of Sleep is an international, peer-reviewed, open  access journal covering all aspects of sleep science and sleep medicine,  including the neurophysiology and functions of sleep, the genetics of  sleep, sleep and society, biological rhythms, dreaming, sleep disorders and  therapy, and strategies to optimize healthy sleep.",Non-OADS,/arxiv_data1/oa_pdf/d3/23/nss-7-171.PMC4689288.pdf
Visit http://www.dovepress.com/   testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/d3/23/nss-7-171.PMC4689288.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/f4/e6/ndt-11-3105.PMC4689289.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpNeuropsychiatric Disease and Treatment 2015:11 3105–3110Neuropsychiatric Disease and Treatment Dove press submit your manuscript | www.dovepress.co m Dove press  3105OrigiNal researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/NDT .S9501 8Cerebrospinal fluid biomarkers for Alzheimer’s  disease: the role of apolipoprotein E genotype,  age, and sex shima Mehrabian1 Panagiotis Alexopoulos2,3 Marion Ortner2 Latchezar Traykov1 Timo grimmer2 Alexander Kurz2 hans Förstl2 Horst Bickel2 Janine Diehl-schmid2 1Department of Neurology, University  Hospital “Alexandrovska”, Sofia,   Bulgaria; 2Department of Psychiatry,   T echnische Universität München,   Munich, Germany; 3Department  of Psychiatry, University of Patras,   Patras,  GreeceIntroduction:  Cerebrospinal fluid (CSF) biomarkers improve the diagnostic accuracy for  Alzheimer’s disease (AD), even at the predementia stage of the disease.",Non-OADS,/arxiv_data1/oa_pdf/f4/e6/ndt-11-3105.PMC4689289.pdf
"At 90% specificity, A β1-42 discriminates AD from cognitively healthy persons  with 85% sensitivity.4 Furthermore, A β1-42 has a high positive predictive value for correspondence: shima Mehrabian Department of Neurology, University  Hospital “Alexandrovska”, 1, Georgi  Sofiiski Street, 1431 Sofia, Bulgaria Tel +359 2 923 0544 Fax +359 2 952 0427 email shima_meh@yahoo.co m Journal name: Neuropsychiatric Disease and Treatment Article Designation: Original Research Y ear: 2015 Volume: 11 Running head verso: Mehrabian et al Running head recto: Cerebrospinal fluid biomarkers for Alzheimer’s disease DOI: http://dx.doi.org/10.2147/NDT.S95018",Non-OADS,/arxiv_data1/oa_pdf/f4/e6/ndt-11-3105.PMC4689289.pdf
"Neuropsychiatric Disease and Treatment Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/neuropsychiatric-disease-and-treatment-journa lNeuropsychiatric Disease and Treatment is an international, peer- reviewed journal of clinical therapeutics and pharmacology focusing   on concise rapid reporting of clinical or pre-clinical studies on a   range of neuropsychiatric and neurological disorders.",Non-OADS,/arxiv_data1/oa_pdf/f4/e6/ndt-11-3105.PMC4689289.pdf
Visit http://www.dovepress.com/testimonials.ph p to  read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/f4/e6/ndt-11-3105.PMC4689289.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/13/85/ndt-11-3111.PMC4689290.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpNeuropsychiatric Disease and Treatment 2015:11 3111–3125Neuropsychiatric Disease and Treatment Dove press submit your manuscript | www.dovepress.co m Dove press  3111Reviewopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/NDT .S7670 0Cognitive dysfunction in bipolar disorder and  schizophrenia: a systematic review of meta-analyses Beatrice Bortolato1 Kamilla w Miskowiak2 Cristiano A Köhler3 eduard vieta4 André F Carvalho3 1Department of Mental Health, ULSS  10 “veneto Orientale”, venice, italy;   2Psychiatric Centre Copenhagen,   Copenhagen University Hospital,   Rigshospitalet, Copenhagen, Denmark;   3Translational Psychiatry Research  Group and Department of Clinical  Medicine, Faculty of Medicine, Federal  University of Ceará, Fortaleza,   Ce, Brazil; 4Bipolar Disorders  Program, institute of Neuroscience,   Hospital Clínic Barcelona, iDiBAPS,   CiBeRSAM, University of Barcelona,   Catalonia, SpainAbstract:  Cognitive impairment is a core feature of schizophrenia (SZ) and bipolar disorder  (BD).",Non-OADS,/arxiv_data1/oa_pdf/13/85/ndt-11-3111.PMC4689290.pdf
"A neurocognitive profile characterized by cognitive  deficits across multiple domains in the context of a general intellectual impairment  has been consistently reported in the SZ literature.1,2 More recently, the evaluation  of neuropsychological profile in young individuals at clinical high risk (CHR) for  psychosis and in individuals with familiar high risk (FHR) has become a focus for  research designed to explore putative neurocognitive predictors of transition to full- blown psychosis.3,4 In youth, prodromic conditions associated with increased risk of  psychosis are operationally defined by the presence of either an attenuated psychosis  syndrome or brief limited intermittent psychotic symptoms or genetic/familial risk  to psychosis associated with functional decline.5 Evidence suggests that cognitive  dysfunction occurs in individuals with FHR to psychosis and in young populations  at ultra-high-risk (UHR) to psychosis.6 In addition, reduced premorbid intelligence  quotient ( ~0.5 standard deviations [SDs] below average)7 during childhood has been  associated with a higher risk to develop SZ.1,8 For bipolar disorder (BD), substantial albeit less severe cognitive dysfunction  has been consistently shown across several domains in affected individuals even Correspondence: André F Carvalho Department of Clinical Medicine, Faculty  of Medicine, Federal University of Ceará,  Rua Prof Costa Mendes, 1608, 4 ° Andar,  60430-040 Fortaleza, Ce, Brazil Tel +55 85 3366 8054 Fax +55 85 3366 8054 email andrefc7@terra.com.b r Journal name: Neuropsychiatric Disease and Treatment Article Designation: Review Y ear: 2015 Volume: 11 Running head verso: Bortolato et al Running head recto: Cognitive impairment in BD and SZ DOI: http://dx.doi.org/10.2147/NDT.S76700",Non-OADS,/arxiv_data1/oa_pdf/13/85/ndt-11-3111.PMC4689290.pdf
"Neuropsychiatric Disease and Treatment Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/neuropsychiatric-disease-and-treatment-journa lNeuropsychiatric Disease and Treatment is an international, peer- reviewed journal of clinical therapeutics and pharmacology focusing   on concise rapid reporting of clinical or pre-clinical studies on a   range of neuropsychiatric and neurological disorders.",Non-OADS,/arxiv_data1/oa_pdf/13/85/ndt-11-3111.PMC4689290.pdf
Visit http://www.dovepress.com/testimonials.ph p to  read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/13/85/ndt-11-3111.PMC4689290.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/cc/54/opth-9-2339.PMC4689291.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpDove press submit your manuscript | www.dovepress.co m Dove press  2339Original researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/OPTH.S9212 7clinical Ophthalmology 2015:9 2339–2344Clinical Ophthalmology Novel approach for phacoemulsification during  combined phacovitrectomy Wael ahmed ewais ashraf abdel Maqsoud  nossair lamia samy ali Department of Ophthalmology,   Faculty of Medicine, cairo University,   cairo, egyptPurpose:  To evaluate the safety and efficacy of surgeon’s superior sitting position during  temporal clear corneal incision (TCCI) phacoemulsification, with a 90 ° working angle, during  combined phacovitrectomy.",Non-OADS,/arxiv_data1/oa_pdf/cc/54/opth-9-2339.PMC4689291.pdf
"The advantages of temporal approach include: it induces the least surgically induced  astigmatism (SIA); it provides adequate visualization of the posterior segment because  the temporal incision is further from the visual axis than the superior incision; it pro - vides better accessibility, especially in deep set eyes or prominent orbital rims; and it  offers an excellent red reflex.5–9 The major drawback for the temporal approach during combined phacovitrectomy is  that the surgeon and assistants need to arrange the situation with the operating table and correspondence: Wael ahmed ewais Department of Ophthalmology, Faculty  of Medicine, cairo University, 24 shehab  street, Mohandessin, PO Box 11411  cairo, egypt Tel +20 2 3762 3391 email waelewais74@gmail.co m Journal name: Clinical Ophthalmology Article Designation: Original Research Y ear: 2015 Volume: 9 Running head verso: Ewais et al Running head recto: Phacoemulsification during combined phacovitrectomy DOI: http://dx.doi.org/10.2147/OPTH.S92127",Non-OADS,/arxiv_data1/oa_pdf/cc/54/opth-9-2339.PMC4689291.pdf
"Clinical Ophthalmology Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/clinical-ophthalmology-journa lClinical Ophthalmology is an international, peer-reviewed journal  covering all subspecialties within ophthalmology.",Non-OADS,/arxiv_data1/oa_pdf/cc/54/opth-9-2339.PMC4689291.pdf
Visit http://www.dovepress.com/ testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/cc/54/opth-9-2339.PMC4689291.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0/ .,Non-OADS,/arxiv_data1/oa_pdf/f3/79/oajsm-6-353.PMC4689292.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpOpen Access Journal of Sports Medicine 2015:6 353–360Open Access Journal of Sports Medicine Dovepress submit your manuscript | www.dovepress.co m Dovepress 353OriginAl reSeArchopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/OAJSM.S9317 4Optimal V.O2max-to-mass ratio for predicting  15 km performance among elite male   cross-country skiers T omas carlsson1,2 Magnus carlsson1,2 Daniel hammarström3 Bent r rønnestad3 christer B Malm2 Michail T onkonogi1 1School of education, health and  Social Studies, Dalarna University,   Falun, 2Sports Medicine Unit, Umeå  University, Umeå, Sweden; 3The  lillehammer research center for  Medicine and exercise Physiology,   lillehammer University college,   lillehammer, norway correspondence: Tomas carlsson   School of education, health and  Social Studies, Dalarna University, högskolegatan 2, 79188 Falun, Sweden   Tel +46 23 77 8402   Fax +46 23 79 4324   email tca@du.s eAbstract: The aim of this study was 1) to validate the 0.5 body-mass exponent for maximal  oxygen uptake (V.O2max) as the optimal predictor of performance in a 15 km classical-technique  skiing competition among elite male cross-country skiers and 2) to evaluate the influence of dis- tance covered on the body-mass exponent for V.O2max among elite male skiers.",Non-OADS,/arxiv_data1/oa_pdf/f3/79/oajsm-6-353.PMC4689292.pdf
"Open Access Journal of Sports Medicine Publish your work in this journal Submit your manuscript here: http://www.dovepress.com/open-access-journal-of-sports-medicine-journalOpen Access Journal of Sports Medicine is an international,  peer-reviewed, open access journal publishing original research, reports, reviews and commentaries on all areas of sports medicine.",Non-OADS,/arxiv_data1/oa_pdf/f3/79/oajsm-6-353.PMC4689292.pdf
Visit http://www.dovepress.com/testimonials.php to read real quotes  from published authors.,Non-OADS,/arxiv_data1/oa_pdf/f3/79/oajsm-6-353.PMC4689292.pdf
"This work was supported by the Lafay-ette College Chemistry Department, the EXCEL ResearchScholarship Program (http://www.lafayette.edu), a Single-Investigator Cottrell College Science Award (Award #21010)from the Research Corporation for Science Advancement(http://www.rescorp.org/) and by the National Institute ofGeneral Medical Sciences of the National Institutes of Healthunder Award Number R15GM110606.",Non-OADS,/arxiv_data1/oa_pdf/e9/1c/MMI-97-926.PMC4689296.pdf
"There are several large, multimillion-dollar prospective stud-ies that have been recently initiated in Europe and the United States,including the Innovative Medicines Initiative DIRECT Study inEurope (112) and the Google Baseline Study in the United States(https://www.dtmi.duke.edu/news/duke-and-stanford-assist-google-x-defining-health); both studies involve repeated intensive phenotypingand objective long-term measures of behavior assessed with weara-ble devices, from which much will be learned about the genetic andenvironmental influences on weight change and metabolic health.Although interrogating existing trials for gene-intervention interac-tions is pragmatic and should be done, new trials that are specifi- cally designed to assess the combined effects of genotypes and inter- ventions are needed.",Non-OADS,/arxiv_data1/oa_pdf/d2/10/oby0024-0014.PMC4689320.pdf
http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?token=wnaxqakubzglvip&acc=GSE70772).,OADS,/arxiv_data1/oa_pdf/72/cf/or-35-02-0659.PMC4689484.pdf
The Fisher's exact test was applied to identify overrepresented Gene Ontology (GO) terms (25) (http://geneontology.org).,OADS,/arxiv_data1/oa_pdf/72/cf/or-35-02-0659.PMC4689484.pdf
The target genes of miRNAs were identified  from miRTarBase (http://mirtarbase.mbc.nctu.edu.tw) (27)  and were subjected to DAVID for GO biological process analysis.,OADS,/arxiv_data1/oa_pdf/72/cf/or-35-02-0659.PMC4689484.pdf
miRNA pathway analysis was predicted using DIANA-miRPath (http://diana.imis.athena-innovation.gr/DianaTools/index.php?r=mirpath/index)  (28) with FDR  corrected P<0.05.,OADS,/arxiv_data1/oa_pdf/72/cf/or-35-02-0659.PMC4689484.pdf
LINCS or  the Library or Integrated Network-based Cellular Signatures  project is the extensive version of CMAP (29) which is available on the http://lincscloud.org website.,OADS,/arxiv_data1/oa_pdf/72/cf/or-35-02-0659.PMC4689484.pdf
"Colonies were counted using ImageJ software (ImageJ v.1.48, http://imagej.nih.gov/ij/).",OADS,/arxiv_data1/oa_pdf/97/5d/or-35-02-0878.PMC4689486.pdf
World Bank: Vietnam overview [http://www.worldbank.org/ en/country/vietnam/overview].,Non-OADS,/arxiv_data1/oa_pdf/64/7d/jrm-10-065.PMC4689735.pdf
77 [http://www.who.int/mediacentre/factsheets/fs290/en/].,Non-OADS,/arxiv_data1/oa_pdf/64/7d/jrm-10-065.PMC4689735.pdf
[http://www.chinhphu.vn/portal/page/portal/English/strategies/strategiesdetails?categoryId=29&articleId=3034].,Non-OADS,/arxiv_data1/oa_pdf/64/7d/jrm-10-065.PMC4689735.pdf
"Bron: Nederlandse Kankerregistratie, beheerd door IKNL© [Januari](2015) http://www.cijfersoverkanker.nl/selecties/ Incidentie_ darmkanker/img54dded375b587.",Non-OADS,/arxiv_data1/oa_pdf/ab/7c/520_2015_Article_2808.PMC4689743.pdf
http://www.ich.org/ fileadmin/Public_Web_Site/ICH_Products/Guidelines/Efficacy/E14/E14_Guideline.pdf Accessed 3 Feb 2014 12.,Non-OADS,/arxiv_data1/oa_pdf/17/db/520_2015_Article_2822.PMC4689761.pdf
"Open Access This article is distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org /licenses/by-nc/4.0/), which permits any noncommercial use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, andindicate if changes were made.",Non-OADS,/arxiv_data1/oa_pdf/00/46/520_2015_Article_2864.PMC4689762.pdf
"Individuals diagnosed be- tween 2000 and 2009 with colon or rectal cancer stage I –III (N=3323) as registered in the ECR, were eligible for partici- pation (see flowchart: http://www.profilesregistry.nl/ dataarchive/study_units/view/22 ).",Non-OADS,/arxiv_data1/oa_pdf/ef/42/520_2015_Article_2816.PMC4689770.pdf
"Open Access This article is distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org /licenses/by-nc/4.0/), which per- mits any noncommercial use, distribution, and reproduction in any medi- um, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate ifchanges were made.",Non-OADS,/arxiv_data1/oa_pdf/20/e7/520_2015_Article_2826.PMC4689771.pdf
Available from: http://globocan.iarc.fr .A c c e s s e d1 0 May 2015 2.,Non-OADS,/arxiv_data1/oa_pdf/a6/64/520_2015_Article_2860.PMC4689774.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0)  which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.pISSN 1011-8934 eISSN 1598-6357WMA Guidelines on Promotional Mass Media Appearances by  Physicians Adopted by the 66th WMA General Assembly, Moscow, Russia, October 2015http://dx.doi.org/10.3346/jkms.2015.30.12.1715  • J Korean Med Sci 2015; 30: 1715 PREAMBLE Mass media can effectively play diverse roles in medical com - munication.",Non-OADS,/arxiv_data1/oa_pdf/78/8b/jkms-30-1715.PMC4689812.pdf
*Source: WMA website (http://www.wma.net/en/30publications/  10policies/m39/index.html).,Non-OADS,/arxiv_data1/oa_pdf/78/8b/jkms-30-1715.PMC4689812.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0)  which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.pISSN 1011-8934 eISSN 1598-6357World Medical Association Guidelines on Promotional Mass  Media Appearances by Physicians: Starting Campaigns for Ethics Moo-Jin Choo,1 Dong Chun Shin,2 Cheong Hee Kang,3 and Hyun-Young Shin4 1President, Korean Medical Association, Seoul; 2Department of Preventive Medicine, Yonsei University College of Medicine, Seoul & Chair, Finance and Planning  Committee, World Medical Association; 3Vice President, Korean Medical Association, Seoul; 4Director of Public Relations and Spokesperson, Korean Medical Association &  Department of Family Medicine, Myongji Hospital, Seonam University, College of Medicine, Goyang, Koreahttp://dx.doi.org/10.3346/jkms.2015.30.12.1716  • J Korean Med Sci 2015; 30: 1716-1717 For physicians, professional ethics is vital in preserving the dig - nity of the profession.",Non-OADS,/arxiv_data1/oa_pdf/45/43/jkms-30-1716.PMC4689813.pdf
• WMA Ethics Campaign for Physicians http://jkms.org   1717 http://dx.doi.org/10.3346/jkms.2015.30.12.1716REFERENCES 1.,Non-OADS,/arxiv_data1/oa_pdf/45/43/jkms-30-1716.PMC4689813.pdf
Avail - able at https://www.kma.org/board2/view.php?w_seq=5810&page=  1&kind_code=2&search_part=w_title&search_name=%B9%E6%BC%  DB&subjecttype=w_title2&search_name2=&start_year=2015&start_ month=11&start_day=01&end_year=2015&end_month=11&end_day=01  [accessed on 1 November 2015].2.,Non-OADS,/arxiv_data1/oa_pdf/45/43/jkms-30-1716.PMC4689813.pdf
Available at http://www.wma.net/en/30publications/10  policies/m39/index.htm [accessed on 1 November 2015].,Non-OADS,/arxiv_data1/oa_pdf/45/43/jkms-30-1716.PMC4689813.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0)  which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.pISSN 1011-8934 eISSN 1598-6357The Legal Doctrine on ‘Limitation of Liability’ in the Precedent  Analysis on Plastic Surgery Medical Malpractice Lawsuits This study intended to review the precedents on plastic surgery medical malpractice  lawsuits in lower-court trials, classify the reasons of ‘limitation of liability’ by type, and  suggest a standard in the acknowledgement of limitation of liability ratio.",Non-OADS,/arxiv_data1/oa_pdf/23/a2/jkms-30-1718.PMC4689814.pdf
"Keywords:  Plastic Surgery; Malpractice; Lawsuits; LiabilityBo Young Park, Ji-Hyun Pak,   Seung-Eun Hong, and So Ra Kang Department of Plastic Surgery, Ewha Womans  University Mokdong Hospital, Seoul, Korea Received: 18 May 2015 Accepted: 14 September 2015 Address for Correspondence: Seung-Eun Hong, MD Department of Plastic Surgery, Ewha Womans University  Mokdong Hospital, 1071 Anyangcheon-ro, Yangcheon-gu,   Seoul 07985, Korea Tel: +82.2-2650-5149, Fax: +82.2-3410-0036 E-mail: monkeyhong@hanmail.nethttp://dx.doi.org/10.3346/jkms.2015.30.12.1718  • J Korean Med Sci 2015; 30: 1718-1722 INTRODUCTION In cases where the court finds in favor of patients in medical  malpractice lawsuits, the amount of monetary damage initially  claimed by patients often significantly differs from that finally  awarded by the courts.",Non-OADS,/arxiv_data1/oa_pdf/23/a2/jkms-30-1718.PMC4689814.pdf
• Precedents in Lower-court’s Rulings for Plastic Surgery http://jkms.org   1719 http://dx.doi.org/10.3346/jkms.2015.30.12.1718practices have a lifesaving nature and medical malpractice is  not intentional; and 3) certain inevitable outcomes might occur  due to the constitutional predispositions of patients and the  limitations of the modern clinical medicine.,Non-OADS,/arxiv_data1/oa_pdf/23/a2/jkms-30-1718.PMC4689814.pdf
"• Precedents in Lower-court’s Rulings for Plastic Surgery 1720  http://jkms.org http://dx.doi.org/10.3346/jkms.2015.30.12.1718treatments (deficits in sensory and motor functions), and mor - phologic abnormalities (scars, deformities, effacements, depres - sions, and so on) (Table 2).",Non-OADS,/arxiv_data1/oa_pdf/23/a2/jkms-30-1718.PMC4689814.pdf
• Precedents in Lower-court’s Rulings for Plastic Surgery http://jkms.org   1721 http://dx.doi.org/10.3346/jkms.2015.30.12.1718bility differed in the appellate trial from that of the first trial.,Non-OADS,/arxiv_data1/oa_pdf/23/a2/jkms-30-1718.PMC4689814.pdf
• Precedents in Lower-court’s Rulings for Plastic Surgery 1722  http://jkms.org http://dx.doi.org/10.3346/jkms.2015.30.12.1718damage.,Non-OADS,/arxiv_data1/oa_pdf/23/a2/jkms-30-1718.PMC4689814.pdf
ORCID Bo Young Park http://orcid.org/0000-0003-4612-6672 Ji-Hyun Pak http://orcid.org/0000-0002-2309-1588 Seung-Eun Hong http://orcid.org/0000-0002-2657-7428REFERENCES 1.,Non-OADS,/arxiv_data1/oa_pdf/23/a2/jkms-30-1718.PMC4689814.pdf
Available at http://www.law.go.kr/lsInfoP .do?lsiSeq=160862&ef Yd=20151016#0000 [accessed on 5 June 2015].,Non-OADS,/arxiv_data1/oa_pdf/23/a2/jkms-30-1718.PMC4689814.pdf
Available at http://uijeongbu.scourt.go.kr/main/new/Main.work  [accessed on 5 June 2015].,Non-OADS,/arxiv_data1/oa_pdf/23/a2/jkms-30-1718.PMC4689814.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0)  which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.pISSN 1011-8934 eISSN 1598-6357Cost-Utility Analysis of Screening Strategies for Diabetic  Retinopathy in Korea This study involved a cost-utility analysis of early diagnosis and treatment of diabetic  retinopathy depending on the screening strategy used.",Non-OADS,/arxiv_data1/oa_pdf/4b/77/jkms-30-1723.PMC4689815.pdf
"Keywords:  Diabetic Retinopathy; Markov Model; Cost-utility Analysis; Quality-Adjusted  Life Years (QALY)Sang-Won Kim1 and Gil-Won Kang2 1Department of Ophthalmology, National Police  Hospital, Seoul; 2Department of Health Informatics  and Management, College of Medicine, Chungbuk  National University, Cheongju, Korea Received: 22 May 2015 Accepted: 1 September 2015 Address for Correspondence: Gilwon Kang, MD Department of Health Informatics and Management,   College of Medicine and Medical Research Institute,   Chungbuk National University, 776 1sunhwan-ro, Seowon-gu,  Cheongju 28644, Korea  Tel: +82.43-261-2838, Fax: +82.43-261-3459  E-mail: gilwon67@chungbuk.ac.krhttp://dx.doi.org/10.3346/jkms.2015.30.12.1723  • J Korean Med Sci 2015; 30: 1723-1732 INTRODUCTION Diabetic retinopathy is one of the important complications of  chronic diabetes and is characterized by abnormalities in the  retinal vasculature.",Non-OADS,/arxiv_data1/oa_pdf/4b/77/jkms-30-1723.PMC4689815.pdf
• Screening Strategies for Diabetic Retinopathy 1724  http://jkms.org http://dx.doi.org/10.3346/jkms.2015.30.12.1723MATERIALS AND METHODS Study design  Population  A hypothetical cohort for cost-utility analysis was determined  for each screening strategy used in this study.,Non-OADS,/arxiv_data1/oa_pdf/4b/77/jkms-30-1723.PMC4689815.pdf
• Screening Strategies for Diabetic Retinopathy http://jkms.org   1725 http://dx.doi.org/10.3346/jkms.2015.30.12.1723retinopathy according to the probabilities of the Markov model.,Non-OADS,/arxiv_data1/oa_pdf/4b/77/jkms-30-1723.PMC4689815.pdf
• Screening Strategies for Diabetic Retinopathy 1726  http://jkms.org http://dx.doi.org/10.3346/jkms.2015.30.12.1723Fig.,Non-OADS,/arxiv_data1/oa_pdf/4b/77/jkms-30-1723.PMC4689815.pdf
"• Screening Strategies for Diabetic Retinopathy http://jkms.org   1727 http://dx.doi.org/10.3346/jkms.2015.30.12.1723mation Service (KERIS) was used to obtain domestic literature,  while PubMed (http://ncbi.nih.gov), a biomedical information  search engine provided by the U.S. National Institutes of Health  National Library of Medicine (NIH/NLM), was used to obtain  international literature.",OADS,/arxiv_data1/oa_pdf/4b/77/jkms-30-1723.PMC4689815.pdf
"• Screening Strategies for Diabetic Retinopathy 1728  http://jkms.org http://dx.doi.org/10.3346/jkms.2015.30.12.1723surance fees vary by the type of health care provider, we used  the weighted average fees considering the frequencies of these  tests for each type of health care provider.",Non-OADS,/arxiv_data1/oa_pdf/4b/77/jkms-30-1723.PMC4689815.pdf
• Screening Strategies for Diabetic Retinopathy http://jkms.org   1729 http://dx.doi.org/10.3346/jkms.2015.30.12.1723Table 2.,Non-OADS,/arxiv_data1/oa_pdf/4b/77/jkms-30-1723.PMC4689815.pdf
• Screening Strategies for Diabetic Retinopathy 1730  http://jkms.org http://dx.doi.org/10.3346/jkms.2015.30.12.1723cussing the compliance rate for the examination as well as ICER  is required for the decision-making process with regard to sys - tematic screening strategies for diabetic retinopathy.,Non-OADS,/arxiv_data1/oa_pdf/4b/77/jkms-30-1723.PMC4689815.pdf
• Screening Strategies for Diabetic Retinopathy http://jkms.org   1731 http://dx.doi.org/10.3346/jkms.2015.30.12.1723be calculated.,Non-OADS,/arxiv_data1/oa_pdf/4b/77/jkms-30-1723.PMC4689815.pdf
ORCID Gil-Won Kang http://orcid.org/0000-0003-0222-1870 Sang-Won Kim http://orcid.org/0000-0003-4751-4298  REFERENCES 1.,Non-OADS,/arxiv_data1/oa_pdf/4b/77/jkms-30-1723.PMC4689815.pdf
• Screening Strategies for Diabetic Retinopathy 1732  http://jkms.org http://dx.doi.org/10.3346/jkms.2015.30.12.1723Automated detection of diabetic retinopathy in digital retinal images: a  tool for diabetic retinopathy screening.,Non-OADS,/arxiv_data1/oa_pdf/4b/77/jkms-30-1723.PMC4689815.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0)  which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.pISSN 1011-8934 eISSN 1598-6357National Priority Setting of Clinical Practice Guidelines  Development for Chronic Disease Management By November 2013, a total of 125 clinical practice guidelines (CPGs) have been developed  in Korea.",Non-OADS,/arxiv_data1/oa_pdf/a8/08/jkms-30-1733.PMC4689816.pdf
"Keywords:  Clinical Practice Guideline; Chronic Disease; Primary Health Care; Health  Priorities; KoreaHeui-Sug Jo,1,2 Dong Ik Kim,3 and Moo-Kyung Oh4 1Department of Health Management and Policy,  Kangwon National University School of Medicine,  Chuncheon; 2The Executive Committee for Clinical  Practice Guidelines, The Korean Academy of Medical  Sciences, Seoul; 3Department of Radiology, Yonsei  University Sevrance Hospital, Yonsei University  College of Medicine, Seoul; 4Department of  Preventive Medicine, Kangwon National University  Hospital, Chuncheon, Korea  Received: 5 June 2015 Accepted: 18 August 2015 Address for Correspondence:  Moo-Kyung Oh, MD Department of Preventive Medicine, Kangwon National  University Hospital, 156 Baengnyeong-ro, Chuncheon 24289,  Korea Tel: +82.33-258-9031, Fax: +82.33-258-9294 E-mail: somanghana@gmail.com Funding:  This study was supported by a 2013 project grant for  health promotion policy development from the Korea Health  Promotion Foundation and Korea Centers for Disease Control  and Prevention (2013-84).http://dx.doi.org/10.3346/jkms.2015.30.12.1733  • J Korean Med Sci 2015; 30: 1733-1742 INTRODUCTION As is the case worldwide, the disease burden of chronic disease  is continually increasing in Korea (1-3).",Non-OADS,/arxiv_data1/oa_pdf/a8/08/jkms-30-1733.PMC4689816.pdf
"• Building an Environment for Evidence-based Primary Care in Korea 1734  http://jkms.org http://dx.doi.org/10.3346/jkms.2015.30.12.1733chronic diseases, iii) collecting statistical data on those chronic  diseases and examining the current developmental status of  CPGs in Korea, iv) surveying the opinions of experts from the  CPG Priority-Setting Committee by using the analytic hierarchy  process (AHP) and a subjective assessment, and v) determin - ing final priorities.",Non-OADS,/arxiv_data1/oa_pdf/a8/08/jkms-30-1733.PMC4689816.pdf
• Building an Environment for Evidence-based Primary Care in Korea http://jkms.org   1735 http://dx.doi.org/10.3346/jkms.2015.30.12.1733step was to calculate the geometric mean of each criterion in  the matrix to obtain an approximate eigenvector that is the  weighted value of the 4 criteria.,Non-OADS,/arxiv_data1/oa_pdf/a8/08/jkms-30-1733.PMC4689816.pdf
• Building an Environment for Evidence-based Primary Care in Korea 1736  http://jkms.org http://dx.doi.org/10.3346/jkms.2015.30.12.1733summing the scores from the evaluators.,Non-OADS,/arxiv_data1/oa_pdf/a8/08/jkms-30-1733.PMC4689816.pdf
"• Building an Environment for Evidence-based Primary Care in Korea http://jkms.org   1737 http://dx.doi.org/10.3346/jkms.2015.30.12.1733 Cerebrovascular diseases and ischemic heart disease are se - rious causes of death in Korea, and the medical expenses and  numbers of patients with these diseases are very high.",Non-OADS,/arxiv_data1/oa_pdf/a8/08/jkms-30-1733.PMC4689816.pdf
ORCID  Heui-Sug Jo http://orcid.org/0000-0003-0245-3583 Dong-Ik Kim http://orcid.org/0000-0001-7527-3829 Moo-Kyung Oh http://orcid.org/0000-0002-2011-5708 REFERENCES 1.,Non-OADS,/arxiv_data1/oa_pdf/a8/08/jkms-30-1733.PMC4689816.pdf
• Building an Environment for Evidence-based Primary Care in Korea 1738  http://jkms.org http://dx.doi.org/10.3346/jkms.2015.30.12.1733gies to control them in Korea.,Non-OADS,/arxiv_data1/oa_pdf/a8/08/jkms-30-1733.PMC4689816.pdf
• Building an Environment for Evidence-based Primary Care in Korea http://jkms.org   1739 http://dx.doi.org/10.3346/jkms.2015.30.12.1733Table S1.,Non-OADS,/arxiv_data1/oa_pdf/a8/08/jkms-30-1733.PMC4689816.pdf
• Building an Environment for Evidence-based Primary Care in Korea 1740  http://jkms.org http://dx.doi.org/10.3346/jkms.2015.30.12.1733Table S1.,Non-OADS,/arxiv_data1/oa_pdf/a8/08/jkms-30-1733.PMC4689816.pdf
• Building an Environment for Evidence-based Primary Care in Korea http://jkms.org   1741 http://dx.doi.org/10.3346/jkms.2015.30.12.1733Table S1.,Non-OADS,/arxiv_data1/oa_pdf/a8/08/jkms-30-1733.PMC4689816.pdf
• Building an Environment for Evidence-based Primary Care in Korea 1742  http://jkms.org http://dx.doi.org/10.3346/jkms.2015.30.12.1733Table S1.,Non-OADS,/arxiv_data1/oa_pdf/a8/08/jkms-30-1733.PMC4689816.pdf
